Variant Annotation ID	Variant/Haplotypes	Drug(s)	Phenotype Category	Significance	Sentence	Allele Of Frequency In Cases	Allele Of Frequency In Controls	P Value	Ratio Stat Type	Ratio Stat	Confidence Interval Start	Confidence Interval Stop
1451307925	rs9839376	ritodrine	Efficacy	yes	Genotype CC is associated with decreased response to ritodrine as compared to genotypes CT + TT.			< 0.05	HR	2.68	1.16	6.2
1451307920	rs7624046	ritodrine	Efficacy	yes	Genotype TT is associated with decreased response to ritodrine as compared to genotypes CC + CT.			< 0.05	HR	2.06	1.14	3.73
1451161780	rs1045642	methadone	Dosage	no	Allele G is not associated with dose of methadone in people with Opioid-Related Disorders as compared to allele A.			= 0.828				
1449716734	rs1128503	fentanyl	Dosage	yes	Genotype AA is associated with increased dose of fentanyl in women with Pain, Postoperative as compared to genotypes AG + GG.	A		< 0.05	OR			
1451151724	rs3812718	phenytoin	Efficacy	no	Allele T is not associated with resistance to phenytoin in people with Epilepsy as compared to allele C.			= 0.34				
1451151829	rs6313	risperidone	Efficacy	yes	Genotypes AA + AG are associated with increased response to risperidone in people with Schizophrenia as compared to genotype GG.	A		= 0.05				
1451151848	rs6313	olanzapine	Efficacy	yes	Genotypes AG + GG are associated with increased response to olanzapine in people with Schizophrenia as compared to genotype AA.	G		= 0.03				
1451151860	rs6313	olanzapine	Efficacy	yes	Genotypes AA + AG are associated with increased response to olanzapine in people with Schizophrenia as compared to genotype GG.	G		= 0.046				
1451341440	rs1042713	salmeterol	Efficacy	yes	Allele G is associated with increased response to salmeterol in children Asthma as compared to allele A.	G		= 0.044				
1451341447	rs1042714	salmeterol	Efficacy	no	Allele G is not associated with increased response to salmeterol in children Asthma as compared to allele C.	G		= 0.955				
1451164700	rs4149056	rosuvastatin	Efficacy	no	Genotypes CC + CT are associated with response to rosuvastatin as compared to genotype TT.			> 0.05				
1451164700	rs4149056	rosuvastatin	Efficacy	no	Genotypes CC + CT are associated with response to rosuvastatin as compared to genotype TT.			> 0.05				
1451164800	rs2231142	rosuvastatin	Efficacy	no	Genotypes GT + TT are not associated with response to rosuvastatin as compared to genotype GG.			> 0.05				
1451339660	rs10011796	allopurinol	Efficacy	no	Allele T is not associated with decreased response to allopurinol in people with Gout as compared to allele C.			= 0.689	OR	1.063	0.789	1.431
1451339600	rs2231142	allopurinol	Efficacy	yes	Allele T is associated with decreased response to allopurinol in people with Gout as compared to allele G.			< 0.001	OR	2.424	1.71	3.436
1451340046	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.							
1451340140	rs2884737	warfarin	Dosage	yes	Genotypes AC + CC are associated with decreased dose of warfarin as compared to genotype AA.							
1451158300	rs199944431	methylphenidate	Dosage	no	Genotype CG is not associated with dose of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype CC.	G			OR			
1451158369	rs1555511231	methylphenidate	Efficacy	no	Genotype CT is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype TT.	C			OR			
1451158440	rs147055479	methylphenidate	Dosage	no	Genotype GG is not associated with dose of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes AA + AG.	A			OR			
1451158360	rs1555511231	methylphenidate	Dosage	no	Genotype CT is not associated with dose of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype TT.	C			OR			
1451158401	rs199944431	methylphenidate	Efficacy	no	Genotype CG is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype CC.	G			OR			
1449192125	rs113993960	lumacaftor	Efficacy	yes	Genotype del/del is associated with response to lumacaftor.			< 0.05	OR			
1451347680	rs16969968	combination nicotine replacement therapy	Efficacy	yes	Genotype GG is associated with increased response to combination nicotine replacement therapy in people with Tobacco Use Disorder.			= 0.029				
1451347701	rs16969968	varenicline	Efficacy	yes	Genotypes AA + AG are associated with increased response to varenicline in people with Tobacco Use Disorder.			= 0.0014				
1184753725	rs1799971	morphine	Dosage	no	Genotypes AG + GG is not associated with increased dose of morphine in infants as compared to genotype AA.			= 0.096	OR			
1447984881	rs78655421	ivacaftor	Efficacy	not stated	Genotype AG is associated with response to ivacaftor in women with Cystic Fibrosis.				OR			
1451351843	rs1799971	naltrexone	Efficacy	no	Allele G is not associated with response to naltrexone in people with Alcoholism as compared to allele A.							
1451352200	rs1799971	sufentanil	Dosage	yes	Genotype AG is associated with increased dose of sufentanil in people with Pain, Postoperative as compared to genotype AA.	G		< 0.01				
1451352241	rs1045642	sufentanil	Dosage	no	Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele G.	G		> 0.05				
1451352281	rs2032582	sufentanil	Dosage	no	Allele C is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele A.	A		> 0.05				
1447981017	rs113993960	ivacaftor	Efficacy	yes	Allele del is associated with increased response to ivacaftor in people with Cystic Fibrosis.			< 0.05	OR			
1451352861	rs2273697	atorvastatin	Efficacy	yes	Genotype AG is associated with decreased response to atorvastatin in healthy individuals as compared to genotype GG.			= 0.023				
1451353640	rs1799971	naltrexone	Efficacy	not stated	Genotype AG is associated with increased response to naltrexone in men with hypersexuality state and Parkinson Disease.							
1451354452	rs6010717	methadone	Dosage	no	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.			= 0.6041				
1451354470	rs933271	methadone	Dosage	no	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.			= 0.5294				
1451354446	rs1997794	methadone	Dosage	no	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.			= 0.2069				
1451354160	rs17078877	methadone	Dosage	no	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.			= 0.8363				
1451354268	rs211105	methadone	Dosage	no	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.			= 0.8532				
1451354380	rs2285907	methadone	Dosage	no	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.			= 0.9924				
1451354349	rs1487275	methadone	Dosage	no	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.			= 0.0638				
1451354458	rs7271530	methadone	Dosage	no	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.			= 0.7233				
1451354420	rs910080	methadone	Dosage	no	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.			= 0.636				
1451354488	rs174699	methadone	Dosage	no	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.			= 0.4838				
1451354482	rs5993882	methadone	Dosage	no	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.			= 0.2717				
1451354166	rs2067011	methadone	Dosage	no	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.			= 0.9473				
1451354281	rs7305115	methadone	Dosage	no	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.			= 0.1196				
1451353780	rs806368	methadone	Dosage	yes	Genotypes CT + TT are associated with increased dose of methadone in people with Heroin Dependence as compared to genotype CC.	T		< 0.0001				
1451353806	rs1386493	methadone	Dosage	yes	Genotype GG is associated with increased dose of methadone in people with Heroin Dependence as compared to genotype AG.	A		= 0.0277				
1183697996	rs776746	tacrolimus	Dosage	yes	Genotypes CT + TT are associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to genotype CC.	T		< 0.001	OR			
1451353817	rs2229205	methadone	Dosage	yes	Genotype CT is associated with increased dose of methadone in people with Heroin Dependence as compared to genotype CC.	C		= 0.0433				
1451353812	rs16974799	methadone	Dosage	yes	Genotype CT is associated with increased dose of methadone in people with Heroin Dependence as compared to genotype CC.	T		= 0.0035				
1451354800	rs4149056	simvastatin	Efficacy	not stated	Genotypes CC + CT are associated with decreased response to simvastatin as compared to genotype TT.			= 0.26			-0.47	-0.05
1451354845	rs4149056	atorvastatin	Efficacy	no	Genotypes CC + CT is not associated with decreased response to atorvastatin in people with Dyslipidaemia as compared to genotype TT.			= 0.212	OR			
1184514552	rs776746	tacrolimus	Dosage	yes	Genotypes CT + TT is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to genotype CC.			< 0.05	OR			
1451354923	rs4149056	simvastatin	Efficacy	yes	Allele C is associated with decreased response to simvastatin as compared to genotype TT.			= 0.038				
1451355040	rs4149056	simvastatin	Efficacy	yes	Genotypes CC + CT are associated with decreased response to simvastatin as compared to genotype TT.			= 5e-8			-1.57	-0.74
1451355120	rs4149056	simvastatin	Efficacy	yes	Genotypes CC + CT are associated with decreased response to simvastatin.			= 0.0153	OR			
1451356341	rs11265549	methadone	Dosage	yes	Genotype AA is associated with decreased dose of methadone in people with Opioid-Related Disorders as compared to genotypes AG + GG.	A		= 0.0003				
1451221900	rs9923231	warfarin	Dosage	yes	Genotype AA is associated with increased dose of warfarin in people with Atrial Fibrillation as compared to genotypes AG + GG.	G		< 0.001				
1451221840	rs2260863	warfarin	Dosage	yes	Genotype CC is associated with decreased dose of warfarin in people with Atrial Fibrillation as compared to genotype CG.	G		= 0.026				
1451356707	rs17561	sufentanil	Dosage	no	Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele C.	A		= 0.179				
1451356727	rs16944	sufentanil	Dosage	no	Allele G is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele A.	A		= 0.372				
1451356739	rs4073	sufentanil	Dosage	no	Allele T is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele A.	A		= 0.802				
1451221905	rs1057910	warfarin	Dosage	yes	Genotype AC is associated with decreased dose of warfarin in people with Atrial Fibrillation as compared to genotype AA.	C		= 0.003				
1451356757	rs1800896	sufentanil	Dosage	no	Allele C is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele T.	C		= 0.141				
1451356787	rs842647	sufentanil	Dosage	no	Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele G.	A		= 0.456				
1451356800	rs8904	sufentanil	Dosage	no	Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele G.	A		= 0.052				
1451356805	rs696	sufentanil	Dosage	yes	Genotype TT is associated with increased dose of sufentanil in people with Pain, Postoperative as compared to genotypes CC + CT.	T		= 0.025				
1451357220	rs4149056	rosuvastatin	Efficacy	yes	Genotypes CC + CT are associated with decreased response to rosuvastatin as compared to genotype TT.			= 7.7e-5	OR			
1451356940	rs1437153	anastrozole	Efficacy	yes	Allele T is associated with decreased response to anastrozole in women with Breast Neoplasms as compared to allele G.			= 2.82E-9				
1451356980	rs6981827	anastrozole	Efficacy	yes	Allele T is associated with decreased response to anastrozole in women with Breast Neoplasms as compared to allele C.			= 2.02E-8				
1451356971	rs2449598	anastrozole	Efficacy	yes	Allele T is associated with decreased response to anastrozole in women with Breast Neoplasms as compared to allele G.			= 2.23E-10				
1451359472	rs1611114	methadone	Dosage	no	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	C		= 0.841	OR	0.976	0.774	1.233
1183689393	rs9923231	warfarin	Dosage	yes	Genotype TT is associated with decreased dose of warfarin as compared to genotypes CC + CT.	T		< 0.04	OR			
1451359106	rs10064525	heroin	Efficacy	no	Allele G is not associated with response to heroin as compared to allele T.	G		= 0.286	OR	0.734	0.416	1.297
1451359340	rs10064525	heroin	Dosage	no	Allele G is not associated with dose of heroin in people with Heroin Dependence as compared to allele T.	G		= 0.482	OR	0.856	0.555	1.321
1451359100	rs1611114	heroin	Efficacy	no	Allele T is not associated with response to heroin as compared to allele C.	C		= 0.485	OR	1.092	0.852	1.4
1451359274	rs1611114	heroin	Dosage	no	Allele T is not associated with dose of heroin in people with Heroin Dependence as compared to allele C.	C		= 0.545	OR	1.066	0.867	1.309
1451359481	rs10064525	methadone	Dosage	no	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	G		= 0.210	OR	1.363	0.838	2.215
1448255689	rs9923231	phenprocoumon	Dosage	yes	Genotypes CT + TT are associated with decreased dose of phenprocoumon as compared to genotype CC.			< 0.0001	OR			
1451359111	rs10770140	heroin	Efficacy	no	Allele T is not associated with response to heroin as compared to allele C.	C		= 0.047	OR			
1448275984	rs2108622	warfarin	Dosage	yes	Genotype CC is associated with decreased dose of warfarin as compared to genotype TT.	T		= 0.0501	OR			
1450370810	rs2108622	warfarin	Dosage	no	Allele T is not associated with dose of warfarin as compared to allele C.			= 0.31	OR			
1450370810	rs2108622	warfarin	Dosage	no	Allele T is not associated with dose of warfarin as compared to allele C.			= 0.48	OR			
1451359140	rs27072	heroin	Efficacy	no	Allele T is not associated with response to heroin as compared to allele C.	T		= 0.172	OR	1.206	0.921	1.579
1451359240	rs10770141	heroin	Efficacy	no	Allele G is not associated with response to heroin as compared to allele A.	A		= 0.035	OR			
1451359336	rs129882	heroin	Dosage	no	Allele T is not associated with dose of heroin in people with Heroin Dependence as compared to allele C.	T		= 0.697	OR	0.96	0.782	1.178
1451359149	rs129882	heroin	Efficacy	no	Allele T is not associated with response to heroin as compared to allele C.	T		= 0.797	OR	1.033	0.806	1.323
1451359247	rs3842727	heroin	Efficacy	no	Allele T is not associated with response to heroin as compared to allele G.	G		= 0.956	OR	0.982	0.526	1.835
1451359269	rs5320	heroin	Efficacy	no	Allele A is not associated with response to heroin as compared to allele G.	A		= 0.246	OR	1.216	0.873	1.692
1451359440	rs11575553	heroin	Dosage	no	Allele A is not associated with dose of heroin in people with Heroin Dependence as compared to allele G.	A		= 0.230	OR	0.831	0.614	1.125
1447682783	rs1142345	mercaptopurine	Dosage	yes	Genotype CT is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype TT.	T		= 0.034	OR			
1451359160	rs6347	heroin	Efficacy	no	Allele C is not associated with response to heroin as compared to allele T.	C		= 0.696	OR	1.074	0.75	1.539
1451359200	rs12666409	heroin	Efficacy	no	Allele A is not associated with response to heroin as compared to allele T.	A		= 0.801	OR	0.97	0.764	1.231
1451359260	rs11575553	heroin	Efficacy	no	Allele A is not associated with response to heroin as compared to allele G.	A		= 0.724	OR	0.935	0.646	1.354
1451359460	rs129915	heroin	Dosage	no	Allele G is not associated with dose of heroin in people with Heroin Dependence as compared to allele A.	G		= 0.672	OR	1.044	0.857	1.271
1451359252	rs6356	heroin	Efficacy	no	Allele T is not associated with response to heroin as compared to allele C.	T		= 0.974	OR	0.995	0.711	1.391
1451359265	rs129915	heroin	Efficacy	no	Allele G is not associated with response to heroin as compared to allele A.	G		= 0.179	OR	1.178	0.928	1.795
1451359432	rs6356	heroin	Dosage	no	Allele T is not associated with dose of heroin in people with Heroin Dependence as compared to allele C.	T		= 0.401	OR	0.888	0.673	1.172
1451390700	rs4149056	atorvastatin	Efficacy	no	Genotypes CC + CT is not associated with decreased response to atorvastatin in children with familial hypercholesterolemia as compared to genotype TT.			> 0.05	OR			
1451390620	rs4149056	atorvastatin	Efficacy	yes	Genotypes CC + CT is associated with decreased response to atorvastatin as compared to genotype TT.			< 0.00001				
1451228860	rs4149056	simvastatin	Efficacy	no	Genotypes CC + CT are not associated with response to simvastatin in people with Hypercholesterolemia as compared to genotype TT.			> 0.05				
1448601898	rs11178998	venlafaxine	Efficacy	no	Allele A is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele G.			= 0.009	OR	1.16	0.64	2.12
1448601887	rs11178997	venlafaxine	Efficacy	no	Allele A is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele T.			= 0.009	OR	1.09	0.63	1.88
1449716014	rs3845744	fentanyl	Dosage	no	Allele C is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele T.			= 0.792	OR			
1183701330	rs9934438	warfarin	Dosage	not stated	Allele A is associated with decreased dose of warfarin as compared to allele G.				OR			
1449716020	rs268214	fentanyl	Dosage	no	Allele C is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele T.			= 0.480	OR			
1448601874	rs1800532	venlafaxine	Efficacy	no	Allele G is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele T.			= 0.009	OR	0.8	0.57	1.13
1450813798	rs7164594	varenicline	Efficacy	yes	Genotypes CT + TT are associated with increased response to varenicline in people with Tobacco Use Disorder as compared to genotype CC.	T		= 0.0019	OR	1.76	1.23	2.52
1451354464	rs2020917	methadone	Dosage	no	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.			= 0.4437				
1449716026	rs1982235	fentanyl	Dosage	no	Allele G is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele T.			= 0.967	OR			
1448601868	rs9567746	venlafaxine	Efficacy	no	Allele A is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele G.			= 0.009	OR	1.04	0.69	1.57
1448601857	rs6311	venlafaxine	Efficacy	no	Allele C is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele T.			= 0.009	OR	0.74	0.54	1.03
1449716072	rs1799971	fentanyl	Efficacy	yes	Genotypes AG + GG are associated with increased response to fentanyl in women with Pain as compared to genotype AA.	A		= 0.012	OR			
1448601851	rs2274639	venlafaxine	Efficacy	no	Allele C is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele G.			= 0.009	OR	0.89	0.54	1.46
1449191784	rs193922525	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			< 0.0001	OR			
1451354440	rs2235751	methadone	Dosage	no	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.			= 0.9561				
1448601840	rs6296	venlafaxine	Efficacy	no	Allele C is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele G.			= 0.009	OR	1.05	0.73	1.52
1449191796	rs121909013	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			< 0.0001	OR			
1448601834	rs130058	venlafaxine	Efficacy	no	Allele A is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele T.			= 0.009	OR	1.12	0.77	1.63
1448601828	rs11568817	venlafaxine	Efficacy	no	Allele C is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele A.			= 0.009	OR	0.99	0.71	1.36
1448601816	rs6295	venlafaxine	Efficacy	no	Allele C is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele G.			= 0.009	OR	1.0	0.72	1.4
1449191818	rs74503330	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			< 0.0001	OR			
1448601808	rs25531	venlafaxine	Efficacy	no	Allele C is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele T.			= 0.009	OR	1.23	0.91	1.66
1450813804	rs8109525	bupropion	Efficacy	yes	Genotype GG is associated with increased response to bupropion in people with Tobacco Use Disorder as compared to genotypes AA + AG.	G		= 0.0008	OR	1.78	1.27	2.5
1449191831	rs121908755	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			< 0.0001	OR			
1451354476	rs174675	methadone	Dosage	no	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.			= 0.5383				
1449191837	rs121908757	ivacaftor	Efficacy	yes	Allele C is associated with response to ivacaftor in people with Cystic Fibrosis.			< 0.0001	OR			
1450944900	rs1801253	atenolol	Efficacy	yes	Allele C is associated with increased response to atenolol in healthy individuals as compared to allele G.			= 0.03				
1449191843	rs121909005	ivacaftor	Efficacy	yes	Allele G is associated with response to ivacaftor in people with Cystic Fibrosis.			< 0.0001	OR			
1185012207	rs2032582	cyclosporine	Dosage	yes	Genotypes AC + CC is associated with increased dose of cyclosporine in people with Kidney Transplantation as compared to genotypes AA + CT.	C		< 0.05	OR			
1185012234	rs2032582	cyclosporine	Dosage	yes	Genotypes AC + CC is associated with decreased dose-adjusted trough concentrations of cyclosporine in people with Kidney Transplantation as compared to genotypes AA + CT.	C		< 0.05	OR			
1449732574	rs776746	tacrolimus	Dosage	yes	Genotype CC is associated with decreased dose of tacrolimus in people with Colitis, Ulcerative as compared to genotypes CT + TT.	T		< 0.0001	OR			
1449716194	rs13093031	fentanyl	Efficacy	yes	Genotype GG is associated with increased response to fentanyl in people with Pain, Postoperative as compared to genotypes AA + AG.			= 1E-7	OR			
1185012251	rs4646437	cyclosporine	Efficacy	yes	Genotypes AG + GG is associated with increased response to cyclosporine in people with Kidney Transplantation as compared to genotype AA.	G		= 0.034	OR			
1449732581	rs776746	tacrolimus	Dosage	yes	Genotype CC is associated with increased dose-adjusted trough concentrations of tacrolimus in people with Colitis, Ulcerative as compared to genotypes CT + TT.	T		< 0.0001	OR			
1449716201	rs6961071	fentanyl	Efficacy	yes	Genotype GG is associated with increased response to fentanyl in people with Pain, Postoperative as compared to genotypes AA + AG.			= 2E-7	OR			
1450371553	rs396991	tocilizumab	Efficacy	yes	Genotype AA is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes AC + CC.	A		= 0.027	OR	5.075	1.2	21.33
1450371553	rs396991	tocilizumab	Efficacy	yes	Genotype AA is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes AC + CC.	A		= 0.149	OR			
1450371553	rs396991	tocilizumab	Efficacy	yes	Genotype AA is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes AC + CC.	A		= 0.223	OR			
1450371553	rs396991	tocilizumab	Efficacy	yes	Genotype AA is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes AC + CC.	A		= 0.257	OR			
1450371553	rs396991	tocilizumab	Efficacy	yes	Genotype AA is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes AC + CC.	A		= 0.304	OR			
1450371553	rs396991	tocilizumab	Efficacy	yes	Genotype AA is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes AC + CC.	A		= 0.398	OR			
1450371553	rs396991	tocilizumab	Efficacy	yes	Genotype AA is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes AC + CC.	A		= 0.473	OR			
1450371553	rs396991	tocilizumab	Efficacy	yes	Genotype AA is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes AC + CC.	A		= 0.744	OR			
1450371553	rs396991	tocilizumab	Efficacy	yes	Genotype AA is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes AC + CC.	A		= 0.749	OR			
1450371553	rs396991	tocilizumab	Efficacy	yes	Genotype AA is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes AC + CC.	A		= 0.858	OR			
1450371553	rs396991	tocilizumab	Efficacy	yes	Genotype AA is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes AC + CC.	A		= 1	OR			
1450371553	rs396991	tocilizumab	Efficacy	yes	Genotype AA is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes AC + CC.	A		= 1	OR			
1450813969	rs4680	modafinil	Efficacy	no	Genotype GG is not associated with response to modafinil in people with methamphetamine dependence as compared to allele A.			> 0.01				
1447946341	rs1045642	tacrolimus	Dosage	yes	Genotype AA is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to genotype AG.	A		= 0.042	OR			
1450928668	rs1799971	naltrexone	Efficacy	no	Allele G is not associated with response to naltrexone as compared to allele A.			= 0.41				
1450928668	rs1799971	naltrexone	Efficacy	no	Allele G is not associated with response to naltrexone as compared to allele A.			= 0.47				
1450928668	rs1799971	naltrexone	Efficacy	no	Allele G is not associated with response to naltrexone as compared to allele A.			= 0.47				
1450928668	rs1799971	naltrexone	Efficacy	no	Allele G is not associated with response to naltrexone as compared to allele A.			= 0.84				
1450813982	rs1799971	modafinil	Efficacy	no	Allele G is not associated with response to modafinil in people with methamphetamine dependence as compared to allele A.			> 0.01				
1449732592	rs776746	tacrolimus	Dosage	yes	Genotype CC is associated with increased trough concentration of tacrolimus in people with Colitis, Ulcerative as compared to genotypes CT + TT.	T		< 0.0001	OR			
1450371578	rs1801274	rituximab	Efficacy	yes	Genotype AA is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	A		= 0.025	OR		0.19	2.63
1450371578	rs1801274	rituximab	Efficacy	yes	Genotype AA is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	A		= 0.035	OR	4.861	1.11	21.12
1450371578	rs1801274	rituximab	Efficacy	yes	Genotype AA is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	A		= 0.044	OR	10.625	1.07	105.47
1450371578	rs1801274	rituximab	Efficacy	yes	Genotype AA is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	A		= 0.066	OR	4.667	0.9	24.12
1450371578	rs1801274	rituximab	Efficacy	yes	Genotype AA is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	A		= 0.098	OR		-0.15	1.71
1450371578	rs1801274	rituximab	Efficacy	yes	Genotype AA is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	A		= 0.136	OR			
1450371578	rs1801274	rituximab	Efficacy	yes	Genotype AA is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	A		= 0.197	OR			
1450371578	rs1801274	rituximab	Efficacy	yes	Genotype AA is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	A		= 0.233	OR			
1450371578	rs1801274	rituximab	Efficacy	yes	Genotype AA is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	A		= 0.357	OR	2.487	0.35	17.31
1450371578	rs1801274	rituximab	Efficacy	yes	Genotype AA is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	A		= 1	OR			
1450371578	rs1801274	rituximab	Efficacy	yes	Genotype AA is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	A		= 1	OR			
1450371578	rs1801274	rituximab	Efficacy	yes	Genotype AA is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	A		= 1	OR			
1183701528	rs2108622	warfarin	Dosage	yes	Allele C is associated with decreased dose of warfarin in people with venous thromboembolism as compared to allele T.	T		< 0.0002	OR			
1183701524	rs9923231	warfarin	Dosage	yes	Allele T is associated with decreased dose of warfarin in people with venous thromboembolism as compared to allele C.	A		< 0.0001	OR			
1450928634	rs1799971	ethanol	Other	no	Allele G is not associated with dose of ethanol as compared to allele A.			= 0.21				
1450928634	rs1799971	ethanol	Other	no	Allele G is not associated with dose of ethanol as compared to allele A.			= 0.26				
1450928634	rs1799971	ethanol	Other	no	Allele G is not associated with dose of ethanol as compared to allele A.			= 0.52				
1450928634	rs1799971	ethanol	Other	no	Allele G is not associated with dose of ethanol as compared to allele A.			= 0.96				
1448601657	rs2046934	clopidogrel	Efficacy	yes	Genotype AA is associated with increased response to clopidogrel in people with Coronary Disease as compared to genotypes AG + GG.	G		< 0.05	OR			
1448601648	rs7428575	clopidogrel	Efficacy	no	Allele G is not associated with response to clopidogrel in people with Coronary Disease as compared to allele T.	G		> 0.05	OR			
1449716295	rs1128503	fentanyl	Efficacy	yes	Genotype AA is associated with decreased response to fentanyl in people with Neoplasms and Pain as compared to genotypes AG + GG.	G		= 0.036	OR	0.17	0.03	0.89
1185012360	rs1045642	tacrolimus	Dosage	no	Genotype AA is not associated with concentrations of tacrolimus in children with liver transplantation.			> 0.05	OR			
1185012354	rs2032582	tacrolimus	Dosage	no	Genotype TT is not associated with concentrations of tacrolimus in children with liver transplantation.			> 0.05	OR			
1450928686	rs1799971	ethanol	Other	yes	Genotypes AG + GG are associated with decreased dose of ethanol as compared to genotype AA.			= 0.02				
1450043998	rs35068180	pravastatin	Efficacy	yes	Genotypes A/del + AA are associated with increased response to pravastatin in men with Coronary Artery Disease.			= 0.04	OR	0.46	0.19	1.14
1449716341	rs1045642	fentanyl	Efficacy	no	Genotype AA is associated with decreased response to fentanyl in people with Neoplasms and Pain as compared to genotypes AG + GG.	A		= 0.14	OR	5.21	0.58	46.99
1449192081	rs397508442	ivacaftor	Efficacy	not stated	Allele T is associated with response to ivacaftor in people with Cystic Fibrosis.				OR			
1449192093	rs75527207	ivacaftor	Efficacy	not stated	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.				OR			
1450814162	rs1799971	ethanol	Dosage	yes	Allele G is associated with increased dose of ethanol in children as compared to allele A.			= 0.045				
1449192136	rs80034486	lumacaftor	Efficacy	no	Allele G is not associated with response to lumacaftor.				OR			
1450814181	rs671531	highly active antiretroviral therapy (haart)	Efficacy	yes	Genotype GG is associated with decreased response to highly active antiretroviral therapy (haart) in people with HIV Infections as compared to genotypes AA + AG.			= 0.0252				
1450814181	rs671531	highly active antiretroviral therapy (haart)	Efficacy	yes	Genotype GG is associated with decreased response to highly active antiretroviral therapy (haart) in people with HIV Infections as compared to genotypes AA + AG.			= 0.2761				
1450814181	rs671531	highly active antiretroviral therapy (haart)	Efficacy	yes	Genotype GG is associated with decreased response to highly active antiretroviral therapy (haart) in people with HIV Infections as compared to genotypes AA + AG.			= 05724				
1448995530	rs8094439	methadone	Efficacy	yes	Genotype AA is associated with increased response to methadone as compared to genotypes AG + GG.	A		= 0.022	OR			
1449192131	rs121909047	lumacaftor	Efficacy	yes	Genotype AA is associated with response to lumacaftor.			< 0.05	OR			
1448995536	rs17446819	methadone	Efficacy	yes	Genotype CC is associated with increased response to methadone as compared to genotypes AA + AC.	C		= 0.025	OR			
1448617859	rs4148323	irinotecan	Efficacy	no	Allele A is not associated with response to irinotecan in people with Lung Neoplasms as compared to allele G.			= 0.22	OR	1.5	0.78	2.92
1448995554	rs1062613	granisetron	Efficacy	no	Genotype CC is not associated with response to granisetron in healthy individuals as compared to genotypes CT + TT.	C		= 0.364	OR			
1448995554	rs1062613	granisetron	Efficacy	no	Genotype CC is not associated with response to granisetron in healthy individuals as compared to genotypes CT + TT.	C		= 0.401	OR			
1448995554	rs1062613	granisetron	Efficacy	no	Genotype CC is not associated with response to granisetron in healthy individuals as compared to genotypes CT + TT.	C		= 0.708	OR			
1448995554	rs1062613	granisetron	Efficacy	no	Genotype CC is not associated with response to granisetron in healthy individuals as compared to genotypes CT + TT.	C		= 0.718	OR			
1448995554	rs1062613	granisetron	Efficacy	no	Genotype CC is not associated with response to granisetron in healthy individuals as compared to genotypes CT + TT.	C		= 0.724	OR			
1448995554	rs1062613	granisetron	Efficacy	no	Genotype CC is not associated with response to granisetron in healthy individuals as compared to genotypes CT + TT.	C		= 0.810	OR			
1448995554	rs1062613	granisetron	Efficacy	no	Genotype CC is not associated with response to granisetron in healthy individuals as compared to genotypes CT + TT.	C		= 0.948	OR			
1448995554	rs1062613	granisetron	Efficacy	no	Genotype CC is not associated with response to granisetron in healthy individuals as compared to genotypes CT + TT.	C		= 0.965	OR			
1447520081	rs9934438	warfarin	Dosage	no	Genotypes AG + GG are not associated with decreased dose of warfarin as compared to genotype AA.			= 0.05	OR			
1448995581	rs1176744	granisetron	Efficacy	no	Genotype AA is not associated with response to granisetron in healthy individuals as compared to genotypes AC + CC.	A		= 0.149	OR			
1448995581	rs1176744	granisetron	Efficacy	no	Genotype AA is not associated with response to granisetron in healthy individuals as compared to genotypes AC + CC.	A		= 0.249	OR			
1448995581	rs1176744	granisetron	Efficacy	no	Genotype AA is not associated with response to granisetron in healthy individuals as compared to genotypes AC + CC.	A		= 0.321	OR			
1448995581	rs1176744	granisetron	Efficacy	no	Genotype AA is not associated with response to granisetron in healthy individuals as compared to genotypes AC + CC.	A		= 0.433	OR			
1448995581	rs1176744	granisetron	Efficacy	no	Genotype AA is not associated with response to granisetron in healthy individuals as compared to genotypes AC + CC.	A		= 0.464	OR			
1448995581	rs1176744	granisetron	Efficacy	no	Genotype AA is not associated with response to granisetron in healthy individuals as compared to genotypes AC + CC.	A		= 0.804	OR			
1448995581	rs1176744	granisetron	Efficacy	no	Genotype AA is not associated with response to granisetron in healthy individuals as compared to genotypes AC + CC.	A		= 0.848	OR			
1448995581	rs1176744	granisetron	Efficacy	no	Genotype AA is not associated with response to granisetron in healthy individuals as compared to genotypes AC + CC.	A		= 0.924	OR			
1448257356	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.			= 0.01	OR			
1447520074	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.			< 0.00001	OR			
1183849199	rs2032582	paroxetine	Efficacy	no	Allele A is not associated with response to paroxetine in people with Depressive Disorder, Major as compared to allele C.				OR			
1449749318	rs186364861	mercaptopurine	Dosage	yes	Allele A is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.			= 0.004	HR	3.09	1.42	7.72
982044493	rs11269124	clonidine	Efficacy	yes	Genotypes GGGGAGCTTTCCCAGAGACCC/del + del/del are associated with increased response to clonidine in people with Liver Cirrhosis as compared to genotype GGGGAGCTTTCCCAGAGACCC/GGGGAGCTTTCCCAGAGACCC.			= 0.013	OR	3.87	2.27	33.12
1449192282	rs1799853	warfarin	Dosage	yes	Genotype CT is associated with decreased dose of warfarin as compared to genotype CC.			= 0.001	OR			
1449192282	rs1799853	warfarin	Dosage	yes	Genotype CT is associated with decreased dose of warfarin as compared to genotype CC.			= 0.001	OR			
1449749328	rs116855232	mercaptopurine	Dosage	yes	Allele T is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.			= 5.24E-9	HR	5.08	2.94	8.76
982044485	rs5443	clonidine	Efficacy	yes	Genotypes CT + TT are associated with increased response to clonidine in people with Liver Cirrhosis as compared to genotype CC.			< 0.001	OR	4.54	1.54	21.93
1449192290	rs1057910	warfarin	Dosage	yes	Genotype AC is associated with decreased dose of warfarin as compared to genotype AA.			= 0.001	OR			
1449192290	rs1057910	warfarin	Dosage	yes	Genotype AC is associated with decreased dose of warfarin as compared to genotype AA.			= 0.001	OR			
1448257253	rs2288344	warfarin	Dosage	yes	Allele G is associated with increased dose of warfarin as compared to allele T.	G		= 3.96e-8	OR			
1448257237	rs17126068	warfarin	Dosage	yes	Allele G is associated with decreased dose of warfarin as compared to allele A.	G		= 4.14e-8	OR			
1447519925	rs9923231	warfarin	Dosage	yes	Allele T is associated with decreased dose of warfarin as compared to allele C.			= 8.3e-10	OR			
1448126131	rs1051266	methotrexate	Efficacy	yes	Genotype CT is associated with decreased response to methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype TT.	C		= 0.0463	HR	3.8	1.39	10.0
1447519944	rs2359612	warfarin	Dosage	yes	Allele A is associated with decreased dose of warfarin as compared to allele G.			= 8.3e-10	OR			
1450371982	rs1799971	ethanol	Toxicity	no	Allele G is not associated with response to ethanol in healthy individuals as compared to allele A.			= 0.621	OR			
1450371982	rs1799971	ethanol	Toxicity	no	Allele G is not associated with response to ethanol in healthy individuals as compared to allele A.			= 0.700	OR			
1450371982	rs1799971	ethanol	Toxicity	no	Allele G is not associated with response to ethanol in healthy individuals as compared to allele A.			= 0.938	OR			
1450371982	rs1799971	ethanol	Toxicity	no	Allele G is not associated with response to ethanol in healthy individuals as compared to allele A.			= 0.991	OR			
1447519938	rs2860905	warfarin	Dosage	yes	Allele A is associated with decreased dose of warfarin as compared to allele G.			= 8.3e-10	OR			
1448617649	rs3212185	metformin	Efficacy	no	Genotype CT is not associated with response to metformin as compared to genotype CC.			= 0.03	OR			
1447519932	rs1057910	warfarin	Dosage	yes	Allele C is associated with decreased dose of warfarin as compared to allele A.			= 2.55e-05	OR			
1184472053	rs3093105	vitamin e	Efficacy	no	Allele C is not associated with response to vitamin e in people with hepatic steatosis as compared to allele A.	C		> 0.05	OR			
1184472053	rs3093105	vitamin e	Efficacy	no	Allele C is not associated with response to vitamin e in people with hepatic steatosis as compared to allele A.	C		> 0.05	OR			
1448617627	rs11868513	metformin	Efficacy	yes	Genotypes AA + AG are associated with increased response to metformin as compared to genotype GG.			= 0.002	OR			
1448617627	rs11868513	metformin	Efficacy	yes	Genotypes AA + AG are associated with increased response to metformin as compared to genotype GG.			= 0.008	OR			
1448617616	rs11086926	metformin	Efficacy	no	Genotype GG is not associated with response to metformin as compared to genotypes GT + TT.			= 0.83	OR			
1449716700	rs4818	fentanyl	Dosage	no	Allele C is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele G.	G		= 0.148	OR			
1449716700	rs4818	fentanyl	Dosage	no	Allele C is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele G.	G		= 0.207	OR			
1183685564	rs12708954	atomoxetine	Efficacy	yes	Allele A is associated with increased response to atomoxetine in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.			< 0.01	OR	3.1	1.4	6.9
1183685564	rs12708954	atomoxetine	Efficacy	yes	Allele A is associated with increased response to atomoxetine in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.			> 0.05	OR			
1449716707	rs4680	fentanyl	Dosage	no	Allele A is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele G.	A		= 0.228	OR			
1449716707	rs4680	fentanyl	Dosage	no	Allele A is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele G.	A		= 0.784	OR			
1448617603	rs6719578	metformin	Efficacy	yes	Genotype CG is associated with increased response to metformin as compared to genotype GG.			= 0.0002	OR			
1450814388	rs1801133	l-methylfolate	Efficacy	not stated	Genotype AG is associated with increased response to l-methylfolate in men with Bipolar Disorder, Depression and Obsessive-Compulsive Disorder.							
1447945867	rs2237897	gliclazide	Efficacy	no	Allele T is not associated with response to gliclazide in people with Diabetes Mellitus, Type 2 as compared to allele C.				OR			
1449716684	rs6269	fentanyl	Dosage	no	Allele A is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele G.	G		= 0.150	OR			
1449716684	rs6269	fentanyl	Dosage	no	Allele A is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele G.	G		= 0.422	OR			
1448257142	rs3815455	warfarin	Dosage	no	Genotypes CT + TT is not associated with dose of warfarin as compared to genotype CC.			= 0.186	OR			
1450814400	rs1801131	l-methylfolate	Efficacy	not stated	Genotype GT is associated with increased response to l-methylfolate in children with Depressive Disorder, Major.							
1448257131	rs10239977	warfarin	Dosage	no	Genotypes CT + TT is not associated with dose of warfarin as compared to genotype CC.			= 0.83	OR			
1448257121	rs41301394	warfarin	Dosage	yes	Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.			< 0.001	OR			
1447945831	rs2237897	gliclazide	Efficacy	yes	Genotypes CT + TT are associated with increased response to gliclazide in people with Diabetes Mellitus, Type 2 as compared to genotype CC.			= 0.006	OR			
1447945831	rs2237897	gliclazide	Efficacy	yes	Genotypes CT + TT are associated with increased response to gliclazide in people with Diabetes Mellitus, Type 2 as compared to genotype CC.			< 0.05	OR			
1449192458	rs121908757	ivacaftor	Efficacy	not stated	Allele C is associated with response to ivacaftor in children with Cystic Fibrosis.				OR			
1448257102	rs2108622	warfarin	Dosage	yes	Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.			< 0.001	OR			
1449192465	rs121909005	ivacaftor	Efficacy	not stated	Allele G is associated with response to ivacaftor in children with Cystic Fibrosis.				OR			
1447945779	rs1072388	clozapine	Efficacy	no	Genotypes AA + AG are associated with increased response to clozapine in people with Schizophrenia as compared to genotype GG.	G		= 0.067	OR			
1449192494	rs75527207	ivacaftor	Efficacy	not stated	Allele A is associated with response to ivacaftor in children with Cystic Fibrosis.				OR			
1448995913	rs7574865	etanercept	Efficacy	yes	Allele T is associated with decreased response to etanercept in people with Arthritis, Rheumatoid as compared to allele G.	T		= 0.02	OR	0.14	0.03	0.73
1448995921	rs7574865	adalimumab	Efficacy	no	Allele T is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to allele G.	T		= 0.53	OR	0.58	0.11	3.16
1450814517	rs1800497	ethanol	Dosage	yes	Allele A is associated with increased dose of ethanol in children as compared to allele G.	A		= 0.018				
1184472218	rs2032582	fluoxetine	Efficacy	yes	Allele A is associated with increased response to fluoxetine in children with Depressive Disorder as compared to allele C.			< 0.05	OR			
1448995927	rs33980500	adalimumab	Efficacy	no	Allele T is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.	T		= 0.16	OR	0.16	0.02	1.57
1450814522	rs1799971	ethanol	Dosage	yes	Allele G is associated with increased dose of ethanol in children as compared to allele A.	G		< 0.001				
1450373239	rs3192723	methadone	Efficacy	no	Genotype CC is associated with decreased response to methadone in people with Heroin Dependence as compared to genotypes CT + TT.	C		= 0.03	OR			
1450373239	rs3192723	methadone	Efficacy	no	Genotype CC is associated with decreased response to methadone in people with Heroin Dependence as compared to genotypes CT + TT.	C		= 0.4	OR	1.24	0.75	2.06
1448125943	rs1967309	dalcetrapib	Efficacy	yes	Genotype AA is associated with increased response to dalcetrapib in people with as compared to genotype GG.	A		= 0.004	OR			
1448995949	rs33980500	etanercept	Efficacy	no	Allele T is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele C.	T		= 1	OR			
982032418	rs4358872	methadone	Dosage	no	Genotype GG is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes GT + TT.			= 0.019	OR	1.695	0.88	3.266
1450814610	rs363225	bupropion	Efficacy	yes	Genotype CC is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CT + TT.	C		= 0.008				
1450814625	rs17614642	bupropion	Efficacy	yes	Genotype TT is associated with decreased response to bupropion in people with Depressive Disorder, Major as compared to genotype CT.	C		= 0.027				
1448995977	rs7234029	etanercept	Efficacy	no	Allele G is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele A.	G		= 0.86	OR	0.88	0.22	3.5
1448256969	rs6785930	ticagrelor	Efficacy	no	Genotype GG is associated with decreased response to ticagrelor in healthy individuals as compared to genotype AG.	A		= 0.035	OR			
1448633799	rs854560	clopidogrel	Efficacy	no	Allele A is not associated with response to clopidogrel as compared to allele T.			= 0.466	OR			
1448125884	rs67376798	fluorouracil	Efficacy	no	Genotype AT is not associated with response to fluorouracil in people with Colonic Neoplasms as compared to genotype TT.	A		= 0.89	HR	0.95	0.5	1.84
1449192603	rs78655421	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			< 0.01	OR			
1448256957	rs6787801	ticagrelor	Efficacy	no	Genotype AG is associated with decreased response to ticagrelor in healthy individuals as compared to genotype AA.	G		= 0.052	OR			
1450814583	rs2770296	bupropion	Efficacy	yes	Genotype CC is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CT + TT.	C		= 0.018				
1447519665	rs9934438	warfarin	Dosage	yes	Genotypes AA + AG are associated with decreased dose of warfarin as compared to genotype GG.			< 0.005	OR			
1447519665	rs9934438	warfarin	Dosage	yes	Genotypes AA + AG are associated with decreased dose of warfarin as compared to genotype GG.			< 0.01	OR			
1448633787	rs5918	clopidogrel	Efficacy	no	Allele C is not associated with response to clopidogrel as compared to allele T.			= 0.518	OR			
1450814589	rs8075924	bupropion	Efficacy	yes	Genotype TT is associated with decreased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CC + CT.	T		= 0.01				
1449192615	rs75527207	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			< 0.001	OR			
1449192615	rs75527207	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			= 0.011	OR			
1449192615	rs75527207	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			= 0.035	OR			
1450814595	rs2873804	bupropion	Efficacy	yes	Genotype CC is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CT + TT.	T		= 0.008				
1450814601	rs6347	bupropion	Efficacy	no	Genotype TT is not associated with decreased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CC + CT.	C		= 0.108				
1447519677	rs8050894	warfarin	Dosage	yes	Genotypes CG + GG are associated with decreased dose of warfarin as compared to genotype CC.			< 0.01	OR			
1447519677	rs8050894	warfarin	Dosage	yes	Genotypes CG + GG are associated with decreased dose of warfarin as compared to genotype CC.			= 0.15	OR			
1448633764	rs1045642	clopidogrel	Efficacy	no	Allele A is not associated with response to clopidogrel as compared to allele G.			= 0.581	OR			
982044907	rs5443	atenolol	Efficacy	yes	Genotype CC is associated with increased response to atenolol in people with Essential hypertension as compared to genotypes CT + TT.			< 0.001				
982044907	rs5443	atenolol	Efficacy	yes	Genotype CC is associated with increased response to atenolol in people with Essential hypertension as compared to genotypes CT + TT.			< 0.001				
1446765943	rs1800566	warfarin	Dosage	yes	Genotype AA is associated with decreased dose of warfarin as compared to genotypes AG + GG.			= 0.029	OR			
981848236	rs4680	venlafaxine	Efficacy	yes	Genotypes AA + AG are associated with increased response to venlafaxine in people with Anxiety Disorders as compared to genotype GG.	A		= 0.036	OR	3.26		
981848236	rs4680	venlafaxine	Efficacy	yes	Genotypes AA + AG are associated with increased response to venlafaxine in people with Anxiety Disorders as compared to genotype GG.	A		= 0.251	OR	1.71		
1448633725	rs1267067	adalimumab	Efficacy	yes	Genotype CC is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.	C		= 0.008951	OR	1.719	1.145	2.581
1448633712	rs1126535	adalimumab	Efficacy	yes	Allele T is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.	C		= 0.006627	OR	1.871	1.19	2.942
1444699419	rs1778929	clozapine	Efficacy	no	Genotype TT is associated with decreased response to clozapine in people with Schizophrenia as compared to genotypes CC + CT.			= 0.032	OR			
1448633699	rs25648	adalimumab	Efficacy	yes	Allele T is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.	T		= 0.003902	OR	2.571	1.354	4.883
1444668728	rs1800629	etanercept	Efficacy	yes	Genotypes AG + GG is associated with increased response to etanercept in people with Arthritis, Rheumatoid as compared to genotype AA.	A		= 0.001	OR			
1444668728	rs1800629	etanercept	Efficacy	yes	Genotypes AG + GG is associated with increased response to etanercept in people with Arthritis, Rheumatoid as compared to genotype AA.	A		= 0.018	OR			
1448633692	rs2230926	adalimumab	Efficacy	yes	Allele T is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to allele G.	G		= 0.003733	OR	5.395	1.727	16.86
1444668735	rs1800629	infliximab	Efficacy	no	Genotypes AG + GG is not associated with response to infliximab in people with Arthritis, Rheumatoid as compared to genotype AA.	A		= 0.179	OR			
1444668735	rs1800629	infliximab	Efficacy	no	Genotypes AG + GG is not associated with response to infliximab in people with Arthritis, Rheumatoid as compared to genotype AA.	A		= 0.769	OR			
1444668744	rs361525	etanercept	Efficacy	no	Genotype AG is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to genotype GG.	A		= 0.424	OR			
1444668744	rs361525	etanercept	Efficacy	no	Genotype AG is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to genotype GG.	A		= 0.586	OR			
1448568141	rs10995	hydrochlorothiazide	Efficacy	yes	Genotypes AG + GG are associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype AA.			< 3e-4	OR			
1444668751	rs361525	infliximab	Efficacy	yes	Genotype GG is associated with increased response to infliximab in people with Arthritis, Rheumatoid as compared to genotype AG.	A		= 0.03	OR			
1444668751	rs361525	infliximab	Efficacy	yes	Genotype GG is associated with increased response to infliximab in people with Arthritis, Rheumatoid as compared to genotype AG.	A		= 0.09	OR			
1449192721	rs75527207	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			= 0.002	OR			
1449192721	rs75527207	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			= 0.006	OR			
1449192721	rs75527207	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			= 0.014	OR			
1449192721	rs75527207	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			= 0.020	OR			
1449192721	rs75527207	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			= 0.05	OR			
1449192721	rs75527207	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			= 0.280	OR			
1449192721	rs75527207	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			= 0.408	OR			
1184226554	rs5522	enalapril	Efficacy	yes	Genotype TT is associated with increased response to enalapril in people with Hypertension as compared to genotypes CC + CT.	T		= 0.003	OR			
1184472429	rs9934438	warfarin	Dosage	yes	Allele A is associated with decreased dose of warfarin as compared to allele G.			< 0.001	OR			
1184472436	rs2359612	warfarin	Dosage	yes	Allele A is associated with decreased dose of warfarin as compared to allele G.			< 0.001	OR			
1449192774	rs121908755	ivacaftor	Efficacy	not stated	Allele A is associated with response to ivacaftor in children with Cystic Fibrosis.				OR			
1184472447	rs7294	warfarin	Dosage	yes	Allele T is associated with increased dose of warfarin as compared to allele C.			< 0.001	OR			
1451126120	rs2229109	temozolomide	Efficacy	not stated	Genotype CT is associated with decreased response to temozolomide in people with Glioma as compared to genotype CC.	T		= 0.012				
1451126120	rs2229109	temozolomide	Efficacy	not stated	Genotype CT is associated with decreased response to temozolomide in people with Glioma as compared to genotype CC.	T		= 0.085				
1451126120	rs2229109	temozolomide	Efficacy	not stated	Genotype CT is associated with decreased response to temozolomide in people with Glioma as compared to genotype CC.			= 0.19				
1183680176	rs295114	salbutamol	Efficacy	no	Allele C is not associated with response to salbutamol in children with Asthma as compared to allele T.			= 0.73	OR			
1448126187	rs1801133	methotrexate	Efficacy	no	Genotype AG is not associated with response to methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG.	A		= 0.379	HR	0.74	0.52	1.1
1447945457	rs78060119	fluorouracil	Efficacy	no	Genotype CC is not associated with response to fluorouracil in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AA + AC.	A		> 0.05	OR			
1448568038	rs2010963	pazopanib	Efficacy	yes	Allele G is associated with decreased response to pazopanib in people with Carcinoma, Renal Cell as compared to allele C.	C		= 0.03	OR			
1448568032	rs699947	pazopanib	Efficacy	yes	Allele A is associated with decreased response to pazopanib in people with Carcinoma, Renal Cell as compared to allele C.	A		= 0.02	OR			
1184505152	rs4570625	citalopram	Efficacy	no	Genotypes GT + TT is associated with increased response to citalopram in children with Depressive Disorder as compared to genotype GG.			> 0.05	OR			
1184472389	rs2108622	warfarin	Dosage	no	Allele T is not associated with dose of warfarin as compared to allele C.			= 0.15	OR			
1447945405	rs3918290	fluorouracil	Efficacy	yes	Genotype CC is associated with increased response to fluorouracil in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CT.	T		= 0.02	OR			
1451126126	rs1128503	temozolomide	Efficacy	no	Allele A is not associated with response to temozolomide in people with Glioma as compared to allele G.			= 0.405				
1184472404	rs2189784	warfarin	Dosage	no	Allele A is not associated with dose of warfarin as compared to allele G.			= 0.49	OR			
1184472408	rs2290228	warfarin	Dosage	no	Allele A is not associated with dose of warfarin as compared to allele G.			= 0.16	OR			
1447945413	rs1801160	fluorouracil	Efficacy	no	Genotype CT is not associated with response to fluorouracil in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.	T		= 0.341	OR			
1184472412	rs11676382	warfarin	Dosage	no	Allele C is not associated with dose of warfarin as compared to allele G.			= 0.80	OR			
1447814319	rs67376798	fluorouracil	Toxicity	not stated	Genotype AT is associated with increased exposure to fluorouracil in women with Colonic Neoplasms.				OR			
1447945392	rs1801265	fluorouracil	Efficacy	yes	Genotype AA is associated with increased response to fluorouracil in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG.	G		= 0.005	OR			
1184472416	rs61742245	warfarin	Dosage	no	Allele A is not associated with dose of warfarin as compared to allele C.			= 0.27	OR			
1451126143	rs2032582	temozolomide	Efficacy	no	Allele T is not associated with response to temozolomide in people with Glioma as compared to allele A.			= 0.614				
1184472420	rs17708472	warfarin	Dosage	no	Allele A is not associated with dose of warfarin as compared to allele G.			= 0.27	OR			
1184472424	rs9923231	warfarin	Dosage	yes	Allele T is associated with decreased dose of warfarin as compared to allele C.			< 0.001	OR			
1451126149	rs1045642	temozolomide	Efficacy	no	Allele A is not associated with response to temozolomide in people with Glioma as compared to allele G.			= 0.745				
1446765769	rs3745274	bupropion	Efficacy	no	Allele T is not associated with response to bupropion in people with Tobacco Use Disorder.		T	= 0.10	OR	0.62	0.35	1.09
1448256681	rs8192675	metformin	Efficacy	yes	Allele C is associated with increased response to metformin in people with Diabetes Mellitus as compared to allele T.			= 2.6e-8	OR			
1450814947	rs1799971	ethanol	Toxicity	yes	Allele G is associated with increased response to ethanol in people with Alcoholism as compared to allele A.			= 0.05				
1450814947	rs1799971	ethanol	Toxicity	yes	Allele G is associated with increased response to ethanol in people with Alcoholism as compared to allele A.			< 0.05				
1450814947	rs1799971	ethanol	Toxicity	yes	Allele G is associated with increased response to ethanol in people with Alcoholism as compared to allele A.			< 0.05				
1444668552	rs1800629	etanercept	Efficacy	yes	Genotype GG is associated with increased response to etanercept in people with Arthritis, Rheumatoid as compared to genotype AG.	A		= 0.005	OR			
1444668552	rs1800629	etanercept	Efficacy	yes	Genotype GG is associated with increased response to etanercept in people with Arthritis, Rheumatoid as compared to genotype AG.	A		= 0.0057	OR			
1444668552	rs1800629	etanercept	Efficacy	yes	Genotype GG is associated with increased response to etanercept in people with Arthritis, Rheumatoid as compared to genotype AG.	A		= 0.027	OR			
1444668552	rs1800629	etanercept	Efficacy	yes	Genotype GG is associated with increased response to etanercept in people with Arthritis, Rheumatoid as compared to genotype AG.	A		= 0.098	OR			
1450814898	rs1801282	pioglitazone	Efficacy	yes	Genotype CG is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotype CC.	G		= 0.010				
1450814898	rs1801282	pioglitazone	Efficacy	yes	Genotype CG is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotype CC.	G		= 0.015				
1450814898	rs1801282	pioglitazone	Efficacy	yes	Genotype CG is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotype CC.	G		= 0.132				
1450814898	rs1801282	pioglitazone	Efficacy	yes	Genotype CG is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotype CC.	G		= 0.260				
1450814898	rs1801282	pioglitazone	Efficacy	yes	Genotype CG is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotype CC.	G		= 0.539				
1450814898	rs1801282	pioglitazone	Efficacy	yes	Genotype CG is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotype CC.	G		= 0.580				
1450814898	rs1801282	pioglitazone	Efficacy	yes	Genotype CG is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotype CC.	G		= 0.830				
1449733611	rs61747221	hydrochlorothiazide	Efficacy	yes	Genotypes AA + AG is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype GG.	A		= 0.02	OR			
1449733611	rs61747221	hydrochlorothiazide	Efficacy	yes	Genotypes AA + AG is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype GG.	A		= 0.02	OR			
1449733611	rs61747221	hydrochlorothiazide	Efficacy	yes	Genotypes AA + AG is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype GG.	A		= 0.04	OR			
1449733611	rs61747221	hydrochlorothiazide	Efficacy	yes	Genotypes AA + AG is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype GG.	A		= 0.05	OR			
1450814910	rs17584499	pioglitazone	Efficacy	yes	Genotype CC is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotypes CT + TT.			= 0.005				
1450814910	rs17584499	pioglitazone	Efficacy	yes	Genotype CC is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotypes CT + TT.			= 0.130				
1450814910	rs17584499	pioglitazone	Efficacy	yes	Genotype CC is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotypes CT + TT.			= 0.303				
1450814910	rs17584499	pioglitazone	Efficacy	yes	Genotype CC is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotypes CT + TT.			= 0.400				
1450814910	rs17584499	pioglitazone	Efficacy	yes	Genotype CC is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotypes CT + TT.			= 0.530				
1450814910	rs17584499	pioglitazone	Efficacy	yes	Genotype CC is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotypes CT + TT.			= 0.830				
1450814910	rs17584499	pioglitazone	Efficacy	yes	Genotype CC is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotypes CT + TT.			= 0.857				
1450814990	rs6688363	olanzapine	Efficacy	yes	Allele T is associated with decreased response to olanzapine in people with Schizophrenia as compared to allele C.	T		= 1.59E-07				
1450814996	rs8050896	risperidone	Efficacy	yes	Allele T is associated with increased response to risperidone in people with Schizophrenia as compared to allele A.	T		= 3.85E-08				
1450815009	rs2980976	risperidone	Efficacy	yes	Allele A is associated with decreased response to risperidone in people with Schizophrenia as compared to allele G.	A		= 2.97E-07				
1184472513	rs662	clopidogrel	Efficacy	no	Allele C is not associated with response to clopidogrel in people with Acute coronary syndrome as compared to allele T.			= 0.8	OR			
1450373158	rs562859	methadone	Efficacy	no	Genotype TT is not associated with response to methadone in people with Heroin Dependence as compared to genotypes CC + CT.	C		> 0.05	OR			
1450373158	rs562859	methadone	Efficacy	no	Genotype TT is not associated with response to methadone in people with Heroin Dependence as compared to genotypes CC + CT.	C		> 0.05	OR			
1450815015	rs2636697	risperidone	Efficacy	yes	Allele G is associated with decreased response to risperidone in people with Schizophrenia as compared to allele A.	G		= 3.68E-07				
1444668512	rs1800629	adalimumab	Efficacy	yes	Genotype GG is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to genotype AG.	A		= 0.04	OR			
1444668512	rs1800629	adalimumab	Efficacy	yes	Genotype GG is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to genotype AG.	A		= 0.05	OR			
1451126280	rs616147	creatine	Efficacy	yes	Genotypes AA + AG are associated with increased response to creatine in people with Amyotrophic Lateral Sclerosis as compared to genotype GG.	A		= 0.015	HR	0.48	0.22	1.07
1450815058	rs17742120	quetiapine	Efficacy	yes	Allele G is associated with increased response to quetiapine in people with Schizophrenia as compared to allele A.	G		= 1.58E-07				
1447519253	rs112445441	cetuximab	Efficacy	no	Allele T is not associated with increased response to cetuximab in people with Colorectal Neoplasms.				OR			
1450372675	rs7905446	paroxetine	Efficacy	yes	Genotype TT is associated with decreased response to paroxetine in people with Bipolar Disorder as compared to genotypes GG + GT.			= 0.005	OR	5.25		
1450815067	rs2164660	quetiapine	Efficacy	yes	Allele A is associated with increased response to quetiapine in people with Schizophrenia as compared to allele G.	A		= 1.87E-07				
1444668415	rs1800629	infliximab	Efficacy	yes	Genotype GG is associated with increased response to infliximab in people with Arthritis, Rheumatoid as compared to genotype AG.	A		< 0.01	OR			
1450815073	rs711355	risperidone	Efficacy	yes	Allele T is associated with increased response to risperidone in people with Schizophrenia as compared to allele C.	T		= 2.25E-07				
1450815079	rs785423	risperidone	Efficacy	yes	Allele A is associated with increased response to risperidone in people with Schizophrenia as compared to allele G.	A		= 4.86E-07				
1450815024	rs2636719	risperidone	Efficacy	yes	Allele A is associated with decreased response to risperidone in people with Schizophrenia as compared to allele C.	A		= 5.05E-07				
1450372715	rs7905446	escitalopram	Efficacy	yes	Genotype TT is associated with decreased response to escitalopram in people with Depression as compared to genotypes GG + GT.			= 0.008	OR	1.669		
1450815030	rs7395555	risperidone	Efficacy	yes	Allele C is associated with increased response to risperidone in people with Schizophrenia as compared to allele G.	C		= 1.98E-07				
1448125427	rs1801159	capecitabine	Efficacy	yes	Genotypes CC + CT are associated with increased response to capecitabine in people with gastroesophageal cancer as compared to genotype TT.	C		= 0.03	OR			
1450815036	rs10170310	olanzapine	Efficacy	yes	Allele C is associated with decreased response to olanzapine in people with Schizophrenia as compared to allele A.	G		= 1.03E-07				
1445297534	rs1045642	tacrolimus	Other	no	Genotype AA is not associated with discontinuation of tacrolimus in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	A		> 0.05	OR			
1450815045	rs17382202	quetiapine	Efficacy	yes	Allele T is associated with increased response to quetiapine in people with Schizophrenia as compared to allele C.	T		= 4.21E-08				
1446847493	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT is associated with decreased dose of warfarin as compared to genotype CC.			< 0.001	OR			
1444668343	rs1799964	etanercept	Efficacy	no	Allele C is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele T.			= 0.72	OR	0.65	0.16	2.6
1444668343	rs1799964	etanercept	Efficacy	no	Allele C is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele T.				OR	0.53	0.17	1.64
1444668343	rs1799964	etanercept	Efficacy	no	Allele C is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele T.				OR	1.1	0.38	3.4
981502615	rs13064530	clozapine	Efficacy	no	Allele G is not associated with response to clozapine in people with Schizophrenia as compared to allele A.	A		= 0.6461	OR	2.6	1.05	6.37
1444668354	rs1800630	etanercept	Efficacy	no	Allele C is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele A.			= 0.7	OR	0.67	0.15	3.1
1444668354	rs1800630	etanercept	Efficacy	no	Allele C is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele A.				OR	0.53	0.15	1.81
1444668354	rs1800630	etanercept	Efficacy	no	Allele C is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele A.				OR	1.2	0.35	3.9
1450372722	rs7905446	nortriptyline	Efficacy	no	Genotype TT is not associated with response to nortriptyline in people with Depression as compared to genotypes GG + GT.			= 0.154	OR	0.694		
1444668362	rs1041981	etanercept	Efficacy	no	Allele C is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele A.			= 1.0	OR	0.92	0.29	2.9
1444668362	rs1041981	etanercept	Efficacy	no	Allele C is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele A.				OR	0.84	0.33	2.2
1444668362	rs1041981	etanercept	Efficacy	no	Allele C is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele A.				OR	1.1	0.47	2.5
981502629	rs4938013	clozapine	Efficacy	no	Allele C is not associated with response to clozapine in people with Schizophrenia as compared to allele A.	A		= 0.6479	OR	2.49	1.01	6.14
1448262090	rs2229193	methylphenidate	Efficacy	no	Genotype CC is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype CT.	C		= 0.691	OR	1.62	0.15	17.49
1450815085	rs813676	risperidone	Efficacy	yes	Allele T is associated with increased response to risperidone in people with Schizophrenia as compared to allele C.	T		= 4.91E-07				
1444668370	rs361525	etanercept	Efficacy	no	Allele A is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele G.			= 1.0	OR	0.7	0.04	12.0
1444668370	rs361525	etanercept	Efficacy	no	Allele A is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele G.				OR	0.66	0.07	6.2
1444668370	rs361525	etanercept	Efficacy	no	Allele A is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele G.				OR	1.0	0.11	9.3
1451110120	rs1051266	methotrexate	Efficacy	no	Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.			= 0.889				
1184472851	rs9923231	warfarin	Dosage	yes	Genotype TT is associated with decreased dose of warfarin in children as compared to genotypes CC + CT.			< 0.001	OR			
1446896503	rs16846673	clopidogrel	Efficacy	no	Genotype TT is not associated with decreased response to clopidogrel as compared to genotype CC.			= 0.009	OR			
1448567673	rs2189784	warfarin	Dosage	yes	Genotypes AG + GG are associated with increased dose of warfarin in people with heart valve replacement as compared to genotype AA.			< 0.05	OR			
1446896509	rs6809699	clopidogrel	Efficacy	no	Genotype AA is not associated with decreased response to clopidogrel as compared to genotype CC.			= 0.009	OR			
1446896521	rs6785930	clopidogrel	Efficacy	no	Genotype AA is not associated with decreased response to clopidogrel as compared to genotype GG.			= 0.009	OR			
1448567667	rs2260863	warfarin	Dosage	yes	Genotype CG is associated with increased dose of warfarin in people with heart valve replacement as compared to genotype CC.			< 0.05	OR			
1448567661	rs7412	warfarin	Dosage	yes	Genotype CC is associated with decreased dose of warfarin in people with heart valve replacement as compared to genotype CT.			< 0.05	OR			
1451110160	rs1045642	methotrexate	Efficacy	no	Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G.			= 0.706				
1450372874	rs3746544	methylphenidate	Efficacy	no	Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.			> 0.05	OR			
1448567655	rs28371759	warfarin	Dosage	yes	Genotype AA are associated with decreased dose of warfarin in people with heart valve replacement as compared to genotype AG.			< 0.05	OR			
1448567649	rs2069514	warfarin	Dosage	yes	Genotype GG are associated with decreased dose of warfarin in people with heart valve replacement as compared to genotype AA.			< 0.05	OR			
1446896476	rs1045642	clopidogrel	Efficacy	yes	Genotype AA is associated with decreased response to clopidogrel as compared to genotypes AG + GG.			= 0.009	OR	2.39		
1448567630	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT are associated with decreased dose of warfarin in people with heart valve replacement as compared to genotype CC.			< 0.01	OR			
1444668242	rs1800629	infliximab	Efficacy	yes	Genotype GG is associated with increased response to infliximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.	A		= 0.0086	OR	1.93		
1444668242	rs1800629	infliximab	Efficacy	yes	Genotype GG is associated with increased response to infliximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.	A		= 0.029	OR			
1448567620	rs12488654	rituximab	Efficacy	no	Genotype GG is not associated with response to rituximab in people with Lymphoma, Follicular as compared to genotypes AA + AG.			= 0.36	OR			
1451110126	rs7499	methotrexate	Efficacy	no	Allele G is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele A.			= 0.598				
1451110132	rs2838956	methotrexate	Efficacy	no	Allele G is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele A.			= 0.666				
1448567608	rs2230229	rituximab	Efficacy	no	Genotype TT is not associated with response to rituximab in people with Lymphoma, Follicular as compared to genotypes CC + CT.			= 0.110	OR			
1448567593	rs20576	rituximab	Efficacy	no	Genotype TT is not associated with response to rituximab in people with Lymphoma, Follicular as compared to genotypes GG + GT.			= 0.803	OR			
1450372933	rs1051312	methylphenidate	Efficacy	no	Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.				OR			
1450372926	rs3746544	methylphenidate	Efficacy	no	Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.				OR			
1448567570	rs20575	rituximab	Efficacy	no	Genotype GG is not associated with response to rituximab in people with Lymphoma, Follicular as compared to genotypes CC + CG.			= 0.064	OR			
1450372908	rs1051312	methylphenidate	Efficacy	no	Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.			= 0.05	OR			
1444668176	rs1800629	etanercept	Efficacy	yes	Genotype GG is associated with increased response to etanercept in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.			< 0.05	OR			
1444668176	rs1800629	etanercept	Efficacy	yes	Genotype GG is associated with increased response to etanercept in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.			= 0.33	OR			
748042563	rs13120400	methotrexate	Efficacy	yes	Genotype CC is associated with increased response to methotrexate in people with Psoriasis as compared to genotypes CT + TT.			= 0.03	OR	1.8		
1444668195	rs1800896	etanercept	Efficacy	yes	Genotype CC is associated with increased response to etanercept in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.			< 0.05	OR			
1444668195	rs1800896	etanercept	Efficacy	yes	Genotype CC is associated with increased response to etanercept in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.			= 0.22	OR			
1444668201	rs1800471	etanercept	Efficacy	yes	Genotype CG is associated with decreased response to etanercept in people with Arthritis, Rheumatoid as compared to genotype GG.			< 0.05	OR			
1444668201	rs1800471	etanercept	Efficacy	yes	Genotype CG is associated with decreased response to etanercept in people with Arthritis, Rheumatoid as compared to genotype GG.			= 1.0	OR			
1446896334	rs4149056	atorvastatin	Efficacy	no	Genotypes CC + CT is not associated with response to atorvastatin in people with Hypercholesterolemia as compared to genotype TT.	C			OR			
1449144201	rs6942227	lithium	Efficacy	yes	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.			= 8.45E-3	OR			
1447680330	rs5443	amlodipine	Efficacy	no	Genotype TT is not associated with response to amlodipine in people with Essential hypertension as compared to genotypes CC + CT.	C		= 0.627	OR			
1447682776	rs116855232	mercaptopurine	Dosage	yes	Allele T is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.	C		< 0.0001	OR			
1450979180	rs9923231	warfarin	Dosage	yes	Allele A is associated with decreased dose of warfarin in people with total knee or hip arthroplasty as compared to allele G.			= 0.018	OR			
1449144207	rs1611259	lithium	Efficacy	yes	Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.			= 9.92E-3	OR			
1449144219	rs61123830	lithium	Efficacy	yes	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.			= 2.60E-3	OR			
1449144213	rs59724122	lithium	Efficacy	yes	Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.			= 7.21E-3	OR			
1449144225	rs7959663	lithium	Efficacy	yes	Allele C is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.			= 2.06E-4	OR			
1184472932	rs7089580	warfarin	Dosage	yes	Allele T is associated with decreased dose of warfarin in children as compared to allele A.			= 0.020	OR			
1449144231	rs66486766	lithium	Efficacy	yes	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.			= 4.95E-3	OR			
1446896327	rs2306283	atorvastatin	Efficacy	yes	Genotypes AG + GG is associated with increased response to atorvastatin in people with Hypercholesterolemia as compared to genotype AA.	G		= 0.02	OR			
1449144238	rs7405404	lithium	Efficacy	yes	Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.			= 5.27E-3	OR			
1450979280	rs7294	warfarin	Dosage	yes	Allele T is associated with decreased dose of warfarin as compared to allele C.			< 0.05	OR			
982043600	rs776746	amlodipine	Efficacy	no	Genotype TT is not associated with response to amlodipine in people with Hypertension as compared to genotypes CC + CT.			= 0.06	HR	0.6	0.35	1.02
982043600	rs776746	amlodipine	Efficacy	no	Genotype TT is not associated with response to amlodipine in people with Hypertension as compared to genotypes CC + CT.			= 0.95	HR	0.99	0.6	1.61
1449144244	rs6728642	lithium	Efficacy	yes	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.			= 1.34E-4	OR			
1449144256	rs7588746	lithium	Efficacy	yes	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.			= 6.33E-3	OR			
1444668038	rs1800629	infliximab	Efficacy	no	Allele A is not associated with response to infliximab in people with Crohn Disease as compared to allele G.	G		> 0.05	OR			
1449144274	rs209474	lithium	Efficacy	yes	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.			= 3.41E-3	OR			
1447682688	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.			< 0.0001	OR			
1447682688	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.			= 0.007	OR			
1449144268	rs1611255	lithium	Efficacy	yes	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.			= 3.93E-3	OR			
1447813766	rs6314	olanzapine	Efficacy	yes	Genotype GG is associated with increased response to olanzapine in people with Schizophrenia as compared to genotypes AA + AG.			= 0.04	OR			
982043591	rs2740574	amlodipine	Efficacy	yes	Genotypes CT + TT are associated with increased response to amlodipine in women with Hypertension as compared to genotype CC.			= 0.02	HR	3.41	1.2	9.64
1447813735	rs1076560	olanzapine	Efficacy	yes	Genotypes AA + AC is associated with increased response to olanzapine in people with Schizophrenia as compared to genotype CC.			< 0.04	OR			
982043660	rs2740574	amlodipine	Efficacy	no	Genotypes CT + TT are not associated with response to amlodipine in men with Hypertension as compared to genotype CC.			= 0.51	HR	1.31	0.58	2.93
982043660	rs2740574	amlodipine	Efficacy	no	Genotypes CT + TT are not associated with response to amlodipine in men with Hypertension as compared to genotype CC.			= 0.832	HR	1.1	0.46	2.65
1447682637	rs116855232	mercaptopurine	Other	no	Genotypes CT + TT is not associated with discontinuation of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.	T		= 0.479	OR	1.48	0.57	3.85
982043687	rs2246709	amlodipine	Efficacy	no	Genotypes AG + GG are not associated with response to amlodipine in men with Hypertension as compared to genotype AA.			= 0.04	HR	2.22	1.03	4.79
982043687	rs2246709	amlodipine	Efficacy	no	Genotypes AG + GG are not associated with response to amlodipine in men with Hypertension as compared to genotype AA.			= 0.92	HR	0.82	0.46	1.85
1450979360	rs17708472	warfarin	Dosage	yes	Allele A is associated with increased dose of warfarin as compared to allele G.			< 0.05	OR			
1447682626	rs116855232	mercaptopurine	Dosage	yes	Genotypes CT + TT is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.	T		= 0.002	OR	5.08	1.84	14.03
1450373150	rs675026	methadone	Efficacy	no	Allele G is not associated with response to methadone in people with Heroin Dependence as compared to allele A.	A		= 0.24	OR	1.81	0.66	5.04
1450373150	rs675026	methadone	Efficacy	no	Allele G is not associated with response to methadone in people with Heroin Dependence as compared to allele A.	A		= 0.71	OR			
1448616510	rs3761548	methotrexate	Other	yes	Allele G is associated with decreased response to methotrexate in people with Psoriasis as compared to allele T.			= 0.003	OR	3.21	1.5	6.87
1448616510	rs3761548	methotrexate	Other	yes	Allele G is associated with decreased response to methotrexate in people with Psoriasis as compared to allele T.			= 0.004	OR	2.82	1.39	5.72
1450373190	rs2236258	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.	C		= 0.16	OR	1.4	0.88	2.2
1450373190	rs2236258	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.	C		= 0.25	OR			
982043737	rs776746	amlodipine	Efficacy	no	Genotype TT is not associated with response to amlodipine in women with Hypertension as compared to genotypes CC + CT.			= 0.649	HR	1.2	0.55	2.59
982043737	rs776746	amlodipine	Efficacy	no	Genotype TT is not associated with response to amlodipine in women with Hypertension as compared to genotypes CC + CT.			= 0.72	HR	1.16	0.52	2.6
1450373183	rs2236257	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele G.	C		= 0.8	OR	0.92	0.49	1.72
1450373183	rs2236257	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele G.	C		= 0.85	OR			
1449750599	rs558614	cetuximab	Efficacy	no	Allele A is not associated with response to cetuximab in people with Colorectal Neoplasms as compared to allele G.	G		> 0.05	OR			
1450373174	rs2236256	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele A.	A		= 0.33	OR	1.35	0.74	2.47
1450373174	rs2236256	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele A.	A		= 0.76	OR			
1447813645	rs78015114	lithium	Efficacy	yes	Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.			= 0.033	HR	3.814		
1449750580	rs2073498	cetuximab	Efficacy	no	Genotypes AA + AC is not associated with response to cetuximab in people with Colorectal Neoplasms as compared to genotype CC.	A		> 0.05	OR			
1447813652	rs74795342	lithium	Efficacy	yes	Allele G is associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.			= 0.03268	HR	3.8	1.1	13.0
1447813652	rs74795342	lithium	Efficacy	yes	Allele G is associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.			= 0.033	HR	3.814		
1447813659	rs75222709	lithium	Efficacy	yes	Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele G.			= 0.033	HR	3.812		
1450373168	rs6912029	methadone	Efficacy	no	Allele G is not associated with response to methadone in people with Heroin Dependence as compared to allele T.	T		= 0.14	OR			
1450373168	rs6912029	methadone	Efficacy	no	Allele G is not associated with response to methadone in people with Heroin Dependence as compared to allele T.	T		= 0.58	OR	1.14	0.71	1.83
1450373223	rs2032582	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.	C		= 0.71	OR	0.91	0.55	1.5
1450373223	rs2032582	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.	C		= 0.78	OR			
1447813633	rs79663003	lithium	Efficacy	yes	Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.			= 0.033	HR	3.814		
982043698	rs2246709	amlodipine	Efficacy	no	Genotypes AG + GG are not associated with response to amlodipine in women with Hypertension as compared to genotype AA.			= 0.05	HR	2.33	1.01	5.4
982043698	rs2246709	amlodipine	Efficacy	no	Genotypes AG + GG are not associated with response to amlodipine in women with Hypertension as compared to genotype AA.			= 0.46	HR	1.39	0.59	3.27
1450373217	rs1128503	methadone	Efficacy	no	Allele A is not associated with response to methadone in people with Heroin Dependence as compared to allele G.	G		= 0.56	OR			
1450373217	rs1128503	methadone	Efficacy	no	Allele A is not associated with response to methadone in people with Heroin Dependence as compared to allele G.	G		= 0.68	OR	0.9	0.54	1.48
1449750606	rs3811715	cetuximab	Efficacy	no	Genotype GG is not associated with response to cetuximab in people with Colorectal Neoplasms as compared to genotypes AA + AG.			> 0.05	OR			
1450373204	rs6902403	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.	T		= 0.47	OR			
1450373204	rs6902403	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.	T		= 0.87	OR	0.95	0.54	1.68
982043719	rs776746	amlodipine	Efficacy	no	Genotype TT is not associated with response to amlodipine in men with Hypertension as compared to genotypes CC + CT.			= 0.32	HR	0.73	0.38	1.38
982043719	rs776746	amlodipine	Efficacy	no	Genotype TT is not associated with response to amlodipine in men with Hypertension as compared to genotypes CC + CT.			= 0.66	HR	0.85	0.42	1.73
1450373211	rs1045642	methadone	Efficacy	no	Allele A is not associated with response to methadone in people with Heroin Dependence as compared to allele G.	A		= 0.59	OR	0.88	0.56	1.4
1450373211	rs1045642	methadone	Efficacy	no	Allele A is not associated with response to methadone in people with Heroin Dependence as compared to allele G.	A		= 0.73	OR			
1450373197	rs2236259	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.	T		= 0.05	OR	0.63	0.4	1.0
1450373197	rs2236259	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.	T		= 0.62	OR			
982043709	rs2246709	amlodipine	Efficacy	no	Genotypes AG + GG are not associated with response to amlodipine in people with Hypertension as compared to genotype AA.			= 0.34	HR	0.77	0.46	1.31
1450373248	rs56038477	capecitabine	Dosage	not stated	Genotype CT is associated with dose of capecitabine in people with Neoplasms.				OR			
1450373242	rs67376798	capecitabine	Dosage	not stated	Genotype AT is associated with dose of capecitabine in people with Neoplasms.				OR			
1450373232	rs3918290	capecitabine	Dosage	not stated	Genotype CT is associated with dose of capecitabine in people with Neoplasms.				OR			
1450979500	rs9934438	acenocoumarol	Dosage	not stated	Genotypes AA + AG is associated with decreased dose of acenocoumarol as compared to genotype GG.				OR			
1449259246	rs2108622	warfarin	Dosage	no	Allele T is associated with increased dose of warfarin as compared to allele C.			< 0.00001	OR			
1449259246	rs2108622	warfarin	Dosage	no	Allele T is associated with increased dose of warfarin as compared to allele C.			= 0.0002	OR			
1449259246	rs2108622	warfarin	Dosage	no	Allele T is associated with increased dose of warfarin as compared to allele C.			= 0.0003	OR			
1449750780	rs4261893	duloxetine	Efficacy	yes	Genotype TT is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotypes CC + CT.	T		= 0.005	OR			
1449750780	rs4261893	duloxetine	Efficacy	yes	Genotype TT is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotypes CC + CT.	T		= 0.006	OR			
1446895961	rs1801253	dobutamine	Efficacy	yes	Genotype CC is associated with increased response to dobutamine in healthy individuals as compared to genotype GG.			= 0.012	OR			
1446895961	rs1801253	dobutamine	Efficacy	yes	Genotype CC is associated with increased response to dobutamine in healthy individuals as compared to genotype GG.			= 0.032	OR			
1184473273	rs1051741	warfarin	Dosage	yes	Genotype CT is associated with decreased dose of warfarin as compared to genotype CC.			= 0.04	OR			
1449750794	rs2303377	duloxetine	Efficacy	yes	Genotype TT is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotypes CC + CT.	T		= 0.0003	OR			
1449750794	rs2303377	duloxetine	Efficacy	yes	Genotype TT is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotypes CC + CT.	T		= 0.038	OR			
1447682410	rs1127354	mercaptopurine	Dosage	no	Genotype CC is not associated with dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AA + AC.	C			OR			
1183703313	rs1876828	fluticasone propionate	Efficacy	yes	Allele T is associated with increased response to fluticasone propionate in people with Asthma as compared to allele C.	A		< 0.05	OR			
1447944531	rs1801274	adalimumab	Efficacy	yes	Allele A is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to allele G.	A		= 0.017	OR	1.53	1.08	2.17
1447682392	rs116855232	mercaptopurine	Dosage	yes	Genotypes CT + TT is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.	C		= 0.001	OR			
1447682392	rs116855232	mercaptopurine	Dosage	yes	Genotypes CT + TT is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.	C		= 0.001	OR			
1447682392	rs116855232	mercaptopurine	Dosage	yes	Genotypes CT + TT is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.	C		= 0.03	OR			
1447960897	rs1799732	nicotine	Efficacy	yes	Genotypes G/del + del/del is associated with increased response to nicotine in people with Tobacco Use Disorder as compared to genotype GG.			= 0.006	OR	0.44	0.25	0.79
1449750812	rs117986340	duloxetine	Efficacy	yes	Genotype GG is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotype GT.	T		= 1.9E-6	OR			
1183703293	rs739645	fluticasone propionate	Efficacy	yes	Allele G is associated with increased response to fluticasone propionate in people with Asthma as compared to allele T.	G		< 0.05	OR			
1183703305	rs1876831	fluticasone propionate	Efficacy	yes	Allele T is associated with increased response to fluticasone propionate in people with Asthma as compared to allele C.	T		< 0.05	OR			
1447960889	rs1799732	bupropion	Efficacy	yes	Genotype GG is associated with increased response to bupropion in people with Tobacco Use Disorder as compared to genotypes G/del + del/del.			= 0.01	OR	4.99	1.42	17.62
1449713980	rs1799971	fentanyl	Dosage	no	Allele G is not associated with dose of fentanyl in women with Pain, Postoperative as compared to allele A.	G			OR			
1183699298	rs1800544	methylphenidate	Efficacy	yes	Genotypes CG + GG are associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype CC.	C		= 0.001	OR			
1183699298	rs1800544	methylphenidate	Efficacy	yes	Genotypes CG + GG are associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype CC.	C		= 0.024	OR			
1448423713	rs6269	quetiapine	Efficacy	yes	Allele A is associated with decreased response to quetiapine in people with Schizophrenia as compared to allele G.			= 0.008	OR	1.938	1.307	2.873
1450811735	rs1461773	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	A		= 0.003				
1450811735	rs1461773	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	A		= 0.005				
1450811735	rs1461773	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	A		= 0.009				
1450811735	rs1461773	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	A		= 0.01				
1450811735	rs1461773	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	A		= 0.01				
1450811735	rs1461773	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	A		= 0.01				
1450811735	rs1461773	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	A		= 0.02				
1450811735	rs1461773	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	A		= 0.03				
1450811735	rs1461773	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	A		= 0.03				
1450811735	rs1461773	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	A		= 0.03				
1450811735	rs1461773	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	A		= 0.07				
1450811735	rs1461773	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	A		= 0.08				
1450811735	rs1461773	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	A		= 0.60				
1450811735	rs1461773	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	A		= 0.67				
1450811735	rs1461773	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	A		= 0.94				
1449714013	rs2032582	fentanyl	Dosage	no	Allele C is not associated with dose of fentanyl in women with Pain, Postoperative as compared to allele T.	A			OR			
1449714020	rs2032582	fentanyl	Dosage	no	Allele C is not associated with dose of fentanyl in women with Pain, Postoperative as compared to allele A.	A			OR			
1450811713	rs3778148	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele G.	T		= 0.000				
1450811713	rs3778148	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele G.	T		= 0.000				
1450811713	rs3778148	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele G.	T		= 0.001				
1450811713	rs3778148	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele G.	T		= 0.003				
1450811713	rs3778148	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele G.	T		= 0.003				
1450811713	rs3778148	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele G.	T		= 0.01				
1450811713	rs3778148	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele G.	T		= 0.01				
1450811713	rs3778148	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele G.	T		= 0.02				
1450811713	rs3778148	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele G.	T		= 0.02				
1450811713	rs3778148	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele G.	T		= 0.02				
1450811713	rs3778148	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele G.	T		= 0.09				
1450811713	rs3778148	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele G.	T		= 0.11				
1450811713	rs3778148	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele G.	T		= 0.39				
1450811713	rs3778148	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele G.	T		= 0.52				
1450811713	rs3778148	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele G.	T		= 0.92				
1449173340	rs2032582	morphine	Dosage	no	Allele T is not associated with dose of morphine in people with Pain, Postoperative as compared to allele C.	T		= 0.12	OR			
1449173340	rs2032582	morphine	Dosage	no	Allele T is not associated with dose of morphine in people with Pain, Postoperative as compared to allele C.	T		= 0.38	OR			
1451404160	rs7967354	rocuronium	Dosage	yes	Genotype CC is associated with decreased dose of rocuronium in women as compared to genotypes CT + TT.			= 5.302E-11				
1451404160	rs7967354	rocuronium	Dosage	yes	Genotype CC is associated with decreased dose of rocuronium in women as compared to genotypes CT + TT.			< 0.001				
1449714007	rs1045642	fentanyl	Dosage	no	Allele G is not associated with dose of fentanyl in women with Pain, Postoperative as compared to allele A.	A			OR			
1451404202	rs11045995	rocuronium	Dosage	yes	Genotype CC is associated with decreased dose of rocuronium in women as compared to genotypes CT + TT.			= 1.416E-10				
1451404202	rs11045995	rocuronium	Dosage	yes	Genotype CC is associated with decreased dose of rocuronium in women as compared to genotypes CT + TT.			< 0.001				
1448112349	rs772583466	succinylcholine	Efficacy	not stated	Genotype CT is associated with increased response to succinylcholine as compared to genotype CC.				OR			
1448112362	rs755648929	mivacurium	Efficacy	not stated	Genotype AG is associated with increased response to mivacurium as compared to genotype AA.				OR			
1448423646	rs177852	hydrochlorothiazide	Efficacy	yes	Genotypes CC + CT is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype TT.			= 1.43E-3	OR			
1450811804	rs648893	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.09				
1450811804	rs648893	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.28				
1450811804	rs648893	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.34				
1450811804	rs648893	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.37				
1450811804	rs648893	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.41				
1450811804	rs648893	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.42				
1450811804	rs648893	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.45				
1450811804	rs648893	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.50				
1450811804	rs648893	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.51				
1450811804	rs648893	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.60				
1450811804	rs648893	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.62				
1450811804	rs648893	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.78				
1450811804	rs648893	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.82				
1450811804	rs648893	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.82				
1450811804	rs648893	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.85				
1184747838	rs9370867	atorvastatin	Efficacy	yes	Genotype AA is associated with increased response to atorvastatin in people with Hypercholesterolemia as compared to genotypes AG + GG.			= 0.001	OR			
1448423632	rs7553527	hydrochlorothiazide	Efficacy	yes	Genotypes CC + CT is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype TT.			= 3.67E-5	OR			
1449566589	rs2165870	dexamethasone	Efficacy	not stated	Genotype AA is associated with increased response to dexamethasone in people with Postoperative Nausea and Vomiting as compared to genotypes AG + GG.	A			OR			
1184747846	rs1076560	venlafaxine	Efficacy	no	Allele C is not associated with response to venlafaxine in people with Anxiety Disorders as compared to allele A.			> 0.05	OR			
1448276164	rs3784943	amphetamine	Efficacy	yes	Genotypes AG + GG is associated with increased response to amphetamine as compared to genotype AA.			< 0.05	OR			
1183699325	rs1799853	warfarin	Dosage	yes	Allele T is associated with decreased dose of warfarin in people with total knee or hip arthroplasty as compared to allele C.	T		= 0.001	OR			
1450811764	rs506247	ethanol	Efficacy	no	Allele C is not associated with response to ethanol as compared to allele A.	C		= 0.06				
1450811764	rs506247	ethanol	Efficacy	no	Allele C is not associated with response to ethanol as compared to allele A.	C		= 0.07				
1450811764	rs506247	ethanol	Efficacy	no	Allele C is not associated with response to ethanol as compared to allele A.	C		= 0.35				
1450811764	rs506247	ethanol	Efficacy	no	Allele C is not associated with response to ethanol as compared to allele A.	C		= 0.40				
1450811764	rs506247	ethanol	Efficacy	no	Allele C is not associated with response to ethanol as compared to allele A.	C		= 0.44				
1450811764	rs506247	ethanol	Efficacy	no	Allele C is not associated with response to ethanol as compared to allele A.	C		= 0.47				
1450811764	rs506247	ethanol	Efficacy	no	Allele C is not associated with response to ethanol as compared to allele A.	C		= 0.48				
1450811764	rs506247	ethanol	Efficacy	no	Allele C is not associated with response to ethanol as compared to allele A.	C		= 0.51				
1450811764	rs506247	ethanol	Efficacy	no	Allele C is not associated with response to ethanol as compared to allele A.	C		= 0.55				
1450811764	rs506247	ethanol	Efficacy	no	Allele C is not associated with response to ethanol as compared to allele A.	C		= 0.58				
1450811764	rs506247	ethanol	Efficacy	no	Allele C is not associated with response to ethanol as compared to allele A.	C		= 0.63				
1450811764	rs506247	ethanol	Efficacy	no	Allele C is not associated with response to ethanol as compared to allele A.	C		= 0.64				
1450811764	rs506247	ethanol	Efficacy	no	Allele C is not associated with response to ethanol as compared to allele A.	C		= 0.83				
1450811764	rs506247	ethanol	Efficacy	no	Allele C is not associated with response to ethanol as compared to allele A.	C		= 0.91				
1450811764	rs506247	ethanol	Efficacy	no	Allele C is not associated with response to ethanol as compared to allele A.	C		= 0.95				
1184747866	rs1800497	venlafaxine	Efficacy	no	Allele A is not associated with response to venlafaxine in people with Anxiety Disorders as compared to allele G.			> 0.05	OR			
1184747882	rs28363170	venlafaxine	Efficacy	no	Allele GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT is not associated with response to venlafaxine in people with Anxiety Disorders as compared to allele del.			> 0.05	OR			
1450811783	rs563649	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele C.	T		= 0.06				
1450811783	rs563649	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele C.	T		= 0.12				
1450811783	rs563649	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele C.	T		= 0.38				
1450811783	rs563649	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele C.	T		= 0.39				
1450811783	rs563649	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele C.	T		= 0.56				
1450811783	rs563649	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele C.	T		= 0.57				
1450811783	rs563649	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele C.	T		= 0.58				
1450811783	rs563649	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele C.	T		= 0.62				
1450811783	rs563649	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele C.	T		= 0.70				
1450811783	rs563649	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele C.	T		= 0.73				
1450811783	rs563649	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele C.	T		= 0.73				
1450811783	rs563649	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele C.	T		= 0.77				
1450811783	rs563649	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele C.	T		= 0.84				
1450811783	rs563649	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele C.	T		= 0.91				
1450811783	rs563649	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele C.	T		= 0.91				
1450811856	rs2075572	ethanol	Efficacy	yes	Allele G is associated with increased response to ethanol as compared to allele C.	G		= 0.002				
1450811856	rs2075572	ethanol	Efficacy	yes	Allele G is associated with increased response to ethanol as compared to allele C.	G		= 0.003				
1450811856	rs2075572	ethanol	Efficacy	yes	Allele G is associated with increased response to ethanol as compared to allele C.	G		= 0.01				
1450811856	rs2075572	ethanol	Efficacy	yes	Allele G is associated with increased response to ethanol as compared to allele C.	G		= 0.04				
1450811856	rs2075572	ethanol	Efficacy	yes	Allele G is associated with increased response to ethanol as compared to allele C.	G		= 0.05				
1450811856	rs2075572	ethanol	Efficacy	yes	Allele G is associated with increased response to ethanol as compared to allele C.	G		= 0.06				
1450811856	rs2075572	ethanol	Efficacy	yes	Allele G is associated with increased response to ethanol as compared to allele C.	G		= 0.07				
1450811856	rs2075572	ethanol	Efficacy	yes	Allele G is associated with increased response to ethanol as compared to allele C.	G		= 0.12				
1450811856	rs2075572	ethanol	Efficacy	yes	Allele G is associated with increased response to ethanol as compared to allele C.	G		= 0.17				
1450811856	rs2075572	ethanol	Efficacy	yes	Allele G is associated with increased response to ethanol as compared to allele C.	G		= 0.21				
1450811856	rs2075572	ethanol	Efficacy	yes	Allele G is associated with increased response to ethanol as compared to allele C.	G		= 0.31				
1450811856	rs2075572	ethanol	Efficacy	yes	Allele G is associated with increased response to ethanol as compared to allele C.	G		= 0.69				
1450811856	rs2075572	ethanol	Efficacy	yes	Allele G is associated with increased response to ethanol as compared to allele C.	G		= 0.74				
1450811856	rs2075572	ethanol	Efficacy	yes	Allele G is associated with increased response to ethanol as compared to allele C.	G		= 0.76				
1449191908	rs75527207	ivacaftor	Efficacy	not stated	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.				OR			
1449192481	rs75527207	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			< 0.05	OR			
1451406248	rs20417	ibuprofen	Efficacy	no	Genotypes CG + GG are not associated with response to ibuprofen in people with Pain, Postoperative as compared to genotype CC.			= 0.268				
1451406248	rs20417	ibuprofen	Efficacy	no	Genotypes CG + GG are not associated with response to ibuprofen in people with Pain, Postoperative as compared to genotype CC.			= 0.316				
1451406248	rs20417	ibuprofen	Efficacy	no	Genotypes CG + GG are not associated with response to ibuprofen in people with Pain, Postoperative as compared to genotype CC.			= 0.438				
1451406248	rs20417	ibuprofen	Efficacy	no	Genotypes CG + GG are not associated with response to ibuprofen in people with Pain, Postoperative as compared to genotype CC.			= 0.749				
1449192439	rs75527207	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			< 0.0222	OR			
1450811875	rs548646	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.001				
1450811875	rs548646	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.005				
1450811875	rs548646	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.01				
1450811875	rs548646	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.01				
1450811875	rs548646	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.02				
1450811875	rs548646	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.02				
1450811875	rs548646	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.02				
1450811875	rs548646	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.02				
1450811875	rs548646	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.03				
1450811875	rs548646	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.04				
1450811875	rs548646	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.06				
1450811875	rs548646	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.12				
1450811875	rs548646	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.33				
1450811875	rs548646	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.77				
1450811875	rs548646	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.91				
1451406160	rs3745274	ibuprofen	Efficacy	no	Genotype TT is associated with decreased response to ibuprofen in people with Pain, Postoperative as compared to genotypes GG + GT (assigned as normal metabolizer genotype phenotype) .			= 0.079				
1451406160	rs3745274	ibuprofen	Efficacy	no	Genotype TT is associated with decreased response to ibuprofen in people with Pain, Postoperative as compared to genotypes GG + GT (assigned as normal metabolizer genotype phenotype) .			= 0.283				
1451406160	rs3745274	ibuprofen	Efficacy	no	Genotype TT is associated with decreased response to ibuprofen in people with Pain, Postoperative as compared to genotypes GG + GT (assigned as normal metabolizer genotype phenotype) .			= 0.348				
1451406160	rs3745274	ibuprofen	Efficacy	no	Genotype TT is associated with decreased response to ibuprofen in people with Pain, Postoperative as compared to genotypes GG + GT (assigned as normal metabolizer genotype phenotype) .			= 0.478				
1449192576	rs75527207	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			< 0.0305	OR			
1449192055	rs75527207	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			< 0.005	OR			
1450811823	rs642489	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele G.	T		= 0.09				
1450811823	rs642489	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele G.	T		= 0.25				
1450811823	rs642489	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele G.	T		= 0.28				
1450811823	rs642489	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele G.	T		= 0.31				
1450811823	rs642489	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele G.	T		= 0.36				
1450811823	rs642489	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele G.	T		= 0.40				
1450811823	rs642489	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele G.	T		= 0.43				
1450811823	rs642489	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele G.	T		= 0.45				
1450811823	rs642489	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele G.	T		= 0.50				
1450811823	rs642489	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele G.	T		= 0.55				
1450811823	rs642489	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele G.	T		= 0.55				
1450811823	rs642489	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele G.	T		= 0.71				
1450811823	rs642489	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele G.	T		= 0.79				
1450811823	rs642489	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele G.	T		= 0.80				
1450811823	rs642489	ethanol	Efficacy	no	Allele T is not associated with response to ethanol as compared to allele G.	T		= 0.83				
981861811	rs1800795	peginterferon alfa-2a	Efficacy	yes	Allele G is associated with decreased response to peginterferon alfa-2a in people with Hepatitis C, Chronic as compared to allele C.			= 0.0489	RR	0.78	0.62	1.0
1448276076	rs9332098	warfarin	Dosage	yes	Genotype GG is associated with increased dose of warfarin as compared to genotype AG.	A		< 0.0001	OR			
1451406260	rs3745274	tramadol	Efficacy	no	Genotype TT is not associated with response to tramadol in people with Pain, Postoperative as compared to genotypes GG + GT (assigned as normal metabolizer genotype phenotype) .			= 0.513				
1451406260	rs3745274	tramadol	Efficacy	no	Genotype TT is not associated with response to tramadol in people with Pain, Postoperative as compared to genotypes GG + GT (assigned as normal metabolizer genotype phenotype) .			= 0.614				
1451406260	rs3745274	tramadol	Efficacy	no	Genotype TT is not associated with response to tramadol in people with Pain, Postoperative as compared to genotypes GG + GT (assigned as normal metabolizer genotype phenotype) .			= 0.767				
1451406260	rs3745274	tramadol	Efficacy	no	Genotype TT is not associated with response to tramadol in people with Pain, Postoperative as compared to genotypes GG + GT (assigned as normal metabolizer genotype phenotype) .			= 0.790				
1450811918	rs681243	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.001				
1450811918	rs681243	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.006				
1450811918	rs681243	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.007				
1450811918	rs681243	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.01				
1450811918	rs681243	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.02				
1450811918	rs681243	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.02				
1450811918	rs681243	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.02				
1450811918	rs681243	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.03				
1450811918	rs681243	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.05				
1450811918	rs681243	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.06				
1450811918	rs681243	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.06				
1450811918	rs681243	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.15				
1450811918	rs681243	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.37				
1450811918	rs681243	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.90				
1450811918	rs681243	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.91				
1448276066	rs9332092	warfarin	Dosage	yes	Genotype TT is associated with increased dose of warfarin as compared to genotype CT.	C		< 0.0001	OR			
1451406389	rs4680	tramadol	Efficacy	no	Allele A is not associated with response to tramadol in people with Pain, Postoperative as compared to allele G.			= 0.441				
1451406389	rs4680	tramadol	Efficacy	no	Allele A is not associated with response to tramadol in people with Pain, Postoperative as compared to allele G.			= 0.458				
1451406389	rs4680	tramadol	Efficacy	no	Allele A is not associated with response to tramadol in people with Pain, Postoperative as compared to allele G.			= 0.743				
1451406389	rs4680	tramadol	Efficacy	no	Allele A is not associated with response to tramadol in people with Pain, Postoperative as compared to allele G.			= 0.768				
1451406380	rs1799971	tramadol	Efficacy	yes	Genotypes AG + GG are associated with increased response to tramadol in people with Pain, Postoperative as compared to genotype AA.			= 0.013				
1451406380	rs1799971	tramadol	Efficacy	yes	Genotypes AG + GG are associated with increased response to tramadol in people with Pain, Postoperative as compared to genotype AA.			= 0.016				
1451406380	rs1799971	tramadol	Efficacy	yes	Genotypes AG + GG are associated with increased response to tramadol in people with Pain, Postoperative as compared to genotype AA.			= 0.048				
1451406380	rs1799971	tramadol	Efficacy	yes	Genotypes AG + GG are associated with increased response to tramadol in people with Pain, Postoperative as compared to genotype AA.			= 0.051				
1449173508	rs4680	morphine	Efficacy	yes	Allele A is associated with increased response to morphine in people with Low Back Pain as compared to allele G.	A		= 0.037	OR	0.26	0.07	0.96
1449191776	rs267606723	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			< 0.0001	OR			
1449157145	rs678849	buprenorphine	Efficacy	yes	Genotype CC is associated with decreased response to buprenorphine in people with Opioid-Related Disorders as compared to genotypes CT + TT.	C		= 0.008	RR	2.17	1.95	2.68
1449191825	rs121909041	ivacaftor	Efficacy	yes	Allele C is associated with response to ivacaftor in people with Cystic Fibrosis.			< 0.0001	OR			
1450811896	rs648007	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	T		= 0.01				
1450811896	rs648007	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	T		= 0.01				
1450811896	rs648007	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	T		= 0.02				
1450811896	rs648007	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	T		= 0.03				
1450811896	rs648007	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	T		= 0.05				
1450811896	rs648007	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	T		= 0.08				
1450811896	rs648007	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	T		= 0.09				
1450811896	rs648007	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	T		= 0.09				
1450811896	rs648007	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	T		= 0.10				
1450811896	rs648007	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	T		= 0.12				
1450811896	rs648007	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	T		= 0.21				
1450811896	rs648007	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	T		= 0.23				
1450811896	rs648007	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	T		= 0.82				
1450811896	rs648007	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	T		= 0.85				
1450811896	rs648007	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele G.	T		= 0.95				
1448603703	rs3813008	empagliflozin	Efficacy	no	Allele A is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G.				OR			
1449191790	rs80282562	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			< 0.0001	OR			
1451406403	rs1045642	tramadol	Efficacy	no	Allele G is not associated with response to tramadol in people with Pain, Postoperative as compared to allele A.			= 0.176				
1451406403	rs1045642	tramadol	Efficacy	no	Allele G is not associated with response to tramadol in people with Pain, Postoperative as compared to allele A.			= 0.317				
1451406403	rs1045642	tramadol	Efficacy	no	Allele G is not associated with response to tramadol in people with Pain, Postoperative as compared to allele A.			= 0.430				
1451406403	rs1045642	tramadol	Efficacy	no	Allele G is not associated with response to tramadol in people with Pain, Postoperative as compared to allele A.			= 0.844				
1451406420	rs1128503	tramadol	Efficacy	no	Allele G is not associated with response to tramadol in people with Pain, Postoperative as compared to allele A.			= 0.027				
1451406420	rs1128503	tramadol	Efficacy	no	Allele G is not associated with response to tramadol in people with Pain, Postoperative as compared to allele A.			= 0.110				
1451406420	rs1128503	tramadol	Efficacy	no	Allele G is not associated with response to tramadol in people with Pain, Postoperative as compared to allele A.			= 0.459				
1451406420	rs1128503	tramadol	Efficacy	no	Allele G is not associated with response to tramadol in people with Pain, Postoperative as compared to allele A.			= 0.953				
1449157158	rs10753331	buprenorphine	Efficacy	no	Allele A is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele G.	A		= 0.44	OR			
1449157158	rs10753331	buprenorphine	Efficacy	no	Allele A is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele G.	A		= 0.96	OR			
1448603694	rs3116150	empagliflozin	Efficacy	no	Allele A is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G.				OR			
1449157166	rs529520	buprenorphine	Efficacy	no	Allele C is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele A.	C		= 0.28	OR			
1449157166	rs529520	buprenorphine	Efficacy	no	Allele C is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele A.	A		= 0.35	OR			
1448603685	rs3116149	empagliflozin	Efficacy	no	Allele A is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G.				OR			
1449157174	rs581111	buprenorphine	Efficacy	no	Allele G is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele A.	A		= 0.23	OR			
1449157174	rs581111	buprenorphine	Efficacy	no	Allele G is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele A.	G		= 0.84	OR			
1449157181	rs2234918	buprenorphine	Efficacy	no	Allele T is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.	T		= 0.76	OR			
1449157181	rs2234918	buprenorphine	Efficacy	no	Allele T is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.	C		= 0.93	OR			
1448603665	rs9924771	empagliflozin	Efficacy	no	Allele A is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G.				OR			
1451406461	rs2032582	tramadol	Efficacy	no	Genotypes AC + CT are not associated with response to tramadol in people with Pain, Postoperative as compared to genotype CC.			= 0.249				
1451406461	rs2032582	tramadol	Efficacy	no	Genotypes AC + CT are not associated with response to tramadol in people with Pain, Postoperative as compared to genotype CC.			= 0.578				
1451406461	rs2032582	tramadol	Efficacy	no	Genotypes AC + CT are not associated with response to tramadol in people with Pain, Postoperative as compared to genotype CC.			= 0.844				
1451406461	rs2032582	tramadol	Efficacy	no	Genotypes AC + CT are not associated with response to tramadol in people with Pain, Postoperative as compared to genotype CC.			= 0.864				
1448275978	rs699664	warfarin	Dosage	yes	Genotype CC is associated with increased dose of warfarin as compared to genotypes CT + TT.	T		= 0.0233	OR			
1449157205	rs678849	buprenorphine	Efficacy	no	Allele C is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele T.	C		= 0.28	OR			
1451406470	rs2032582	tramadol	Efficacy	no	Genotypes AA + AT are not associated with response to tramadol in people with Pain, Postoperative as compared to genotype CC.			= 0.249				
1451406470	rs2032582	tramadol	Efficacy	no	Genotypes AA + AT are not associated with response to tramadol in people with Pain, Postoperative as compared to genotype CC.			= 0.578				
1451406470	rs2032582	tramadol	Efficacy	no	Genotypes AA + AT are not associated with response to tramadol in people with Pain, Postoperative as compared to genotype CC.			= 0.844				
1451406470	rs2032582	tramadol	Efficacy	no	Genotypes AA + AT are not associated with response to tramadol in people with Pain, Postoperative as compared to genotype CC.			= 0.864				
1449157212	rs1042114	buprenorphine	Efficacy	no	Allele G is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele T.	G		= 0.33	OR			
1447981047	rs1801131	methotrexate	Efficacy	yes	Genotype GT is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype TT.	G		= 0.043	OR			
1449157221	rs1042114	methadone	Efficacy	no	Allele G is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele T.	G		= 0.088	OR			
1448423402	rs12436663	zileuton	Efficacy	yes	Genotype AA is associated with decreased response to zileuton in people with Asthma as compared to genotypes AG + GG.	A		= 0.03	OR			
1447981032	rs1801133	methotrexate	Efficacy	yes	Genotype AG is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes AA + GG.	A		= 0.025	OR			
1449157237	rs678849	methadone	Efficacy	yes	Genotype CC is associated with increased response to methadone in people with Opioid-Related Disorders as compared to genotypes CT + TT.	C		= 0.001	RR	0.52	0.44	0.6
1449157250	rs10753331	methadone	Efficacy	no	Allele A is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele G.	A		= 0.48	OR			
1449157250	rs10753331	methadone	Efficacy	no	Allele A is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele G.	A		= 0.69	OR			
1449157244	rs678849	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele T.	C		= 0.63	OR			
981239462	rs104894539	warfarin	Dosage	not stated	Allele A is associated with increased dose of warfarin as compared to allele C.				OR			
1449157257	rs529520	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele A.	A		= 0.15	OR			
1449157257	rs529520	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele A.	C		= 0.44	OR			
1449157264	rs581111	methadone	Efficacy	no	Allele G is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele A.	G		= 0.17	OR			
1449157264	rs581111	methadone	Efficacy	no	Allele G is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele A.	A		= 0.45	OR			
1448112064	rs3766355	latanoprost	Efficacy	yes	Genotype CC is associated with increased response to latanoprost in people with Glaucoma or Ocular Hypertension as compared to genotypes AA + AC.	C		= 0.024	OR			
1449157271	rs2234918	methadone	Efficacy	no	Allele T is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele C.	T		= 0.07	OR			
1449157271	rs2234918	methadone	Efficacy	no	Allele T is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele C.	C		= 0.93	OR			
1447980961	rs2289669	metformin	Efficacy	yes	Genotype GG is associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to genotypes AA + AG.				OR			
1183699677	rs10490924	bevacizumab	Efficacy	no	Genotypes GT + TT are not associated with response to bevacizumab in people with Macular Degeneration as compared to genotype GG.	T		= 0.352	OR			
1183699677	rs10490924	bevacizumab	Efficacy	no	Genotypes GT + TT are not associated with response to bevacizumab in people with Macular Degeneration as compared to genotype GG.	T		= 0.964	OR			
1448993465	rs3745274	efavirenz	Efficacy	yes	Genotype TT is associated with increased response to efavirenz in people with HIV Infections and Tuberculosis as compared to genotypes GG + GT.			= 0.022	OR			
1183699689	rs10490924	bevacizumab	Dosage	no	Genotypes GT + TT are not associated with dose of bevacizumab in people with Macular Degeneration as compared to genotype GG.	T		= 0.065	OR			
1183699684	rs1061170	bevacizumab	Dosage	yes	Genotype CT is associated with increased dose of bevacizumab in people with Macular Degeneration as compared to genotype TT.	C		= 0.02	OR			
1183699670	rs10490924	bevacizumab	Efficacy	yes	Genotypes GT + TT are associated with increased response to bevacizumab in people with Macular Degeneration as compared to genotype GG.	T		= 0.037	OR			
1183699670	rs10490924	bevacizumab	Efficacy	yes	Genotypes GT + TT are associated with increased response to bevacizumab in people with Macular Degeneration as compared to genotype GG.	T		= 0.058	OR			
1447980951	rs594709	metformin	Efficacy	yes	Genotypes AA + AG are associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to genotype GG.				OR			
1451407420	rs1799971	morphine	Efficacy	not stated	Genotype AG is not associated with increased response to morphine in healthy individuals as compared to genotype AA.			= 0.03				
1451407420	rs1799971	morphine	Efficacy	not stated	Genotype AG is not associated with increased response to morphine in healthy individuals as compared to genotype AA.			= 0.34				
1451407420	rs1799971	morphine	Efficacy	not stated	Genotype AG is not associated with increased response to morphine in healthy individuals as compared to genotype AA.			= 0.41				
1451407420	rs1799971	morphine	Efficacy	not stated	Genotype AG is not associated with increased response to morphine in healthy individuals as compared to genotype AA.			= 0.52				
1451407420	rs1799971	morphine	Efficacy	not stated	Genotype AG is not associated with increased response to morphine in healthy individuals as compared to genotype AA.			= 0.52				
1451407420	rs1799971	morphine	Efficacy	not stated	Genotype AG is not associated with increased response to morphine in healthy individuals as compared to genotype AA.			= 0.81				
1451407420	rs1799971	morphine	Efficacy	not stated	Genotype AG is not associated with increased response to morphine in healthy individuals as compared to genotype AA.			= 0.87				
1451407460	rs1051660	morphine	Efficacy	no	Allele A is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.042				
1451407460	rs1051660	morphine	Efficacy	no	Allele A is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.081				
1451407460	rs1051660	morphine	Efficacy	no	Allele A is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.19				
1451407460	rs1051660	morphine	Efficacy	no	Allele A is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.28				
1451407460	rs1051660	morphine	Efficacy	no	Allele A is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.32				
1451407460	rs1051660	morphine	Efficacy	no	Allele A is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.37				
1451407460	rs1051660	morphine	Efficacy	no	Allele A is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.86				
1183699659	rs1061170	bevacizumab	Efficacy	no	Genotype CT is not associated with response to bevacizumab in people with Macular Degeneration as compared to genotype TT.	C		= 0.625	OR			
1183699659	rs1061170	bevacizumab	Efficacy	no	Genotype CT is not associated with response to bevacizumab in people with Macular Degeneration as compared to genotype TT.	C		= 0.756	OR			
1183699659	rs1061170	bevacizumab	Efficacy	no	Genotype CT is not associated with response to bevacizumab in people with Macular Degeneration as compared to genotype TT.	C		= 0.773	OR			
1183699659	rs1061170	bevacizumab	Efficacy	no	Genotype CT is not associated with response to bevacizumab in people with Macular Degeneration as compared to genotype TT.	C		= 0.859	OR			
1451407539	rs4818	morphine	Efficacy	no	Allele G is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.067				
1451407539	rs4818	morphine	Efficacy	no	Allele G is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.15				
1451407539	rs4818	morphine	Efficacy	no	Allele G is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.20				
1451407539	rs4818	morphine	Efficacy	no	Allele G is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.31				
1451407539	rs4818	morphine	Efficacy	no	Allele G is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.42				
1451407539	rs4818	morphine	Efficacy	no	Allele G is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.46				
1451407539	rs4818	morphine	Efficacy	no	Allele G is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.49				
1451407529	rs4680	morphine	Efficacy	not stated	Genotype AA is associated with decreased response to morphine in healthy individuals as compared to genotypes AG + GG.			= 0.041				
1451407529	rs4680	morphine	Efficacy	not stated	Genotype AA is associated with decreased response to morphine in healthy individuals as compared to genotypes AG + GG.			= 0.28				
1451407529	rs4680	morphine	Efficacy	not stated	Genotype AA is associated with decreased response to morphine in healthy individuals as compared to genotypes AG + GG.			= 0.49				
1451407529	rs4680	morphine	Efficacy	not stated	Genotype AA is associated with decreased response to morphine in healthy individuals as compared to genotypes AG + GG.			= 0.80				
1451407529	rs4680	morphine	Efficacy	not stated	Genotype AA is associated with decreased response to morphine in healthy individuals as compared to genotypes AG + GG.			= 0.84				
1451407529	rs4680	morphine	Efficacy	not stated	Genotype AA is associated with decreased response to morphine in healthy individuals as compared to genotypes AG + GG.			= 0.88				
1451407529	rs4680	morphine	Efficacy	not stated	Genotype AA is associated with decreased response to morphine in healthy individuals as compared to genotypes AG + GG.			= 0.98				
1448603519	rs1045642	pantoprazole	Efficacy	no	Allele A (assigned as poor metabolizer genotype phenotype) is not associated with response to pantoprazole in people with Helicobacter Infections as compared to allele G.			= 0.14	OR			
981239480	rs104894540	warfarin	Dosage	not stated	Allele G is associated with increased dose of warfarin as compared to allele A.				OR			
981239489	rs104894542	warfarin	Dosage	not stated	Allele C is associated with increased dose of warfarin as compared to allele A.				OR			
1451407800	rs702764	butorphanol	Efficacy	no	Genotype CC is associated with increased response to butorphanol in healthy individuals as compared to genotypes CT + TT.			= 0.037				
1451407800	rs702764	butorphanol	Efficacy	no	Genotype CC is associated with increased response to butorphanol in healthy individuals as compared to genotypes CT + TT.			= 0.15				
1451407800	rs702764	butorphanol	Efficacy	no	Genotype CC is associated with increased response to butorphanol in healthy individuals as compared to genotypes CT + TT.			= 0.25				
1451407800	rs702764	butorphanol	Efficacy	no	Genotype CC is associated with increased response to butorphanol in healthy individuals as compared to genotypes CT + TT.			= 0.46				
1451407800	rs702764	butorphanol	Efficacy	no	Genotype CC is associated with increased response to butorphanol in healthy individuals as compared to genotypes CT + TT.			= 0.69				
1451407800	rs702764	butorphanol	Efficacy	no	Genotype CC is associated with increased response to butorphanol in healthy individuals as compared to genotypes CT + TT.			= 0.76				
1451407800	rs702764	butorphanol	Efficacy	no	Genotype CC is associated with increased response to butorphanol in healthy individuals as compared to genotypes CT + TT.			= 0.87				
1451407809	rs16918875	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele G.			= 0.14				
1451407809	rs16918875	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele G.			= 0.25				
1451407809	rs16918875	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele G.			= 0.37				
1451407809	rs16918875	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele G.			= 0.47				
1451407809	rs16918875	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele G.			= 0.64				
1451407809	rs16918875	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele G.			= 0.83				
1451407809	rs16918875	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele G.			= 0.96				
1451407492	rs16918875	morphine	Efficacy	no	Allele A is not associated with response to morphine in healthy individuals as compared to allele G.			= 0.21				
1451407492	rs16918875	morphine	Efficacy	no	Allele A is not associated with response to morphine in healthy individuals as compared to allele G.			= 0.26				
1451407492	rs16918875	morphine	Efficacy	no	Allele A is not associated with response to morphine in healthy individuals as compared to allele G.			= 0.37				
1451407492	rs16918875	morphine	Efficacy	no	Allele A is not associated with response to morphine in healthy individuals as compared to allele G.			= 0.53				
1451407492	rs16918875	morphine	Efficacy	no	Allele A is not associated with response to morphine in healthy individuals as compared to allele G.			= 0.60				
1451407492	rs16918875	morphine	Efficacy	no	Allele A is not associated with response to morphine in healthy individuals as compared to allele G.			= 0.74				
1451407492	rs16918875	morphine	Efficacy	no	Allele A is not associated with response to morphine in healthy individuals as compared to allele G.			= 0.79				
1451407482	rs702764	morphine	Efficacy	no	Allele C is not associated with response to morphine in healthy individuals as compared to allele T.			= 0.10				
1451407482	rs702764	morphine	Efficacy	no	Allele C is not associated with response to morphine in healthy individuals as compared to allele T.			= 0.15				
1451407482	rs702764	morphine	Efficacy	no	Allele C is not associated with response to morphine in healthy individuals as compared to allele T.			= 0.67				
1451407482	rs702764	morphine	Efficacy	no	Allele C is not associated with response to morphine in healthy individuals as compared to allele T.			= 0.68				
1451407482	rs702764	morphine	Efficacy	no	Allele C is not associated with response to morphine in healthy individuals as compared to allele T.			= 0.68				
1451407482	rs702764	morphine	Efficacy	no	Allele C is not associated with response to morphine in healthy individuals as compared to allele T.			= 0.84				
1451407482	rs702764	morphine	Efficacy	no	Allele C is not associated with response to morphine in healthy individuals as compared to allele T.			= 0.99				
1451407521	rs4633	morphine	Efficacy	no	Allele T is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.14				
1451407521	rs4633	morphine	Efficacy	no	Allele T is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.16				
1451407521	rs4633	morphine	Efficacy	no	Allele T is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.19				
1451407521	rs4633	morphine	Efficacy	no	Allele T is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.73				
1451407521	rs4633	morphine	Efficacy	no	Allele T is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.84				
1451407521	rs4633	morphine	Efficacy	no	Allele T is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.92				
1451407521	rs4633	morphine	Efficacy	no	Allele T is not associated with response to morphine in healthy individuals as compared to allele C.			= 0.94				
1451123480	rs2392165	nedocromil	Efficacy	no	Genotypes AG + GG are not associated with response to nedocromil in children with Asthma as compared to genotype AA.			= 1.1E-7				
1451123480	rs2392165	nedocromil	Efficacy	no	Genotypes AG + GG are not associated with response to nedocromil in children with Asthma as compared to genotype AA.			= 0.06				
1451407512	rs6269	morphine	Efficacy	not stated	Genotypes AG + GG are associated with increased response to morphine in healthy individuals as compared to genotype AA.			= 0.044				
1451407512	rs6269	morphine	Efficacy	not stated	Genotypes AG + GG are associated with increased response to morphine in healthy individuals as compared to genotype AA.			= 0.046				
1451407512	rs6269	morphine	Efficacy	not stated	Genotypes AG + GG are associated with increased response to morphine in healthy individuals as compared to genotype AA.			= 0.12				
1451407512	rs6269	morphine	Efficacy	not stated	Genotypes AG + GG are associated with increased response to morphine in healthy individuals as compared to genotype AA.			= 0.26				
1451407512	rs6269	morphine	Efficacy	not stated	Genotypes AG + GG are associated with increased response to morphine in healthy individuals as compared to genotype AA.			= 0.30				
1451407512	rs6269	morphine	Efficacy	not stated	Genotypes AG + GG are associated with increased response to morphine in healthy individuals as compared to genotype AA.			= 0.36				
1451407512	rs6269	morphine	Efficacy	not stated	Genotypes AG + GG are associated with increased response to morphine in healthy individuals as compared to genotype AA.			= 0.63				
1451407680	rs1799971	butorphanol	Efficacy	no	Allele G is not associated with response to butorphanol in healthy individuals as compared to allele A.			= 0.091				
1451407680	rs1799971	butorphanol	Efficacy	no	Allele G is not associated with response to butorphanol in healthy individuals as compared to allele A.			= 0.15				
1451407680	rs1799971	butorphanol	Efficacy	no	Allele G is not associated with response to butorphanol in healthy individuals as compared to allele A.			= 0.36				
1451407680	rs1799971	butorphanol	Efficacy	no	Allele G is not associated with response to butorphanol in healthy individuals as compared to allele A.			= 0.61				
1451407680	rs1799971	butorphanol	Efficacy	no	Allele G is not associated with response to butorphanol in healthy individuals as compared to allele A.			= 0.61				
1451407680	rs1799971	butorphanol	Efficacy	no	Allele G is not associated with response to butorphanol in healthy individuals as compared to allele A.			= 0.75				
1451407680	rs1799971	butorphanol	Efficacy	no	Allele G is not associated with response to butorphanol in healthy individuals as compared to allele A.			= 0.91				
1451407705	rs1051660	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele C.			= 0.35				
1451407705	rs1051660	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele C.			= 0.37				
1451407705	rs1051660	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele C.			= 0.43				
1451407705	rs1051660	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele C.			= 0.56				
1451407705	rs1051660	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele C.			= 0.58				
1451407705	rs1051660	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele C.			= 0.70				
1451407705	rs1051660	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele C.			= 0.72				
1451407765	rs4818	butorphanol	Efficacy	no	Allele G is not associated with response to butorphanol in healthy individuals as compared to allele C.			= 0.025				
1451407765	rs4818	butorphanol	Efficacy	no	Allele G is not associated with response to butorphanol in healthy individuals as compared to allele C.			= 0.16				
1451407765	rs4818	butorphanol	Efficacy	no	Allele G is not associated with response to butorphanol in healthy individuals as compared to allele C.			= 0.39				
1451407765	rs4818	butorphanol	Efficacy	no	Allele G is not associated with response to butorphanol in healthy individuals as compared to allele C.			= 0.65				
1451407765	rs4818	butorphanol	Efficacy	no	Allele G is not associated with response to butorphanol in healthy individuals as compared to allele C.			= 0.77				
1451407765	rs4818	butorphanol	Efficacy	no	Allele G is not associated with response to butorphanol in healthy individuals as compared to allele C.			= 0.77				
1451407765	rs4818	butorphanol	Efficacy	no	Allele G is not associated with response to butorphanol in healthy individuals as compared to allele C.			= 0.82				
1447964483	rs12050217	perindopril	Efficacy	yes	Genotypes AA + AG is associated with decreased response to perindopril in people with Coronary Artery Disease as compared to genotype GG.			< 0.001	OR			
1448259403	rs429358	acenocoumarol	Dosage	yes	Genotype CC is associated with increased dose of acenocoumarol in people with Atrial Fibrillation or venous thromboembolism as compared to genotypes CT + TT.			= 0.05	OR			
1451407860	rs4633	butorphanol	Efficacy	yes	Genotype CC is associated with decreased response to butorphanol in healthy individuals as compared to genotypes CT + TT.			= 0.015				
1451407860	rs4633	butorphanol	Efficacy	yes	Genotype CC is associated with decreased response to butorphanol in healthy individuals as compared to genotypes CT + TT.			= 0.43				
1451407860	rs4633	butorphanol	Efficacy	yes	Genotype CC is associated with decreased response to butorphanol in healthy individuals as compared to genotypes CT + TT.			= 0.47				
1451407860	rs4633	butorphanol	Efficacy	yes	Genotype CC is associated with decreased response to butorphanol in healthy individuals as compared to genotypes CT + TT.			= 0.60				
1451407860	rs4633	butorphanol	Efficacy	yes	Genotype CC is associated with decreased response to butorphanol in healthy individuals as compared to genotypes CT + TT.			= 0.81				
1451407860	rs4633	butorphanol	Efficacy	yes	Genotype CC is associated with decreased response to butorphanol in healthy individuals as compared to genotypes CT + TT.			= 0.81				
1451407860	rs4633	butorphanol	Efficacy	yes	Genotype CC is associated with decreased response to butorphanol in healthy individuals as compared to genotypes CT + TT.			= 0.96				
1451407825	rs4680	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele G.			= 0.12				
1451407825	rs4680	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele G.			= 0.31				
1451407825	rs4680	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele G.			= 0.70				
1451407825	rs4680	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele G.			= 0.88				
1451407825	rs4680	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele G.			= 0.89				
1451407825	rs4680	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele G.			= 0.92				
1451407825	rs4680	butorphanol	Efficacy	no	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele G.			= 0.96				
981419765	rs2284018	lithium	Efficacy	yes	Genotype TT is associated with decreased response to lithium in people with Bipolar Disorder as compared to genotypes CC + CT.			= 0.036	OR	0.11		
1451407844	rs6269	butorphanol	Efficacy	yes	Genotype GG is associated with decreased response to butorphanol in healthy individuals as compared to genotypes AA + AG.			= 0.014				
1451407844	rs6269	butorphanol	Efficacy	yes	Genotype GG is associated with decreased response to butorphanol in healthy individuals as compared to genotypes AA + AG.			= 0.085				
1451407844	rs6269	butorphanol	Efficacy	yes	Genotype GG is associated with decreased response to butorphanol in healthy individuals as compared to genotypes AA + AG.			= 0.12				
1451407844	rs6269	butorphanol	Efficacy	yes	Genotype GG is associated with decreased response to butorphanol in healthy individuals as compared to genotypes AA + AG.			= 0.40				
1451407844	rs6269	butorphanol	Efficacy	yes	Genotype GG is associated with decreased response to butorphanol in healthy individuals as compared to genotypes AA + AG.			= 0.52				
1451407844	rs6269	butorphanol	Efficacy	yes	Genotype GG is associated with decreased response to butorphanol in healthy individuals as compared to genotypes AA + AG.			= 0.68				
1451407844	rs6269	butorphanol	Efficacy	yes	Genotype GG is associated with decreased response to butorphanol in healthy individuals as compared to genotypes AA + AG.			= 0.91				
1448259376	rs9923231	acenocoumarol	Dosage	yes	Genotype CC is associated with increased dose of acenocoumarol in people with Atrial Fibrillation or venous thromboembolism as compared to genotypes CT + TT.			< 0.05	OR			
1451123460	rs2392165	budesonide	Efficacy	yes	Genotypes AG + GG are associated with increased response to budesonide in children with Asthma as compared to genotype AA.			= 1.1E-7				
1451123460	rs2392165	budesonide	Efficacy	yes	Genotypes AG + GG are associated with increased response to budesonide in children with Asthma as compared to genotype AA.			= 1.48E-7				
1448993587	rs3892097	haloperidol	Efficacy	yes	Genotype CC is associated with decreased response to haloperidol in men with Alcohol-Related Disorders, Alcoholic psychosis NOS and Alcoholism as compared to genotype CT.	C		< 0.001	OR			
1448993587	rs3892097	haloperidol	Efficacy	yes	Genotype CC is associated with decreased response to haloperidol in men with Alcohol-Related Disorders, Alcoholic psychosis NOS and Alcoholism as compared to genotype CT.	C		< 0.001	OR			
1449157431	rs2279343	cyclophosphamide	Efficacy	yes	Genotypes AG + GG are associated with decreased response to cyclophosphamide in people with Lymphoma, Non-Hodgkin as compared to genotype AA.			< 0.0001	OR			
1451408520	rs12777823	warfarin	Dosage	yes	Allele A is associated with dose of warfarin as compared to allele G.	A		= 1.66E-7	OR			
1451408520	rs12777823	warfarin	Dosage	yes	Allele A is associated with dose of warfarin as compared to allele G.	A		= 3.0E-5	OR			
1448259332	rs7412	acenocoumarol	Dosage	not stated	Allele T is not associated with dose of acenocoumarol.			= 0.067	OR			
1448275994	rs9934438	warfarin	Dosage	yes	Genotype GG is associated with increased dose of warfarin as compared to genotype AA.	G		= 0.0003	OR			
1448259328	rs2108622	acenocoumarol	Dosage	not stated	Allele T is associated with dose of acenocoumarol.			= 0.002	OR			
1447964381	rs275651	perindopril	Efficacy	yes	Genotypes AA + AT is associated with decreased response to perindopril in people with Coronary Artery Disease as compared to genotype TT.			< 0.001	OR			
1451408180	rs708272	rosuvastatin	Efficacy	yes	Allele A is associated with decreased response to rosuvastatin as compared to allele G.	A		= 0.028	OR	10.56	1.27	19.86
1451408180	rs708272	rosuvastatin	Efficacy	yes	Allele A is associated with decreased response to rosuvastatin as compared to allele G.	A		= 0.030	OR	0.2	0.05	0.83
1451408180	rs708272	rosuvastatin	Efficacy	yes	Allele A is associated with decreased response to rosuvastatin as compared to allele G.	A		= 0.042	OR	8.05	0.32	15.77
1451408800	rs5882	rosuvastatin	Efficacy	yes	Allele G is associated with increased response to rosuvastatin as compared to allele A.	G		= 0.019	OR	11.61	2.07	21.5
1451408800	rs5882	rosuvastatin	Efficacy	yes	Allele G is associated with increased response to rosuvastatin as compared to allele A.	G		= 0.032	OR	13.33	1.28	25.38
981502454	rs6127921	citalopram	Efficacy	no	Allele C is associated with decreased response to citalopram in people with Depressive Disorder, Major as compared to allele A.			= 1.4	OR	0.61	0.49	0.75
1450812316	rs6277	nicotine	Efficacy	yes	Allele A is associated with increased response to nicotine in men as compared to allele G.			= 0.041				
1450812316	rs6277	nicotine	Efficacy	yes	Allele A is associated with increased response to nicotine in men as compared to allele G.			= 0.045				
1448993666	rs3745274	efavirenz	Efficacy	no	Genotype TT is not associated with response to efavirenz in people with HIV Infections and Tuberculosis as compared to genotypes GG + GT.	G		> 0.05	OR			
1451409502	rs9923231	warfarin	Dosage	yes	Genotypes CC + CT is associated with increased dose of warfarin in people with Heart Failure as compared to genotype TT.	T		= 0.011				
1447947949	rs1799853	atenolol	Efficacy	no	Genotype CT is not associated with response to atenolol in people with Hypertension as compared to genotype CC.			= 0.036	OR			
1447947949	rs1799853	atenolol	Efficacy	no	Genotype CT is not associated with response to atenolol in people with Hypertension as compared to genotype CC.			= 0.23	OR			
1450812294	rs1800497	nicotine	Efficacy	no	Allele A is not associated with response to nicotine in healthy individuals as compared to allele G.							
1451270680	rs4680	bupropion	Efficacy	yes	Genotypes AG + GG is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotype AA.			< 0.04				
1450812368	rs1045642	nimodipine	Efficacy	no	Allele A is not associated with exposure to nimodipine in healthy individuals as compared to allele G.	A						
1184470005	rs4244285	clopidogrel	Efficacy	yes	Genotypes AA + AG is associated with decreased response to clopidogrel in people with Coronary Artery Disease as compared to genotype GG.	A		< 0.0001	OR	4.6	2.5	8.7
1450812373	rs2032582	nimodipine	Efficacy	no	Allele C is not associated with exposure to nimodipine in healthy individuals as compared to allele A.	C						
1184470013	rs12248560	clopidogrel	Efficacy	no	Genotypes CT + TT is not associated with response to clopidogrel in people with Coronary Artery Disease as compared to genotype CC.	T		= 0.14	OR	0.62	0.34	1.14
1450812385	rs2239050	nimodipine	Efficacy	yes	Genotype CG is associated with increased response to nimodipine in healthy individuals as compared to genotype CC.	G		= 0.049				
1450812390	rs2238032	nimodipine	Efficacy	no	Genotype TT is not associated with response to nimodipine in healthy individuals as compared to genotype GT.	G						
1447964285	rs734644	methylphenidate	Efficacy	yes	Genotypes CC + CT are associated with increased response to methylphenidate in children Attention Deficit Disorder with Hyperactivity as compared to genotype TT.	T		< 0.001	OR			
1447947908	rs1799853	irbesartan	Efficacy	yes	Genotype CT is associated with increased response to irbesartan in people with Hypertension as compared to genotype CC.			= 0.036	OR			
1447947908	rs1799853	irbesartan	Efficacy	yes	Genotype CT is associated with increased response to irbesartan in people with Hypertension as compared to genotype CC.			= 0.23	OR			
1447964271	rs1355368	methylphenidate	Efficacy	yes	Genotypes AG + GG are associated with increased response to methylphenidate in children Attention Deficit Disorder with Hyperactivity as compared to genotype AA.	A		< 0.001	OR			
1451140040	rs2153628	indomethacin	Efficacy	yes	Allele G is associated with increased response to indomethacin as compared to allele A.			= 0.031	OR	1.918	1.056	3.483
1447964257	rs6813183	methylphenidate	Efficacy	yes	Genotypes CC + CG are associated with increased response to methylphenidate in children Attention Deficit Disorder with Hyperactivity as compared to genotype GG.	G		< 0.001	OR			
1183863845	rs7624766	methotrexate	Efficacy	no	Allele G is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to allele A.			= 3.9E-7	OR			
1449747466	rs9934438	phenprocoumon	Dosage	yes	Allele A is associated with decreased dose of phenprocoumon in children as compared to allele G.	A		= 0.008	OR			
1447964243	rs1947275	methylphenidate	Efficacy	no	Genotypes CT + TT are associated with increased response to methylphenidate in children Attention Deficit Disorder with Hyperactivity as compared to genotype CC.	T		= 0.04	OR			
1451411342	rs2298383	methotrexate	Efficacy	no	Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.	C		= 0.249				
1451411348	rs2236624	methotrexate	Efficacy	no	Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.	T		= 0.871				
1451411377	rs1544223	methotrexate	Efficacy	no	Allele C is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.	C		= 0.442				
1444668324	rs1799724	etanercept	Efficacy	yes	Genotypes CT + TT is associated with increased response to etanercept in people with Arthritis, Rheumatoid as compared to genotype CC.			= 0.049	OR	12.0	1.2	120.0
1451411361	rs5751876	methotrexate	Efficacy	no	Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.	T		= 0.139				
1451159760	rs371194629	methotrexate	Efficacy	yes	Genotype del/del is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes ATTTGTTCATGCCT/ATTTGTTCATGCCT + ATTTGTTCATGCCT/del.	del		= 0.009	OR	2.46	1.26	4.84
1451411372	rs2298191	methotrexate	Efficacy	no	Allele C is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.	C		= 0.831				
1451411423	rs3393	methotrexate	Efficacy	no	Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.	C		= 0.871				
1451411381	rs17004921	methotrexate	Efficacy	yes	Genotypes CT + TT are associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.	T		= 0.013				
1451411381	rs17004921	methotrexate	Efficacy	yes	Genotypes CT + TT are associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.	T		= 0.428				
1451273890	rs1059513	esomeprazole	Efficacy	yes	Genotypes CC + CT are associated with increased response to esomeprazole in children with eosinophilic esophagitis as compared to genotype TT.			= 0.028	OR	6.16	1.44	26.35
1449157673	rs9923231	warfarin	Dosage	yes	Genotype TT is associated with decreased dose of warfarin as compared to genotype CC.			< 0.0001	OR			
1450812426	rs1799971	ethanol	Dosage	no	Genotype AG is not associated with dose of ethanol in people with Alcoholism and Stress as compared to genotype AA.	G		= 0.222				
1450812426	rs1799971	ethanol	Dosage	no	Genotype AG is not associated with dose of ethanol in people with Alcoholism and Stress as compared to genotype AA.	G		= 0.453				
1450812426	rs1799971	ethanol	Dosage	no	Genotype AG is not associated with dose of ethanol in people with Alcoholism and Stress as compared to genotype AA.	G		= 0.851				
1451414440	rs1045642	pantoprazole	Efficacy	no	Genotypes AG + GG is not associated with increased response to pantoprazole in people with Helicobacter Infections as compared to genotype AA.			= 0.97	OR	0.98	0.39	2.45
1451414463	rs1143634	pantoprazole	Efficacy	no	Genotype AA is not associated with increased response to pantoprazole in people with Helicobacter Infections as compared to genotypes AG + GG.			= 0.32	OR	1.53	0.66	3.54
1448259324	rs9923231	acenocoumarol	Dosage	yes	Allele T is associated with dose of acenocoumarol.			< 0.0001	OR			
1451414561	rs1045642	pantoprazole	Efficacy	no	Genotype GG is not associated with increased response to pantoprazole in people with Helicobacter Infections as compared to genotypes AA + AG.			= 0.66				
1451415203	rs2032582	lamotrigine	Dosage	no	Allele C is not associated with dose of lamotrigine in people with Epilepsy as compared to allele A.							
1451415146	rs1045642	lamotrigine	Dosage	no	Allele A is not associated with dose of lamotrigine in people with Epilepsy as compared to allele G.	A						
1451415140	rs1128503	lamotrigine	Dosage	no	Allele G is not associated with dose of lamotrigine in people with Epilepsy as compared to allele A.	A						
1451415246	rs3114020	lamotrigine	Dosage	no	Allele C is not associated with dose of lamotrigine in people with Epilepsy as compared to allele T.	T						
1451415197	rs2032582	lamotrigine	Dosage	no	Allele T is not associated with dose of lamotrigine in people with Epilepsy as compared to allele A.							
1451415263	rs628031	lamotrigine	Dosage	no	Allele G is not associated with dose of lamotrigine in people with Epilepsy as compared to allele A.	A						
1451415240	rs2231142	lamotrigine	Dosage	no	Allele T is not associated with dose of lamotrigine in people with Epilepsy as compared to allele G.	T						
1451415086	rs28365063	lamotrigine	Dosage	no	Genotype AG is not associated with dose of lamotrigine in people with Epilepsy as compared to genotype AA.	G						
1451414860	rs7668258	lamotrigine	Dosage	yes	Genotypes CT + TT are associated with increased dose of lamotrigine in people with Epilepsy as compared to genotype CC.	T		= 0.0047				
1451414860	rs7668258	lamotrigine	Dosage	yes	Genotypes CT + TT are associated with increased dose of lamotrigine in people with Epilepsy as compared to genotype CC.	T		= 0.0111				
1451437220	rs2740574	phenprocoumon	Dosage	no	Genotype CC are not associated with decreased dose of phenprocoumon as compared to genotypes CT + TT.			= 0.971	OR			
1451439780	rs2740574	phenprocoumon	Dosage	yes	Allele C is associated with decreased dose of phenprocoumon in children as compared to allele T.			= 0.013	OR			
1451440360	rs2740574	buprenorphine	Dosage	no	Genotype CT is associated with increased dose of buprenorphine in people with Opioid-Related Disorders.				OR			
1451454162	rs1319501	nitric oxide	Efficacy	yes	Genotype TT is associated with increased concentrations of nitric oxide in women with Pre-Eclampsia as compared to genotypes CC + CT.			< 0.05				
1451440801	rs2740574	cyclosporine	Dosage	no	Genotype TT is associated with decreased dose of cyclosporine in people with Kidney Transplantation as compared to genotype CT.			= 0.14				
1449258301	rs1057910	warfarin	Dosage	yes	Allele C is associated with decreased dose of warfarin as compared to allele A.			< 0.00001	OR			
1449258301	rs1057910	warfarin	Dosage	yes	Allele C is associated with decreased dose of warfarin as compared to allele A.			< 0.00001	OR			
1449258301	rs1057910	warfarin	Dosage	yes	Allele C is associated with decreased dose of warfarin as compared to allele A.			< 0.00001	OR			
1451444938	rs1800544	dexmedetomidine	Dosage	no	Allele C is not associated with dose of dexmedetomidine in men as compared to allele G.	C		= 0.684				
1183703309	rs1876829	fluticasone propionate	Efficacy	yes	Allele C is associated with increased response to fluticasone propionate in people with Asthma as compared to allele T.	C		< 0.05	OR			
1451445120	rs2484516	dexmedetomidine	Dosage	no	Genotype CC is not associated with dose of dexmedetomidine in men as compared to genotype CG.	G		= 0.313				
1451445125	rs3750625	dexmedetomidine	Dosage	no	Allele A is not associated with dose of dexmedetomidine in men as compared to allele C.	A		= 0.322				
1451445141	rs1800545	dexmedetomidine	Dosage	no	Allele A is not associated with dose of dexmedetomidine in men as compared to allele G.	A		= 0.217				
1451445180	rs553668	dexmedetomidine	Dosage	no	Allele G is not associated with dose of dexmedetomidine in men as compared to allele A.	A		= 0.544				
1451443460	rs2740574	tacrolimus	Dosage	yes	Genotype TT is associated with decreased dose of tacrolimus in people with Kidney Transplantation as compared to genotype CC.	*1		= 0.001	OR			
1451446281	rs4680	sufentanil	Dosage	no	Allele A is not associated with dose of sufentanil as compared to allele G.			= 0.319				
1451447380	rs12422149	rosuvastatin	Efficacy	yes	Genotypes AA + AG are associated with decreased response to rosuvastatin in healthy individuals as compared to genotype GG.			= 0.012				
1451447393	rs2413739	azathioprine	Efficacy	yes	Genotypes CT + TT is associated with decreased response to azathioprine in children with Irritable Bowel Syndrome as compared to genotype CC.			= 0.0058				
1451447501	rs2231142	rosuvastatin	Efficacy	yes	Genotype CT is associated with increased response to rosuvastatin in healthy individuals as compared to genotype CC.			= 0.049				
1451447487	rs2306168	rosuvastatin	Efficacy	no	Genotype CT is not associated with decreased response to rosuvastatin in healthy individuals as compared to genotype CC.			= 0.343				
1451450560	rs4149056	pravastatin	Efficacy	yes	Genotypes CC + CT are associated with decreased response to pravastatin as compared to genotype TT.			= 0.003				
1451450580	rs2306283	pravastatin	Efficacy	no	Genotypes AG + GG are not associated with decreased response to pravastatin as compared to genotype AA.			= 0.775				
981962878	rs20455	pravastatin	Efficacy	yes	Genotypes AG + GG are associated with increased response to pravastatin in people with Myocardial Infarction as compared to genotype AA.			= 9.0E-4	HR	0.63	0.49	0.83
1451451700	rs4149056	pitavastatin	Efficacy	no	Genotypes CC + CT are not associated with response to pitavastatin in people with Hyperlipidemias as compared to genotype TT.	C		> 0.05				
1451451706	rs2306283	pitavastatin	Efficacy	no	Genotypes AG + GG are not associated with response to pitavastatin in people with Hyperlipidemias as compared to genotype AA.	G		> 0.05				
1451489140	rs16851030	caffeine	Efficacy	yes	Genotype CC is associated with increased response to caffeine in infants with apnea of prematurity as compared to genotypes CT + TT.			= 0.002				
1451489140	rs16851030	caffeine	Efficacy	yes	Genotype CC is associated with increased response to caffeine in infants with apnea of prematurity as compared to genotypes CT + TT.			= 0.311				
1451493546	rs699	atenolol	Efficacy	no	Allele G is not associated with response to atenolol in people with Hypertrophy, Left Ventricular as compared to allele A.	A						
1451493540	rs699	irbesartan	Efficacy	yes	Genotypes AG + GG are associated with increased response to irbesartan in people with Hypertrophy, Left Ventricular as compared to genotype AA.	G		= 0.02				
1451493586	rs5186	atenolol	Efficacy	no	Allele C is not associated with response to atenolol in people with Hypertrophy, Left Ventricular as compared to allele A.	C						
1451493580	rs5186	irbesartan	Efficacy	yes	Genotype AC is associated with increased response to irbesartan in people with Hypertrophy, Left Ventricular as compared to genotype AA.	C		= 0.02				
1451499280	rs3892097	fluoxetine	Efficacy	yes	Genotype CC is associated with increased response to fluoxetine in men with Alcoholism and Depressive Disorder, Major as compared to genotype CT.			= 0.005				
1451499681	rs3892097	fluoxetine	Efficacy	yes	Genotype CT is associated with increased concentrations of fluoxetine in men with Alcoholism and Depressive Disorder, Major as compared to genotype CC.			< 0.001				
1451504420	rs2236225	methotrexate	Efficacy	no	Allele A is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.	A						
1451504441	rs1801133	methotrexate	Efficacy	no	Allele A is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.	A						
1451504503	rs1801131	methotrexate	Efficacy	no	Allele G is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.	G						
1451504521	rs45445694	methotrexate	Efficacy	no	Allele (CCGCGCCACTTGGCCTGCCTCCGTCCCG)2 is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele (CCGCGCCACTTGGCCTGCCTCCGTCCCG)3.							
1451535103	rs11545078	methotrexate	Toxicity	yes	Genotypes AA + AG is associated with increased discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.			= 0.037	OR	2.14	1.05	4.39
1451535140	rs717620	methotrexate	Toxicity	yes	Genotypes CT + TT is associated with decreased discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.			= 0.026	OR	0.54	0.32	0.93
1451506220	rs1051266	methotrexate	Efficacy	yes	Genotypes CC + TT are associated with decreased response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CT.	C		< 0.05				
1451506260	rs1801133	methotrexate	Efficacy	yes	Genotype AA is associated with increased response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma.	A		< 0.05				
1451506300	rs1801131	methotrexate	Efficacy	yes	Genotype GG is associated with increased response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes GT + TT.	G		< 0.05				
1451506467	rs1801131	methotrexate	Efficacy	yes	Genotype TT is associated with decreased response to methotrexate in children with Lymphoma, Non-Hodgkin or Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes GG + GT.	G		= 0.004				
1451506600	rs11045879	methotrexate	Efficacy	no	Allele C is not associated with response to methotrexate in children with Lymphoma, Non-Hodgkin or Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.	C		= 0.696				
1451506520	rs1801133	methotrexate	Efficacy	no	Allele A is not associated with response to methotrexate in children with Lymphoma, Non-Hodgkin or Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.	A		= 0.540				
1451506620	rs4149056	methotrexate	Efficacy	no	Allele C is not associated with response to methotrexate in children with Lymphoma, Non-Hodgkin or Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.	C		= 0.511				
1451589723	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.	T		= 0.00				
1451589728	rs61742245	warfarin	Dosage	yes	Genotypes AA + AC are associated with increased dose of warfarin as compared to genotype CC.	A		= 0.007				
1451547391	rs1544105	methotrexate	Efficacy	yes	Genotype TT is associated with increased response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes CC + CT.	C		= 0.013	OR	0.447	0.237	0.842
1451589737	rs8050894	warfarin	Dosage	yes	Genotypes CG + GG are associated with decreased dose of warfarin as compared to genotype CC.	G		= 0.00				
1451589745	rs2359612	warfarin	Dosage	yes	Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA.	A		= 0.00				
1451589740	rs9934438	warfarin	Dosage	yes	Genotype AA is associated with decreased dose of warfarin as compared to genotypes AC + CC.	A		= 0.00				
1451589825	rs17708472	warfarin	Dosage	no	Allele A is not associated with dose of warfarin as compared to allele G.	A		= 0.258				
1451589820	rs188009042	warfarin	Dosage	no	Allele C is not associated with dose of warfarin as compared to allele T.	C		= 0.18				
1451589762	rs7294	warfarin	Dosage	yes	Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.	T		= 0.00				
1451548305	rs4149009	methotrexate	Dosage	no	Allele T is not associated with dose of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.	T						
1184510128	rs61742245	warfarin	Dosage	yes	Allele A is associated with increased dose of warfarin as compared to allele C.	A		< 0.05	OR			
1451592449	rs7858836	fentanyl	Dosage	yes	Genotypes CT + TT are associated with decreased dose of fentanyl in people with Pain, Postoperative as compared to genotype CC.	T		= 0.0017				
1451592449	rs7858836	fentanyl	Dosage	yes	Genotypes CT + TT are associated with decreased dose of fentanyl in people with Pain, Postoperative as compared to genotype CC.	T		= 0.0033				
1451592449	rs7858836	fentanyl	Dosage	yes	Genotypes CT + TT are associated with decreased dose of fentanyl in people with Pain, Postoperative as compared to genotype CC.	T		= 0.0098				
1451592449	rs7858836	fentanyl	Dosage	yes	Genotypes CT + TT are associated with decreased dose of fentanyl in people with Pain, Postoperative as compared to genotype CC.	T		= 0.0136				
1451592467	rs958804	fentanyl	Dosage	yes	Genotypes CC + CT are associated with decreased dose of fentanyl in people with Pain, Postoperative as compared to genotype TT.	C		= 0.0019				
1451592467	rs958804	fentanyl	Dosage	yes	Genotypes CC + CT are associated with decreased dose of fentanyl in people with Pain, Postoperative as compared to genotype TT.	C		= 0.0028				
1451592467	rs958804	fentanyl	Dosage	yes	Genotypes CC + CT are associated with decreased dose of fentanyl in people with Pain, Postoperative as compared to genotype TT.	C		= 0.0051				
1451592467	rs958804	fentanyl	Dosage	yes	Genotypes CC + CT are associated with decreased dose of fentanyl in people with Pain, Postoperative as compared to genotype TT.	C		= 0.02				
1451551143	rs11615	cisplatin	Efficacy	yes	Allele A is associated with decreased response to cisplatin in women with Ovarian Neoplasms as compared to allele G.	A		= 0.003	OR	2.87	1.35	6.07
1451551246	rs3212964	cisplatin	Efficacy	no	Allele T is not associated with response to cisplatin in women with Ovarian Neoplasms as compared to allele C.	T		= 0.69	OR	1.05	0.81	1.36
1451551320	rs3212961	cisplatin	Efficacy	no	Allele A is not associated with response to cisplatin in women with Ovarian Neoplasms as compared to allele G.	A		= 0.74	OR	1.04	0.08	1.34
1451551220	rs735482	cisplatin	Efficacy	no	Allele C is not associated with response to cisplatin in women with Ovarian Neoplasms as compared to allele A.	C		= 0.24	OR	0.85	0.66	1.1
1451551177	rs3212980	cisplatin	Efficacy	no	Genotype GT is associated with increased response to cisplatin in women with Ovarian Neoplasms as compared to genotype TT.	G		= 0.012	OR	0.61	-0.59	0.89
1451551340	rs2298881	cisplatin	Efficacy	no	Allele A is not associated with response to cisplatin in women with Ovarian Neoplasms as compared to allele C.	A		= 0.79	OR	0.96	0.75	1.24
1451551149	rs3212986	cisplatin	Efficacy	yes	Allele A is associated with decreased response to cisplatin in women with Ovarian Neoplasms as compared to allele C.	A		= 0.002	OR	1.53	1.15	2.02
1451551163	rs2336219	cisplatin	Efficacy	no	Genotypes AG + GG are associated with increased response to cisplatin in women with Ovarian Neoplasms as compared to genotype AA.	A		= 0.015	OR	0.55	0.34	0.89
1451551163	rs2336219	cisplatin	Efficacy	no	Genotypes AG + GG are associated with increased response to cisplatin in women with Ovarian Neoplasms as compared to genotype AA.	A		= 0.042	OR	0.56	0.33	0.97
1451551742	rs11545078	methotrexate	Efficacy	no	Allele A is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.	A		= 0.73	OR	0.57	0.12	2.73
1451551800	rs11545076	methotrexate	Efficacy	yes	Genotypes AC + CC are associated with increased response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AA.	C		= 0.04	OR	0.31	0.1	0.96
1451610560	rs3213422	leflunomide	Efficacy	yes	Genotype CC is associated with increased clinical benefit to leflunomide in people with Arthritis, Rheumatoid as compared to genotypes AA + AC.	A		< 0.001	OR	19.13	3.699	85.23
1451610560	rs3213422	leflunomide	Efficacy	yes	Genotype CC is associated with increased clinical benefit to leflunomide in people with Arthritis, Rheumatoid as compared to genotypes AA + AC.	A		= 0.0172	OR	4.722	1.222	14.84
1451551760	rs1800909	methotrexate	Efficacy	no	Allele G is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.	G		= 0.06	OR	0.34	0.11	1.05
1451551766	rs11545077	methotrexate	Efficacy	yes	Genotypes CC + CT are associated with increased response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype TT.	A		= 0.04	OR	0.31	0.1	0.96
1451551777	rs3758149	methotrexate	Efficacy	yes	Genotypes AA + AG are associated with increased response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG.	A		= 0.04	OR	0.31	0.1	0.96
1451553044	rs6729738	cannabidiol	Efficacy	yes	Genotype CC is associated with increased response to cannabidiol in people with Epilepsy as compared to genotypes AA + AC.			= 0.001	OR	6.69	2.19	20.41
1451553125	rs12539	cannabidiol	Efficacy	yes	Genotypes CT + TT are associated with increased response to cannabidiol in people with Epilepsy as compared to genotype CC.			= 0.002	OR	3.96	1.62	9.73
1451553150	rs1339067	cannabidiol	Efficacy	yes	Genotype TT is associated with decreased response to cannabidiol in people with Epilepsy as compared to genotypes AA + AT.			= 0.001	OR	0.06	0.01	0.56
1451553420	rs3749442	cannabidiol	Efficacy	yes	Genotypes AA + AG are associated with decreased response to cannabidiol in people with Epilepsy as compared to genotype GG.			= 0.03	OR	0.36	0.15	0.85
1451554360	rs1799971	morphine	Dosage	yes	Genotype GG is associated with increased dose of morphine in women with Pain, Postoperative as compared to genotypes AA + AG.	G		< 0.05				
1451564980	rs1042714	salbutamol	Efficacy	no	Allele C is not associated with response to salbutamol in people with Asthma as compared to allele G.			= 0.35				
1451564980	rs1042714	salbutamol	Efficacy	no	Allele C is not associated with response to salbutamol in people with Asthma as compared to allele G.			= 0.59				
1451564980	rs1042714	salbutamol	Efficacy	no	Allele C is not associated with response to salbutamol in people with Asthma as compared to allele G.			= 0.69				
1451493920	rs1042713	salbutamol	PD	yes	Genotype AA is associated with decreased response to salbutamol in healthy individuals as compared to genotypes AG + GG.	A		< 0.05				
1451564962	rs1042713	salbutamol	Efficacy	no	Allele A is not associated with response to salbutamol in people with Asthma as compared to allele G.			= 0.43				
1451564962	rs1042713	salbutamol	Efficacy	no	Allele A is not associated with response to salbutamol in people with Asthma as compared to allele G.			= 0.47				
1451564962	rs1042713	salbutamol	Efficacy	no	Allele A is not associated with response to salbutamol in people with Asthma as compared to allele G.			= 0.83				
1449715484	rs7668282	fentanyl	Efficacy	no	Allele C is not associated with response to fentanyl in people with Pain, Postoperative as compared to allele T.	C			OR			
1451635420	rs678849	disulfiram	Efficacy	yes	Genotype CC is associated with increased response to disulfiram in people with Cocaine-Related Disorders as compared to genotypes CT + TT.			= 0.0001	OR	0.05		
1451638380	rs13303344	methadone	Efficacy	no	Allele A is not associated with response to methadone in people with Heroin Dependence as compared to allele C.	A		= 0.206				
1451638466	rs2376805	methadone	Efficacy	no	Allele A is not associated with response to methadone in people with Heroin Dependence as compared to allele G.	A		= 0.225				
1451638460	rs4481796	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.	C		= 0.994				
1451638472	rs2229110	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.	C		= 0.070				
1451640200	rs12749274	naltrexone	Efficacy	yes	Allele A is associated with decreased response to naltrexone in people with Alcoholism as compared to allele G.	A		= 3.9E-8	HR	2.9		
1451640186	rs77583603	acamprosate	Efficacy	yes	Allele G is associated with decreased response to acamprosate in people with Alcoholism as compared to allele A.	G		= 3.1E-9	HR	2.38		
1451647580	rs62368105	buprenorphine	Efficacy	yes	Allele G is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele A.			= 6.76E-6	OR	1.9437		
1451647569	rs6973474	buprenorphine	Efficacy	yes	Allele T is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.			= 8.36E-6	OR	1.4043		
1451647563	rs13169373	buprenorphine	Efficacy	yes	Allele T is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.			= 9.54E-6	OR	1.4364		
1451647600	rs11782370	buprenorphine	Efficacy	yes	Allele T is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.			= 6.97E-6	OR	1.4843		
1451647605	rs756770	buprenorphine	Efficacy	yes	Allele A is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.			= 7.93E-6	OR	1.8599		
1451647610	rs7205113	buprenorphine	Efficacy	yes	Allele T is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.			= 8.05E-6	OR	1.6486		
1451643611	rs1128503	methadone	Dosage	no	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.			= 0.87				
1451648760	rs34059508	morphine	Dosage	no	Allele A is not associated with dose of morphine in people with Pain, Postoperative as compared to allele G.			> 0.05				
1451643605	rs1045642	methadone	Dosage	no	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.			= 0.49				
1451643540	rs2032582	methadone	Dosage	yes	Genotype CC is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes AA + AC.			< 0.02				
1451643586	rs2279343	methadone	Dosage	yes	Genotype AA is associated with increased dose of methadone in people with Heroin Dependence as compared to genotypes AG + GG.			< 0.03				
1451648769	rs72552763	morphine	Dosage	no	Allele del is not associated with dose of morphine in people with Pain, Postoperative as compared to allele GAT.			> 0.05				
1451643580	rs3745274	methadone	Dosage	yes	Genotype GG is associated with increased dose of methadone in people with Heroin Dependence as compared to genotypes GT + TT.			< 0.008				
1451643617	rs1065852	methadone	Dosage	no	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.			= 0.34				
1451648740	rs12208357	morphine	Dosage	no	Allele T is not associated with dose of morphine in people with Pain, Postoperative as compared to allele C.			> 0.05				
1451648830	rs1229984	naltrexone	Efficacy	no	Allele T is not associated with response to naltrexone in men with Alcoholism as compared to allele C.			> 0.05				
1451648927	rs698	naltrexone	Efficacy	yes	Allele C is associated with increased response to naltrexone in men with Alcoholism as compared to allele T.			< 0.001				
1451648933	rs671	naltrexone	Efficacy	yes	Allele G is associated with increased response to naltrexone in men with Alcoholism as compared to allele A.			< 0.001				
1451648921	rs2066702	naltrexone	Efficacy	yes	Allele A is associated with decreased response to naltrexone in men with Alcoholism as compared to allele G.			< 0.001				
1451649100	rs1799971	morphine	Dosage	yes	Genotypes AG + GG are associated with increased dose of morphine in people with Liver Neoplasms and Pain as compared to genotype AA.	G		< 0.001				
1451645240	rs1799971	methadone	Dosage	no	Allele G is not associated with dose of methadone in people with Neoplasms and Pain as compared to allele A.	G		= 0.518				
1451645340	rs1799971	methadone	Efficacy	no	Allele G is not associated with response to methadone in people with Neoplasms and Pain as compared to allele A.	G		= 0.550				
1451645407	rs1045642	methadone	Dosage	no	Allele G is not associated with dose of methadone in people with Neoplasms and Pain as compared to allele A.	G		= 0.876				
1451645368	rs1128503	methadone	Dosage	no	Allele G is not associated with dose of methadone in people with Neoplasms and Pain as compared to allele A.	G		= 0.669				
1451645400	rs2032582	methadone	Dosage	no	Allele C is not associated with dose of methadone in people with Neoplasms and Pain as compared to allele T.	C		= 0.607				
1451645382	rs2032582	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Neoplasms and Pain as compared to allele T.	C		= 1				
1451645347	rs1128503	methadone	Efficacy	no	Allele G is not associated with response to methadone in people with Neoplasms and Pain as compared to allele A.	G		= 1				
1451645393	rs1045642	methadone	Efficacy	no	Allele G is not associated with response to methadone in people with Neoplasms and Pain as compared to allele A.	G		= 0.486				
1451646560	rs5326	methadone	Dosage	yes	Genotype TT is associated with increased dose of methadone in people with Heroin Dependence as compared to genotypes CC + CT.			= 0.01				
1451679040	rs3745274	methadone	Efficacy	no	Allele T is associated with increased response to methadone in men with Opioid-Related Disorders as compared to allele G.			= 0.06	OR	0.73	0.52	1.01
1451679140	rs73568641	methadone	Efficacy	no	Allele C is associated with increased response to methadone in women with Opioid-Related Disorders as compared to allele T.			= 0.098	OR	0.71	0.47	1.07
1451679146	rs1799971	methadone	Efficacy	no	Allele G is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele A.			= 0.17	OR	0.82	0.61	1.9
1451679146	rs1799971	methadone	Efficacy	no	Allele G is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele A.			= 0.88	OR	0.97	0.7	1.36
1451679300	rs10485058	methadone	Efficacy	no	Allele G is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele A.			= 0.51	OR	1.1	0.83	1.44
1451679300	rs10485058	methadone	Efficacy	no	Allele G is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele A.			= 0.78	OR	0.96	0.71	1.3
1451679523	rs55944529	methadone	Dosage	yes	Genotype TT is associated with increased dose of methadone in people with Heroin Dependence as compared to genotypes CC + CT.	T		= 0.003				
1451679541	rs11114083	methadone	Dosage	no	Genotypes AA + AC are not associated with dose of methadone in people with Heroin Dependence as compared to genotype CC.	A		= 0.55				
1451679547	rs2070586	methadone	Dosage	no	Genotypes AG + GG are not associated with dose of methadone in people with Heroin Dependence as compared to genotype AA.	A		= 0.53				
1451679565	rs2070587	methadone	Dosage	no	Genotypes GT + TT are not associated with dose of methadone in people with Heroin Dependence as compared to genotype GG.	G		= 0.52				
1451683380	rs523349	abiraterone	Efficacy	yes	Genotype CC is associated with increased response to abiraterone in men with Prostatic Neoplasms as compared to genotypes CG + GG.	C		= 0.017	HR	0.43	0.2	0.87
1451683600	rs743572	abiraterone	Efficacy	no	Genotypes AG + GG are not associated with response to abiraterone in men with Prostatic Neoplasms as compared to genotype AA.	G		= 0.86	HR	0.96	0.59	1.57
1451683680	rs12529	abiraterone	Efficacy	no	Genotypes CC + CG are not associated with response to abiraterone in men with Prostatic Neoplasms as compared to genotype GG.	C		= 0.57	HR	1.18	0.66	2.12
1451683620	rs2486758	abiraterone	Efficacy	no	Genotypes CC + CT are not associated with response to abiraterone in men with Prostatic Neoplasms as compared to genotype TT.	C		= 0.20	HR	1.35	0.85	2.13
1451684880	rs2075748	clozapine	Dosage	yes	Genotype CC is associated with decreased dose of clozapine in people with Schizophrenia as compared to genotypes CT + TT.			= 0.01				
1451684940	rs1942499	clozapine	Dosage	yes	Genotype GG is associated with decreased dose of clozapine in people with Schizophrenia as compared to genotypes AA + AG.			= 0.01				
1451686520	rs28371686	warfarin	Dosage	yes	Genotype CG is associated with decreased dose of warfarin as compared to genotype CC.	G						
1451686520	rs28371686	warfarin	Dosage	yes	Genotype CG is associated with decreased dose of warfarin as compared to genotype CC.	G						
1451686940	rs115629050	sofosbuvir	Efficacy	no	Allele A is associated with decreased response to sofosbuvir in people with Hepatitis C, Chronic as compared to allele C.			= 0.0057	OR	5.43	1.64	18.01
1451686950	rs4513095	sofosbuvir	Efficacy	yes	Allele A is associated with decreased response to sofosbuvir in people with Hepatitis C, Chronic as compared to allele C.			= 0.0057	OR	5.43	1.64	18.01
1451140100	rs1799853	indomethacin	Efficacy	no	Allele T is associated with increased response to indomethacin as compared to allele C.			= 0.174	OR	1.727	0.78	3.827
1447964201	rs6551665	methylphenidate	Efficacy	no	Genotypes AG + GG are associated with increased response to methylphenidate in children Attention Deficit Disorder with Hyperactivity as compared to genotype AA.	G		= 0.04	OR			
1451676000	rs678849	buprenorphine	Efficacy	yes	Genotypes CT + TT are associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to genotype CC.	T		= 0.04				
1451701983	rs324026	olanzapine	Efficacy	yes	Allele C is associated with increased clinical benefit to olanzapine in people with Schizophrenia as compared to allele T.			= 0.023	OR	2.11	1.1	4.0
1451676184	rs678849	buprenorphine	Efficacy	no	Genotype CC is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to genotypes CT + TT.	T		= 0.44				
1451702080	rs12610827	olanzapine	Efficacy	yes	Allele T is associated with increased clinical benefit to olanzapine in people with Schizophrenia as compared to allele G.			= 0.043	OR	2.49	1.0	6.0
1451715786	rs4244285	citalopram	Efficacy	yes	Genotype AG is associated with decreased response to citalopram in men with Alcoholism and Depressive Disorder, Major as compared to genotype GG.			< 0.001				
1451722660	rs12199316	mercaptopurine	Dosage	yes	Allele G is associated with increased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.	G		= 0.0029				
1451722660	rs12199316	mercaptopurine	Dosage	yes	Allele G is associated with increased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.	G		= 0.043				
1451725060	rs73189762	mercaptopurine	Dosage	yes	Allele T is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.	T		= 0.01				
1451725060	rs73189762	mercaptopurine	Dosage	yes	Allele T is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.	T		= 0.43				
1449157689	rs4149117	warfarin	Dosage	yes	Genotype GG is associated with decreased dose of warfarin as compared to genotypes GT + TT.			= 0.011	OR			
1451144740	rs35599367	alprazolam	Efficacy	yes	Genotype AG is associated with decreased response to alprazolam in men with Alcoholism and Anxiety Disorders as compared to genotype GG.	A		= 0.007				
1449269443	rs2242480	oxycodone	Efficacy	no	Genotype TT is not associated with response to oxycodone in people with Neoplasms and Pain as compared to genotype CC.	T		= 1.0	OR			
1451734503	rs4244285	diazepam	Efficacy	yes	Genotypes AA + AG is associated with increased clinical benefit to diazepam in men with Alcoholism as compared to genotype GG.			= 0.021				
1451734560	rs12248560	diazepam	Efficacy	yes	Genotypes CT + TT is associated with decreased clinical benefit to diazepam in men with Alcoholism as compared to genotype CC.			= 0.001				
1451735260	rs35599367	diazepam	Efficacy	yes	Genotype GG is associated with increased clinical benefit to diazepam in men with Alcoholism as compared to genotypes AA + AG.			= 0.014				
1451740000	rs163184	exenatide	Efficacy	yes	Allele G is associated with decreased clinical benefit to exenatide in people with Diabetes Mellitus, Type 2 as compared to allele T.	G		= 0.015				
1450375583	rs4148155	allopurinol	Efficacy	no	Allele G is associated with decreased response to allopurinol as compared to allele A.			= 1.4E-7	OR			
1450375583	rs4148155	allopurinol	Efficacy	no	Allele G is associated with decreased response to allopurinol as compared to allele A.			= 7.89E-7	OR			
1451782460	rs1048943	nilotinib	Efficacy	yes	Genotypes CT + TT is associated with increased response to nilotinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype CC.	T		= 0.001				
1451782460	rs1048943	nilotinib	Efficacy	yes	Genotypes CT + TT is associated with increased response to nilotinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype CC.	T		= 0.05				
1451782480	rs1695	nilotinib	Efficacy	yes	Allele A is associated with increased response to nilotinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.	A		= 0.001				
1451782480	rs1695	nilotinib	Efficacy	yes	Allele A is associated with increased response to nilotinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.	A		= 0.001				
1451782480	rs1695	nilotinib	Efficacy	yes	Allele A is associated with increased response to nilotinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.	A		= 0.034				
1183680038	rs8191725	salbutamol	Efficacy	yes	Genotype AG is associated with increased response to salbutamol in children with Asthma as compared to genotype AA.	G		= 3.3e-9	OR			
1183680038	rs8191725	salbutamol	Efficacy	yes	Genotype AG is associated with increased response to salbutamol in children with Asthma as compared to genotype AA.			= 0.939	OR			
1183680038	rs8191725	salbutamol	Efficacy	yes	Genotype AG is associated with increased response to salbutamol in children with Asthma as compared to genotype AA.			= 0.990	OR			
1451753800	rs17026688	lithium	Efficacy	yes	Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.			= 6.69e-62	OR	82.2	36.2	195.6
1451753800	rs17026688	lithium	Efficacy	yes	Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.			= 6.18e-43	OR	73.9	30.8	191.0
1451753800	rs17026688	lithium	Efficacy	yes	Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.			= 9.17e-20	OR	180.0	32.7	1173.0
1451760997	rs3742106	tenofovir	Toxicity	yes	Genotypes AC + CC are associated with increased concentrations of tenofovir in people with HIV Infections as compared to genotype AA.			= 0.011				
1451760997	rs3742106	tenofovir	Toxicity	yes	Genotypes AC + CC are associated with increased concentrations of tenofovir in people with HIV Infections as compared to genotype AA.			= 0.013	OR	1.69	1.12	2.56
1451760997	rs3742106	tenofovir	Toxicity	yes	Genotypes AC + CC are associated with increased concentrations of tenofovir in people with HIV Infections as compared to genotype AA.			= 0.018	OR	1.82	1.11	2.94
1451761040	rs1751034	tenofovir	Toxicity	yes	Genotype TT is associated with increased concentrations of tenofovir in people with HIV Infections as compared to genotypes CC + CT.			= 0.004				
1451761040	rs1751034	tenofovir	Toxicity	yes	Genotype TT is associated with increased concentrations of tenofovir in people with HIV Infections as compared to genotypes CC + CT.			= 0.005	OR	1.85	1.2	2.85
1451761040	rs1751034	tenofovir	Toxicity	yes	Genotype TT is associated with increased concentrations of tenofovir in people with HIV Infections as compared to genotypes CC + CT.			= 0.013	OR	1.85	1.14	2.94
1451804900	rs4880	bilirubin	Toxicity	yes	Genotype GG is associated with increased concentrations of bilirubin in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AA + AG.			< 0.001				
1451804900	rs4880	bilirubin	Toxicity	yes	Genotype GG is associated with increased concentrations of bilirubin in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AA + AG.			= 0.02				
1451804900	rs4880	bilirubin	Toxicity	yes	Genotype GG is associated with increased concentrations of bilirubin in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AA + AG.			= 0.02				
1448099582	rs112936952	warfarin	Dosage	no	Allele TTG is not associated with dose of warfarin as compared to genotype TTG/TTGTTGTTG.			= 0.26	OR			
1451799880	rs2292596	methotrexate	Efficacy	not stated	Allele G is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.							
1451809220	rs34130495	morphine	Dosage	no	Allele A is not associated with dose of morphine in people with Pain, Postoperative as compared to allele G.			> 0.05				
1451768380	rs116855232	mercaptopurine	Dosage	no	Genotype CT is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.							
1451769040	rs1800460	mercaptopurine	Dosage	no	Genotype CT is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.							
1451769140	rs1076560	methylphenidate	Efficacy	no	Allele A is not associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity and Fetal Alcohol Syndrome as compared to allele C.							
1451769162	rs1800497	methylphenidate	Efficacy	no	Allele A is not associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity and Fetal Alcohol Syndrome as compared to allele G.							
1449157684	rs1143672	warfarin	Dosage	yes	Genotype AA is associated with decreased dose of warfarin as compared to genotype GG.			= 0.022	OR			
1448601675	rs3732759	clopidogrel	Efficacy	yes	Genotype GG is associated with decreased response to clopidogrel in people with Coronary Disease as compared to genotypes AA + AG.	G		< 0.05	OR			
1450371570	rs396991	rituximab	Efficacy	yes	Genotypes AC + CC are associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotype AA.	C		= 0.021	OR	-1.083	-1.98	-0.18
1450371570	rs396991	rituximab	Efficacy	yes	Genotypes AC + CC are associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotype AA.	C		= 0.077	OR	4.904	0.84	28.48
1450371570	rs396991	rituximab	Efficacy	yes	Genotypes AC + CC are associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotype AA.	C		= 0.398	OR			
1450371570	rs396991	rituximab	Efficacy	yes	Genotypes AC + CC are associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotype AA.	C		= 0.560	OR			
1450371570	rs396991	rituximab	Efficacy	yes	Genotypes AC + CC are associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotype AA.	C		= 0.572	OR			
1450371570	rs396991	rituximab	Efficacy	yes	Genotypes AC + CC are associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotype AA.	C		= 0.719	OR			
1450371570	rs396991	rituximab	Efficacy	yes	Genotypes AC + CC are associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotype AA.	C		= 0.943	OR			
1450371570	rs396991	rituximab	Efficacy	yes	Genotypes AC + CC are associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotype AA.	C		= 1	OR			
1450371570	rs396991	rituximab	Efficacy	yes	Genotypes AC + CC are associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotype AA.	C		= 1	OR			
1450371570	rs396991	rituximab	Efficacy	yes	Genotypes AC + CC are associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotype AA.	C		= 1	OR			
1450371570	rs396991	rituximab	Efficacy	yes	Genotypes AC + CC are associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotype AA.	C		= 1	OR			
1450371570	rs396991	rituximab	Efficacy	yes	Genotypes AC + CC are associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotype AA.	C		= 1	OR			
1183863874	rs1703794	methotrexate	Efficacy	no	Allele T is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.			= 3.05E-5	OR			
1183863870	rs2650972	methotrexate	Efficacy	no	Allele T is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.			= 2.82E-5	OR			
1447964156	rs78655421	ivacaftor	Efficacy	not stated	Allele A is associated with response to ivacaftor in Cystic Fibrosis as compared to allele G.				OR			
1183863878	rs6064463	methotrexate	Efficacy	no	Allele C is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.			= 3.62E-5	OR			
1183863858	rs1901633	methotrexate	Efficacy	no	Allele G is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to allele A.			= 1.17E-5	OR			
1183863853	rs6506569	methotrexate	Efficacy	no	Allele C is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.			= 7.19E-6	OR			
1183863864	rs4982133	methotrexate	Efficacy	no	Allele C is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to allele A.			= 2.6E-5	OR			
1447964109	rs113993960	cysteamine	Efficacy	yes	Genotypes CTT/del + del/del are associated with increased response to cysteamine in people with Cystic Fibrosis as compared to genotype CTT/CTT.	CTT		< 0.0001	OR			
1450812627	rs2337980	nicotine	Efficacy	yes	Genotype CC is associated with increased response to nicotine in women as compared to genotypes CT + TT.			< 0.05				
1448635810	rs7314976	niacin	Efficacy	no	Genotypes AA + AG is not associated with response to niacin as compared to genotype GG.			> 0.05	OR			
1450812634	rs2777511	nicotine	Efficacy	no	Allele G is not associated with response to nicotine in women as compared to allele A.			> 0.05				
1448635798	rs2454727	niacin	Efficacy	no	Genotypes CT + TT is not associated with response to niacin as compared to genotype CC.			> 0.05	OR			
1444933003	rs3745274	propofol	Dosage	yes	Genotypes GT + TT are associated with decreased dose of propofol as compared to genotype GG.	T		= 0.043	OR			
1448635792	rs2454727	niacin	Efficacy	yes	Genotypes CT + TT is associated with decreased response to niacin as compared to genotype CC.			= 0.0053	OR			
1184748821	rs16853826	methotrexate	Toxicity	yes	Genotype GG is associated with increased discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.			= 0.039	OR			
1448639482	rs6313	propofol	Dosage	yes	Genotype AA is associated with decreased dose of propofol as compared to genotypes AG + GG.			= 0.03	OR			
1183680053	rs77977790	salbutamol	Efficacy	yes	Genotype CT is associated with increased response to salbutamol in children with Asthma as compared to genotype TT.	C		= 4.6e-10	OR			
1183680053	rs77977790	salbutamol	Efficacy	yes	Genotype CT is associated with increased response to salbutamol in children with Asthma as compared to genotype TT.			> 0.05	OR			
1183680053	rs77977790	salbutamol	Efficacy	yes	Genotype CT is associated with increased response to salbutamol in children with Asthma as compared to genotype TT.			> 0.05	OR			
1183680047	rs77441273	salbutamol	Efficacy	yes	Genotype AG is associated with increased response to salbutamol in children with Asthma as compared to genotype GG.	A		= 4.0e-10	OR			
1183680047	rs77441273	salbutamol	Efficacy	yes	Genotype AG is associated with increased response to salbutamol in children with Asthma as compared to genotype GG.			> 0.05	OR			
1183680047	rs77441273	salbutamol	Efficacy	yes	Genotype AG is associated with increased response to salbutamol in children with Asthma as compared to genotype GG.			= 0.376	OR			
981750332	rs2071427	lithium	Efficacy	no	Allele T is not associated with response to lithium in people with Bipolar Disorder as compared to allele C.				OR			
981750338	rs2269457	lithium	Efficacy	no	Allele T is not associated with response to lithium in people with Bipolar Disorder as compared to allele C.				OR			
1183680162	rs73294475	salbutamol	Efficacy	yes	Genotype CT is associated with increased response to salbutamol in children with Asthma as compared to genotype TT.	C		= 0.04	OR			
1183680156	rs144315541	salbutamol	Efficacy	yes	Genotype AG is associated with increased response to salbutamol in children with Asthma as compared to genotype GG.	A		= 0.03	OR			
1183680170	rs295137	salbutamol	Efficacy	no	Allele C is not associated with response to salbutamol in children with Asthma as compared to allele T.			= 0.48	OR			
1183680146	rs116551936	salbutamol	Efficacy	yes	Genotype AG is associated with increased response to salbutamol in children with Asthma as compared to genotype GG.	A		< 0.05	OR			
1449260681	rs9923231	warfarin	Dosage	yes	Allele T is associated with decreased dose of warfarin as compared to allele C.			< 0.00001	OR			
1449260681	rs9923231	warfarin	Dosage	yes	Allele T is associated with decreased dose of warfarin as compared to allele C.			< 0.00001	OR			
1449260681	rs9923231	warfarin	Dosage	yes	Allele T is associated with decreased dose of warfarin as compared to allele C.			< 0.0001	OR			
1183680142	rs115501901	salbutamol	Efficacy	yes	Genotype CT is associated with increased response to salbutamol in children with Asthma as compared to genotype CC.	C		< 0.05	OR			
1183680150	rs74973995	salbutamol	Efficacy	yes	Genotype AG is associated with increased response to salbutamol in children with Asthma as compared to genotype AA.	G		< 0.05	OR			
1449752221	rs17602729	methotrexate	Efficacy	no	Genotypes AA + AG is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.			= 0.7	OR			
1444936658	rs1045642	sunitinib	Efficacy	yes	Genotype GG is associated with decreased response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AA + AG.	G		= 0.05	RR	4.57	1.08	19.42
1449752227	rs1127354	methotrexate	Efficacy	no	Genotypes AA + AC is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.			= 0.6	OR			
1449752233	rs2372536	methotrexate	Efficacy	no	Genotypes CG + GG is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.			= 0.6	OR			
1449752214	rs2236225	methotrexate	Efficacy	no	Genotypes AG + GG is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype AA.			= 0.7	OR			
1449752258	rs1801274	cetuximab	Efficacy	yes	Genotype AA is associated with increased response to cetuximab in people with Colorectal Neoplasms as compared to genotypes AG + GG.	G		< 0.001	HR	0.61	0.5	0.74
1449752258	rs1801274	cetuximab	Efficacy	yes	Genotype AA is associated with increased response to cetuximab in people with Colorectal Neoplasms as compared to genotypes AG + GG.	G		< 0.001	OR	0.71	0.63	0.8
1449752258	rs1801274	cetuximab	Efficacy	yes	Genotype AA is associated with increased response to cetuximab in people with Colorectal Neoplasms as compared to genotypes AG + GG.	G		= 0.02	HR	0.8	0.66	0.97
1449244338	rs2032582	morphine	Efficacy	no	Allele A is not associated with dose of morphine in people with Pain, Postoperative as compared to allele C.	C		= 0.44	OR			
1448998602	rs2289669	metformin	Efficacy	no	Allele A is not associated with response to metformin in women with Polycystic Ovary Syndrome as compared to allele G.			> 0.05	OR			
1448998602	rs2289669	metformin	Efficacy	no	Allele A is not associated with response to metformin in women with Polycystic Ovary Syndrome as compared to allele G.			> 0.05	OR			
1448998602	rs2289669	metformin	Efficacy	no	Allele A is not associated with response to metformin in women with Polycystic Ovary Syndrome as compared to allele G.			> 0.05	OR			
1448998602	rs2289669	metformin	Efficacy	no	Allele A is not associated with response to metformin in women with Polycystic Ovary Syndrome as compared to allele G.			> 0.05	OR			
1448998602	rs2289669	metformin	Efficacy	no	Allele A is not associated with response to metformin in women with Polycystic Ovary Syndrome as compared to allele G.			> 0.05	OR			
1450931941	rs45476395	sertraline	Efficacy	no	Allele T is not associated with response to sertraline in people with Depressive Disorder, Major as compared to allele A.	T		= 0.920	OR	0.9	0.34	2.57
1184483081	rs1045642	cyclosporine	Efficacy	yes	Allele A is associated with decreased response to cyclosporine in people with Psoriasis as compared to allele G.	A		= 0.0075	OR	2.995	1.448	6.226
1184483086	rs3213619	cyclosporine	Efficacy	no	Allele A is not associated with response to cyclosporine in people with Psoriasis as compared to allele G.	A		> 0.05	OR			
1450342120	rs717620	doxorubicin	Efficacy	no	Allele T is not associated with decreased response to doxorubicin in people with Breast Neoplasms as compared to allele C.			= 1	OR			
1450374888	rs2070762	methylphenidate	Efficacy	yes	Genotype GG is associated with decreased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes AA + AG.			= 0.0055	OR	4.34	1.54	12.2
1450374888	rs2070762	methylphenidate	Efficacy	yes	Genotype GG is associated with decreased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes AA + AG.			= 0.017	OR	4.33	1.21	15.5
1184483091	rs2229109	cyclosporine	Efficacy	no	Allele C is not associated with response to cyclosporine in people with Psoriasis as compared to allele T.	T		> 0.05	OR			
1184483095	rs1128503	cyclosporine	Efficacy	no	Allele A is not associated with response to cyclosporine in people with Psoriasis as compared to allele G.	A		> 0.05	OR			
1449752269	rs396991	cetuximab	Efficacy	no	Allele C is not associated with response to cetuximab in people with Colorectal Neoplasms as compared to allele A.	A		= 0.39	HR	0.93	0.78	1.1
1449752269	rs396991	cetuximab	Efficacy	no	Allele C is not associated with response to cetuximab in people with Colorectal Neoplasms as compared to allele A.	A		= 0.44	HR	0.93	0.78	1.11
1449752269	rs396991	cetuximab	Efficacy	no	Allele C is not associated with response to cetuximab in people with Colorectal Neoplasms as compared to allele A.	A		= 0.80	HR	0.99	0.87	1.12
1449244383	rs7439366	morphine	Efficacy	no	Genotypes CC + CT are not associated with dose of morphine in people with Pain, Postoperative as compared to genotype TT.	T		= 0.92	OR			
1446902609	rs7439366	codeine	Dosage	yes	Genotype TT is associated with decreased dose of codeine in women as compared to genotype CC.	C		= 0.002	OR			
1450374923	rs4680	methylphenidate	Efficacy	yes	Allele G is associated with increased clearance of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.			= 0.009	OR			
1450374923	rs4680	methylphenidate	Efficacy	yes	Allele G is associated with increased clearance of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.			= 0.036	OR			
1445296945	rs887829	atazanavir	Toxicity	yes	Genotype TT is associated with increased discontinuation of atazanavir in people with HIV Infections as compared to genotypes CC + CT.			= 9.3E-14	OR			
1445296945	rs887829	atazanavir	Toxicity	yes	Genotype TT is associated with increased discontinuation of atazanavir in people with HIV Infections as compared to genotypes CC + CT.	T		= 1.8E-11	OR			
1445296945	rs887829	atazanavir	Toxicity	yes	Genotype TT is associated with increased discontinuation of atazanavir in people with HIV Infections as compared to genotypes CC + CT.	T		= 3.0E-4	OR			
1445296945	rs887829	atazanavir	Toxicity	yes	Genotype TT is associated with increased discontinuation of atazanavir in people with HIV Infections as compared to genotypes CC + CT.	T		= 2.3E-3	OR			
1444936497	rs10512734	adalimumab	Efficacy	no	Genotype GG is associated with increased response to adalimumab in people with Crohn Disease as compared to genotypes AA + AG.	A		= 4.62E-3	OR			
1444936506	rs8049439	adalimumab	Efficacy	no	Genotypes CT + TT is associated with increased response to adalimumab in people with Crohn Disease as compared to genotype CC.	C		= 5.56E-3	OR			
1450931989	rs1799971	sufentanil	Dosage	yes	Genotypes AG + GG are associated with increased dose of sufentanil in people with Lung Neoplasms and Pain, Postoperative as compared to genotype AA.	G		< 0.05				
1444707135	rs1043550	acenocoumarol	Dosage	no	Genotype AA is associated with decreased dose of acenocoumarol as compared to genotypes AG + GG.			= 0.063	OR			
1450931998	rs1323040	sufentanil	Dosage	yes	Genotypes AG + GG are associated with increased dose of sufentanil in people with Lung Neoplasms and Pain, Postoperative as compared to genotype AA.	G		< 0.05				
1444936514	rs7927894	adalimumab	Efficacy	no	Genotype CC is associated with increased response to adalimumab in people with Crohn Disease as compared to genotypes CT + TT.	C		= 5.83E-3	OR			
1184515781	rs776746	tacrolimus	Toxicity	no	Genotype CC is not associated with decreased metabolism of tacrolimus in people with Kidney Transplantation as compared to genotype CT.			< 0.05	OR			
1450374950	rs4680	methylphenidate	Efficacy	no	Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.				OR			
1444936520	rs12777960	adalimumab	Efficacy	no	Genotype CC is associated with increased response to adalimumab in people with Crohn Disease as compared to genotypes AA + AC.	A		= 6.69E-3	OR			
1450931954	rs5441	sertraline	Efficacy	yes	Genotype GG is associated with increased response to sertraline in people with Depressive Disorder, Major as compared to genotypes AA + AG.	G		= 0.004	OR	5.9	1.66	21.99
1444936532	rs1295686	adalimumab	Efficacy	no	Genotype TT is associated with increased response to adalimumab in people with Crohn Disease as compared to genotypes CC + CT.	C		= 6.07E-3	OR			
1444936526	rs3814057	adalimumab	Efficacy	no	Genotype CC is associated with increased response to adalimumab in people with Crohn Disease as compared to genotypes AA + AC.	A		= 9.64E-3	OR			
1450374932	rs4680	methylphenidate	Efficacy	yes	Genotype GG is associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype AA.			= 0.015	OR			
1450374939	rs4680	methylphenidate	Efficacy	not stated	Genotype GG is associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes AA + AG.			= 0.035	OR			
1446902603	rs1799971	codeine	Dosage	yes	Genotype AA is associated with decreased dose of codeine in women as compared to genotype AG.	A		= 0.000	OR			
1444707179	rs9923231	acenocoumarol	Dosage	yes	Genotypes CT + TT are associated with decreased dose of acenocoumarol as compared to genotype CC.			= 0.006	OR			
1444936434	rs10210302	adalimumab	Efficacy	yes	Genotypes CT + TT is associated with increased response to adalimumab in people with Crohn Disease as compared to genotype CC.	C		= 8.11E-4	OR	9.44	2.49	35.83
1450931972	rs2242480	fentanyl	Efficacy	yes	Genotype TT is associated with increased response to fentanyl in women with Pain, Postoperative as compared to genotypes CC + CT.	T		< 0.001				
1451226960	rs4149056	simvastatin	Efficacy	yes	Genotype TT is associated with increased response to simvastatin in people with Hypercholesterolemia as compared to genotypes CC + CT.			= 0.016				
1448998711	rs6318	clozapine	Efficacy	yes	Allele C is associated with increased response to clozapine in people with Schizophrenia as compared to allele G.			= 0.005	OR			
1450374964	rs2550956	methylphenidate	Efficacy	no	Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.				OR			
1451161440	rs11280056	methotrexate	Toxicity	no	Allele del is associated with increased discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele TTAAAGTTA.			= 0.07	OR	2.56	0.89	7.34
1450374971	rs11564750	methylphenidate	Efficacy	no	Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.				OR			
1450374957	rs2652510	methylphenidate	Efficacy	no	Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.				OR			
1450932012	rs2032582	sufentanil	Dosage	yes	Genotypes AA + AC are associated with increased dose of sufentanil in people with Lung Neoplasms and Pain, Postoperative as compared to genotype CC.	A		< 0.05				
1450932019	rs1045642	sufentanil	Dosage	no	Allele A is not associated with dose of sufentanil in people with Lung Neoplasms and Pain, Postoperative as compared to allele G.	A		> 0.05				
1184483225	rs12083537	tocilizumab	Efficacy	yes	Genotype AA is associated with decreased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotype AG.			= 0.02	OR			
608431344	rs2284017	lithium	Efficacy	not stated	Allele C is associated with increased response to lithium in people with Bipolar Disorder as compared to allele T.			= 0.029	OR	0.35		
1450932030	rs563649	sufentanil	Dosage	no	Allele C is not associated with dose of sufentanil in people with Lung Neoplasms and Pain, Postoperative as compared to allele T.	T		> 0.05				
1444936470	rs4645983	adalimumab	Efficacy	no	Genotypes AA + AG is associated with increased response to adalimumab in people with Crohn Disease as compared to genotype GG.	A		= 6.91E-3	OR			
1444936470	rs4645983	adalimumab	Efficacy	no	Genotypes AA + AG is associated with increased response to adalimumab in people with Crohn Disease as compared to genotype GG.	A		= 7.22E-3	OR			
1184483234	rs4329505	tocilizumab	Efficacy	yes	Genotypes CC + CT is associated with decreased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotype TT.			= 0.02	OR			
1451161488	rs1045642	methadone	Efficacy	no	Allele G is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele A.			= 0.266				
1451227020	rs2306283	simvastatin	Efficacy	no	Genotypes AG + GG are not associated with increased response to simvastatin in people with Hypercholesterolemia as compared to genotype AA.			= 0.52				
1448998827	rs518147	risperidone	Efficacy	yes	Genotype CC is associated with increased response to risperidone in women with Schizophrenia as compared to genotypes CG + GG.	C		= 0.011	OR			
1448998839	rs1023574	risperidone	Efficacy	yes	Genotype CC is associated with increased response to risperidone in women with Schizophrenia as compared to genotypes CG + GG.	C		= 0.016	OR			
1448998848	rs9698290	risperidone	Efficacy	yes	Genotype TT is associated with increased response to risperidone in women with Schizophrenia as compared to genotypes CC + CT.	T		= 0.019	OR			
1449244619	rs7439366	morphine	Dosage	no	Genotype CT is not associated with dose of morphine in women with Pain, Postoperative as compared to genotype TT.	C		= 0.005	OR			
1449179077	rs628031	imatinib	Efficacy	yes	Genotypes AA + AG is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype GG.			= 0.011	OR	0.58	0.38	0.88
1448998855	rs3813929	risperidone	Efficacy	no	Genotype TT is not associated with increased response to risperidone in women with Schizophrenia as compared to genotypes CC + CT.	T		= 0.062	OR			
1444936324	rs699664	warfarin	Dosage	no	Allele T is not associated with dose of warfarin as compared to genotype CC.			= 0.60	OR			
1444706967	rs9923231	acenocoumarol	Dosage	yes	Genotype TT are associated with decreased dose of acenocoumarol as compared to genotype CC.			< 0.001	OR			
655386443	rs11042725	paroxetine	Efficacy	yes	Genotype CC is associated with decreased response to paroxetine in people with Depressive Disorder, Major as compared to genotypes AA + AC.			= 0.001	OR	0.075	0.019	0.295
1445296785	rs1799971	morphine	Efficacy	yes	Genotypes AG + GG is associated with decreased response to morphine in children as compared to genotype AA.	G		= 0.045	OR			
1444706973	rs9934438	acenocoumarol	Dosage	yes	Genotypes AA + AG are associated with decreased dose of acenocoumarol as compared to genotype GG.			< 0.0001	OR			
1445296694	rs2108622	warfarin	Dosage	yes	Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.			= 0.004	OR			
1445296694	rs2108622	warfarin	Dosage	yes	Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.			= 0.01	OR			
1445296694	rs2108622	warfarin	Dosage	yes	Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.			= 0.76	OR			
1451341865	rs4961	hydrochlorothiazide	Efficacy	yes	Genotypes GT + TT is associated with increased response to hydrochlorothiazide as compared to genotype GG.							
1445296716	rs12777823	warfarin	Dosage	yes	Genotypes AA + AG are associated with decreased dose of warfarin as compared to genotype GG.			< 0.001	OR			
1445296716	rs12777823	warfarin	Dosage	yes	Genotypes AA + AG are associated with decreased dose of warfarin as compared to genotype GG.			= 0.002	OR			
1445296716	rs12777823	warfarin	Dosage	yes	Genotypes AA + AG are associated with decreased dose of warfarin as compared to genotype GG.			= 0.41	OR			
1448589873	rs45445694	methotrexate	Efficacy	yes	Genotype (CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3 is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes (CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2 + (CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3.			= 0.01	OR	0.47	0.26	0.86
1448589833	rs4673993	methotrexate	Efficacy	yes	Genotype CC is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.			= 0.01	OR	2.54	1.23	5.26
1445296652	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.			< 0.001	OR			
1445296652	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.			< 0.001	OR			
1445296652	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.			< 0.001	OR			
1445296571	rs10161126	alendronate	Efficacy	yes	Genotype GG is associated with increased response to alendronate in women with Bone Diseases as compared to genotypes AA + AG.	G		= 0.002	OR	2.06	1.08	6.41
1445296586	rs2032582	imatinib	Efficacy	yes	Allele C is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive.			= 0.031	OR	1.42	1.03	1.96
1448573389	rs1045642	tacrolimus	Efficacy	not stated	Genotypes AG + GG is not associated with response to tacrolimus in people with Colitis, Ulcerative as compared to genotype AA.	A			OR			
1449752734	rs1042522	oxaliplatin	Efficacy	yes	Genotypes CG + GG is associated with decreased response to oxaliplatin in people with Colorectal Neoplasms as compared to genotype CC.	G		= 0.001	OR			
1449752734	rs1042522	oxaliplatin	Efficacy	yes	Genotypes CG + GG is associated with decreased response to oxaliplatin in people with Colorectal Neoplasms as compared to genotype CC.	G		= 0.5	HR	0.87	0.57	1.32
1449752734	rs1042522	oxaliplatin	Efficacy	yes	Genotypes CG + GG is associated with decreased response to oxaliplatin in people with Colorectal Neoplasms as compared to genotype CC.	G		= 0.58	HR	0.88	0.57	1.37
1448573382	rs2032582	tacrolimus	Efficacy	not stated	Genotype AA is not associated with response to tacrolimus in people with Colitis, Ulcerative.	C			OR			
1445296591	rs1045642	imatinib	Efficacy	yes	Genotype GG is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes AA + AG.			= 0.011	OR	0.73	0.57	0.93
608431045	rs6280	clozapine	Efficacy	not stated	Allele T is not associated with response to clozapine in people with Schizophrenia as compared to allele C.			= 0.1	OR	0.82	0.65	1.04
1448262073	rs2284411	methylphenidate	Efficacy	yes	Genotype CC is associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes CT + TT.	C		= 0.026	OR	14.2	1.4	146.2
1444706671	rs8099917	peginterferon alfa-2b	Efficacy	yes	Genotype TT is associated with increased response to peginterferon alfa-2b in people with Hepatitis C, Chronic as compared to genotypes GG + GT.			< 0.001	OR			
1449162934	rs7439366	morphine	Dosage	yes	Genotype CC is associated with decreased dose of morphine in women with Pain, Postoperative as compared to genotype TT.	C		= 0.005	OR			
1449162954	rs1799971	morphine	Dosage	no	Genotype GG is associated with increased dose of morphine in women with Pain, Postoperative as compared to genotypes AA + AG.	G			OR			
1445296539	rs4532	risperidone	Efficacy	no	Allele C is not associated with response to risperidone in people with Schizophrenia as compared to allele T.				OR			
1445296532	rs4867798	risperidone	Efficacy	no	Allele C is not associated with response to risperidone in people with Schizophrenia as compared to allele T.				OR			
1448573312	rs1128503	tacrolimus	Efficacy	yes	Genotypes AG + GG are associated with increased response to tacrolimus in people with Colitis, Ulcerative as compared to genotype AA.	G		= 0.002	OR			
1448573312	rs1128503	tacrolimus	Efficacy	yes	Genotypes AG + GG are associated with increased response to tacrolimus in people with Colitis, Ulcerative as compared to genotype AA.	G		= 0.002	OR			
1448573312	rs1128503	tacrolimus	Efficacy	yes	Genotypes AG + GG are associated with increased response to tacrolimus in people with Colitis, Ulcerative as compared to genotype AA.	G		= 0.003	OR			
1448573312	rs1128503	tacrolimus	Efficacy	yes	Genotypes AG + GG are associated with increased response to tacrolimus in people with Colitis, Ulcerative as compared to genotype AA.	G		= 0.004	OR			
1449162966	rs1799971	morphine	Dosage	no	Allele G is associated with increased concentrations of morphine in women with Pain, Postoperative as compared to allele A.	G			OR			
1445296525	rs5326	risperidone	Efficacy	no	Allele C is not associated with response to risperidone in people with Schizophrenia as compared to allele T.				OR			
1449162979	rs2229109	morphine	Dosage	no	Allele T is not associated with concentrations of morphine in women with Pain, Postoperative as compared to allele C.	T			OR			
1449162972	rs2229109	morphine	Dosage	no	Allele T is not associated with dose of morphine in women with Pain, Postoperative as compared to allele C.	T			OR			
1449162985	rs1128503	morphine	Dosage	no	Allele A is not associated with dose of morphine in women with Pain, Postoperative as compared to allele G.	A			OR			
1449162993	rs1128503	morphine	Dosage	no	Allele A is not associated with concentrations of morphine in women with Pain, Postoperative as compared to allele G.	A			OR			
1449163001	rs2032582	morphine	Dosage	no	Allele A is not associated with dose of morphine in women with Pain, Postoperative as compared to allele C.	A			OR			
699639234	rs5443	sildenafil	Efficacy	yes	Genotype TT is associated with increased response to sildenafil in people with Erectile Dysfunction as compared to genotypes CC + CT.			= 0.01	OR	10.0	1.2	81.1
1449163009	rs2032582	morphine	Dosage	no	Allele A is not associated with concentrations of morphine in women with Pain, Postoperative as compared to allele C.	A			OR			
1449163018	rs1045642	morphine	Dosage	no	Allele A is not associated with dose of morphine in women with Pain, Postoperative as compared to allele G.	A			OR			
1448589644	rs1045642	methotrexate	Efficacy	yes	Genotype AA is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.			= 0.01	OR	0.57	0.36	0.9
1449163026	rs1045642	morphine	Dosage	no	Allele A is not associated with concentrations of morphine in women with Pain, Postoperative as compared to allele G.	A			OR			
1448573250	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.			= 0.004	OR			
1448573250	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.			= 0.02	OR			
1447983413	rs1800544	methylphenidate	Efficacy	no	Allele G is associated with decreased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity as compared to allele C.			= 0.033	OR	0.56	0.329	0.953
1448265990	rs77010898	ivacaftor	Efficacy	yes	Genotype AA is associated with increased response to ivacaftor in people with Cystic Fibrosis as compared to genotype GG.	A			OR			
1444694293	rs776746	tacrolimus	Dosage	yes	Genotypes CT + TT is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to genotype CC.	C		= 0.481	OR			
1450822034	rs1799971	ethanol	Other	yes	Genotype AG is associated with increased response to ethanol in people with Alcoholism as compared to genotype AA.	G		< 0.001				
1450822015	rs1799971	heroin	Toxicity	no	Allele G is not associated with dose of heroin in men Heroin Dependence as compared to allele A.			= 0.17				
981954002	rs2279287	lithium	Efficacy	no	Allele T is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	T		= 0.57	OR	1.11		
1184512509	rs12505410	imatinib	Efficacy	yes	Allele G is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele T.			< 0.001	OR			
1184512509	rs12505410	imatinib	Efficacy	yes	Allele G is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele T.			= 0.005	OR			
1184512509	rs12505410	imatinib	Efficacy	yes	Allele G is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele T.			= 0.006	OR			
1184512509	rs12505410	imatinib	Efficacy	yes	Allele G is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele T.			= 0.185	OR			
1450822109	rs510769	nicotine	Dosage	no	Allele T is not associated with dose of nicotine as compared to allele C.			= 0.772				
1184512515	rs12505410	imatinib	Efficacy	yes	Genotypes GG + GT is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype TT.			= 0.035	OR			
1449003454	rs10841753	methotrexate	Efficacy	no	Allele C is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.			> 0.05	HR			
981954014	rs1982350	lithium	Efficacy	no	Allele A is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele G.	A		= 0.86	OR	0.97		
1184512524	rs13120400	imatinib	Efficacy	yes	Genotypes CC + CT is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype TT.			= 0.046	OR			
1184512528	rs2725252	imatinib	Efficacy	yes	Genotypes AC + CC is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype AA.			< 0.047	OR			
981953971	rs1062613	clozapine	Efficacy	yes	Allele T is associated with increased response to clozapine in people with Schizophrenia as compared to allele C.	T		= 0.02	OR	28.36	1.69	476.03
1450822078	rs1799971	ethanol	Dosage	yes	Genotypes AG + GG are associated with decreased dose of ethanol in women as compared to genotype AA.			= 0.049	OR	0.55	0.304	0.998
1450822083	rs1799971	nicotine	Dosage	no	Genotypes AG + GG are not associated with dose of nicotine as compared to genotype AA.			= 0.716				
1184512440	rs75527207	ivacaftor	Efficacy	yes	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.			= 0.023	OR			
981954089	rs228697	lithium	Efficacy	no	Allele G is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	G		= 0.66	OR	1.12		
981954083	rs228666	lithium	Efficacy	no	Allele C is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele T.	C		= 0.61	OR	0.92		
981954077	rs228642	lithium	Efficacy	no	Allele C is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele T.	C		= 0.58	OR	1.11		
1450822133	rs10485057	ethanol	Dosage	yes	Genotype AA is associated with increased dose of ethanol as compared to genotype AG.			= 0.001	OR	2.4	1.4	4.12
1450822133	rs10485057	ethanol	Dosage	yes	Genotype AA is associated with increased dose of ethanol as compared to genotype AG.			= 0.026				
981954029	rs2278749	lithium	Efficacy	no	Allele T is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	T		= 0.47	OR	1.18		
1450822141	rs10485057	nicotine	Dosage	no	Genotype AA is associated with increased dose of nicotine as compared to genotypes AG + GG.			> 0.05				
1449577002	rs17834628	salbutamol	Efficacy	yes	Allele A is associated with increased response to salbutamol in children with as compared to allele G.			= 1.18E-8	OR	1.67	1.29	2.16
981954051	rs34897046	lithium	Efficacy	no	Allele C is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele G.			= 0.45	OR	1.34		
981954045	rs3736544	lithium	Efficacy	no	Allele A is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele G.	A		= 0.1	OR	0.75		
1444694003	rs776746	tacrolimus	Dosage	yes	Genotypes CT + TT is associated with increased dose of tacrolimus in people with liver transplantation as compared to genotype CC.			< 0.001	OR			
1449577012	rs35661809	salbutamol	Efficacy	yes	Allele G is associated with increased response to salbutamol in children with as compared to allele A.			= 3.33E-8	OR	1.59	1.2	2.1
981954104	rs2640909	lithium	Efficacy	no	Allele C is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele T.	C		= 0.47	OR	0.88		
1444694034	rs776746	tacrolimus	Dosage	yes	Genotypes CT + TT is associated with increased dose of tacrolimus in people with heart transplantation as compared to genotype CC.	C		< 0.003	OR			
981954096	rs2859388	lithium	Efficacy	no	Allele G is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.	G		= 0.79	OR	1.05		
981954198	rs2276302	clozapine	Efficacy	yes	Allele G is associated with increased response to clozapine in people with Schizophrenia as compared to allele A.	G		= 0.02	OR	6.59	1.32	32.95
1450822293	rs16969968	varenicline	Efficacy	no	Allele G is not associated with response to varenicline in people with Tobacco Use Disorder as compared to allele A.							
1449003637	rs2740574	lumefantrine	Efficacy	yes	Allele T is associated with decreased response to lumefantrine in women with Malaria and Pregnancy as compared to allele C.			= 0.018	OR			
1450822299	rs16969968	nicotine	Efficacy	yes	Genotypes AA + AG are associated with increased response to nicotine in people with Tobacco Use Disorder as compared to genotype GG.			= 0.016	OR	10.0	1.54	65.1
1450822299	rs16969968	nicotine	Efficacy	yes	Genotypes AA + AG are associated with increased response to nicotine in people with Tobacco Use Disorder as compared to genotype GG.			= 0.028	OR	3.03	1.13	8.15
1449003645	rs3745274	lumefantrine	Efficacy	no	Allele T is not associated with response to lumefantrine in women with Malaria and Pregnancy as compared to allele G.			> 0.05	OR			
1449003659	rs776746	lumefantrine	Efficacy	no	Allele C is not associated with response to lumefantrine in women with Malaria and Pregnancy as compared to allele T.			> 0.05	OR			
1449003652	rs28399499	lumefantrine	Efficacy	no	Allele C is not associated with response to lumefantrine in women with Malaria and Pregnancy as compared to allele T.			> 0.05	OR			
1449003666	rs10264272	lumefantrine	Efficacy	no	Allele T is not associated with response to lumefantrine in women with Malaria and Pregnancy as compared to allele C.			> 0.05	OR			
1449003673	rs41303343	lumefantrine	Efficacy	no	Allele A is not associated with response to lumefantrine in women with Malaria and Pregnancy as compared to allele del.			> 0.05	OR			
1449003680	rs3842	lumefantrine	Efficacy	no	Allele T is not associated with response to lumefantrine in women with Malaria and Pregnancy as compared to allele C.			> 0.05	OR			
1450117776	rs2254638	clopidogrel	Efficacy	yes	Allele G is associated with decreased response to clopidogrel in people with Coronary Artery Disease as compared to allele A.			= 1.87e-3	OR			
1444693994	rs776746	tacrolimus	Dosage	yes	Genotypes CT + TT is associated with increased dose of tacrolimus in people with liver transplantation as compared to genotype CC.			< 0.001	OR			
1451117264	rs1275988	candesartan	Efficacy	yes	Allele C is associated with increased response to candesartan in people with Hypertension as compared to allele T.			= 3.8E-8				
1184168650	rs610604	ustekinumab	Efficacy	no	Genotype GG is not associated with response to ustekinumab in people with Psoriasis as compared to genotype TT.	G		= 0.75	OR	1.6		
1447675769	rs465646	cisplatin	Efficacy	no	Genotypes AG + GG are not associated with increased response to cisplatin in people with Osteosarcoma as compared to genotype AA.	G		= 0.335	OR	1.5	0.66	3.44
1444693810	rs361525	adalimumab	Efficacy	yes	Genotype GG is associated with decreased response to adalimumab in people with Arthritis, Rheumatoid.			= 0.015	OR			
1447675747	rs3087399	cisplatin	Efficacy	no	Genotypes CC + CT are not associated with increased response to cisplatin in people with Osteosarcoma as compared to genotype TT.	C		= 0.707	OR	0.87	0.41	1.82
1447675754	rs3204953	cisplatin	Efficacy	no	Genotypes CT + TT are not associated with increased response to cisplatin in people with Osteosarcoma as compared to genotype CC.	T		= 0.265	OR	1.56	0.71	3.51
1451117340	rs1378942	hydrochlorothiazide	Efficacy	yes	Allele C is associated with decreased response to hydrochlorothiazide in people with Hypertension as compared to allele A.			= 8.8E-7				
1447675738	rs3087386	cisplatin	Efficacy	no	Genotypes AA + AG are not associated with increased response to cisplatin in people with Osteosarcoma as compared to genotype GG.	A		= 0.189	OR	1.96	0.72	5.33
1451117350	rs12579720	hydrochlorothiazide	Efficacy	yes	Allele C is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to allele G.			= 2.96E-5				
1447675704	rs3087403	cisplatin	Efficacy	yes	Genotypes CT + TT are associated with increased response to cisplatin in people with Osteosarcoma as compared to genotype CC.	T		< 0.001	OR	4.44	1.92	10.27
1451117391	rs932764	hydrochlorothiazide	Efficacy	yes	Allele A is associated with decreased response to hydrochlorothiazide in people with Hypertension as compared to allele G.			= 6.55E-5				
1451117401	rs10995311	hydrochlorothiazide	Efficacy	yes	Allele C is associated with decreased response to hydrochlorothiazide in people with Hypertension as compared to allele G.			= 4.94E-5				
1451101020	rs10046	exemestane	PD	no	Genotype AA is not associated with response to exemestane in women with Breast Neoplasms as compared to genotypes AG + GG.	G						
1451117407	rs740406	candesartan	Efficacy	yes	Allele A is associated with decreased response to candesartan in people with Hypertension as compared to allele G.			= 1.1E-4				
1451117412	rs757081	hydrochlorothiazide	Efficacy	yes	Allele C is associated with decreased response to hydrochlorothiazide in people with Hypertension as compared to allele G.			= 1.77E-4				
1444693768	rs1799724	adalimumab	Efficacy	no	Genotype CC is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.			= 0.11	OR			
1451117360	rs6722745	candesartan	Efficacy	yes	Allele T is associated with decreased response to candesartan in people with Hypertension as compared to allele C.			= 1.81E-5				
1451117356	rs4387287	atenolol	Efficacy	yes	Allele A is associated with decreased response to atenolol in people with Hypertension as compared to allele C.			= 3.38E-5				
1444693781	rs361525	adalimumab	Efficacy	no	Genotype GG is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.			= 0.18	OR			
1444693787	rs1799724	adalimumab	Efficacy	yes	Genotype CC is associated with decreased response to adalimumab in people with Arthritis, Rheumatoid.			= 0.015	OR			
1451117379	rs1446468	metoprolol	Efficacy	yes	Allele T is associated with increased response to metoprolol in people with Hypertension as compared to allele C.			= 2.65E-4				
1444693800	rs1800629	adalimumab	Efficacy	yes	Genotype GG is associated with decreased response to adalimumab in people with Arthritis, Rheumatoid.			= 0.015	OR			
1184168874	rs662	clopidogrel	Efficacy	no	Genotypes CC + CT is not associated with response to clopidogrel in people with Acute coronary syndrome as compared to genotype TT.	T		= 0.33	HR	0.92	0.62	1.37
1449167728	rs6700741	duloxetine	Efficacy	yes	Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.			< 5E-5	OR	0.16		
1449167736	rs4971678	duloxetine	Efficacy	yes	Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	0.14		
1184168867	rs1045642	clopidogrel	Efficacy	no	Genotypes AA + AG is not associated with response to clopidogrel in people with Acute coronary syndrome as compared to genotype GG.	A		= 0.45	HR	1.17	0.78	1.78
1451117460	rs12521868	hydrochlorothiazide	Efficacy	yes	Allele G is associated with decreased response to hydrochlorothiazide in people with Hypertension as compared to allele T.			= 1.17E-4				
1448265433	rs4570625	fluoxetine	Efficacy	yes	Genotype TT is associated with increased response to fluoxetine in children with Mental Disorders as compared to genotypes GG + GT.			= 0.00002	OR			
1449167742	rs2933304	duloxetine	Efficacy	yes	Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.			< 5E-5	OR	0.27		
1451117480	rs3184504	candesartan	Efficacy	yes	Allele T is associated with increased response to candesartan in people with Hypertension as compared to allele C.			= 2.29E-4				
1449167758	rs12630569	duloxetine	Efficacy	yes	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.			< 5E-5	OR	0.18		
1448265419	rs130058	fluoxetine	Efficacy	yes	Genotypes AA + TT are associated with increased response to fluoxetine in children with Mental Disorders as compared to genotype AT.			= 0.00009	OR			
1449167770	rs4334661	duloxetine	Efficacy	yes	Allele T is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.			< 5E-5	OR	8.67		
1449167764	rs13093500	duloxetine	Efficacy	yes	Allele T is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	8.67		
1449167785	rs7616119	duloxetine	Efficacy	yes	Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.			< 5E-5	OR	8.67		
1451101060	rs4646	exemestane	PD	no	Genotype CC is not associated with response to exemestane in women with Breast Neoplasms as compared to genotypes AA + AC.	A						
1450970060	rs1042028	tamoxifen	Efficacy	yes	Genotype TT is associated with decreased response to tamoxifen in women with Breast Neoplasms as compared to genotypes CC + CT.	T		= 0.004	HR	2.9	1.1	7.6
1450970060	rs1042028	tamoxifen	Efficacy	yes	Genotype TT is associated with decreased response to tamoxifen in women with Breast Neoplasms as compared to genotypes CC + CT.	T		= 0.45	HR	0.7	0.3	1.5
1449167791	rs7625956	duloxetine	Efficacy	yes	Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	4.11		
1449167803	rs9310657	duloxetine	Efficacy	yes	Allele T is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.			< 5E-5	OR	8.67		
1449167797	rs7653345	duloxetine	Efficacy	yes	Allele A is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.			< 5E-5	OR	8.67		
1449167809	rs9310658	duloxetine	Efficacy	yes	Allele C is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.			< 5E-5	OR	8.67		
1449167815	rs9819548	duloxetine	Efficacy	yes	Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	8.67		
1449167827	rs9873889	duloxetine	Efficacy	yes	Allele C is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.			< 5E-5	OR	4.63		
1449167821	rs9824595	duloxetine	Efficacy	yes	Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.			< 5E-5	OR	8.67		
1449167833	rs9879065	duloxetine	Efficacy	yes	Allele C is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.			< 5E-5	OR	4.63		
769171199	rs1051266	methotrexate	Efficacy	yes	Allele T is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.			= 0.013	OR	1.78	1.13	2.81
1449167839	rs10007051	duloxetine	Efficacy	yes	Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.			< 5E-5	OR	0.29		
1449167845	rs11933890	duloxetine	Efficacy	yes	Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.			< 5E-5	OR	0.3		
1449167857	rs55881666	duloxetine	Efficacy	yes	Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.			< 5E-5	OR	0.3		
1449167863	rs56229625	duloxetine	Efficacy	yes	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.			< 5E-5	OR	0.3		
1449167875	rs62319299	duloxetine	Efficacy	yes	Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.			< 5E-5	OR	0.3		
1449167869	rs61692318	duloxetine	Efficacy	yes	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	0.15		
1449167881	rs10123866	duloxetine	Efficacy	yes	Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	4.4		
1449167888	rs10124893	duloxetine	Efficacy	yes	Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	4.19		
1449167894	rs10989064	duloxetine	Efficacy	yes	Allele T is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.			< 5E-5	OR	4.4		
1449167900	rs6479008	duloxetine	Efficacy	yes	Allele C is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	4.4		
1449167912	rs7472	duloxetine	Efficacy	yes	Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	4.4		
1450822736	rs1799971	nicotine	Other	no	Allele G is not associated with dose of nicotine in people with Tobacco Use Disorder as compared to allele A.			> 0.41	OR	0.8	0.4	1.59
1450822736	rs1799971	nicotine	Other	no	Allele G is not associated with dose of nicotine in people with Tobacco Use Disorder as compared to allele A.			> 0.41	OR	0.63	0.23	1.76
1450822736	rs1799971	nicotine	Other	no	Allele G is not associated with dose of nicotine in people with Tobacco Use Disorder as compared to allele A.			> 0.41	OR	0.63	0.21	1.89
1449167918	rs12595802	duloxetine	Efficacy	yes	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	0.18		
982036564	rs1800206	fenofibrate	Efficacy	no	Allele C is not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to allele G.				OR	1.06	0.55	2.01
982036564	rs1800206	fenofibrate	Efficacy	no	Allele C is not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to allele G.				OR	1.3	0.64	2.62
1449167924	rs12603700	duloxetine	Efficacy	yes	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	0.14		
1449167936	rs56355515	duloxetine	Efficacy	yes	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	0.14		
1449167942	rs58042962	duloxetine	Efficacy	yes	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	0.14		
1448576460	rs1051266	methotrexate	Efficacy	yes	Genotype TT is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes CC + CT.			= 0.01	OR	1.91	1.16	3.15
1448576417	rs17602729	methotrexate	Efficacy	yes	Genotypes AA + AG is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.			= 0.005	OR	1.77	1.19	2.63
1448576417	rs17602729	methotrexate	Efficacy	yes	Genotypes AA + AG is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.			= 0.02	OR	1.82	1.08	3.07
1449168106	rs12094644	duloxetine	Efficacy	yes	Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	0.27		
1449168100	rs12502866	duloxetine	Efficacy	yes	Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	4.36		
1449168118	rs4437856	duloxetine	Efficacy	yes	Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.			< 5E-5	OR	0.27		
1449168131	rs4639250	duloxetine	Efficacy	yes	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.			< 5E-5	OR	0.3		
1449168125	rs12657120	duloxetine	Efficacy	yes	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.			< 5E-5	OR	0.31		
1449168137	rs13204353	duloxetine	Efficacy	yes	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	0.32		
769170891	rs55754655	azathioprine	Efficacy	yes	Allele G is associated with decreased response to azathioprine in people with Inflammatory Bowel Diseases as compared to allele A.			= 0.035	OR	2.54	1.06	6.13
1449168143	rs9369266	duloxetine	Efficacy	yes	Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.			< 5E-5	OR	0.31		
1449168155	rs3128624	duloxetine	Efficacy	yes	Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.			< 5E-5	OR	0.32		
1449168149	rs3124955	duloxetine	Efficacy	yes	Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.			< 5E-5	OR	0.32		
1449168161	rs10771997	duloxetine	Efficacy	yes	Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.			< 5E-5	OR	0.17		
1448592688	rs1801131	methotrexate	Efficacy	yes	Genotype GG is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes GT + TT.			= 0.04	OR	0.42	0.19	0.94
1449168167	rs10771998	duloxetine	Efficacy	yes	Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.			< 5E-5	OR	0.17		
1449168173	rs7306991	duloxetine	Efficacy	yes	Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.			< 5E-5	OR	0.17		
1449168185	rs7316769	duloxetine	Efficacy	yes	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.			< 5E-5	OR	0.13		
1449168191	rs17724452	duloxetine	Efficacy	yes	Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	0.18		
1449577793	rs7196161	warfarin	Dosage	not stated	Allele G is associated with dose of warfarin as compared to allele A.	G			OR			
1449168199	rs17724464	duloxetine	Efficacy	yes	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.			< 5E-5	OR	0.18		
1449168205	rs17724494	duloxetine	Efficacy	yes	Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.			< 5E-5	OR	0.18		
1449577814	rs7196161	warfarin	Dosage	not stated	Allele A is associated with dose of warfarin in people with Atrial Fibrillation, Pulmonary Embolism, Stroke and Venous Thrombosis as compared to allele G.	A			OR			
1449168233	rs61908402	duloxetine	Efficacy	yes	Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.			< 5E-5	OR	0.18		
1449168240	rs61908403	duloxetine	Efficacy	yes	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	0.18		
1184136618	rs6759892	deferiprone	Efficacy	no	Genotype GG is not associated with response to deferiprone in people with beta-Thalassemia as compared to genotype TT.	G		= 0.6	OR	1.1	0.5	2.3
1184136611	rs2070959	deferiprone	Efficacy	yes	Genotype AA is associated with increased response to deferiprone in people with beta-Thalassemia as compared to genotype GG.	A		= 0.001	OR	4.6	1.65	12.8
1449168258	rs61908406	duloxetine	Efficacy	yes	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	0.18		
1184136603	rs6759892	deferiprone	Efficacy	yes	Genotype GG is associated with increased response to deferiprone in people with beta-Thalassemia as compared to genotypes GT + TT.	G		= 0.04	OR	1.8	1.0	3.3
1184136590	rs2070959	deferiprone	Efficacy	yes	Genotype AA is associated with increased response to deferiprone in people with beta-Thalassemia as compared to genotypes AG + GG.	A		= 0.01	OR	3.1	1.2	8.3
1449168264	rs61908407	duloxetine	Efficacy	yes	Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.			< 5E-5	OR	0.18		
1449168271	rs61908408	duloxetine	Efficacy	yes	Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.			< 5E-5	OR	0.18		
1449168283	rs61908410	duloxetine	Efficacy	yes	Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	0.18		
1449168277	rs61908409	duloxetine	Efficacy	yes	Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.			< 5E-5	OR	0.18		
1449168289	rs61908411	duloxetine	Efficacy	yes	Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.			< 5E-5	OR	0.18		
1449168295	rs78482393	duloxetine	Efficacy	yes	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	0.18		
1449168301	rs78615940	duloxetine	Efficacy	yes	Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.			< 5E-5	OR	0.18		
1451134420	rs2032582	lamotrigine		no	Allele A is not associated with decreased clinical benefit to lamotrigine in children with Epilepsy as compared to allele C.			= 0.35	OR	1.17		
1447986312	rs78655421	ivacaftor	Efficacy	yes	Genotypes AA + AG is associated with response to ivacaftor in people with Cystic Fibrosis.			< 0.05	OR			
1447675015	rs3215400	azacitidine	Efficacy	no	Genotype del/del is associated with increased resistance to azacitidine in people with Leukemia.				OR			
1184136634	rs1105879	deferiprone	Efficacy	no	Allele A is not associated with response to deferiprone in people with beta-Thalassemia as compared to allele C.	A		= 0.6	OR			
1447674959	rs17671591	atorvastatin	Efficacy	yes	Genotypes CT + TT is associated with increased response to atorvastatin in people with Hypercholesterolemia as compared to genotype CC.	T		= 0.021	OR			
1447674959	rs17671591	atorvastatin	Efficacy	yes	Genotypes CT + TT is associated with increased response to atorvastatin in people with Hypercholesterolemia as compared to genotype CC.	T		= 0.035	OR			
1447674959	rs17671591	atorvastatin	Efficacy	yes	Genotypes CT + TT is associated with increased response to atorvastatin in people with Hypercholesterolemia as compared to genotype CC.	T		= 0.039	OR			
1184513472	rs2725252	imatinib	Efficacy	yes	Allele C is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.			< 0.001	OR			
1184513472	rs2725252	imatinib	Efficacy	yes	Allele C is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.			= 0.005	OR			
1184513472	rs2725252	imatinib	Efficacy	yes	Allele C is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.			= 0.006	OR			
1184513472	rs2725252	imatinib	Efficacy	yes	Allele C is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.			= 0.185	OR			
1184513485	rs12505410	imatinib	Efficacy	yes	Allele G is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele T.			= 0.001	OR			
1184513485	rs12505410	imatinib	Efficacy	yes	Allele G is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele T.			= 0.022	OR			
1184513485	rs12505410	imatinib	Efficacy	yes	Allele G is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele T.			= 0.025	OR			
769170633	rs1232027	methotrexate	Efficacy	yes	Allele A is associated with increased response to methotrexate in people with Arthritis, Psoriatic as compared to allele G.			= 0.02	OR	2.99	1.2	7.55
1184988646	rs17035723	acamprosate	Efficacy	no	Allele T is not associated with response to acamprosate in people with Alcoholism as compared to allele C.			= 0.000098	HR	2.88		
1184988646	rs17035723	acamprosate	Efficacy	no	Allele T is not associated with response to acamprosate in people with Alcoholism as compared to allele C.			= 0.00012	HR	2.14		
1184988646	rs17035723	acamprosate	Efficacy	no	Allele T is not associated with response to acamprosate in people with Alcoholism as compared to allele C.			= 0.48	HR	0.82		
1447674916	rs2066992	duloxetine	Efficacy	no	Genotype GT is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotype GG.			= 0.047	OR			
1184513697	rs41271330	escitalopram	Efficacy	yes	Allele A is associated with decreased response to escitalopram in people with Depressive Disorder, Major as compared to allele G.			= 0.001	OR			
1184513697	rs41271330	escitalopram	Efficacy	yes	Allele A is associated with decreased response to escitalopram in people with Depressive Disorder, Major as compared to allele G.			= 0.001	OR			
1447674849	rs1570360	cetuximab	Efficacy	yes	Genotype GG is associated with increased response to cetuximab in people with Colorectal Neoplasms as compared to genotypes AA + AG.			= 0.007	OR			
982035107	rs4253778	fenofibrate	Efficacy	yes	Genotype GG is associated with increased response to fenofibrate in people with Diabetes Mellitus as compared to genotypes CC + CG.			= 0.013	OR	3.19	1.28	7.92
1184513638	rs581111	buprenorphine	Efficacy	yes	Genotypes AA + AG is associated with decreased response to buprenorphine in women with Opioid-Related Disorders as compared to genotype GG.			= 0.009	RR	1.56	1.41	1.78
1184513638	rs581111	buprenorphine	Efficacy	yes	Genotypes AA + AG is associated with decreased response to buprenorphine in women with Opioid-Related Disorders as compared to genotype GG.			= 0.03	RR	1.67	1.06	2.1
1184513638	rs581111	buprenorphine	Efficacy	yes	Genotypes AA + AG is associated with decreased response to buprenorphine in women with Opioid-Related Disorders as compared to genotype GG.			= 0.031	RR	1.72	1.25	1.97
1184513638	rs581111	buprenorphine	Efficacy	yes	Genotypes AA + AG is associated with decreased response to buprenorphine in women with Opioid-Related Disorders as compared to genotype GG.			> 0.05	OR			
1451134681	rs1799971	sufentanil	Efficacy	no	Genotypes AG + GG are not associated with response to sufentanil in people with Pain, Postoperative as compared to genotype AA.	G		> 0.05				
1450823384	rs1799971	ethanol	Other	not stated	Genotypes AG + GG are associated with increased response to ethanol in people with Alcoholism as compared to genotype AA.							
1184513812	rs2592551	warfarin	Dosage	yes	Genotypes AA + AG is associated with increased dose of warfarin in people with Atrial Fibrillation as compared to genotype GG.	A		< 0.000	OR			
1184513812	rs2592551	warfarin	Dosage	yes	Genotypes AA + AG is associated with increased dose of warfarin in people with Atrial Fibrillation as compared to genotype GG.	A		< 0.000	OR			
1184513812	rs2592551	warfarin	Dosage	yes	Genotypes AA + AG is associated with increased dose of warfarin in people with Atrial Fibrillation as compared to genotype GG.	A		= 0.057	OR			
1448100703	rs1061170	bevacizumab	Efficacy	yes	Genotype CC is associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotypes CT + TT.	C			OR			
1184513712	rs41271330	escitalopram	Efficacy	not stated	Genotypes AA + AG is associated with increased dose of escitalopram in people with Depressive Disorder, Major as compared to genotype GG.			= 0.010	OR			
1184513712	rs41271330	escitalopram	Efficacy	not stated	Genotypes AA + AG is associated with increased dose of escitalopram in people with Depressive Disorder, Major as compared to genotype GG.			= 0.17	OR			
1450807128	rs1137070	nicotine	Dosage	yes	Genotype TT is associated with increased dose of nicotine in people with Tobacco Use Disorder as compared to genotypes CC + CT.			= 0.008	OR		1.4	8.8
1450807128	rs1137070	nicotine	Dosage	yes	Genotype TT is associated with increased dose of nicotine in people with Tobacco Use Disorder as compared to genotypes CC + CT.			= 0.013	OR		0.6	5.1
1450807128	rs1137070	nicotine	Dosage	yes	Genotype TT is associated with increased dose of nicotine in people with Tobacco Use Disorder as compared to genotypes CC + CT.			= 0.048	OR		0.0	5.0
1450807128	rs1137070	nicotine	Dosage	yes	Genotype TT is associated with increased dose of nicotine in people with Tobacco Use Disorder as compared to genotypes CC + CT.			= 0.139	OR		-0.9	6.7
1450807128	rs1137070	nicotine	Dosage	yes	Genotype TT is associated with increased dose of nicotine in people with Tobacco Use Disorder as compared to genotypes CC + CT.			= 0.150	OR		-0.7	4.8
1450807128	rs1137070	nicotine	Dosage	yes	Genotype TT is associated with increased dose of nicotine in people with Tobacco Use Disorder as compared to genotypes CC + CT.			= 0.232	OR		-1.14	4.7
1185234819	rs1803274	rivastigmine	Efficacy	no	Genotype CC is not associated with increased response to rivastigmine in people with Lewy Body Disease as compared to genotype TT.			= 0.156	OR			
1185234819	rs1803274	rivastigmine	Efficacy	no	Genotype CC is not associated with increased response to rivastigmine in people with Lewy Body Disease as compared to genotype TT.			= 0.207	OR			
1185234844	rs1803274	rivastigmine	Efficacy	yes	Genotype CT is associated with increased response to rivastigmine in people with Lewy Body Disease as compared to genotype TT.			= 0.024	OR			
1185234844	rs1803274	rivastigmine	Efficacy	yes	Genotype CT is associated with increased response to rivastigmine in people with Lewy Body Disease as compared to genotype TT.			= 0.135	OR			
1450807114	rs77905	nicotine	Dosage	yes	Genotype GG is associated with decreased dose of nicotine in people with Tobacco Use Disorder as compared to genotypes AA + AG.			= 0.007	OR		-6.4	
1450807114	rs77905	nicotine	Dosage	yes	Genotype GG is associated with decreased dose of nicotine in people with Tobacco Use Disorder as compared to genotypes AA + AG.			= 0.007	OR		-6.6	-1.1
1450807114	rs77905	nicotine	Dosage	yes	Genotype GG is associated with decreased dose of nicotine in people with Tobacco Use Disorder as compared to genotypes AA + AG.			= 0.022	OR		-5.5	-0.4
1450807114	rs77905	nicotine	Dosage	yes	Genotype GG is associated with decreased dose of nicotine in people with Tobacco Use Disorder as compared to genotypes AA + AG.			= 0.498	OR		-6.0	3.0
1448116927	rs776746	clopidogrel	Efficacy	no	Genotype CC is not associated with response to clopidogrel in people with Carotid Artery Diseases as compared to genotypes CT + TT.	C		= 0.432	OR			
1449004961	rs4680	clozapine	Efficacy	no	Allele A is not associated with response to clozapine in people with Schizophrenia as compared to allele G.			> 0.05	OR			
1184169928	rs1801274	infliximab	Efficacy	yes	Allele G is associated with decreased response to infliximab in people with Arthritis, Rheumatoid as compared to allele A.			= 0.022	OR			
1447674471	rs1801131	methotrexate	Efficacy	yes	Genotypes GT + TT is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.	G		= 0.02	OR	2.6	1.1	5.8
1184514020	rs116855232	azathioprine	Toxicity	yes	Genotype TT is associated with decreased dose of azathioprine in people with Leukopenia as compared to genotype CC.	T		= 4.93E-11	OR			
1451118680	rs1045642	remifentanil	Dosage	yes	Genotype GG is associated with increased dose of remifentanil as compared to genotype AA.	G		< 0.05				
769169820	rs2246709	amlodipine	Efficacy	yes	Genotypes AG + GG are associated with increased response to amlodipine in people with Hypertension as compared to genotype AA.			= 0.01	HR	2.04	1.17	3.56
1451118687	rs1045642	remifentanil	Dosage	no	Genotype AG is not associated with dose of remifentanil as compared to genotypes AA + GG.	G		> 0.05				
1451118697	rs1045642	remifentanil	Efficacy	yes	Genotype GG is associated with decreased response to remifentanil as compared to genotype AA.	G		< 0.01				
1451118697	rs1045642	remifentanil	Efficacy	yes	Genotype GG is associated with decreased response to remifentanil as compared to genotype AA.	G		< 0.05				
1451118697	rs1045642	remifentanil	Efficacy	yes	Genotype GG is associated with decreased response to remifentanil as compared to genotype AA.	G		< 0.05				
1451118692	rs1045642	remifentanil	Efficacy	no	Genotype AG is not associated with response to remifentanil as compared to genotypes AA + GG.	G		> 0.05				
1449005162	rs1057910	warfarin	Dosage	yes	Genotype AC is associated with decreased dose of warfarin as compared to genotype AA.			< 0.001	OR			
1449005156	rs9934438	warfarin	Dosage	yes	Genotype AA is associated with decreased dose of warfarin as compared to genotypes AG + GG.			< 0.001	OR			
1449005167	rs2108622	warfarin	Dosage	yes	Genotype TT is associated with increased dose of warfarin as compared to genotypes CC + CT.			= 0.014	OR			
1449005185	rs4072879	warfarin	Dosage	yes	Genotype AA is associated with decreased dose of warfarin as compared to genotypes AG + GG.			= 0.001	OR			
1449005190	rs1877724	warfarin	Dosage	no	Genotype CC is associated with decreased dose of warfarin as compared to genotypes CT + TT.			= 0.098	OR			
1449005203	rs9934438	warfarin	Dosage	yes	Genotype AA is associated with decreased dose of warfarin as compared to genotypes AG + GG.			< 0.001	OR			
1449005213	rs1057910	warfarin	Dosage	yes	Genotype AC is associated with decreased dose of warfarin as compared to genotype AA.			< 0.001	OR			
1449005223	rs7975232	warfarin	Dosage	no	Genotype CC is not associated with decreased dose of warfarin as compared to genotypes AA + AC.			= 0.153	OR			
1449005229	rs2228570	warfarin	Dosage	no	Genotype AA is not associated with decreased dose of warfarin as compared to genotypes AG + GG.			= 0.342	OR			
1448116648	rs2242480	clopidogrel	Efficacy	no	Genotype CC is not associated with response to clopidogrel in people with Carotid Artery Diseases as compared to genotypes CT + TT.	C		= 0.532	OR			
1448264089	rs17716942	ustekinumab	Efficacy	no	Genotype CC is not associated with response to ustekinumab in people with Psoriasis as compared to genotype TT.	C		= 0.545	OR			
1448264077	rs17716942	etanercept	Efficacy	no	Genotype CC is not associated with response to etanercept in people with Psoriasis as compared to genotype TT.	C		= 0.663	OR			
1448264083	rs17716942	adalimumab	Efficacy	no	Genotype CC is not associated with response to adalimumab in people with Psoriasis as compared to genotype TT.	C		= 0.297	OR			
1447952771	rs75039782	ataluren	Efficacy	yes	Allele T is associated with response to ataluren in children with Cystic Fibrosis as compared to allele C.			= 0.002	OR			
1447952765	rs77010898	ataluren	Efficacy	yes	Allele A is associated with response to ataluren in children with Cystic Fibrosis as compared to allele G.	A		= 0.002	OR			
1448264060	rs27524	adalimumab	Efficacy	no	Genotype AA is not associated with response to adalimumab in people with Psoriasis as compared to genotype GG.	A		= 0.377	OR			
1448264066	rs27524	ustekinumab	Efficacy	no	Genotype AA is not associated with response to ustekinumab in people with Psoriasis as compared to genotype GG.	A		= 0.341	OR			
1449005283	rs9923231	warfarin	Dosage	yes	Genotype TT is associated with decreased dose of warfarin in people with venous thromboembolism as compared to genotype CC.			< 0.001	OR			
1448264054	rs27524	etanercept	Efficacy	no	Genotype AA is not associated with response to etanercept in people with Psoriasis as compared to genotype GG.	A		= 0.341	OR			
1450823878	rs1799971	nicotine	Other	yes	Genotypes AG + GG are associated with increased exposure to nicotine as compared to genotype GG.			= 0.00	OR	2.28	1.39	3.74
1450823878	rs1799971	nicotine	Other	yes	Genotypes AG + GG are associated with increased exposure to nicotine as compared to genotype GG.			= 0.51	OR	3.26	2.63	4.05
1450823878	rs1799971	nicotine	Other	yes	Genotypes AG + GG are associated with increased exposure to nicotine as compared to genotype GG.			= 0.97	OR	1.13	0.88	1.45
1184514346	rs3745274	imatinib	Efficacy	yes	Genotypes GG + GT is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype TT.	G		= 0.024	OR			
1447952758	rs113993959	ataluren	Efficacy	yes	Allele T is associated with response to ataluren in children with Cystic Fibrosis as compared to allele G.	T		= 0.002	OR			
1448264037	rs240993	adalimumab	Efficacy	no	Genotype TT is not associated with response to adalimumab in people with Psoriasis as compared to genotype CC.	C		= 0.328	OR			
1448264043	rs240993	ustekinumab	Efficacy	no	Genotype TT is not associated with response to ustekinumab in people with Psoriasis as compared to genotype CC.	C		= 0.093	OR			
1448264031	rs240993	etanercept	Efficacy	no	Genotype TT is not associated with response to etanercept in people with Psoriasis as compared to genotype CC.	C		= 0.266	OR			
1448264020	rs11209026	ustekinumab	Efficacy	no	Genotype AG is not associated with response to ustekinumab in people with Psoriasis as compared to genotype GG.	A		= 0.823	OR			
1448264014	rs11209026	adalimumab	Efficacy	no	Genotype AG is not associated with response to adalimumab in people with Psoriasis as compared to genotype GG.	A		= 0.732	OR			
1448264008	rs11209026	etanercept	Efficacy	no	Genotype AG is not associated with response to etanercept in people with Psoriasis as compared to genotype GG.	A		= 0.732	OR			
1448263988	rs4406273	ustekinumab	Efficacy	no	Genotype AA is not associated with response to ustekinumab in people with Psoriasis as compared to genotype GG.	A		= 0.385	OR			
1448268060	rs9934438	warfarin	Dosage	yes	Genotypes AG + GG are associated with increased dose of warfarin in people with Atrial Fibrillation as compared to genotype AA.	G		= 0.047	OR			
1446908186	rs121434568	erlotinib	Efficacy	yes	Allele G is associated with response to erlotinib in people with Carcinoma, Non-Small-Cell Lung.			= 0.001	HR	0.43	0.26	0.72
1446908186	rs121434568	erlotinib	Efficacy	yes	Allele G is associated with response to erlotinib in people with Carcinoma, Non-Small-Cell Lung.				HR	0.98	0.72	1.35
1444696319	rs71647871	clopidogrel	Efficacy	yes	Genotypes CT + TT are associated with increased response to clopidogrel in healthy individuals as compared to genotype CC.			= 0.036	OR			
1184510339	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT is associated with decreased dose of warfarin as compared to genotype CC.			< 0.001	OR			
1448268037	rs2108622	warfarin	Dosage	yes	Genotype TT is associated with increased dose of warfarin in people with Atrial Fibrillation as compared to genotypes CC + CT.	T		< 0.05	OR			
1450934575	rs11045819	grazoprevir	PD	yes	Allele A is associated with increased exposure to grazoprevir in people with Hepatitis C, Chronic as compared to allele C.	A		= 0.0263				
1450934575	rs11045819	grazoprevir	PD	yes	Allele A is associated with increased exposure to grazoprevir in people with Hepatitis C, Chronic as compared to allele C.	A		= 0.0382				
1450934582	rs2306283	grazoprevir	PD	no	Allele G is not associated with increased exposure to grazoprevir in people with Hepatitis C, Chronic as compared to allele A.	G		= 0.3803				
1184510363	rs396991	rituximab	Efficacy	yes	Genotype CC is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AC.	C		= 0.004	OR	9.43	2.08	42.7
1184510363	rs396991	rituximab	Efficacy	yes	Genotype CC is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AC.	C		= 0.02	OR			
1446908159	rs121434568	gefitinib	Efficacy	yes	Allele G is associated with response to gefitinib in people with Carcinoma, Non-Small-Cell Lung.			< 0.001	HR	0.34	0.24	0.49
1446908159	rs121434568	gefitinib	Efficacy	yes	Allele G is associated with response to gefitinib in people with Carcinoma, Non-Small-Cell Lung.				HR	1.14	0.85	1.52
1184510377	rs1061170	ranibizumab	Efficacy	no	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.			= 1.0	OR	0.79	0.43	1.43
1448267977	rs9934438	warfarin	Dosage	yes	Genotype AA is associated with decreased dose of warfarin in people with Atrial Fibrillation as compared to genotypes AG + GG.	G		= 0.044	OR			
1448267942	rs9934438	warfarin	Dosage	not stated	Genotypes AG + GG are associated with increased dose of warfarin in people with Stroke as compared to genotype AA.	G		< 0.05	OR			
1184510446	rs1136287	ranibizumab	Efficacy	no	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.			= 1.0	OR	1.13	0.64	1.97
1184510450	rs5888	ranibizumab	Efficacy	no	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.			= 1.0	OR	1.28	0.78	2.09
1449165252	rs2231142	allopurinol	Dosage	yes	Allele T is associated with increased dose of allopurinol in people with Gout as compared to allele G.			= 0.0008	OR			
1449181636	rs1799971	naltrexone	Efficacy	yes	Genotypes AG + GG are associated with increased response to naltrexone in people with Alcoholism as compared to genotype AA.			= 0.03	OR	2.02	1.26	3.22
1448267909	rs9934438	warfarin	Dosage	yes	Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA.	G		< 0.001	OR			
1448267884	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT are associated with dose of warfarin.	C			OR			
1448267876	rs2954625	metformin	Efficacy	yes	Genotypes CT + TT are associated with decreased response to metformin in people with Diabetes Mellitus as compared to genotype CC.			= 0.029	OR	0.23		
1184510386	rs3753394	ranibizumab	Efficacy	no	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.			= 1.0	OR	0.81	0.48	1.36
1184510390	rs1410996	ranibizumab	Efficacy	no	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.			= 0.847	OR	0.57	0.34	0.97
1184510394	rs1329428	ranibizumab	Efficacy	no	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.			= 0.281	OR	0.51	0.3	0.86
1184510398	rs10737680	ranibizumab	Efficacy	no	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele C.			= 1.0	OR	0.62	0.37	1.05
769169620	rs2290573	imatinib	Efficacy	yes	Genotype GG is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes AA + AG.			= 0.025	OR	6.72	1.51	29.91
1184510406	rs10490924	ranibizumab	Efficacy	no	Allele G is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.			= 1.0	OR	1.19	0.72	1.99
1184510410	rs11200638	ranibizumab	Efficacy	no	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.			= 1.0	OR	1.04	0.63	1.72
1184510414	rs429608	ranibizumab	Efficacy	no	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.			= 1.0	OR	1.5	0.64	3.48
1448267848	rs2617102	metformin	Efficacy	yes	Genotypes AC + CC is associated with decreased response to metformin in people with Diabetes Mellitus as compared to genotype AA.			= 0.02	OR	0.717		
1184510418	rs641153	ranibizumab	Efficacy	no	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.			= 1.0	OR	1.22	0.52	2.84
1184510422	rs9332739	ranibizumab	Efficacy	no	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.			= 1.0	OR	2.23	0.4	12.3
1444712539	rs2289669	metformin	Efficacy	yes	Genotype AA is associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to genotypes AG + GG.			< 0.05	OR			
1184510426	rs10033900	ranibizumab	Efficacy	no	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.			= 1.0	OR	0.53	0.22	1.24
1184510430	rs3025039	ranibizumab	Efficacy	no	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.			= 1.0	OR	2.46	0.8	7.57
1184510434	rs699946	ranibizumab	Efficacy	no	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.			= 1.0	OR	1.25	0.74	2.13
1184510438	rs699947	ranibizumab	Efficacy	no	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele C.			= 0.166	OR	3.53	1.41	8.85
1448267827	rs316009	metformin	Efficacy	yes	Genotype TT is associated with increased response to metformin in people with Diabetes Mellitus as compared to genotypes CC + CT.			= 0.04	OR	1.21	1.11	1.31
1184510442	rs833061	ranibizumab	Efficacy	no	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.			= 0.198	OR	3.44	1.37	8.64
1451147820	rs1799971	ketamine	Efficacy	no	Allele G is not associated with response to ketamine in people with Depressive Disorder, Major as compared to allele A.	G		= 0.34				
1451147820	rs1799971	ketamine	Efficacy	no	Allele G is not associated with response to ketamine in people with Depressive Disorder, Major as compared to allele A.	G		= 0.69				
1184510620	rs12714145	warfarin	Dosage	yes	Genotype TT is associated with increased dose of warfarin as compared to genotype CC.	T		= 0.027	OR			
1450934857	rs1718125	fentanyl	Dosage	yes	Genotypes CT + TT are associated with increased dose of fentanyl in people with Lung Neoplasms and Pain, Postoperative as compared to genotype CC.	T		< 0.05				
1450951310	rs3918290	fluorouracil	Efficacy	no	Genotype CT is not associated with response to fluorouracil in people with Colonic Neoplasms as compared to genotype CC.	T		= 0.73	HR	1.12	0.58	2.17
1184510511	rs5326	methylphenidate	Efficacy	yes	Genotypes CT + TT are associated with increased response to methylphenidate in children with Autism Spectrum Disorder as compared to genotype CC.			= 0.006	OR			
1184510516	rs4867798	methylphenidate	Efficacy	yes	Genotypes CC + CT is associated with increased response to methylphenidate in children with Autism Spectrum Disorder as compared to genotype TT.			= 0.042	OR			
1184510520	rs6280	methylphenidate	Efficacy	yes	Genotype TT is associated with increased response to methylphenidate in children with Autism Spectrum Disorder as compared to genotypes CC + CT.			= 0.044	OR			
1184510524	rs11246226	methylphenidate	Efficacy	yes	Genotype AA is associated with increased response to methylphenidate in children with Autism Spectrum Disorder as compared to genotypes AC + CC.			= 0.038	OR			
1184510528	rs1800544	methylphenidate	Efficacy	yes	Genotype CC is associated with increased response to methylphenidate in children with Autism Spectrum Disorder as compared to genotypes CG + GG.			= 0.015	OR			
1184510536	rs4680	methylphenidate	Efficacy	yes	Genotypes AA + AG is associated with increased response to methylphenidate in children with Autism Spectrum Disorder as compared to genotype GG.			= 0.049	OR			
1450820267	rs1799971	ethanol	Dosage	no	Allele G is not associated with dose of ethanol as compared to allele A.			= 0.24				
1450820267	rs1799971	ethanol	Dosage	no	Allele G is not associated with dose of ethanol as compared to allele A.			= 0.52				
1450820267	rs1799971	ethanol	Dosage	no	Allele G is not associated with dose of ethanol as compared to allele A.			= 0.54				
1450820267	rs1799971	ethanol	Dosage	no	Allele G is not associated with dose of ethanol as compared to allele A.			= 0.63				
1450820267	rs1799971	ethanol	Dosage	no	Allele G is not associated with dose of ethanol as compared to allele A.			= 0.68				
1450934903	rs10841753	estrone sulfate	Efficacy	yes	Allele C is associated with decreased concentrations of estrone sulfate in women with Breast Neoplasms as compared to allele T.			= 0.028				
1448431531	rs4124874	warfarin	Dosage	no	Genotype TT is not associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes GG + GT.	G		= 0.225	OR			
1448431525	rs4148323	warfarin	Dosage	no	Genotypes AG + GG are not associated with increased dose of warfarin in people with heart valve replacement as compared to genotype AA.	A		= 0.283	OR			
827862175	rs2032582	atorvastatin	Efficacy	yes	Allele T is associated with increased response to atorvastatin in people with Hypercholesterolemia as compared to allele A.			= 0.022	OR	5.69	1.28	25.24
1447677865	rs4889606	warfarin	Dosage	yes	Genotypes AG + GG are associated with decreased dose of warfarin as compared to genotype AA.			< 0.0001	OR			
1447677865	rs4889606	warfarin	Dosage	yes	Genotypes AG + GG are associated with decreased dose of warfarin as compared to genotype AA.			= 0.0001	OR			
1448431519	rs887829	warfarin	Dosage	yes	Genotype CC is associated with decreased dose of warfarin in people with heart valve replacement as compared to genotypes CT + TT.	T		= 0.003	OR			
1448431513	rs2108622	warfarin	Dosage	yes	Genotypes CC + CT are associated with decreased dose of warfarin in people with heart valve replacement as compared to genotype TT.	T		= 0.006	OR			
1451148002	rs933271	methadone	Efficacy	yes	Genotypes CC + CT are associated with increased response to methadone in people with Opioid-Related Disorders as compared to genotype TT.	C		= 0.02	OR	1.53	1.06	2.2
827862165	rs2032582	atorvastatin	Efficacy	yes	Allele T is associated with increased response to atorvastatin in people with Hypercholesterolemia as compared to allele C.			= 0.022	OR	5.69	1.28	25.24
1448431507	rs1057910	warfarin	Dosage	yes	Genotype AA is associated with increased dose of warfarin in people with heart valve replacement as compared to genotype AC.	C		< 0.001	OR			
1446907760	rs2229935	ranibizumab	Efficacy	no	Allele G is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele A.			= 0.01	OR			
1446907768	rs2247383	ranibizumab	Efficacy	no	Allele G is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele A.			= 0.01	OR			
1447677830	rs7856096	warfarin	Dosage	no	Genotype AA is not associated with dose of warfarin as compared to genotypes AG + GG.			= 0.46	OR			
1447677830	rs7856096	warfarin	Dosage	no	Genotype AA is not associated with dose of warfarin as compared to genotypes AG + GG.			= 0.86	OR			
1448431482	rs9934438	warfarin	Dosage	yes	Genotypes AG + GG are associated with increased dose of warfarin in people with heart valve replacement as compared to genotype AA.	A		< 0.001	OR			
1446907775	rs2804495	ranibizumab	Efficacy	no	Allele G is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.			= 0.01	OR			
1447677818	rs12714145	warfarin	Dosage	no	Genotype CC is not associated with dose of warfarin as compared to genotypes CT + TT.			= 0.24	OR			
1447677818	rs12714145	warfarin	Dosage	no	Genotype CC is not associated with dose of warfarin as compared to genotypes CT + TT.			= 0.46	OR			
1446907736	rs7231887	alendronate	Efficacy	no	Allele G is not associated with response to alendronate in women with Osteoporosis as compared to allele A.				OR			
1446907744	rs2070296	ranibizumab	Efficacy	yes	Allele T is associated with decreased response to ranibizumab in people with Macular Degeneration as compared to genotype CC.			= 0.01	OR			
1450361636	rs2306283	fluvastatin	Efficacy	no	Genotype AA is not associated with response to fluvastatin as compared to genotypes AG + GG.			> 0.05	OR			
1451148012	rs737866	methadone	Efficacy	no	Allele C is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele T.	C		= 0.14	OR	0.79	0.56	1.08
1450361642	rs4149056	fluvastatin	Efficacy	yes	Genotype TT is associated with increased response to fluvastatin as compared to genotypes CC + CT.			< 0.05	OR			
1451148020	rs4680	methadone	Efficacy	no	Allele A is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele G.	A		= 0.73	OR	0.94	0.68	1.31
1446907702	rs1805034	alendronate	Efficacy	no	Allele C is not associated with response to alendronate in women with Osteoporosis as compared to allele T.				OR			
1446907715	rs8083511	alendronate	Efficacy	no	Allele A is not associated with response to alendronate in women with Osteoporosis as compared to allele C.				OR			
1444843357	rs246240	methotrexate	Efficacy	yes	Genotypes AG + GG are associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype AA.			= 0.008	OR	5.47	1.56	19.25
1444843366	rs3784864	methotrexate	Efficacy	yes	Genotypes AG + GG are associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype AA.			= 0.015	OR	4.24	1.32	13.65
1446907665	rs7239261	alendronate	Efficacy	no	Allele A is not associated with response to alendronate in women with Osteoporosis as compared to allele C.				OR			
1446907679	rs3826619	alendronate	Efficacy	no	Allele G is not associated with response to alendronate in women with Osteoporosis as compared to allele A.				OR			
1450820493	rs3845446	fentanyl	Dosage	yes	Genotypes CC + CT are associated with decreased dose of fentanyl in people with Pain, Postoperative as compared to genotype TT.	C		< 0.05				
1448267496	rs9923231	warfarin	Dosage	not stated	Allele A is associated with dose of warfarin as compared to allele G.				OR			
1185002313	rs55894764	acenocoumarol	Dosage	yes	Genotypes CT + TT is associated with increased dose of acenocoumarol as compared to genotype CC.	T		< 0.001	OR			
1450820473	rs1799971	ethanol	Efficacy	not stated	Genotype AG is associated with increased response to ethanol in people with Alcoholism as compared to genotype AA.							
1447677624	rs3918290	capecitabine	Toxicity	no	Genotype CT is associated with decreased dose of capecitabine.				OR			
1444695597	rs11676382	warfarin	Dosage	yes	Genotypes CG + GG is associated with decreased dose of warfarin as compared to genotype CC.			< 0.00001	OR			
1448267368	rs10517	warfarin	Dosage	yes	Genotype AA is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes AG + GG.			< 0.05	OR			
1444695604	rs699664	warfarin	Dosage	no	Genotypes CT + TT is not associated with decreased dose of warfarin as compared to genotype CC.			= 0.19	OR			
1448267343	rs72800847	warfarin	Dosage	yes	Genotypes AA + AG is associated with decreased dose of warfarin in people with heart valve replacement as compared to genotype GG.			< 0.05	OR			
1448267332	rs3826041	warfarin	Dosage	yes	Genotype CC is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes AA + AC.			< 0.05	OR			
1447677505	rs5925	atorvastatin	Efficacy	no	Genotype CC is not associated with response to atorvastatin in people with Hypercholesterolemia as compared to genotypes CT + TT.	C		= 0.5760	OR			
1448267319	rs2304429	warfarin	Dosage	yes	Genotype TT is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes CC + CT.			< 0.05	OR			
1450820613	rs1799971	ethanol	Dosage	no	Genotypes AG + GG are not associated with dose of ethanol in children as compared to genotype AA.	G		> 0.32				
1450820618	rs1800497	ethanol	Dosage	no	Genotypes AA + AG are not associated with dose of ethanol in children as compared to genotype GG.	A		> 0.32				
981477479	rs1801133	methotrexate	Efficacy	no	Genotype GG is associated with increased response to methotrexate in people with Arthritis, Rheumatoid.	A		= 0.132	OR	2.73	1.03	7.26
1448594922	rs9304742	ustekinumab	Efficacy	yes	Genotypes CC + CT is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype TT.			= 0.012	OR			
1448594916	rs848	ustekinumab	Efficacy	yes	Genotypes AA + AC is associated with decreased response to ustekinumab in people with Psoriasis as compared to genotype CC.			= 0.014	OR			
1448594903	rs774359	ustekinumab	Efficacy	yes	Genotypes CC + CT is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype TT.			= 0.016	OR	0.05	0.01	0.4
1448594895	rs1050152	ustekinumab	Efficacy	yes	Genotype CT is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype CC.			= 0.037	OR			
1451230320	rs4149056	atorvastatin	Efficacy	no	Genotypes CC + CT are not associated with decreased response to atorvastatin in people with Hypercholesterolemia as compared to genotype TT.			> 0.05				
1448594887	rs7574865	ustekinumab	Efficacy	yes	Genotypes GT + TT is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype GG.			= 0.015	OR			
1449165982	rs17685420	methylphenidate	Efficacy	yes	Allele T is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 7.9E-05	OR	3.07	1.76	5.35
1449165990	rs3210967	methylphenidate	Efficacy	no	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 2.4E-03	OR	2.15	1.31	3.52
1451230340	rs2306283	atorvastatin	Efficacy	no	Genotypes AG + GG are not associated with decreased response to atorvastatin in people with Hypercholesterolemia as compared to genotype AA.			> 0.05				
1449166003	rs2071421	methylphenidate	Efficacy	no	Allele T is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 7.71E-03	OR	2.63	1.29	5.37
1450820814	rs1051660	buprenorphine	Efficacy	no	Allele A is not associated with response to buprenorphine in people with Heroin Dependence as compared to allele C.	A		> 0.357				
1449165997	rs10413455	methylphenidate	Efficacy	no	Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 5.7E-03	OR	4.93	1.59	15.3
1449166009	rs12302749	methylphenidate	Efficacy	no	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 8.48E-03	OR	1.91	1.18	3.09
1450820823	rs1800497	prochlorperazine	Efficacy	yes	Genotypes AA + AG are associated with decreased response to prochlorperazine in people with Nausea as compared to genotype GG.	A		= 0.042				
1450820829	rs1800497	prochlorperazine	Efficacy	no	Allele A is not associated with response to prochlorperazine in people with Vomiting as compared to allele G.	A		> 0.05				
1444695427	rs1800497	methadone	Dosage	no	Allele A is not associated with dose of methadone in people with Opioid-Related Disorders as compared to allele G.			= 0.17	OR			
1449166015	rs10420097	methylphenidate	Efficacy	no	Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 9.13E-03	OR	4.98	1.49	16.6
1450820835	rs1799971	prochlorperazine	Efficacy	no	Allele G is not associated with response to prochlorperazine in people with Vomiting as compared to allele A.	G		> 0.05				
1185002754	rs34231037	pazopanib	Efficacy	yes	Genotype AG is associated with increased response to pazopanib in people with Carcinoma, Renal Cell as compared to genotype AA.			= 0.01	OR			
1449166032	rs3810818	methylphenidate	Efficacy	no	Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.019	OR	1.81	1.1	2.97
1449166050	rs9901675	methylphenidate	Efficacy	no	Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.021	OR	2.95	1.18	7.39
1449166044	rs2886059	methylphenidate	Efficacy	no	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.020	OR	2.3	1.14	4.66
1449166057	rs4805162	methylphenidate	Efficacy	no	Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.026	OR	1.72	1.07	2.76
1451148561	rs6265	escitalopram	Efficacy	no	Allele T is not associated with response to escitalopram in people with Depression as compared to allele C.			= 0.98				
1449166063	rs4562	methylphenidate	Efficacy	no	Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.029	OR	1.65	1.05	2.59
1451148571	rs6313	escitalopram	Efficacy	no	Allele A is not associated with response to escitalopram in people with Depression as compared to allele G.			= 0.54				
1449166070	rs17712523	methylphenidate	Efficacy	no	Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.031	OR	2.13	1.07	4.24
1451148566	rs6311	escitalopram	Efficacy	no	Allele T is not associated with response to escitalopram in people with Depression as compared to allele C.			= 0.53				
1449166082	rs12409352	methylphenidate	Efficacy	no	Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.041	OR	2.15	1.03	4.49
1451148576	rs7997012	escitalopram	Efficacy	no	Allele A is not associated with response to escitalopram in people with Depression as compared to allele G.			= 0.36				
1449166076	rs2799018	methylphenidate	Efficacy	no	Allele T is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.038	OR	1.67	1.03	2.71
1449166088	rs4902333	methylphenidate	Efficacy	no	Allele T is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.046	OR	1.68	1.01	2.98
1450935595	rs9923231	warfarin	Dosage	yes	Genotype TT is associated with decreased dose of warfarin as compared to genotypes CC + CT.			< 0.0001				
1450820844	rs1079597	prochlorperazine	Efficacy	yes	Genotypes CT + TT are associated with decreased response to prochlorperazine in people with Nausea as compared to genotype CC.	T		= 0.042				
1449166094	rs2295490	methylphenidate	Efficacy	no	Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.048	OR	1.73	1.01	2.98
1450820850	rs1079597	prochlorperazine	Efficacy	no	Allele T is not associated with response to prochlorperazine in people with Vomiting as compared to allele C.	T		> 0.05				
1449166106	rs1048786	methylphenidate	Efficacy	no	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.074	OR	2.03	0.93	4.43
1449166100	rs4627790	methylphenidate	Efficacy	no	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.060	OR	1.59	0.98	2.59
1449166112	rs9901673	methylphenidate	Efficacy	no	Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.084	OR	1.82	0.92	3.59
1449166122	rs751655	methylphenidate	Efficacy	no	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.104	OR	1.76	0.89	3.49
1449166134	rs7858	methylphenidate	Efficacy	no	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.119	OR	1.78	0.86	3.67
1449166147	rs9032	methylphenidate	Efficacy	no	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.179	OR	1.52	0.82	2.81
1184511361	rs6295	fluoxetine	Efficacy	yes	Genotype CC is associated with increased response to fluoxetine in people with Depressive Disorder, Major as compared to allele G.			= 0.009	OR	4.4	1.1	17.6
1449166140	rs929740	methylphenidate	Efficacy	no	Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.169	OR	1.4	0.87	2.27
1184511375	rs57098334	fluoxetine	Efficacy	no	Genotype (CCCACCCGA)12/(CCCACCCGA)12 is not associated with increased response to fluoxetine in people with Depressive Disorder, Major.			= 0.246	OR			
1449166160	rs11942223	allopurinol	Dosage	no	Allele T is not associated with dose of allopurinol in people with Gout as compared to allele C.			> 0.05	OR			
1184511379	rs6313	fluoxetine	Efficacy	no	Allele G is not associated with increased response to fluoxetine in people with Depressive Disorder, Major as compared to allele A.			= 0.446	OR			
1449166180	rs1183201	allopurinol	Dosage	no	Allele T is not associated with dose of allopurinol in people with Gout as compared to allele A.			> 0.05	OR			
1449166191	rs17300741	allopurinol	Dosage	no	Allele G is not associated with dose of allopurinol in people with Gout as compared to allele A.			> 0.05	OR			
1449166202	rs3825018	allopurinol	Dosage	no	Allele G is not associated with dose of allopurinol in people with Gout as compared to allele A.			> 0.05	OR			
1444842712	rs2740574	tacrolimus	Dosage	yes	Allele C is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to allele T.			< 0.001	OR			
1444842712	rs2740574	tacrolimus	Dosage	yes	Allele C is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to allele T.			= 0.001	OR			
1444842712	rs2740574	tacrolimus	Dosage	yes	Allele C is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to allele T.			= 0.006	OR			
1184511472	rs9621532	ranibizumab	Efficacy	no	Genotype AA is not associated with response to ranibizumab in people with Macular Degeneration as compared to genotype AC.			= 1.0	OR	1.69	0.5	5.66
1449166275	rs1061735	methylphenidate	Efficacy	no	Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.265	OR	1.46	0.75	2.84
1449166269	rs11552708	methylphenidate	Efficacy	no	Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.207	OR	1.7	0.75	3.86
1447988337	rs510432	adalimumab	Efficacy	yes	Genotypes CT + TT are associated with increased response to adalimumab in people with Inflammatory Bowel Diseases as compared to genotype CC.			= 1.14E-4	OR			
1447988322	rs55754655	azathioprine	Dosage	yes	Genotypes AG + GG is associated with increased dose of azathioprine in people with Kidney Transplantation as compared to genotype AA.	G		= 0.046	OR			
1449166319	rs11553441	methylphenidate	Efficacy	no	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.284	OR	1.46	0.73	2.9
1449166331	rs757978	methylphenidate	Efficacy	no	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.325	OR	1.59	0.63	4.01
1449166325	rs362272	methylphenidate	Efficacy	no	Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.324	OR	1.34	0.75	2.41
1447988304	rs1130864	adalimumab	Efficacy	yes	Genotypes AG + GG are associated with increased response to adalimumab in people with Inflammatory Bowel Diseases as compared to genotype AA.	A		= 5.19E-4	OR			
1449166337	rs17279558	methylphenidate	Efficacy	no	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.348	OR	1.56	0.62	3.97
1449166351	rs1061115	methylphenidate	Efficacy	no	Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.438	OR	1.22	0.74	2.02
1450821104	rs3890011	spironolactone	Efficacy	yes	Genotype CC is associated with decreased response to spironolactone in people with Hypertension as compared to genotypes CG + GG.	C		= 0.002				
1450821112	rs3890011	amiloride	Efficacy	no	Allele C is not associated with response to amiloride in people with Hypertension as compared to allele G.	C		> 0.05				
1449166371	rs2013169	methylphenidate	Efficacy	no	Allele T is associated with decreased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.813	OR	0.92	0.46	1.84
1184511615	rs9934438	warfarin	Dosage	yes	Genotype AA is associated with decreased dose of warfarin as compared to genotypes AG + GG.			< 0.001	OR			
1447676944	rs1800497	amisulpride	Efficacy	no	Allele A is not associated with increased response to amisulpride in people with Schizophrenia as compared to allele G.	A		= 0.264	OR			
1184511620	rs1057910	warfarin	Dosage	yes	Genotype AC is associated with decreased dose of warfarin as compared to genotype AA.			< 0.001	OR			
1184511624	rs2645400	warfarin	Dosage	yes	Genotype TT is associated with increased dose of warfarin as compared to genotypes GG + GT.			= 0.026	OR			
1448594444	rs1975974	ustekinumab	Efficacy	yes	Genotypes AG + GG is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype AA.			= 0.012	OR			
1184511628	rs4841588	warfarin	Dosage	yes	Genotype TT is associated with increased dose of warfarin as compared to genotypes GG + GT.			= 0.036	OR			
1448594435	rs2787094	ustekinumab	Efficacy	yes	Genotype CC is associated with decreased response to ustekinumab in people with Psoriasis as compared to genotypes CG + GG.			= 0.015	OR			
1448594422	rs2145623	ustekinumab	Efficacy	yes	Genotype CC is associated with decreased response to ustekinumab in people with Psoriasis as compared to genotypes CG + GG.			= 0.024	OR			
1447676920	rs1079597	amisulpride	Efficacy	yes	Allele C is associated with increased response to amisulpride in people with Schizophrenia as compared to allele T.	C		= 0.023	OR			
1448594411	rs6311	ustekinumab	Efficacy	yes	Genotypes CT + TT is associated with decreased response to ustekinumab in people with Psoriasis as compared to genotype CC.			= 0.037	OR	20.04	1.32	303.34
1448594399	rs11591741	ustekinumab	Efficacy	yes	Genotypes CC + CG is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype GG.			= 0.029	OR	0.03	0.0	0.47
1448594392	rs191190	ustekinumab	Efficacy	yes	Genotypes CC + CT is associated with decreased response to ustekinumab in people with Psoriasis as compared to genotype TT.			= 0.037	OR	28.29	1.64	513.06
1451148962	rs1042173	morphine	Dosage	yes	Genotype CC is associated with decreased dose of morphine in people with Lung Neoplasms and Pain as compared to genotypes AA + AC.	C		< 0.001				
1184511552	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT is associated with decreased dose of warfarin as compared to genotype CC.			= 0.0001	OR			
1184511557	rs9923231	acenocoumarol	Dosage	yes	Genotypes CT + TT is associated with decreased dose of acenocoumarol as compared to genotype CC.			< 0.0001	OR			
1184511577	rs2108622	warfarin	Dosage	yes	Genotypes CT + TT is associated with increased dose of warfarin as compared to genotype CC.			= 0.04	OR			
1184511581	rs2108622	acenocoumarol	Dosage	yes	Genotypes CT + TT is associated with increased dose of acenocoumarol as compared to genotype CC.			= 0.01	OR			
1184511738	rs2002577	methylphenidate	Dosage	no	Genotype CC is not associated with dose of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes CG + GG.				OR			
1184511746	rs2307240	methylphenidate	Dosage	no	Genotype CT is not associated with dose of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype CC.				OR			
1184511750	rs12443580	methylphenidate	Dosage	no	Genotype TT is not associated with dose of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes CC + CT.				OR			
1184511766	rs2002577	methylphenidate	Dosage	no	Genotype CC is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes CG + GG.				OR			
1184511770	rs2244613	methylphenidate	Dosage	no	Genotype TT is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes GG + GT.				OR			
1184511778	rs2307240	methylphenidate	Dosage	no	Genotype CT is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype CC.				OR			
1450821413	rs1799971	ethanol	Dosage	yes	Genotype AA is associated with increased dose of ethanol in children as compared to genotypes AG + GG.	G		< 0.05				
1451165480	rs1045642	tramadol	Dosage	no	Allele G is not associated with dose of tramadol in people with Pain, Postoperative as compared to allele A.	A						
1450821464	rs1180012	fentanyl	Efficacy	no	Allele T is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele C.	T		> 0.05				
1450821470	rs208293	fentanyl	Efficacy	no	Allele A is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele G.	A		> 0.05				
1450821482	rs7132846	fentanyl	Efficacy	no	Allele T is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele C.	T		> 0.05				
1450821424	rs1799971	naltrexone	Efficacy	no	Genotypes AG + GG are not associated with response to naltrexone in people with Alcoholism as compared to genotype AA.							
1450821424	rs1799971	naltrexone	Efficacy	no	Genotypes AG + GG are not associated with response to naltrexone in people with Alcoholism as compared to genotype AA.							
1447676673	rs1143623	metformin	Efficacy	yes	Genotype GG is associated with increased response to metformin in people with Diabetes Mellitus as compared to genotypes CC + CG.	C		= 0.004	OR			
1447676673	rs1143623	metformin	Efficacy	yes	Genotype GG is associated with increased response to metformin in people with Diabetes Mellitus as compared to genotypes CC + CG.	C		= 0.023	OR			
1447676681	rs10783050	metformin	Efficacy	yes	Genotype TT is associated with increased response to metformin in people with Diabetes Mellitus as compared to genotypes CC + CT.	C		= 0.043	OR			
1447676681	rs10783050	metformin	Efficacy	yes	Genotype TT is associated with increased response to metformin in people with Diabetes Mellitus as compared to genotypes CC + CT.	C		= 0.048	OR			
1450821451	rs1718125	fentanyl	Efficacy	no	Allele T is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele C.	T		> 0.05				
827813351	rs45445694	fluorouracil	Efficacy	yes	Genotype (CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2 is associated with decreased response to fluorouracil in people with Colorectal Neoplasms.			= 0.001	HR	1.89	1.29	2.7
827813351	rs45445694	fluorouracil	Efficacy	yes	Genotype (CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2 is associated with decreased response to fluorouracil in people with Colorectal Neoplasms.			= 0.004	HR	2.65	1.4	4.75
827813351	rs45445694	fluorouracil	Efficacy	yes	Genotype (CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2 is associated with decreased response to fluorouracil in people with Colorectal Neoplasms.			= 0.03	HR	1.69	1.03	2.66
1448594141	rs1128503	imatinib	Efficacy	no	Allele G is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.			= 0.847	OR	1.025	0.795	1.322
1448594134	rs1045642	imatinib	Efficacy	no	Allele G is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.			= 0.454	OR	1.096	0.862	1.392
1448594125	rs2231142	imatinib	Efficacy	yes	Allele T is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.			= 0.000	OR	0.556	0.41	0.752
1448594125	rs2231142	imatinib	Efficacy	yes	Allele T is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.			= 0.025	OR	0.646	0.441	0.946
1448594125	rs2231142	imatinib	Efficacy	yes	Allele T is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.			= 0.033	OR	0.707	0.514	0.972
1448594125	rs2231142	imatinib	Efficacy	yes	Allele T is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.			= 0.352	OR	0.831	0.564	1.226
1448594115	rs2032582	imatinib	Efficacy	yes	Genotypes AT + TT is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes CC + CT.			= 0.020	OR	0.632	0.43	0.929
1448594115	rs2032582	imatinib	Efficacy	yes	Genotypes AT + TT is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes CC + CT.			= 0.037	OR	0.653	0.437	0.975
1449002901	rs4149056	methotrexate	Efficacy	yes	Genotype CC is associated with decreased response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes CT + TT.			< 0.001	HR	12.242	3.937	38.059
1449576353	rs1799836	levodopa	Dosage	no	Genotype CT is not associated with dose of levodopa in women with Parkinson Disease as compared to genotype CC.	T		= 0.17	OR	2.4	0.8	7.0
1449002928	rs2838958	methotrexate	Efficacy	yes	Genotype AA is associated with decreased response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AG + GG.			= 0.019	HR	2.342	1.147	4.71
1449576366	rs4680	levodopa	Dosage	no	Genotype AG is not associated with dose of levodopa in people with Parkinson Disease as compared to genotype GG.	A		= 0.43	OR	0.7	0.4	1.4
1449002940	rs11045879	methotrexate	Efficacy	no	Allele C is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.			> 0.05	HR			
1449576387	rs1799836	levodopa	Dosage	no	Allele C is not associated with dose of levodopa in men with Parkinson Disease as compared to allele T.	T		= 0.63	OR	1.5	0.3	6.0
1184512008	rs2274567	eculizumab	Efficacy	yes	Genotypes AG + GG is associated with decreased response to eculizumab in people with paroxysmal nocturnal hemoglobinuria as compared to genotype AA.	A		= 0.012	OR	2.7	1.2	6.2
1184512008	rs2274567	eculizumab	Efficacy	yes	Genotypes AG + GG is associated with decreased response to eculizumab in people with paroxysmal nocturnal hemoglobinuria as compared to genotype AA.	A		= 0.012	OR	7.26	1.4	38.8
1184512015	rs3811381	eculizumab	Efficacy	no	Genotypes CG + GG is not associated with response to eculizumab in people with paroxysmal nocturnal hemoglobinuria as compared to genotype CC.	C		= 0.054	OR	2.1	0.9	4.6
1184512015	rs3811381	eculizumab	Efficacy	no	Genotypes CG + GG is not associated with response to eculizumab in people with paroxysmal nocturnal hemoglobinuria as compared to genotype CC.	C		= 0.054	OR	4.4	0.9	21.6
1184512020	rs2230199	eculizumab	Efficacy	no	Genotypes CC + CG is not associated with response to eculizumab in people with paroxysmal nocturnal hemoglobinuria as compared to genotype GG.	C		= 0.934	OR	1.0	0.4	2.4
1184512020	rs2230199	eculizumab	Efficacy	no	Genotypes CC + CG is not associated with response to eculizumab in people with paroxysmal nocturnal hemoglobinuria as compared to genotype GG.	C		= 0.934	OR	1.0	0.2	5.9
1449002970	rs1051266	methotrexate	Efficacy	no	Allele C is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.			> 0.05	HR			
1449002964	rs2306283	methotrexate	Efficacy	no	Allele G is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.			> 0.05	HR			
1449002987	rs1131596	methotrexate	Efficacy	no	Allele G is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.			> 0.05	HR			
1185003550	rs1801274	trastuzumab	Efficacy	no	Genotype AA is associated with increased response to trastuzumab in people with Breast Neoplasms as compared to genotypes AG + GG.			= 0.17	OR			
1449002981	rs3788200	methotrexate	Efficacy	no	Allele G is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.			> 0.05	HR			
1449002998	rs1128503	methotrexate	Efficacy	no	Allele G is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.			> 0.05	HR			
1449003010	rs2231137	methotrexate	Efficacy	no	Allele C is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.			> 0.05	HR			
1449003004	rs1045642	methotrexate	Efficacy	no	Allele A is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.			> 0.05	HR			
1448266309	rs7703002	platinum	Efficacy	no	Genotype AA is associated with decreased response to platinum in people with Carcinoma, Non-Small-Cell Lung as compared to genotype CC.			= 0.029	OR	2.73	1.16	6.46
1184511950	rs9923231	warfarin	Dosage	yes	Genotype CC is associated with increased dose of warfarin in healthy individuals as compared to genotypes CT + TT.	A		= 0.02	OR			
1447676481	rs763780	infliximab	Efficacy	yes	Genotype CT is associated with increased response to infliximab in people with Psoriasis as compared to genotype TT.	C		= 0.020	OR			
1447676481	rs763780	infliximab	Efficacy	yes	Genotype CT is associated with increased response to infliximab in people with Psoriasis as compared to genotype TT.	C		= 0.023	OR	0.0		
1447676490	rs763780	adalimumab	Efficacy	yes	Genotype TT is associated with increased response to adalimumab in people with as compared to genotype CT.	C		= 0.0044	OR			
1447676490	rs763780	adalimumab	Efficacy	yes	Genotype TT is associated with increased response to adalimumab in people with as compared to genotype CT.	C		= 0.111	OR			
1448266301	rs7719775	platinum	Efficacy	no	Genotype AA is associated with decreased response to platinum in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.			= 0.013	OR	1.82	1.15	2.86
1447676470	rs763780	ustekinumab	Efficacy	yes	Genotype TT is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype CT.	C		= 0.016	OR	14.18	1.35	149.42
1447676470	rs763780	ustekinumab	Efficacy	yes	Genotype TT is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype CT.	C		= 0.022	OR	12.23	1.17	127.36
1449003091	rs1799971	oxycodone	Dosage	no	Genotype AA is not associated with dose of oxycodone in people with Neoplasms as compared to genotypes AG + GG.			= 1	OR			
1449003085	rs1045642	oxycodone	Dosage	no	Genotype GG is not associated with dose of oxycodone in people with Neoplasms as compared to genotypes AA + AG.			= 0.15	OR			
1450821690	rs11280056	fluorouracil	Efficacy	yes	Genotype TTAAAGTTA/del is associated with decreased response to fluorouracil in people with Colorectal Neoplasms as compared to genotype del/del.			= 0.001	HR	1.89	1.29	2.7
1450821690	rs11280056	fluorouracil	Efficacy	yes	Genotype TTAAAGTTA/del is associated with decreased response to fluorouracil in people with Colorectal Neoplasms as compared to genotype del/del.			= 0.004	HR	2.65	1.4	4.65
1450821690	rs11280056	fluorouracil	Efficacy	yes	Genotype TTAAAGTTA/del is associated with decreased response to fluorouracil in people with Colorectal Neoplasms as compared to genotype del/del.			= 0.03	HR	1.69	1.03	2.66
1184512158	rs1570360	docetaxel	Efficacy	yes	Genotype GG is associated with decreased response to docetaxel in women with Breast Neoplasms as compared to genotypes AA + AG.	A		= 0.048	OR			
1450936394	rs1042028	acetaminophen	Efficacy	yes	Genotype CC is associated with increased response to acetaminophen in healthy individuals as compared to genotypes CT + TT.			= 0.04	OR			
1450936460	rs28362731	cisplatin	Efficacy	no	Genotype AG is not associated with response to cisplatin in people with Mesothelioma as compared to genotype GG.			= 0.130	HR	0.56	0.26	1.19
1450936460	rs28362731	cisplatin	Efficacy	no	Genotype AG is not associated with response to cisplatin in people with Mesothelioma as compared to genotype GG.			= 0.299	HR	0.72	0.39	1.33
1450936460	rs28362731	cisplatin	Efficacy	no	Genotype AG is not associated with response to cisplatin in people with Mesothelioma as compared to genotype GG.			= 0.481	HR	1.56	0.46	5.31
827698919	rs3918242	Methyldopa	Efficacy	yes	Genotypes CT + TT are associated with decreased response to Methyldopa in people with Gestational hypertension as compared to genotype CC.			= 0.036	OR	2.23	1.06	4.73
1450936468	rs1049305	cisplatin	Efficacy	no	Genotypes CC + CG are not associated with response to cisplatin in people with Mesothelioma as compared to genotype GG.			= 0.220	HR	0.81	0.58	1.14
1450936468	rs1049305	cisplatin	Efficacy	no	Genotypes CC + CG are not associated with response to cisplatin in people with Mesothelioma as compared to genotype GG.			= 0.233	HR	0.83	0.62	1.13
1450936468	rs1049305	cisplatin	Efficacy	no	Genotypes CC + CG are not associated with response to cisplatin in people with Mesothelioma as compared to genotype GG.			= 0.810	HR	1.08	0.59	1.97
1447676364	rs2514218	clozapine	Efficacy	yes	Allele T is associated with increased response to clozapine in people with Schizophrenia as compared to allele C.	C		= 0.013	OR			
1447676364	rs2514218	clozapine	Efficacy	yes	Allele T is associated with increased response to clozapine in people with Schizophrenia as compared to allele C.	C		= 0.033	OR			
1447676351	rs2071559	ranibizumab	Efficacy	yes	Genotypes AA + AG is associated with decreased response to ranibizumab in people with Macular Degeneration as compared to genotype GG.	G		= 0.024	OR			
1447676351	rs2071559	ranibizumab	Efficacy	yes	Genotypes AA + AG is associated with decreased response to ranibizumab in people with Macular Degeneration as compared to genotype GG.	G		= 0.034	OR			
1447676333	rs4073	ranibizumab	Efficacy	yes	Genotype AA is associated with decreased response to ranibizumab in people with Macular Degeneration as compared to genotypes AT + TT.	A		= 0.021	OR			
1447676333	rs4073	ranibizumab	Efficacy	yes	Genotype AA is associated with decreased response to ranibizumab in people with Macular Degeneration as compared to genotypes AT + TT.	A		= 0.039	OR			
1447676333	rs4073	ranibizumab	Efficacy	yes	Genotype AA is associated with decreased response to ranibizumab in people with Macular Degeneration as compared to genotypes AT + TT.	A		= 0.045	OR			
1447676333	rs4073	ranibizumab	Efficacy	yes	Genotype AA is associated with decreased response to ranibizumab in people with Macular Degeneration as compared to genotypes AT + TT.	A		= 0.079	OR			
1448102319	rs1799752	sertraline	Efficacy	yes	Genotype del/del is associated with increased response to sertraline in people with Depressive Disorder.			= 0.006	OR	3.7	1.66	8.29
1447987564	rs4646	tamoxifen	Efficacy	yes	Genotypes AA + AC are associated with increased response to tamoxifen in women with Breast Neoplasms as compared to genotype CC.	A		= 0.011	HR	0.681	0.506	0.917
1450821908	rs1799971	ethanol	Other	no	Genotypes AG + GG are not associated with exposure to ethanol in healthy individuals as compared to genotype AA.			= 0.107				
1450821908	rs1799971	ethanol	Other	no	Genotypes AG + GG are not associated with exposure to ethanol in healthy individuals as compared to genotype AA.			= 0.329				
1447676212	rs9904341	methotrexate	Efficacy	yes	Genotype CG is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.	C		= 0.046	OR	2.34	1.02	5.38
1447680294	rs2032582	venlafaxine	Efficacy	no	Genotype CC is not associated with response to venlafaxine in people with Narcolepsy as compared to genotypes AA + TT.			= 0.319	OR			
827864092	rs1801058	metoprolol	Efficacy	no	Genotype CT is not associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype CC.	T		= 0.25	HR	0.66	0.33	1.34
1447680268	rs2032582	modafinil	Efficacy	yes	Genotypes AC + CT is associated with increased response to modafinil in people with Narcolepsy as compared to genotype CC.			= 0.019	OR			
1449154881	rs887829	atazanavir	Toxicity	yes	Genotype TT is associated with increased discontinuation of atazanavir as compared to genotype CC.			= 0.026	HR	9.4	1.3	66.9
1449154881	rs887829	atazanavir	Toxicity	yes	Genotype TT is associated with increased discontinuation of atazanavir as compared to genotype CC.			= 0.038	HR	5.2	1.1	24.5
1449154896	rs887829	atazanavir	Toxicity	no	Genotype TT is not associated with increased discontinuation of atazanavir as compared to genotype CC.			= 0.45	HR	0.3	0.01	6.7
1449171287	rs1799971	sufentanil	Dosage	yes	Allele G is associated with decreased dose of sufentanil in women with Pain as compared to allele A.	G		= 0.03	OR			
1449154902	rs887829	atazanavir	Toxicity	no	Genotype CT is not associated with increased discontinuation of atazanavir as compared to genotype CC.			= 0.3	HR	1.5	0.5	8.4
1449154902	rs887829	atazanavir	Toxicity	no	Genotype CT is not associated with increased discontinuation of atazanavir as compared to genotype CC.			= 0.77	HR	1.4	0.1	13.6
1449154902	rs887829	atazanavir	Toxicity	no	Genotype CT is not associated with increased discontinuation of atazanavir as compared to genotype CC.			= 0.78	HR	1.3	0.2	9.4
827864047	rs1024323	metoprolol	Efficacy	yes	Genotype CC is associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype TT.			= 0.001	HR	2.14	1.35	3.39
827864047	rs1024323	metoprolol	Efficacy	yes	Genotype CC is associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype TT.	T		= 0.009	HR	1.54	1.11	2.44
827864047	rs1024323	metoprolol	Efficacy	yes	Genotype CC is associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype TT.			= 0.01	HR	2.24	1.2	4.18
827864047	rs1024323	metoprolol	Efficacy	yes	Genotype CC is associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype TT.			= 0.31	HR	1.99	0.52	7.57
1449154934	rs1801274	cetuximab	Efficacy	yes	Genotype GG is associated with increased response to cetuximab in people with Head and Neck Neoplasms as compared to genotypes AA + AG.	A		= 0.02	HR	1.71	1.11	2.65
1449154934	rs1801274	cetuximab	Efficacy	yes	Genotype GG is associated with increased response to cetuximab in people with Head and Neck Neoplasms as compared to genotypes AA + AG.	A		= 0.19	OR			
1449154943	rs396991	cetuximab	Efficacy	yes	Genotype AA is associated with increased response to cetuximab in people with Head and Neck Neoplasms as compared to genotypes AC + CC.	A		= 0.02	HR	1.71	1.11	2.65
1449154943	rs396991	cetuximab	Efficacy	yes	Genotype AA is associated with increased response to cetuximab in people with Head and Neck Neoplasms as compared to genotypes AC + CC.	A		= 0.23	OR			
1447680216	rs4645974	warfarin	Dosage	yes	Genotype CC is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes CT + TT.	T		= 0.001	OR			
1451121060	rs6848893	oxycodone	Efficacy	yes	Genotype CT is associated with decreased response to oxycodone as compared to genotype TT.			< 0.004				
1447680201	rs4645962	warfarin	Dosage	yes	Genotype CT is associated with decreased dose of warfarin in people with heart valve replacement as compared to genotype TT.	C		= 0.021	OR			
1451121027	rs581111	oxycodone	Efficacy	no	Allele A is not associated with response to oxycodone as compared to allele G.							
1451121020	rs581111	oxycodone	Efficacy	yes	Genotypes AA + AG are associated with decreased response to oxycodone as compared to genotype GG.			< 0.004				
1451121080	rs6848893	oxycodone	Efficacy	no	Genotype CT is not associated with response to oxycodone as compared to genotype TT.							
981794238	rs9394992	gemcitabine	Efficacy	no	Genotype CC is not associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CT + TT.	T		= 0.704	HR	1.08	0.74	1.57
1450973680	rs429358	ranibizumab	Efficacy	no	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.			= 1.0	OR	1.9	0.94	3.81
1183689314	rs1801028	olanzapine	Efficacy	no	Allele G is not associated with response to olanzapine in people with Schizophrenia as compared to allele C.				OR			
1183689310	rs6280	olanzapine	Efficacy	no	Allele T is not associated with response to olanzapine in people with Schizophrenia as compared to allele C.				OR			
1183689306	rs6313	olanzapine	Efficacy	no	Allele G is not associated with response to olanzapine in people with Schizophrenia as compared to allele A.				OR			
1450973740	rs429358	atorvastatin	Efficacy	yes	Genotype CT is associated with decreased response to atorvastatin in people with Hypercholesterolemia as compared to genotype TT.	C		= 0.0008	OR			
1448531970	rs776746	ticagrelor	Efficacy	no	Genotype CC is not associated with response to ticagrelor in healthy individuals as compared to genotypes CT + TT.	C		= 0.522	OR			
1448531965	rs2242480	ticagrelor	Efficacy	no	Genotype CC is not associated with response to ticagrelor in healthy individuals as compared to genotypes CT + TT.	C		= 0.921	OR			
1448531954	rs113681054	ticagrelor	Efficacy	no	Genotype CT is not associated with response to ticagrelor in healthy individuals as compared to genotypes CC + TT.	C		= 0.418	OR			
1448417258	rs1080985	clomipramine	Efficacy	not stated	Genotype CG is associated with decreased response to clomipramine in women with Depression.				OR			
1444698070	rs118192161	halothane	Other	yes	Allele T is associated with increased response to halothane as compared to allele C.			< 0.001	OR			
1444697966	rs1799971	naltrexone	Efficacy	no	Allele G is not associated with response to naltrexone in people with Alcoholism and Depressive Disorder, Major.				OR			
1447679904	rs396991	rituximab	Efficacy	yes	Genotype AA is associated with decreased response to rituximab in people with Neuromyelitis Optica as compared to genotype CC.	A		= 0.03	OR	24.87	2.0	1027.54
1448531842	rs12566888	ticagrelor	Efficacy	yes	Genotype TT is associated with increased response to ticagrelor in healthy individuals as compared to genotype GT.	G		= 0.005	OR			
1448531836	rs12041331	ticagrelor	Efficacy	yes	Genotype AA is associated with increased response to ticagrelor in healthy individuals as compared to genotype GG.	A		= 0.033	OR			
1448105842	rs2289669	metformin	Efficacy	yes	Genotype AA is associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to genotypes AG + GG.			= 0.018	OR			
1448531830	rs12041331	ticagrelor	Efficacy	yes	Genotype AA is associated with increased response to ticagrelor in healthy individuals as compared to genotypes AG + GG.	A		= 0.020	OR			
1450826481	rs28363170	ethanol	Toxicity	yes	Allele del is associated with increased exposure to ethanol in healthy individuals as compared to allele GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT.	del		< 0.001	OR	1.356	1.222	1.503
1450826481	rs28363170	ethanol	Toxicity	yes	Allele del is associated with increased exposure to ethanol in healthy individuals as compared to allele GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT.	del		= 0.068	OR	0.804	0.637	1.016
1450826481	rs28363170	ethanol	Toxicity	yes	Allele del is associated with increased exposure to ethanol in healthy individuals as compared to allele GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT.	del		= 0.174	OR	1.185	0.928	1.512
1450826488	rs1799971	ethanol	Toxicity	yes	Genotypes AG + GG is associated with decreased exposure to ethanol in healthy individuals as compared to genotype AA.	G		< 0.001	OR	0.545	0.415	0.715
1450826488	rs1799971	ethanol	Toxicity	yes	Genotypes AG + GG is associated with decreased exposure to ethanol in healthy individuals as compared to genotype AA.	G		= 0.110	OR	0.913	0.817	1.021
1450826488	rs1799971	ethanol	Toxicity	yes	Genotypes AG + GG is associated with decreased exposure to ethanol in healthy individuals as compared to genotype AA.	G		= 0.375	OR	0.891	0.689	1.151
827864125	rs2960306	metoprolol	Efficacy	no	Genotype TT is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype GG.			= 0.21	HR	0.72	0.44	1.2
827864109	rs1801058	metoprolol	Efficacy	yes	Genotype CT is associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype CC.			= 0.05	HR	0.46	0.21	1.0
1448105757	rs61742245	warfarin	Dosage	yes	Allele A is associated with increased dose of warfarin as compared to allele C.			= 0.002	OR			
1450826585	rs1045642	fentanyl	Dosage	yes	Genotype AA is associated with decreased dose of fentanyl in children as compared to genotypes AG + GG.	A		= 0.041				
1450826590	rs1128503	fentanyl	Dosage	no	Allele G is not associated with dose of fentanyl in children as compared to allele A.	A		> 0.503				
1450826600	rs1045642	fentanyl	Efficacy	no	Genotype AA is not associated with response to fentanyl in children as compared to genotypes AG + GG.	A		> 0.05				
1451137960	rs3762555	methadone	Dosage	yes	Allele G is associated with increased dose of methadone in people with Heroin Dependence as compared to allele C.			= 0.001				
1449155460	rs5744174	ustekinumab	Efficacy	yes	Genotypes AG + GG is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype AA.	A		= 0.0012	OR	5.26	1.93	14.38
1450826625	rs1799971	nicotine	Other	no	Genotypes AG + GG are not associated with exposure to nicotine in people with Bipolar Disorder or Schizophrenia as compared to genotype AA.	G		> 0.05				
1448531631	rs116855232	azathioprine	Dosage	yes	Genotypes CT + TT are associated with decreased dose of azathioprine in people with Inflammatory Bowel Diseases and Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.			< 0.00001	OR			
1183689699	rs4248163	infliximab	Efficacy	no	Genotype CC is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes CG + GG.			= 0.035	OR			
1183689695	rs3093548	infliximab	Efficacy	no	Genotype CC is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes CT + TT.			= 0.035	OR			
1183689707	rs55634887	infliximab	Efficacy	no	Genotype GG is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AA + AG.			= 0.035	OR			
981237722	rs1044457	gemcitabine	Efficacy	yes	Genotype CC is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CT + TT.			= 0.001	HR	1.84	1.28	2.66
981237722	rs1044457	gemcitabine	Efficacy	yes	Genotype CC is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CT + TT.			= 0.002	HR	1.9	1.26	2.87
1183689703	rs55994001	infliximab	Efficacy	no	Genotype CC is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes CT + TT.			= 0.035	OR			
1449188291	rs1043550	acenocoumarol	Dosage	yes	Allele G is associated with increased dose of acenocoumarol in people with Atrial Fibrillation as compared to allele A.			= 0.009	OR	3.96	1.41	11.09
1183689683	rs4248159	infliximab	Efficacy	no	Genotype CC is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AA + AC.			= 0.035	OR			
1183689679	rs4987086	infliximab	Efficacy	no	Genotype GG is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AA + AG.			= 0.035	OR			
1449188284	rs2108622	acenocoumarol	Dosage	yes	Allele T is associated with increased dose of acenocoumarol in people with Atrial Fibrillation as compared to allele C.			= 0.047	OR	3.12	1.01	9.63
1451121640	rs4680	oxycodone	Efficacy	no	Allele A is not associated with response to oxycodone as compared to allele G.							
1183689691	rs4248160	infliximab	Efficacy	no	Genotype GG is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AA + AG.			= 0.035	OR			
1451138021	rs3791878	methadone	Dosage	no	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.			= 0.01				
1183689687	rs2736195	infliximab	Efficacy	no	Genotype AA is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AG + GG.			= 0.035	OR			
1183689667	rs1800630	infliximab	Efficacy	no	Genotype AA is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AC + CC.			= 0.035	OR			
1449270232	rs1045642	methotrexate	Efficacy	yes	Genotype AA is associated with increased response to methotrexate in children with Arthritis, Juvenile Rheumatoid as compared to genotypes AG + GG.				OR	2.21	1.23	3.97
1183689663	rs4647198	infliximab	Efficacy	no	Genotype CC is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes CT + TT.			= 0.035	OR			
1183689675	rs4248158	infliximab	Efficacy	no	Genotype CC is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes CT + TT.			= 0.035	OR			
1449270224	rs1801133	methotrexate	Efficacy	yes	Genotype AA is associated with decreased response to methotrexate in children with Arthritis, Juvenile Rheumatoid as compared to genotypes AG + GG.				OR	0.4	0.19	0.84
1183689671	rs1799724	infliximab	Efficacy	no	Genotype CC is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes CT + TT.			= 0.035	OR			
1451121600	rs4680	oxycodone	Efficacy	yes	Genotypes AA + AG are associated with increased response to oxycodone as compared to genotype GG.			< 0.004				
1451137980	rs3762556	methadone	Dosage	yes	Allele G is associated with increased dose of methadone in people with Heroin Dependence as compared to allele C.			< 0.001				
1449270251	rs12231740	methotrexate	Efficacy	yes	Allele T is associated with decreased response to methotrexate in children with Arthritis, Juvenile Rheumatoid as compared to allele C.				OR	0.63	0.43	0.93
1183689659	rs1799964	infliximab	Efficacy	no	Genotype TT is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes CC + CT.			= 0.035	OR			
1449270240	rs1128503	methotrexate	Efficacy	yes	Genotype AA is associated with increased response to methotrexate in children with Arthritis, Juvenile Rheumatoid as compared to genotypes AG + GG.				OR	2.23	1.35	3.69
1183689654	rs1143634	infliximab	Efficacy	yes	Genotype GG is associated with decreased response to infliximab in people with Crohn Disease as compared to genotypes AA + AG.			= 0.035	OR			
981237777	rs12507552	gemcitabine	Efficacy	yes	Genotype CC is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CT + TT.			< 0.001	HR	2.53	1.51	4.25
981237781	rs3778504	gemcitabine	Efficacy	no	Genotypes AA + AG are associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotype GG.			= 0.208	HR	0.56	0.23	1.38
1449270257	rs3763980	methotrexate	Efficacy	yes	Allele A is associated with decreased response to methotrexate in children with Arthritis, Juvenile Rheumatoid as compared to allele T.				OR	0.53	0.35	0.8
1451121685	rs165599	oxycodone	Efficacy	no	Allele A is not associated with response to oxycodone as compared to allele G.							
1445402159	rs2072660	varenicline	Efficacy	no	Genotypes CT + TT are not associated with response to varenicline in people with Tobacco Use Disorder as compared to genotype CC.			= 0.66	OR	1.01	0.97	1.05
1449155573	rs529520	methadone	Dosage	yes	Genotypes AA + AC is associated with increased dose of methadone in people with Heroin Dependence as compared to genotype CC.			= 0.019	OR			
1449155573	rs529520	methadone	Dosage	yes	Genotypes AA + AC is associated with increased dose of methadone in people with Heroin Dependence as compared to genotype CC.			= 0.029	OR			
1448105573	rs7997012	escitalopram	Efficacy	no	Allele A is not associated with increased response to escitalopram in people with Autistic Disorder as compared to allele G.	A		= 0.655	OR			
1449270277	rs1801394	methotrexate	Efficacy	yes	Genotypes AG + GG is associated with increased response to methotrexate in children with Arthritis, Juvenile Rheumatoid as compared to genotype AA.				OR	2.19	1.01	4.76
1451138080	rs2839669	methadone	Dosage	no	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.			= 0.205				
1451121699	rs963549	oxycodone	Efficacy	no	Allele T is not associated with response to oxycodone as compared to allele C.							
981237788	rs274713	gemcitabine	Efficacy	yes	Genotype GG is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes GT + TT.			= 0.031	HR	1.49	1.04	2.15
981237795	rs274717	gemcitabine	Efficacy	no	Genotypes AG + GG are associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotype AA.			= 0.05	HR	0.71	0.5	1.0
1451121694	rs6473797	oxycodone	Efficacy	no	Allele T is not associated with response to oxycodone as compared to allele C.							
1451121701	rs10753331	oxycodone	Efficacy	no	Allele A is not associated with response to oxycodone as compared to allele G.							
981237802	rs992160	gemcitabine	Efficacy	yes	Genotypes CT + TT are associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotype CC.			= 0.039	HR	0.49	0.25	0.96
1450826733	rs1799971	nicotine	Other	no	Genotypes AG + GG are not associated with exposure to nicotine in people with Bipolar Disorder as compared to genotype AA.			> 0.05				
1450826739	rs1800497	nicotine	Other	no	Genotypes AA + AG are not associated with exposure to nicotine in people with Bipolar Disorder or Schizophrenia as compared to genotype GG.	G		> 0.05				
1451138043	rs769395	methadone	Dosage	no	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.			= 0.291				
1450826746	rs1800497	nicotine	Other	no	Genotypes AA + AG are not associated with exposure to nicotine in people with Bipolar Disorder as compared to genotype GG.			> 0.05				
1184754659	rs9923231	acenocoumarol	Dosage	not stated	Allele T is associated with decreased dose of acenocoumarol as compared to allele C.				OR			
1450826752	rs1800497	nicotine	Other	no	Genotypes AA + AG are not associated with exposure to nicotine in people with Schizophrenia as compared to genotype GG.			> 0.05				
1183689711	rs1800750	infliximab	Efficacy	no	Genotype GG is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AA + AG.			= 0.035	OR			
981237767	rs35687416	gemcitabine	Efficacy	yes	Genotype GG is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes GT + TT.			= 0.001	HR	2.41	1.39	4.18
981237767	rs35687416	gemcitabine	Efficacy	yes	Genotype GG is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes GT + TT.			= 0.011	HR	1.94	1.16	3.24
1183689719	rs361525	infliximab	Efficacy	no	Genotype GG is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AA + AG.			= 0.035	OR			
981237838	rs944050	gemcitabine	Efficacy	yes	Genotype TT is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CC + CT.			= 0.002	HR	1.72	1.21	2.43
1444697587	rs1870377	clopidogrel	Efficacy	no	Allele A is not associated with decreased response to clopidogrel in people with Coronary Disease as compared to allele T.			> 0.05	OR			
1444697594	rs7667298	clopidogrel	Efficacy	no	Allele C is not associated with decreased response to clopidogrel in people with Coronary Disease as compared to allele T.			> 0.05	OR			
1448613393	rs6809699	clopidogrel	Efficacy	yes	Genotypes AA + AC is associated with increased resistance to clopidogrel as compared to genotype CC.			= 0.001	OR	3.68	1.71	7.92
981237807	rs10916852	gemcitabine	Efficacy	yes	Genotypes GT + TT are associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotype GG.			= 0.028	HR	0.57	0.35	0.94
1445402137	rs2236196	varenicline	Efficacy	no	Genotypes AA + AG is not associated with response to varenicline in people with Tobacco Use Disorder as compared to genotype GG.			= 0.66	OR	1.15	0.61	2.17
981237814	rs3925058	gemcitabine	Efficacy	no	Genotype AA is not associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes AG + GG.			= 0.059	HR	1.38	0.99	1.94
1448613376	rs6785930	clopidogrel	Efficacy	yes	Genotypes AA + AG is associated with increased resistance to clopidogrel as compared to genotype GG.			= 0.002	OR	2.89	1.48	5.64
981237819	rs7543016	gemcitabine	Efficacy	yes	Genotype CC is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CG + GG.			= 0.047	HR	1.41	1.0	1.97
1450826813	rs1799971	morphine	Efficacy	no	Genotypes AG + GG are not associated with response to morphine in women with Pain, Postoperative as compared to genotype AA.	G		= 0.22				
1450826813	rs1799971	morphine	Efficacy	no	Genotypes AG + GG are not associated with response to morphine in women with Pain, Postoperative as compared to genotype AA.	G		= 0.48				
1450826813	rs1799971	morphine	Efficacy	no	Genotypes AG + GG are not associated with response to morphine in women with Pain, Postoperative as compared to genotype AA.	G		= 0.57				
1450826813	rs1799971	morphine	Efficacy	no	Genotypes AG + GG are not associated with response to morphine in women with Pain, Postoperative as compared to genotype AA.	G		= 0.66				
1450826813	rs1799971	morphine	Efficacy	no	Genotypes AG + GG are not associated with response to morphine in women with Pain, Postoperative as compared to genotype AA.	G		= 1				
1450826813	rs1799971	morphine	Efficacy	no	Genotypes AG + GG are not associated with response to morphine in women with Pain, Postoperative as compared to genotype AA.	G		= 1				
1451121728	rs678849	oxycodone	Efficacy	no	Allele T is not associated with response to oxycodone as compared to allele C.							
1451121724	rs2234918	oxycodone	Efficacy	no	Allele T is not associated with response to oxycodone as compared to allele C.							
1445402071	rs1044396	varenicline	Efficacy	yes	Genotype GG is associated with decreased response to varenicline in people with Tobacco Use Disorder as compared to genotypes AA + AG.			=  0.007	OR			
1445402071	rs1044396	varenicline	Efficacy	yes	Genotype GG is associated with decreased response to varenicline in people with Tobacco Use Disorder as compared to genotypes AA + AG.			= 0.02	OR	1.67	1.1	2.53
1444697577	rs2305948	clopidogrel	Efficacy	yes	Allele T is associated with decreased response to clopidogrel in people with Coronary Disease as compared to allele C.			< 0.01	OR			
1451138265	rs204047	methadone	Dosage	yes	Genotype GG is associated with increased dose of methadone as compared to genotypes GT + TT.	T		= 0.0004				
1449270476	rs11940694	ethanol	Toxicity	yes	Allele A is associated with decreased dose of ethanol as compared to allele G.	A		= 9.2E-12	OR			
1447990611	rs1076560	rasagiline	Efficacy	yes	Genotype CC is associated with increased response to rasagiline in people with Parkinson Disease as compared to genotypes AA + AC.	A		= 0.063	OR			
1451138340	rs678849	methadone	Dosage	no	Genotype TT is not associated with dose of methadone as compared to genotypes CC + CT.	C		= 0.356				
981483776	rs7787082	clozapine	Efficacy	yes	Allele G is associated with decreased response to clozapine in people with Schizophrenia as compared to allele A.	A		= 0.036	OR	4.87	1.78	13.3
1451138300	rs797397	methadone	Dosage	no	Allele A is not associated with dose of methadone as compared to allele G.	G		= 0.024				
1447990584	rs2283265	rasagiline	Efficacy	yes	Genotype CC is associated with increased response to rasagiline in people with Parkinson Disease as compared to genotypes AA + AC.	A		= 0.047	OR			
981483784	rs10248420	clozapine	Efficacy	yes	Allele A is associated with decreased response to clozapine in people with Schizophrenia as compared to allele G.	A		= 0.046	OR	4.1	1.59	10.55
1184165220	rs3785143	atomoxetine	Efficacy	yes	Allele T is associated with decreased response to atomoxetine in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.			= 0.0048	OR	2.66	1.35	5.26
1451138360	rs482387	methadone	Dosage	no	Genotype AA is not associated with dose of methadone as compared to genotypes AG + GG.	G		= 0.138				
1451138451	rs508448	methadone	Dosage	no	Genotype GG is not associated with dose of methadone as compared to genotypes AA + AG.	A		= 0.862				
1451138446	rs2298895	methadone	Dosage	no	Genotype AA is not associated with dose of methadone as compared to genotypes AT + TT.	T		= 0.971				
1451138455	rs4654327	methadone	Dosage	no	Genotype AA is not associated with dose of methadone as compared to genotypes AG + GG.	G		= 0.714				
1184755018	rs6265	paroxetine	Efficacy	yes	Genotypes CC + CT is associated with decreased response to paroxetine in women with Depressive Disorder, Major as compared to genotype TT.			= 0.019	OR			
1184755051	rs2216711	paroxetine	Efficacy	yes	Genotypes AA + AG is associated with decreased response to paroxetine in women with Depressive Disorder, Major as compared to genotype GG.			= 0.013	OR			
1448268979	rs1142345	mercaptopurine	Efficacy	yes	Allele C is associated with exposure to mercaptopurine in children with Leukemia as compared to allele T.			= 6.8E-5	OR			
1449188786	rs1799971	morphine	Dosage	no	Allele G is not associated with dose of morphine in women with Pain, Postoperative as compared to allele A.	G		> 0.2	OR			
1448268958	rs9923231	warfarin	Dosage	not stated	Genotypes CT + TT is associated with dose of warfarin in people with Atrial Fibrillation and venous thromboembolism.				OR			
1451138480	rs204076	methadone	Dosage	no	Genotype AA is not associated with dose of methadone as compared to genotypes AT + TT.	T		= 0.641				
1448613000	rs7968606	amisulpride	Efficacy	yes	Genotype CC is associated with increased response to amisulpride in people with Schizophrenia as compared to genotypes CT + TT.	C		= 0.041	OR			
1448612973	rs1045642	morphine	Dosage	no	Allele A is not associated with dose of morphine in people with Neoplasms as compared to allele G.	A		= 0.857	OR			
1449188836	rs1799971	naloxone	Other	yes	Genotypes AG + GG is associated with increased response to naloxone as compared to genotype AA.	G		= 0.046	OR			
1449713146	rs1800497	bupropion	Efficacy	no	Allele A are not associated with response to bupropion in people with Tobacco Use Disorder as compared to allele G.			= 0.2	OR			
1448612967	rs4680	morphine	Dosage	no	Allele G is not associated with dose of morphine in people with Neoplasms as compared to allele A.	A		= 0.307	OR			
1448612958	rs1799971	morphine	Dosage	yes	Genotype AG is associated with increased dose of morphine in people with Neoplasms as compared to genotype AA.	A		= 0.010	OR			
1449713162	rs12979860	peginterferon alfa-2a	Efficacy	no	Genotype CC is not associated with response to peginterferon alfa-2a in people with Hepatitis B, Chronic as compared to genotypes CT + TT.			= 0.075	OR			
1449713162	rs12979860	peginterferon alfa-2a	Efficacy	no	Genotype CC is not associated with response to peginterferon alfa-2a in people with Hepatitis B, Chronic as compared to genotypes CT + TT.			= 0.25	OR			
1449713162	rs12979860	peginterferon alfa-2a	Efficacy	no	Genotype CC is not associated with response to peginterferon alfa-2a in people with Hepatitis B, Chronic as compared to genotypes CT + TT.			= 0.528	OR			
1449713162	rs12979860	peginterferon alfa-2a	Efficacy	no	Genotype CC is not associated with response to peginterferon alfa-2a in people with Hepatitis B, Chronic as compared to genotypes CT + TT.			= 0.986	OR			
1449713195	rs8099917	peginterferon alfa-2a	Efficacy	no	Genotype TT is not associated with response to peginterferon alfa-2a in people with Hepatitis B, Chronic as compared to genotypes GG + GT.			= 0.148	OR			
1449713195	rs8099917	peginterferon alfa-2a	Efficacy	no	Genotype TT is not associated with response to peginterferon alfa-2a in people with Hepatitis B, Chronic as compared to genotypes GG + GT.			= 0.451	OR			
1449713195	rs8099917	peginterferon alfa-2a	Efficacy	no	Genotype TT is not associated with response to peginterferon alfa-2a in people with Hepatitis B, Chronic as compared to genotypes GG + GT.			= 0.717	OR			
1449713195	rs8099917	peginterferon alfa-2a	Efficacy	no	Genotype TT is not associated with response to peginterferon alfa-2a in people with Hepatitis B, Chronic as compared to genotypes GG + GT.			= 0.849	OR			
1449713186	rs12980275	peginterferon alfa-2a	Efficacy	no	Genotype AA is not associated with response to peginterferon alfa-2a in people with Hepatitis B, Chronic as compared to genotypes AG + GG.			= 0.075	OR			
1449713186	rs12980275	peginterferon alfa-2a	Efficacy	no	Genotype AA is not associated with response to peginterferon alfa-2a in people with Hepatitis B, Chronic as compared to genotypes AG + GG.			= 0.727	OR			
1449713186	rs12980275	peginterferon alfa-2a	Efficacy	no	Genotype AA is not associated with response to peginterferon alfa-2a in people with Hepatitis B, Chronic as compared to genotypes AG + GG.			= 0.919	OR			
1449713186	rs12980275	peginterferon alfa-2a	Efficacy	no	Genotype AA is not associated with response to peginterferon alfa-2a in people with Hepatitis B, Chronic as compared to genotypes AG + GG.			= 0.92	OR			
1450827343	rs2075652	heroin	Toxicity	no	Allele A is not associated with response to heroin as compared to allele G.			> 0.05				
1450827348	rs4436578	heroin	Toxicity	no	Allele C is not associated with response to heroin as compared to allele T.			> 0.05				
1451105880	rs7903146	glipizide	Efficacy	yes	Allele T is associated with increased response to glipizide as compared to allele C.	T		= 0.04				
1450827353	rs4648318	heroin	Toxicity	no	Allele T is not associated with response to heroin as compared to allele C.			> 0.05				
1450827358	rs508448	heroin	Toxicity	no	Allele A is not associated with response to heroin as compared to allele G.			> 0.05				
1450827363	rs12574471	heroin	Toxicity	no	Allele T is not associated with response to heroin as compared to allele C.			> 0.05				
1450827368	rs6985606	heroin	Toxicity	no	Allele T is not associated with response to heroin as compared to allele C.			> 0.05				
1451138662	rs3802281	methadone	Dosage	yes	Genotype TT is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes CC + CT.	C		= 0.024	OR	0.574	0.354	0.931
1451105843	rs7903146	metformin	Efficacy	yes	Allele T is associated with increased response to metformin as compared to allele C.	T		= 0.04				
1451138607	rs3802279	methadone	Dosage	yes	Genotype CC is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes CT + TT.	T		= 0.024	OR	0.574	0.354	0.931
1448612847	rs2231142	sulfasalazine	Dosage	no	Genotype GT is associated with increased exposure to sulfasalazine in healthy individuals as compared to genotype GG.			< 0.05	OR			
1450827404	rs6265	heroin	Toxicity	no	Allele T is not associated with response to heroin as compared to allele C.			> 0.05				
1451138701	rs16918842	methadone	Dosage	no	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	T		= 0.088	OR	0.615	0.359	1.053
1450827414	rs7813478	heroin	Toxicity	no	Allele C is not associated with response to heroin as compared to allele T.			> 0.05				
1451138721	rs3808627	methadone	Dosage	no	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	T		= 0.364	OR	1.13	0.868	1.47
1450827424	rs2236857	heroin	Toxicity	no	Allele C is not associated with response to heroin as compared to allele T.			> 0.05				
1450827434	rs10835210	heroin	Toxicity	no	Allele A is not associated with response to heroin as compared to allele C.			> 0.05				
1450827374	rs16918909	heroin	Toxicity	no	Allele G is not associated with response to heroin as compared to allele A.			> 0.05				
1451138668	rs963549	methadone	Dosage	yes	Genotype CC is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes CT + TT.	T		= 0.031	OR	0.586	0.361	0.952
1450827379	rs7131056	heroin	Toxicity	no	Allele A is not associated with response to heroin as compared to allele C.			> 0.05				
1450827384	rs6669447	heroin	Toxicity	no	Allele C is not associated with response to heroin as compared to allele T.			> 0.05				
1449172643	rs1799971	morphine	Dosage	no	Allele G is not associated with dose of morphine in people with Pain, Postoperative as compared to allele A.	G		= 0.40	OR			
1449172643	rs1799971	morphine	Dosage	no	Allele G is not associated with dose of morphine in people with Pain, Postoperative as compared to allele A.	G		= 0.69	OR			
1450827389	rs1076560	heroin	Toxicity	no	Allele A is not associated with response to heroin as compared to allele C.			> 0.05				
1450827394	rs1079596	heroin	Toxicity	no	Allele T is not associated with response to heroin as compared to allele C.			> 0.05				
1451138764	rs3802281	heroin	Dosage	no	Allele C is not associated with dose of heroin in people with Heroin Dependence as compared to allele T.	C		= 0.500	OR	0.875	0.595	1.289
1451138773	rs3808627	heroin	Dosage	no	Allele T is not associated with dose of heroin in people with Heroin Dependence as compared to allele C.	T		= 0.512	OR	1.082	0.855	1.368
1451138786	rs16918842	heroin	Dosage	no	Allele T is not associated with dose of heroin in people with Heroin Dependence as compared to allele C.	T		= 0.675	OR	0.909	0.583	1.418
1451138781	rs963549	heroin	Dosage	no	Allele T is not associated with dose of heroin in people with Heroin Dependence as compared to allele C.	T		= 0.547	OR	0.887	0.599	1.312
1183690453	rs45445694	methotrexate	Efficacy	no	Allele (CCGCGCCACTTGGCCTGCCTCCGTCCCG)2 is not associated with decreased response to methotrexate in people with Arthritis, Rheumatoid.				OR			
1451138791	rs12205732	heroin	Dosage	no	Allele A is not associated with dose of heroin in people with Heroin Dependence as compared to allele G.	A		= 0.797	OR	0.958	0.693	1.325
1450811055	rs1799971	nicotine	Efficacy	yes	Genotypes AG + GG are associated with decreased response to nicotine in women with Tobacco Use Disorder as compared to genotype AA.			= 0.029				
1450827439	rs16917234	heroin	Toxicity	no	Allele C is not associated with response to heroin as compared to allele T.			> 0.05				
1451138747	rs6912029	methadone	Dosage	no	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.	T		= 0.208	OR	1.258	0.879	1.801
1450811064	rs1799971	nicotine	Efficacy	no	Genotypes AG + GG are not associated with response to nicotine in men with Tobacco Use Disorder as compared to genotype AA.			= 0.99				
1451138741	rs12205732	methadone	Dosage	no	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.	A		= 0.237	OR	1.242	0.867	1.78
1451138753	rs9322453	methadone	Dosage	no	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.	C		= 0.412	OR	0.905	0.714	1.148
1450827454	rs4936274	heroin	Toxicity	no	Allele A is not associated with response to heroin as compared to allele G.			> 0.05				
1450827459	rs4654327	heroin	Toxicity	no	Allele G is not associated with response to heroin as compared to allele A.			> 0.05				
1451138759	rs3802279	heroin	Dosage	no	Allele T is not associated with dose of heroin in people with Heroin Dependence as compared to allele C.	T		= 0.500	OR	0.875	0.595	1.289
1448612713	rs2032582	imatinib	Efficacy	no	Allele C is not associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.			= 0.453	OR			
1450942220	rs9923231	warfarin	Dosage	yes	Genotype GG is associated with increased dose of warfarin in people with Atrial Fibrillation, Pulmonary Embolism or Venous Thrombosis as compared to genotypes AA + AG.	G		< 0.0001				
1448612707	rs2032582	imatinib	Efficacy	no	Allele C is not associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.			= 0.453	OR			
1448612701	rs1045642	imatinib	Efficacy	yes	Genotype AA is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes AG + GG.			= 0.005	OR	0.309	0.134	0.708
1184165651	rs1043550	warfarin	Dosage	no	Allele A is not associated with dose of warfarin as compared to allele G.	A		= 0.376	OR			
1184165651	rs1043550	warfarin	Dosage	no	Allele A is not associated with dose of warfarin as compared to allele G.	A		= 0.638	OR			
1451138802	rs9322453	heroin	Dosage	no	Allele C is not associated with dose of heroin in people with Heroin Dependence as compared to allele G.	C		= 0.181	OR	0.865	0.7	1.069
1451138797	rs6912029	heroin	Dosage	no	Allele T is not associated with dose of heroin in people with Heroin Dependence as compared to allele G.	T		= 0.778	OR	0.955	0.692	1.318
1450942212	rs7412	warfarin	Dosage	yes	Genotype CC is associated with increased dose of warfarin in people with Atrial Fibrillation, Pulmonary Embolism or Venous Thrombosis as compared to genotypes CT + TT.	T		= 0.022				
1448612656	rs1902023	oxcarbazepine	Efficacy	no	Genotype AA is not associated with increased response to oxcarbazepine in people with Seizures as compared to genotypes AC + CC.	A		= 0.20	OR			
1448612644	rs2011425	oxcarbazepine	Efficacy	no	Genotype GG is not associated with increased response to oxcarbazepine in people with Seizures as compared to genotypes GT + TT.	G		= 0.69	OR			
1448612637	rs2741049	oxcarbazepine	Efficacy	yes	Genotype CC is associated with increased response to oxcarbazepine in people with Seizures as compared to genotypes CT + TT.	T		= 0.011	OR			
1449271127	rs1799971	methadone	Dosage	no	Genotype GG is not associated with dose of methadone in people with Substance-Related Disorders as compared to genotypes AA + AG.	G		> 0.7	OR			
981859123	rs9606186	risperidone	Efficacy	yes	Genotype GG is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CG.			= 0.02	OR	3.95		
1450942260	rs1045642	warfarin	Dosage	no	Genotype AA is not associated with decreased dose of warfarin in people with Atrial Fibrillation, Pulmonary Embolism or Venous Thrombosis.	A		= 0.112				
1449271120	rs6277	methadone	Dosage	no	Genotype GG is not associated with dose of methadone in people with Substance-Related Disorders as compared to genotypes AA + AG.	A		= 0.12	OR			
1449271143	rs2234918	methadone	Dosage	no	Genotype CC is not associated with dose of methadone in people with Substance-Related Disorders as compared to genotypes CT + TT.	C		> 0.7	OR			
1448104687	rs9923231	warfarin	Dosage	yes	Allele T is associated with decreased dose of warfarin in children as compared to allele C.			< 0.001	OR			
1449271133	rs1799971	methadone	Efficacy	no	Genotype GG is not associated with response to methadone in people with Substance-Related Disorders as compared to genotypes AA + AG.	G		= 0.3	OR			
1184509863	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT is associated with decreased dose of warfarin as compared to genotype CC.			< 0.05	OR			
1448104695	rs9923231	warfarin	Dosage	yes	Genotype TT is associated with decreased dose of warfarin in children as compared to genotype CT.			= 0.001	OR			
1449271149	rs4532	methadone	Dosage	no	Genotype CC is not associated with dose of methadone in people with Substance-Related Disorders as compared to genotypes CT + TT.	C		> 0.7	OR			
1449271155	rs1800497	methadone	Dosage	no	Genotype AA is not associated with dose of methadone in people with Substance-Related Disorders as compared to genotypes AG + GG.	A		> 0.7	OR			
1449271175	rs1800497	methadone	Efficacy	no	Genotype AA is not associated with response to methadone in people with Substance-Related Disorders as compared to genotypes AG + GG.	A		= 0.9	OR			
1449271168	rs4532	methadone	Efficacy	no	Genotype CC is not associated with response to methadone in people with Substance-Related Disorders as compared to genotypes CT + TT.	C		= 0.2	OR			
1447989974	rs116855232	mercaptopurine	Dosage	not stated	Genotype CT is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.	T		= 0.04	OR			
1448612553	rs2267076	regadenoson	Efficacy	no	Allele T is not associated with response to regadenoson as compared to allele C.				OR			
1448612543	rs2298383	regadenoson	Efficacy	no	Allele T is not associated with response to regadenoson as compared to allele C.				OR			
1448612534	rs5751862	regadenoson	Efficacy	no	Allele A is not associated with response to regadenoson as compared to allele G.				OR			
1450123149	rs12456693	clopidogrel	Efficacy	yes	Allele T is associated with increased response to clopidogrel in people with Coronary Artery Disease as compared to allele C.			= 6.83e-5	OR			
982006735	rs9923231	acenocoumarol	Dosage	yes	Genotype CT is associated with decreased dose of acenocoumarol as compared to genotype CC.	T		< 0.001	OR	6.5	1.38	30.5
1451106280	rs9828223	adalimumab	Efficacy	yes	Allele T is associated with decreased response to adalimumab in people with Crohn Disease as compared to allele C.	T		= 1.88E-9	OR	20.2	5.57	73.27
1451106280	rs9828223	adalimumab	Efficacy	yes	Allele T is associated with decreased response to adalimumab in people with Crohn Disease as compared to allele C.			= 0.019	OR	1.77	1.09	5.02
1451106280	rs9828223	adalimumab	Efficacy	yes	Allele T is associated with decreased response to adalimumab in people with Crohn Disease as compared to allele C.	T		= 0.044	OR	1.16	1.09	1.23
982006724	rs9923231	acenocoumarol	Dosage	yes	Genotype TT is associated with decreased dose of acenocoumarol as compared to genotypes CC + CT.	T		< 0.001	OR	11.6	2.26	59.58
1450811334	rs1799971	naltrexone	Efficacy	not stated	Genotypes AG + GG are associated with decreased response to naltrexone in people with Tobacco Use Disorder as compared to genotype AA.							
1449140243	rs1799732	aripiprazole	Efficacy	not stated	Genotype G/del is associated with decreased response to aripiprazole in people with schizoaffective disorder.				OR			
1451237363	rs1142345	azathioprine	Dosage	yes	Genotype CT is associated with decreased dose of azathioprine in children with Colitis, Ulcerative or Crohn Disease as compared to genotype TT.	C		= 0.0087				
1451106300	rs17817449	ethanol	Dosage	no	Genotype GG is not associated with dose of ethanol as compared to genotypes GT + TT.	G		= 0.203				
1451106300	rs17817449	ethanol	Dosage	no	Genotype GG is not associated with dose of ethanol as compared to genotypes GT + TT.	G		= 0.302				
982006874	rs1967554	methadone	Efficacy	yes	Allele C is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to allele A.			= 0.011	OR	20.25	1.46	280.5
1450811473	rs1045280	nicotine	Efficacy	no	Allele C is not associated with response to nicotine in people with Tobacco Use Disorder as compared to allele T.	C		> 0.22				
1450811473	rs1045280	nicotine	Efficacy	no	Allele C is not associated with response to nicotine in people with Tobacco Use Disorder as compared to allele T.	C		= 0.45	OR	0.84	0.54	1.32
1450811473	rs1045280	nicotine	Efficacy	no	Allele C is not associated with response to nicotine in people with Tobacco Use Disorder as compared to allele T.	C		= 0.69	OR	1.14	0.61	2.13
1450811473	rs1045280	nicotine	Efficacy	no	Allele C is not associated with response to nicotine in people with Tobacco Use Disorder as compared to allele T.	C		> 0.79				
1449156665	rs3745274	efavirenz	Efficacy	yes	Allele T is associated with decreased clearance of efavirenz in children with HIV Infections as compared to allele G.			= 0.005	OR			
1449713713	rs767455	etanercept	Efficacy	no	Genotype CT is not associated with response to etanercept in people with Spondylitis, Ankylosing as compared to genotypes CC + TT.				OR			
1450811485	rs3786047	nicotine	Efficacy	no	Allele A is not associated with response to nicotine in people with Tobacco Use Disorder as compared to allele G.	A		> 0.22				
1450811485	rs3786047	nicotine	Efficacy	no	Allele A is not associated with response to nicotine in people with Tobacco Use Disorder as compared to allele G.	A		> 0.79				
1444827662	rs1799971	naltrexone	Efficacy	no	Allele G is not associated with response to naltrexone in people with Alcoholism as compared to allele A.			= 0.32	OR			
1184510103	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT is associated with decreased dose of warfarin as compared to genotype CC.			< 0.001	OR			
1450811453	rs3852209	nicotine	Efficacy	yes	Genotypes CT + TT are associated with increased response to nicotine in people with Tobacco Use Disorder as compared to genotype CC.	T		= 0.013	OR	1.96	1.16	3.34
1450811453	rs3852209	nicotine	Efficacy	yes	Genotypes CT + TT are associated with increased response to nicotine in people with Tobacco Use Disorder as compared to genotype CC.	T		= 0.028				
1450811453	rs3852209	nicotine	Efficacy	yes	Genotypes CT + TT are associated with increased response to nicotine in people with Tobacco Use Disorder as compared to genotype CC.	T		= 0.099	OR	1.46	0.93	2.28
1450811453	rs3852209	nicotine	Efficacy	yes	Genotypes CT + TT are associated with increased response to nicotine in people with Tobacco Use Disorder as compared to genotype CC.	T		> 0.22				
982006849	rs7127507	methadone	Efficacy	yes	Allele C is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to allele T.			= 0.011	OR	20.25	1.46	280.5
1450811465	rs2278060	nicotine	Efficacy	no	Genotypes AC + CC are not associated with response to nicotine in people with Tobacco Use Disorder as compared to genotype AA.	C		= 0.053				
1450811465	rs2278060	nicotine	Efficacy	no	Genotypes AC + CC are not associated with response to nicotine in people with Tobacco Use Disorder as compared to genotype AA.	C		> 0.22				
981793945	rs2072671	gemcitabine	Efficacy	yes	Genotype AA is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes AC + CC.	C		= 0.017	OR	2.5	1.18	5.28
982006932	rs11030119	methadone	Efficacy	yes	Allele G is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to allele A.			= 0.011	OR	20.25	1.46	280.5
1184510021	rs9934438	warfarin	Dosage	yes	Genotypes AA + AG is associated with decreased dose of warfarin as compared to genotype GG.			< 0.001	OR			
1445401050	rs72547529	warfarin	Dosage	not stated	Allele T is associated with increased dose of warfarin as compared to allele C.				OR			
1445401042	rs9923231	warfarin	Dosage	not stated	Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.				OR			
982006898	rs11030118	methadone	Efficacy	yes	Allele G is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to allele A.			= 0.011	OR	20.25	1.46	280.5
1184510039	rs2108622	warfarin	Dosage	yes	Genotype TT is associated with increased dose of warfarin as compared to genotypes CC + CT.			= 0.02	OR			
1184510043	rs699664	warfarin	Dosage	no	Allele C is not associated with dose of warfarin as compared to allele T.			= 0.82	OR			
1183690865	rs1799983	enalapril	Efficacy	no	Genotype GG is not associated with response to enalapril in people with Hypertension as compared to genotypes GT + TT.	G		< 0.05	OR			
1184510047	rs2290228	warfarin	Dosage	no	Allele A is not associated with decreased dose of warfarin as compared to allele G.			= 0.67	OR			
982006921	rs2030324	methadone	Efficacy	yes	Allele G is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to allele A.			= 0.011	OR	20.25	1.46	280.5
1445401065	rs72547529	warfarin	Dosage	not stated	Allele T is associated with increased dose of warfarin as compared to allele C.				OR			
1449566369	rs11065987	hydrochlorothiazide	Efficacy	yes	Genotypes AA + AG is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype GG.	A		= 1.7E-3	OR			
1449566369	rs11065987	hydrochlorothiazide	Efficacy	yes	Genotypes AA + AG is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype GG.	A		= 2.9E-3	OR			
1445401057	rs72547529	warfarin	Dosage	not stated	Allele T is associated with increased dose of warfarin as compared to allele C.				OR			
982006910	rs988748	methadone	Efficacy	yes	Allele C is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to allele G.			= 0.011	OR	20.25	1.46	280.5
1183690869	rs1799722	enalapril	Efficacy	yes	Genotype TT is associated with decreased response to enalapril in people with Hypertension as compared to genotypes CC + CT.	T		< 0.05	OR			
1450811601	rs2235067	methadone	Dosage	no	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.			= 0.39				
1450811607	rs2032583	methadone	Dosage	no	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.			= 0.18				
981793996	rs9937	gemcitabine	Efficacy	yes	Genotype AA is associated with decreased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes AG + GG.	G		= 0.048	HR	1.53	1.0	2.34
1450811613	rs2032582	methadone	Dosage	no	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.			= 0.14				
1450811619	rs1922242	methadone	Dosage	no	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.			= 0.15				
1450811625	rs3789243	methadone	Dosage	no	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.			= 0.57				
981793968	rs4694362	gemcitabine	Efficacy	no	Genotype TT is not associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CT + TT.	T		= 0.653	HR	0.92	0.64	1.32
1449173229	rs1045642	morphine	Dosage	no	Allele A is not associated with dose of morphine in people with Pain, Postoperative as compared to allele G.	G		= 0.33	OR			
1449173229	rs1045642	morphine	Dosage	no	Allele A is not associated with dose of morphine in people with Pain, Postoperative as compared to allele G.	G		= 0.69	OR			
1450811671	rs553202	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.001				
1450811671	rs553202	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.001				
1450811671	rs553202	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.008				
1450811671	rs553202	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.008				
1450811671	rs553202	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.01				
1450811671	rs553202	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.01				
1450811671	rs553202	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.02				
1450811671	rs553202	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.03				
1450811671	rs553202	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.10				
1450811671	rs553202	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.10				
1450811671	rs553202	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.15				
1450811671	rs553202	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.21				
1450811671	rs553202	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.32				
1450811671	rs553202	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.48				
1450811671	rs553202	ethanol	Efficacy	yes	Allele T is associated with increased response to ethanol as compared to allele C.	T		= 0.64				
1184510136	rs2108622	warfarin	Dosage	yes	Genotypes CT + TT is associated with increased dose of warfarin as compared to genotype CC.			< 0.00001	OR			
1184510136	rs2108622	warfarin	Dosage	yes	Genotypes CT + TT is associated with increased dose of warfarin as compared to genotype CC.			< 0.00001	OR			
1184510136	rs2108622	warfarin	Dosage	yes	Genotypes CT + TT is associated with increased dose of warfarin as compared to genotype CC.			= 0.0009	OR			
1184166166	rs3025033	bevacizumab	Efficacy	no	Genotype AA is not associated with response to bevacizumab in people with Macular Degeneration as compared to genotypes AG + GG.	A		= 0.223	OR			
1184166162	rs2146323	bevacizumab	Efficacy	no	Genotype CC is not associated with response to bevacizumab in people with Macular Degeneration as compared to genotypes AA + AC.	A		= 1.0	OR			
1448268112	rs9923231	warfarin	Dosage	not stated	Allele T is associated with dose of warfarin.	T			OR			
1450811690	rs524731	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele C.	A		= 0.001				
1450811690	rs524731	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele C.	A		= 0.002				
1450811690	rs524731	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele C.	A		= 0.01				
1450811690	rs524731	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele C.	A		= 0.01				
1450811690	rs524731	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele C.	A		= 0.02				
1450811690	rs524731	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele C.	A		= 0.03				
1450811690	rs524731	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele C.	A		= 0.06				
1450811690	rs524731	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele C.	A		= 0.07				
1450811690	rs524731	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele C.	A		= 0.09				
1450811690	rs524731	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele C.	A		= 0.10				
1450811690	rs524731	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele C.	A		= 0.13				
1450811690	rs524731	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele C.	A		= 0.16				
1450811690	rs524731	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele C.	A		= 0.26				
1450811690	rs524731	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele C.	A		= 0.56				
1450811690	rs524731	ethanol	Efficacy	yes	Allele A is associated with increased response to ethanol as compared to allele C.	A		= 0.94				
1184510155	rs2108622	warfarin	Dosage	yes	Genotype CT is associated with increased dose of warfarin as compared to genotype CC.			= 0.027	OR			
1184166141	rs2230199	bevacizumab	Efficacy	no	Genotype GG is not associated with response to bevacizumab in people with Macular Degeneration as compared to genotypes CC + CG.	G		= 0.827	OR			
1184166132	rs1061170	bevacizumab	Efficacy	no	Genotype CC is not associated with response to bevacizumab in people with Macular Degeneration as compared to genotypes CT + TT.	T		= 0.669	OR			
1450811650	rs1799971	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.02				
1450811650	rs1799971	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.02				
1450811650	rs1799971	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.07				
1450811650	rs1799971	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.20				
1450811650	rs1799971	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.23				
1450811650	rs1799971	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.24				
1450811650	rs1799971	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.26				
1450811650	rs1799971	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.32				
1450811650	rs1799971	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.49				
1450811650	rs1799971	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.64				
1450811650	rs1799971	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.67				
1450811650	rs1799971	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.67				
1450811650	rs1799971	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.71				
1450811650	rs1799971	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.84				
1450811650	rs1799971	ethanol	Efficacy	no	Allele G is not associated with response to ethanol as compared to allele A.	G		= 0.98				
1184510186	rs9934438	warfarin	Dosage	yes	Genotype AA is associated with decreased dose of warfarin as compared to genotypes AG + GG.			< 0.001	OR			
1184166127	rs4073	bevacizumab	Efficacy	yes	Genotype AA is associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotypes AT + TT.	A		= 0.026	OR			
1450824016	rs1799971	ethanol	Other	yes	Genotypes AG + GG are associated with increased exposure to ethanol as compared to genotype AA.			< 0.02				
1448108305	rs699664	warfarin	Dosage	no	Genotypes CT + TT is not associated with dose of warfarin in children as compared to genotype CC.			= 0.880	OR			
1448108296	rs2108622	warfarin	Dosage	no	Genotypes CT + TT is not associated with dose of warfarin in children as compared to genotype CC.			= 0.883	OR			
1444700343	rs1611115	naltrexone	Efficacy	yes	Genotypes CT + TT is associated with increased response to naltrexone in men with Alcoholism as compared to genotype CC.	T		= 0.01	OR			
1449005428	rs1128503	imatinib	Efficacy	no	Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.			= 0.12	OR	0.66	0.29	1.45
1451151740	rs1045642	phenytoin	Efficacy	no	Allele G is not associated with resistance to phenytoin in people with Epilepsy as compared to allele A.			= 0.34				
1183703531	rs1050152	imatinib	Efficacy	yes	Genotype TT is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes CC + CT.	T		= 0.03	HR	0.79	0.63	0.98
1444929667	rs1364805	montelukast	Efficacy	no	Allele T is associated with increased response to montelukast in people with Asthma as compared to allele G.			= 1.69E-4	OR			
1444929661	rs953977	montelukast	Efficacy	no	Allele T is associated with increased response to montelukast in people with Asthma as compared to allele G.			= 5.26E-5	OR			
1184997889	rs2501873	warfarin	Dosage	yes	Genotype TT is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes CC + CT.			= 0.051	OR			
1184997918	rs3212198	warfarin	Dosage	yes	Allele T is associated with increased dose of warfarin in people with heart valve replacement as compared to allele C.			= 0.051	OR			
1183703589	rs1045642	imatinib	Efficacy	yes	Genotypes AA + AG is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype GG.	A		= 0.005	HR	0.56	0.37	0.84
1449005569	rs56240334	paliperidone	Efficacy	no	Allele G is associated with increased response to paliperidone in people with as compared to allele A.			= 4.26E-10	OR			
1183703569	rs2282143	imatinib	Efficacy	no	Genotype CC is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes CT + TT.	T		= 0.08	HR	0.25	0.03	1.79
1183703573	rs1045642	imatinib	Efficacy	no	Genotype GG is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes AA + AG.	A		= 0.09	HR	0.79	0.6	1.04
1450824235	rs3778150	ethanol		yes	Genotypes CC + CT are associated with decreased response to ethanol as compared to genotype TT.			< 0.001				
1450824235	rs3778150	ethanol		yes	Genotypes CC + CT are associated with decreased response to ethanol as compared to genotype TT.			= 0.010				
1450824235	rs3778150	ethanol		yes	Genotypes CC + CT are associated with decreased response to ethanol as compared to genotype TT.			= 0.021				
1450824235	rs3778150	ethanol		yes	Genotypes CC + CT are associated with decreased response to ethanol as compared to genotype TT.			= 0.028				
1450824235	rs3778150	ethanol		yes	Genotypes CC + CT are associated with decreased response to ethanol as compared to genotype TT.			< 0.03				
1450824235	rs3778150	ethanol		yes	Genotypes CC + CT are associated with decreased response to ethanol as compared to genotype TT.			= 0.036				
1450824235	rs3778150	ethanol		yes	Genotypes CC + CT are associated with decreased response to ethanol as compared to genotype TT.			= 0.471				
1450824235	rs3778150	ethanol		yes	Genotypes CC + CT are associated with decreased response to ethanol as compared to genotype TT.			= 0.703				
1450824235	rs3778150	ethanol		yes	Genotypes CC + CT are associated with decreased response to ethanol as compared to genotype TT.			< 0.809				
1450824235	rs3778150	ethanol		yes	Genotypes CC + CT are associated with decreased response to ethanol as compared to genotype TT.			= 0.942				
1444929615	rs7794356	montelukast	Efficacy	no	Allele A is associated with increased response to montelukast in people with Asthma as compared to allele G.			= 9.15E-7	OR			
1183703560	rs1050152	imatinib	Efficacy	no	Genotype TT is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes CC + CT.	T		= 0.06	HR	0.81	0.65	1.01
1183703536	rs3213619	imatinib	Efficacy	no	Genotype AA is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes AG + GG.	G		= 0.06	HR	1.92	1.03	3.56
1183703536	rs3213619	imatinib	Efficacy	no	Genotype AA is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes AG + GG.	G		= 0.07	HR	2.27	1.03	5.0
1183703536	rs3213619	imatinib	Efficacy	no	Genotype AA is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes AG + GG.	G		= 0.07	HR	1.85	0.99	3.44
1183703546	rs2282143	imatinib	Efficacy	no	Genotype CC is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes CT + TT.	T		= 0.05	HR	1.87	1.06	3.29
1448255537	rs9923231	acenocoumarol	Dosage	yes	Genotypes CT + TT are associated with decreased dose of acenocoumarol in people with Rheumatic Heart Disease as compared to genotype CC.			= 0.023	OR			
1183703542	rs1045642	imatinib	Efficacy	no	Genotype GG is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes AA + AG.	A		= 0.06	HR	0.7	0.49	1.02
1183703648	rs1799971	venlafaxine	Efficacy	no	Genotype AA is not associated with response to venlafaxine in people with Anxiety Disorders as compared to genotypes AG + GG.	G		= 0.3401	OR			
1183703648	rs1799971	venlafaxine	Efficacy	no	Genotype AA is not associated with response to venlafaxine in people with Anxiety Disorders as compared to genotypes AG + GG.	G		= 0.3754	OR			
1183703648	rs1799971	venlafaxine	Efficacy	no	Genotype AA is not associated with response to venlafaxine in people with Anxiety Disorders as compared to genotypes AG + GG.	G		= 0.514	OR			
1183703648	rs1799971	venlafaxine	Efficacy	no	Genotype AA is not associated with response to venlafaxine in people with Anxiety Disorders as compared to genotypes AG + GG.	G		= 0.6234	OR			
1446895600	rs2299214	risperidone	Efficacy	yes	Genotypes CC + CT is associated with decreased response to risperidone in people with Schizophrenia as compared to genotype TT.			= 0.039	OR	2.25	1.04	4.87
1183703603	rs1050152	imatinib	Efficacy	yes	Genotype TT is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes CC + CT.	T		= 0.03	HR	0.77	0.61	0.97
1183703597	rs3213619	imatinib	Efficacy	no	Genotype AA is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes AG + GG.	G		= 0.08	HR	2.78	1.01	8.02
1183703611	rs2740574	imatinib	Efficacy	no	Genotypes CT + TT is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype CC.	C		= 0.07	HR	1.78	1.0	3.17
1183703607	rs1050152	imatinib	Efficacy	no	Genotype TT is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes CC + CT.	T		= 0.07	HR	0.7	0.48	1.03
1448108002	rs1801133	methotrexate	Efficacy	no	Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G.				OR			
1448108002	rs1801133	methotrexate	Efficacy	no	Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G.				OR			
1444929453	rs2053044	ramipril	Efficacy	yes	Genotypes AA + AG is associated with increased response to ramipril in people with Hypertension as compared to genotype GG.			< 0.05	HR	2.09	1.21	3.6
1448107984	rs1127354	azathioprine	Efficacy	yes	Genotypes AA + AC is associated with increased response to azathioprine in people with Lupus Erythematosus, Systemic as compared to genotype CC.			< 0.001	OR			
1448107993	rs1801131	methotrexate	Efficacy	no	Allele G is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.				OR			
1448107993	rs1801131	methotrexate	Efficacy	no	Allele G is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.				OR			
1446748136	rs2032582	sunitinib	Efficacy	yes	Genotype AA is associated with decreased response to sunitinib in people with Carcinoma, Renal Cell.			= 0.005	HR	5.0	1.6	15.2
1446748136	rs2032582	sunitinib	Efficacy	yes	Genotype AA is associated with decreased response to sunitinib in people with Carcinoma, Renal Cell.	A		= 0.01	OR	0.1	0.0	0.6
1446748136	rs2032582	sunitinib	Efficacy	yes	Genotype AA is associated with decreased response to sunitinib in people with Carcinoma, Renal Cell.	A		= 0.12	HR	2.0	0.8	5.0
1446748136	rs2032582	sunitinib	Efficacy	yes	Genotype AA is associated with decreased response to sunitinib in people with Carcinoma, Renal Cell.	A		= 0.44	HR	1.5	0.5	4.7
1448632263	rs1057868	acenocoumarol	Dosage	no	Allele T is not associated with dose of acenocoumarol in people with Atrial Fibrillation, heart valve replacement and Thromboembolism as compared to allele C.			= 0.469	OR			
1448632243	rs1908557	bupropion	Efficacy	yes	Allele C is associated with decreased response to bupropion in people with Depression as compared to allele T.			= 2.6E-8	OR			
1444929392	rs6475448	montelukast	Efficacy	yes	Genotype AA is associated with increased response to montelukast in people with Asthma as compared to genotype GG.			= 1.97E-9	OR			
1450824374	rs1799971	ethanol	Other	no	Genotypes AG + GG are not associated with response to ethanol as compared to genotype AA.			= 0.123				
1450824374	rs1799971	ethanol	Other	no	Genotypes AG + GG are not associated with response to ethanol as compared to genotype AA.			= 0.276				
1450824374	rs1799971	ethanol	Other	no	Genotypes AG + GG are not associated with response to ethanol as compared to genotype AA.			= 0.337				
1450824374	rs1799971	ethanol	Other	no	Genotypes AG + GG are not associated with response to ethanol as compared to genotype AA.			= 0.394				
1450824374	rs1799971	ethanol	Other	no	Genotypes AG + GG are not associated with response to ethanol as compared to genotype AA.			= 0.458				
1450824374	rs1799971	ethanol	Other	no	Genotypes AG + GG are not associated with response to ethanol as compared to genotype AA.			= 0.565				
1450824374	rs1799971	ethanol	Other	no	Genotypes AG + GG are not associated with response to ethanol as compared to genotype AA.			= 0.804				
1450824374	rs1799971	ethanol	Other	no	Genotypes AG + GG are not associated with response to ethanol as compared to genotype AA.			= 0.843				
1450824374	rs1799971	ethanol	Other	no	Genotypes AG + GG are not associated with response to ethanol as compared to genotype AA.			= 0.849				
1450808090	rs9479757	heroin	Dosage	yes	Genotype AG is associated with increased dose of heroin in people with Heroin Dependence as compared to genotype GG.			< 0.05	OR			
1450824453	rs1799971	ethanol	Dosage	no	Genotypes AG + GG are not associated with dose of ethanol as compared to genotype AA.			= 0.515				
1450824458	rs3778150	ethanol	Dosage	yes	Genotypes CC + CT are associated with increased dose of ethanol as compared to genotype TT.			= 0.002				
1450971980	rs671	ethanol	Other	yes	Genotype AG is associated with increased exposure to ethanol in men as compared to genotype GG.			< 0.05	OR			
1449169755	rs717620	atorvastatin	Efficacy	yes	Genotypes CT + TT are associated with decreased response to atorvastatin in men with Hypercholesterolemia as compared to genotype CC.			= 0.0078	OR			
1449169755	rs717620	atorvastatin	Efficacy	yes	Genotypes CT + TT are associated with decreased response to atorvastatin in men with Hypercholesterolemia as compared to genotype CC.			= 0.020	OR	4.609	1.27	16.72
1449169755	rs717620	atorvastatin	Efficacy	yes	Genotypes CT + TT are associated with decreased response to atorvastatin in men with Hypercholesterolemia as compared to genotype CC.			= 0.1251	OR			
1184998312	rs776746	tacrolimus	Dosage	yes	Allele T is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to allele C.	C		< 0.0001	OR			
1184998300	rs776746	tacrolimus	Dosage	yes	Genotype CC is associated with decreased dose of tacrolimus in people with Kidney Transplantation as compared to genotype CT.	C			OR			
1448124080	rs116855232	azathioprine	Dosage	yes	Genotypes CT + TT are associated with decreased dose of azathioprine in people with Colitis, Ulcerative, Crohn Disease and Hepatitis, Autoimmune as compared to genotype CC.	T		< 0.01	OR			
1184998398	rs776746	tacrolimus	Dosage	yes	Genotypes CT + TT are associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to genotype CC.	C		< 0.01	OR			
1444699815	rs3836790	levodopa	Efficacy	yes	Genotype ACATACACACTCAGACACACATACCATGCA/ACATACACACTCAGACACACATACCATGCA is associated with increased response to levodopa in people with Parkinson Disease as compared to genotypes ACATACACACTCAGACACACATACCATGCA/del + del/del.			< 0.0001	OR			
1444699815	rs3836790	levodopa	Efficacy	yes	Genotype ACATACACACTCAGACACACATACCATGCA/ACATACACACTCAGACACACATACCATGCA is associated with increased response to levodopa in people with Parkinson Disease as compared to genotypes ACATACACACTCAGACACACATACCATGCA/del + del/del.			= 0.0004	OR			
1448107619	rs1979277	methotrexate	Efficacy	no	Genotype AA is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.			= 0.012	OR			
1448107584	rs16969968	nicotine	Other	yes	Genotype GG is associated with decreased dose of nicotine in people with Tobacco Use Disorder as compared to genotypes AA + AG.			= 0.01	OR			
1450415126	rs1045642	methotrexate	Efficacy	yes	Genotype GG is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.			= 0.047	OR	1.35	1.01	1.82
1448107570	rs35599367	simvastatin	Efficacy	yes	Allele A is associated with increased response to simvastatin in people with Chronic Disease as compared to genotype GG.			= 0.034	OR			
1448107552	rs776746	rosuvastatin	Efficacy	yes	Allele C is associated with increased response to rosuvastatin in people with Myocardial Infarction as compared to allele T.			= 0.017	OR	2.289	1.157	4.527
1448631796	rs1050152	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.			= 0.11	OR			
1450415186	rs293983	belimumab	Efficacy	no	Allele T is not associated with response to belimumab in people with Lupus erythematosus as compared to allele C.			= 0.64	OR	0.9	0.52	1.57
1448631790	rs272893	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.			= 0.57	OR			
1448631778	rs12943590	metformin	Efficacy	no	Allele A is not associated with response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele G.			= 0.51	OR			
1448107497	rs2231142	rosuvastatin	Efficacy	yes	Allele T is associated with increased response to rosuvastatin in people with Myocardial Infarction as compared to allele G.			= 0.017	OR	2.289	1.157	4.527
1448631772	rs2252281	metformin	Efficacy	no	Allele C is not associated with response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele T.			= 0.68	OR			
1448615387	rs34231037	sunitinib	Efficacy	no	Genotype AG is associated with response to sunitinib as compared to genotype GG.			= 0.062	OR	2.58	0.95	6.99
1448631766	rs2289669	metformin	Efficacy	no	Allele A is not associated with response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele G.			= 0.83	OR			
1184998473	rs4149056	simvastatin	Efficacy	yes	Genotypes CC + CT is associated with decreased response to simvastatin in people with Dyslipidaemia as compared to genotype TT.			= 0.02	OR			
1448615381	rs34231037	sunitinib	Efficacy	yes	Genotype AG is associated with increased clinical benefit to sunitinib as compared to genotype GG.			= 0.047	OR	3.78	1.02	14.06
1448631760	rs316019	metformin	Efficacy	no	Allele A is not associated with response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.			= 0.33	OR			
1448615370	rs1799752	interferon beta-1a	Efficacy	no	Allele del is not associated with response to interferon beta-1a in women Multiple Sclerosis as compared to allele ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC.			= 0.817	OR			
1448631754	rs622342	metformin	Efficacy	no	Allele C is not associated with response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele A.			= 0.26	OR			
1448631748	rs72552763	metformin	Efficacy	no	Allele del is not associated with response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele GAT.			= 0.85	OR			
1448615363	rs1799752	interferon beta-1a	Efficacy	yes	Genotype del/del is associated with decreased response to interferon beta-1a in men Multiple Sclerosis.			= 0.009	OR			
1448631741	rs12208357	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.			= 0.47	OR			
1448631732	rs9304742	etanercept	Efficacy	yes	Genotype CC is associated with decreased response to etanercept in people with Psoriasis as compared to genotypes CT + TT.			= 0.006	OR			
1448631715	rs13437088	etanercept	Efficacy	yes	Genotype TT is associated with decreased response to etanercept in people with Psoriasis as compared to genotypes CC + CT.			= 0.020	OR			
1450415284	rs9934438	acenocoumarol	Dosage	no	Genotype AA is associated with decreased dose of acenocoumarol.				OR			
1448631702	rs2431697	etanercept	Efficacy	yes	Genotypes CC + CT is associated with decreased response to etanercept in people with Psoriasis as compared to genotype TT.			= 0.040	OR			
1450415278	rs9923231	acenocoumarol	Dosage	no	Genotype AA is associated with decreased dose of acenocoumarol.				OR			
1448598925	rs7512462	ivacaftor	Efficacy	yes	Genotypes CC + CT is associated with increased response to ivacaftor in children with Cystic Fibrosis as compared to genotype TT.			= 0.01	OR			
1448598925	rs7512462	ivacaftor	Efficacy	yes	Genotypes CC + CT is associated with increased response to ivacaftor in children with Cystic Fibrosis as compared to genotype TT.			= 0.03	OR			
1448631689	rs2546890	etanercept	Efficacy	yes	Genotypes AG + GG is associated with decreased response to etanercept in people with Psoriasis as compared to genotype AA.			= 0.044	OR			
1448631680	rs928655	etanercept	Efficacy	yes	Genotypes AG + GG is associated with increased response to etanercept in people with Psoriasis as compared to genotype AA.			= 0.014	OR			
1448123760	rs2535629	clozapine	Efficacy	yes	Genotype AA is associated with increased response to clozapine in people with Schizophrenia as compared to genotypes AG + GG.	A		= 0.032	OR			
1447681357	rs1449683	fluvoxamine	Efficacy	yes	Genotypes CC + CT are associated with decreased response to fluvoxamine in people with Depressive Disorder as compared to genotype TT.	T		= 0.013	OR			
1447959890	rs4149117	imatinib	Efficacy	yes	Genotypes GG + GT is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype TT.			= 0.04	OR	2.17	1.02	4.64
1448123726	rs4148776	glibenclamide	Efficacy	yes	Allele G is associated with increased response to glibenclamide in people with as compared to allele A.			< 0.05	OR			
1447959896	rs150929	imatinib	Efficacy	yes	Genotypes GG + GT is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype TT.			= 0.012	OR	6.37	1.5	27.18
1447681340	rs6295	milnacipran	Efficacy	yes	Genotypes CC + CG are associated with increased response to milnacipran in people with Depressive Disorder as compared to genotype GG.			= 0.001	OR			
1448123709	rs1054097	glibenclamide	Efficacy	yes	Allele C is associated with increased response to glibenclamide in people with as compared to allele G.			< 0.05	OR			
1447681351	rs1800544	milnacipran	Efficacy	yes	Genotypes CC + CG are associated with increased response to milnacipran in people with Depressive Disorder as compared to genotype GG.	C		= 0.028	OR			
1447959879	rs7311358	imatinib	Efficacy	yes	Genotypes AA + AG is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype GG.			= 0.04	OR	2.17	1.02	4.64
1448123697	rs1803545	glibenclamide	Efficacy	yes	Allele A is associated with increased response to glibenclamide in people with as compared to allele G.			< 0.05	OR			
1444699493	rs4680	clozapine	Efficacy	yes	Genotype GG is associated with increased response to clozapine in people with Schizophrenia as compared to genotypes AA + AG.	A		= 0.01	OR			
1448123633	rs3729910	glibenclamide	Efficacy	yes	Allele G is associated with increased response to glibenclamide in people with as compared to allele A.			< 0.05	OR			
1444699432	rs10465180	clozapine	Efficacy	yes	Genotype CC is associated with decreased response to clozapine in people with Schizophrenia as compared to genotypes CT + TT.			= 0.002	OR	2.15	1.3	3.55
1448123581	rs5224	glibenclamide	Efficacy	yes	Allele A is associated with increased response to glibenclamide in people with as compared to allele G.			< 0.05	OR			
1446534354	rs9332238	warfarin	Dosage	yes	Allele G is associated with increased dose of warfarin as compared to allele A.			= 4.4e-13	OR	6.8	5.0	9.1
1450808749	rs1800497	venlafaxine	Efficacy	no	Genotypes AA + AG are not associated with response to venlafaxine in people with as compared to genotype GG.	A			OR			
1448123507	rs7793861	glibenclamide	Efficacy	yes	Allele G is associated with increased response to glibenclamide in people with as compared to allele C.			< 0.05	OR			
1449170406	rs1045642	tacrolimus	Dosage	no	Genotype AA is not associated with dose of tacrolimus in children with Kidney Transplantation as compared to genotypes AG + GG.	G		= 0.2	OR			
1448123498	rs4148269	glibenclamide	Efficacy	yes	Allele G is associated with increased response to glibenclamide in people with as compared to allele T.			< 0.05	OR			
1448123493	rs7515157	glibenclamide	Efficacy	yes	Allele T is associated with increased response to glibenclamide in people with as compared to allele C.			< 0.05	OR			
1451120169	rs9923231	warfarin	Dosage	yes	Genotype TT is associated with decreased dose of warfarin as compared to genotypes CC + CT.	T		< 0.001				
1448123412	rs7512785	glibenclamide	Efficacy	yes	Allele T is associated with increased response to glibenclamide in people with as compared to allele C.			< 0.05	OR			
1448106998	rs2359612	warfarin	Dosage	yes	Allele A is associated with decreased dose of warfarin as compared to allele G.			< 0.001	OR			
1447959492	rs1042713	propranolol	Efficacy	yes	Genotype GG is associated with increased response to propranolol in people with Liver Cirrhosis as compared to genotype AA.			= 0.03	OR			
1444666236	rs9923231	warfarin	Dosage	yes	Allele T is associated with decreased dose of warfarin as compared to allele C.			< 0.001	OR			
1444666244	rs429358	warfarin	Dosage	yes	Genotypes CC + CT is associated with decreased dose of warfarin as compared to genotype TT.			= 0.038	OR			
1444666251	rs1045642	warfarin	Dosage	yes	Allele A is associated with increased dose of warfarin as compared to allele G.			= 0.04	OR	2.22	0.09	5.11
1449563874	rs2289669	metformin	Efficacy	yes	Allele A is associated with decreased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele G.	A		= 0.006	OR			
1183704839	rs2108622	warfarin	Dosage	yes	Genotype TT is associated with increased dose of warfarin as compared to genotypes CC + CT.			= 0.017	OR		0.006	0.059
1449563982	rs797044887	imatinib	Efficacy	no	Genotype GT is associated with response to imatinib in children.				OR			
1450973000	rs429358	donepezil	Efficacy	no	Allele C is associated with increased response to donepezil in people with Alzheimer Disease as compared to allele T.	E4		> 0.05	OR			
1446533819	rs749671	warfarin	Dosage	yes	Allele G is associated with increased dose of warfarin as compared to allele A.			= 1.08e-33	OR	20.4	14.3	29.0
1444698740	rs2857657	risperidone	Efficacy	yes	Genotype GG is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CG.	C		= 0.004	OR			
1444698740	rs2857657	risperidone	Efficacy	yes	Genotype GG is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CG.	C		= 0.033	OR			
1444698740	rs2857657	risperidone	Efficacy	yes	Genotype GG is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CG.	C		= 0.251	OR			
1444698740	rs2857657	risperidone	Efficacy	yes	Genotype GG is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CG.	C		= 0.331	OR			
1444698740	rs2857657	risperidone	Efficacy	yes	Genotype GG is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CG.	C		= 0.431	OR			
1444698740	rs2857657	risperidone	Efficacy	yes	Genotype GG is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CG.	C		= 0.518	OR			
1444698740	rs2857657	risperidone	Efficacy	yes	Genotype GG is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CG.	C		= 0.573	OR			
1444698740	rs2857657	risperidone	Efficacy	yes	Genotype GG is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CG.	C		= 0.887	OR			
1449564081	rs11212617	metformin	Efficacy	no	Allele C is associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele A.	C		= 0.04	OR			
1449269204	rs1057910	warfarin	Dosage	not stated	Allele C is associated with dose of warfarin as compared to allele A.				OR			
1448123009	rs11212617	metformin	Efficacy	no	Allele C is not associated with response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele A.			= 0.32	OR	0.86	0.52	1.41
1448123019	rs628031	metformin	Efficacy	no	Allele A is not associated with response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele G.			= 0.45	OR			
1449269199	rs1799853	warfarin	Dosage	not stated	Allele T is associated with dose of warfarin as compared to allele C.				OR			
1448122994	rs1128503	losartan	Efficacy	no	Allele G is not associated with increased response to losartan in people with Hypertension as compared to allele A.			= 0.07	OR			
1447680610	rs10490924	photodynamic therapy	Efficacy	no	Genotype TT is not associated with response to photodynamic therapy in people with Macular Degeneration as compared to genotype GG.	G		= 0.4	OR			
1447680594	rs1061170	photodynamic therapy	Efficacy	no	Genotype TT is not associated with response to photodynamic therapy in people with Macular Degeneration as compared to genotype CC.	C		= 0.4	OR	1.57	0.48	5.2
1444698694	rs4795893	risperidone	Efficacy	yes	Genotypes AA + AG is associated with increased response to risperidone in people with Schizophrenia as compared to genotype GG.	A		= 1.66E-4	OR			
1444698694	rs4795893	risperidone	Efficacy	yes	Genotypes AA + AG is associated with increased response to risperidone in people with Schizophrenia as compared to genotype GG.	A		= 0.001	OR			
1444698694	rs4795893	risperidone	Efficacy	yes	Genotypes AA + AG is associated with increased response to risperidone in people with Schizophrenia as compared to genotype GG.	A		= 0.002	OR			
1444698694	rs4795893	risperidone	Efficacy	yes	Genotypes AA + AG is associated with increased response to risperidone in people with Schizophrenia as compared to genotype GG.	A		= 0.105	OR			
1448122968	rs1045642	losartan	Efficacy	yes	Genotypes AA + AG are associated with increased response to losartan in people with Hypertension as compared to genotype GG.			= 0.03	OR			
1444698707	rs4586	risperidone	Efficacy	yes	Genotypes CC + CT is associated with increased response to risperidone in people with Schizophrenia as compared to genotype TT.	C		= 0.001	OR			
1444698707	rs4586	risperidone	Efficacy	yes	Genotypes CC + CT is associated with increased response to risperidone in people with Schizophrenia as compared to genotype TT.	C		= 0.007	OR			
1444698707	rs4586	risperidone	Efficacy	yes	Genotypes CC + CT is associated with increased response to risperidone in people with Schizophrenia as compared to genotype TT.	C		= 0.015	OR			
1444698707	rs4586	risperidone	Efficacy	yes	Genotypes CC + CT is associated with increased response to risperidone in people with Schizophrenia as compared to genotype TT.	C		= 0.208	OR			
1447680563	rs2108622	warfarin	Dosage	yes	Allele T is associated with dose of warfarin as compared to allele C.			= 7.7e-3	OR			
1184753733	rs4680	morphine	Dosage	no	Genotype GG is not associated with increased dose of morphine in infants as compared to genotypes AA + AG.			= 0.93	OR			
1449269428	rs2242480	oxycodone	Efficacy	no	Genotypes CT + TT are not associated with dose of oxycodone in people with Neoplasms and Pain as compared to genotype CC.	T		= 0.819	OR			
1449269421	rs2242480	oxycodone	Efficacy	no	Genotype CT is not associated with response to oxycodone in people with Neoplasms and Pain as compared to genotype CC.	T		= 0.5241	OR			
1449269466	rs7439366	oxycodone	Efficacy	yes	Genotype TT is associated with decreased response to oxycodone in people with Neoplasms and Pain as compared to genotype CC.	T		= 0.047	OR			
1449269452	rs7439366	oxycodone	Efficacy	no	Genotypes CT + TT are not associated with dose of oxycodone in people with Neoplasms and Pain as compared to genotype CC.	T		= 0.487	OR			
1449269459	rs7439366	oxycodone	Efficacy	no	Genotype CT is not associated with response to oxycodone in people with Neoplasms and Pain as compared to genotype CC.	T		= 0.501	OR			
1444698532	rs2760118	methadone	Efficacy	yes	Genotypes CT + TT is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to genotype CC.			= 0.0024	OR	3.16	1.48	6.73
1449154836	rs12917707	cyclosporine	Efficacy	yes	Genotypes GT + TT is associated with increased response to cyclosporine in people with Kidney Transplantation as compared to genotype GG.	T		= 0.05	HR	0.67	0.46	0.97
1448257194	rs9923231	warfarin	Dosage	yes	Allele T is associated with decreased dose of warfarin as compared to allele C.			= 7.26e-64	OR			
1444695613	rs12714145	warfarin	Dosage	no	Genotypes CT + TT is not associated with dose of warfarin as compared to genotype CC.			= 0.72	OR			
1449157667	rs1143671	warfarin	Dosage	yes	Genotype TT is associated with decreased dose of warfarin as compared to genotype CC.			= 0.046	OR			
1451138105	rs2236418	methadone	Dosage	no	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.			= 0.205				
1449715975	rs3845744	fentanyl	Efficacy	no	Allele C is not associated with response to fentanyl in people with Pain, Postoperative as compared to allele T.			= 0.04	OR			
1444608101	rs7089580	warfarin	Dosage	yes	Genotype AT is associated with increased clearance of warfarin as compared to genotype AA.			= 0.04	OR			
1449269209	rs2108622	warfarin	Dosage	not stated	Allele T is associated with dose of warfarin as compared to allele C.				OR			
1449157694	rs7311358	warfarin	Dosage	yes	Genotype AA is associated with decreased dose of warfarin as compared to genotypes AG + GG.			= 0.046	OR			
1447573633	rs9934438	warfarin	Dosage	yes	Allele A is associated with decreased dose of warfarin as compared to allele G.			= 0.004	OR			
1446907672	rs12969154	alendronate	Efficacy	no	Allele G is not associated with response to alendronate in women with Osteoporosis as compared to allele A.				OR			
1445402189	rs2072661	varenicline	Efficacy	no	Genotypes AA + AG are not associated with response to varenicline in people with Tobacco Use Disorder as compared to genotype GG.			= 0.81	OR	1.08	0.59	1.98
1447519319	rs9923231	warfarin	Dosage	not stated	Allele T is associated with decreased dose of warfarin as compared to allele C.				OR			
1449557881	rs1045642	methotrexate	Efficacy	no	Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G.			= 0.6	OR			
1449557881	rs1045642	methotrexate	Efficacy	no	Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G.			= 0.6	OR	0.95	0.8	1.2
655387805	rs1544105	methotrexate	Efficacy	yes	Genotypes CT + TT are associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.			= 0.008	OR	3.47	1.19	10.12
1449144250	rs62200793	lithium	Efficacy	yes	Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.			= 5.45E-3	OR			
1449144286	rs79403677	lithium	Efficacy	yes	Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.			= 2.04E-3	OR			
1447520009	rs9923231	warfarin	Dosage	yes	Allele T is associated with decreased dose of warfarin as compared to allele C.			< 0.001	OR			
1449173347	rs4680	morphine	Dosage	no	Allele A is not associated with dose of morphine in people with Pain, Postoperative as compared to allele G.	A		= 0.53	OR			
1449173347	rs4680	morphine	Dosage	no	Allele A is not associated with dose of morphine in people with Pain, Postoperative as compared to allele G.	A		= 0.70	OR			
1450821476	rs1718136	fentanyl	Efficacy	no	Allele G is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele A.	G		> 0.05				
1448616501	rs3212227	methotrexate	Other	no	Allele G is not associated with response to methotrexate in people with Psoriasis as compared to allele T.			= 0.007	OR	2.88	1.34	6.16
1184513495	rs2725252	imatinib	Efficacy	yes	Allele C is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.			= 0.001	OR			
1184513495	rs2725252	imatinib	Efficacy	yes	Allele C is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.			= 0.022	OR			
1184513495	rs2725252	imatinib	Efficacy	yes	Allele C is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.			= 0.025	OR			
1451117367	rs10224002	hydrochlorothiazide	Efficacy	yes	Allele A is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to allele G.			= 7.22E-5				
981419313	rs737865	bupropion	Efficacy	yes	Genotype AA is associated with decreased response to bupropion in smokers as compared to genotypes AG + GG.			= 0.05	OR	0.32	0.1	0.99
981954037	rs1801260	lithium	Efficacy	no	Allele G is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.	G		= 0.75	OR	1.07		
981954058	rs2304672	lithium	Efficacy	no	Allele G is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	G		= 0.1	OR	0.59		
1451138380	rs12749204	methadone	Dosage	no	Genotype AA is not associated with dose of methadone as compared to genotypes AG + GG.	G		= 0.028				
1449713140	rs1800497	bupropion	Efficacy	no	Genotypes AA + AG are not associated with response to bupropion in people with Tobacco Use Disorder as compared to genotype GG.				OR	0.893	0.705	1.132
1184468799	rs1045642	tacrolimus	Dosage	no	Allele A is not associated with dose of tacrolimus in people with Kidney Transplantation as compared to allele G.				OR			
1451138001	rs769404	methadone	Dosage	yes	Genotype TT is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotype CC.			= 0.001				
1183700033	rs2108622	warfarin	Dosage	yes	Allele T is associated with increased dose of warfarin as compared to allele C.	T		= 0.005	OR			
1449557898	rs17602729	methotrexate	Efficacy	no	Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G.			= 0.10	OR			
1449557898	rs17602729	methotrexate	Efficacy	no	Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G.			= 0.6	OR	1.08	0.8	1.5
1451147943	rs12233719	fentanyl	Efficacy	no	Allele T is not associated with response to fentanyl in women with Pain, Postoperative as compared to allele G.	T						
1451148543	rs1800532	escitalopram	Efficacy	yes	Genotypes GT + TT are associated with decreased response to escitalopram in people with Depression as compared to genotype GG.			= 0.038				
1449168211	rs17786394	duloxetine	Efficacy	yes	Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.			< 5E-5	OR	0.18		
1449168223	rs17786412	duloxetine	Efficacy	yes	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	0.18		
1184510035	rs4244285	warfarin	Dosage	no	Allele A is not associated with decreased dose of warfarin as compared to allele G.			= 0.76	OR			
769165182	rs25487	fluorouracil	Efficacy	yes	Genotype CC is associated with increased response to fluorouracil in people with Rectal Neoplasms as compared to genotype CT.			= 0.01	OR	4.18	1.627	10.741
1448106937	rs3814055	pazopanib	Efficacy	yes	Allele T is associated with decreased response to pazopanib in people with Carcinoma, Renal Cell as compared to allele C.	C		= 0.03	OR			
1449271162	rs2234918	methadone	Efficacy	no	Genotype CC is not associated with response to methadone in people with Substance-Related Disorders as compared to genotypes CT + TT.	C		= 0.5	OR			
982036545	rs1801177	fenofibrate	Efficacy	no	Allele A is not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to allele G.				OR	0.74	0.31	1.72
982036545	rs1801177	fenofibrate	Efficacy	no	Allele A is not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to allele G.				OR	1.15	0.46	2.88
1450930674	rs615470	nicotine	Other	no	Allele T is not associated with exposure to nicotine in men as compared to allele C.	T		= 0.260	OR	1.1		
1449144194	rs324899	lithium	Efficacy	yes	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.			= 4.63E-3	OR			
1449144262	rs3919583	lithium	Efficacy	yes	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.			= 2.65E-4	OR			
1449144280	rs1521470	lithium	Efficacy	yes	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.			= 3.92E-4	OR			
1450934482	rs190347120	migalastat	Efficacy	not stated	Allele A is associated with increased response to migalastat in people with Fabry Disease.							
1444706524	rs3735814	phenprocoumon	Dosage	no	Genotypes AG + GG are not associated with decreased dose of phenprocoumon as compared to genotype AA.			> 0.05	OR			
981239471	rs104894541	warfarin	Dosage	not stated	Allele C is associated with increased dose of warfarin as compared to allele T.				OR			
1449558010	rs4982133	methotrexate	Efficacy	no	Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.			= 0.2	OR	1.19	0.9	1.6
1449558010	rs4982133	methotrexate	Efficacy	no	Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.			= 0.3	OR			
1449715478	rs11931604	fentanyl	Efficacy	no	Allele C is not associated with response to fentanyl in people with Pain, Postoperative as compared to allele T.	C			OR			
1449715544	rs11931604	fentanyl	Dosage	no	Allele C is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele T.	C			OR			
1448612694	rs1128503	imatinib	Efficacy	yes	Genotype GG is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes AA + AG.			= 0.022	OR	4.382	1.145	16.774
1449167930	rs3889402	duloxetine	Efficacy	yes	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.			< 5E-5	OR	0.14		
1449557975	rs699517	methotrexate	Efficacy	no	Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.			= 0.5	OR			
1449557975	rs699517	methotrexate	Efficacy	no	Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.			= 0.8	OR	1.03	0.8	1.3
1449269193	rs9923231	warfarin	Dosage	not stated	Allele A is associated with dose of warfarin as compared to allele G.				OR			
1450813963	rs4680	modafinil	Efficacy	yes	Genotype GG is associated with increased response to modafinil in people with methamphetamine dependence as compared to genotypes AA + AG.			< 0.01				
1183849194	rs1045642	paroxetine	Efficacy	no	Allele A is not associated with response to paroxetine in people with Depressive Disorder, Major as compared to allele G.				OR			
1184483448	rs17650	warfarin	Dosage	yes	Genotypes AG + GG is associated with decreased dose of warfarin as compared to genotype AA.			= 0.002	OR			
1184821109	rs724710	imatinib	Efficacy	yes	Allele T is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele C.			= 0.0488	OR			
1451121689	rs737865	oxycodone	Efficacy	no	Allele G is not associated with response to oxycodone as compared to allele A.							
981861796	rs1800797	peginterferon alfa-2a	Efficacy	yes	Allele G is associated with decreased response to peginterferon alfa-2a in people with Hepatitis C, Chronic as compared to allele A.			= 0.0489	RR	0.78	0.62	1.0
1184483453	rs7294	warfarin	Dosage	yes	Allele C is associated with decreased dose of warfarin as compared to allele T.			< 0.001	OR			
1449716512	rs1799971	fentanyl	Efficacy	no	Genotypes AG + GG are not associated with response to fentanyl in women with Pain as compared to genotype AA.	G		= 0.54	OR			
1447586762	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.	T		< 0.01	OR			
1184468829	rs15524	tacrolimus	Dosage	yes	Allele G is associated with dose of tacrolimus in people with Kidney Transplantation as compared to allele A.			= 1.27E-10	OR			
1451104700	rs8065082	metformin	Efficacy	yes	Genotypes CT + TT is associated with increased response to metformin in people with Glucose Intolerance as compared to genotype CC.			= 0.02	HR	0.78	0.64	0.96
981954065	rs228729	lithium	Efficacy	no	Allele T is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	T		= 0.49	OR	1.14		
981848218	rs4680	venlafaxine	Efficacy	no	Genotype GG is not associated with response to venlafaxine in people with Anxiety Disorders as compared to genotypes AA + AG.	A		= 0.286	OR	1.74		
981848218	rs4680	venlafaxine	Efficacy	no	Genotype GG is not associated with response to venlafaxine in people with Anxiety Disorders as compared to genotypes AA + AG.	A		= 0.501	OR	1.11		
1451117386	rs8068318	atenolol	Efficacy	yes	Allele C is associated with decreased response to atenolol in people with Hypertension as compared to allele T.			= 5.32E-5				
982046735	rs2631372	imatinib	Efficacy	yes	Genotypes CG + GG are associated with increased response to imatinib in people with Gastrointestinal Stromal Tumors as compared to genotype CC.			= 0.043	HR	0.46	0.22	0.97
1184510180	rs1126757	escitalopram	Efficacy	yes	Genotypes CT + TT is associated with increased response to escitalopram in people with Depression as compared to genotype CC.	T		= 0.024	OR			
1184510370	rs2293347	fluorouracil	Efficacy	yes	Genotype CC is associated with decreased response to fluorouracil in people with Stomach Neoplasms as compared to genotypes CT + TT.	C		= 6.32E-8	OR	0.048	0.01	0.38
982043679	rs2740574	amlodipine	Efficacy	no	Genotypes CT + TT are not associated with response to amlodipine in women with Hypertension as compared to genotype CC.			= 0.29	HR	0.67	0.31	1.42
982043670	rs2740574	amlodipine	Efficacy	no	Genotypes CT + TT are not associated with response to amlodipine in people with Hypertension as compared to genotype CC.			= 0.19	HR	1.48	0.82	2.69
982043670	rs2740574	amlodipine	Efficacy	no	Genotypes CT + TT are not associated with response to amlodipine in people with Hypertension as compared to genotype CC.			= 0.44	HR	0.81	0.48	1.38
1451134629	rs1799971	oxycodone	Efficacy	yes	Genotypes AG + GG are associated with decreased response to oxycodone in people with Pain, Postoperative as compared to genotype AA.	G		< 0.05				
1446903446	rs1920145	metformin	Efficacy	no	Allele C is not associated with response to metformin in people with Diabetes Mellitus as compared to allele T.	C		= 0.26530	OR			
1446903458	rs13376631	metformin	Efficacy	no	Allele G is not associated with response to metformin in people with Diabetes Mellitus as compared to allele A.	G		= 0.13560	OR			
1450932005	rs1128503	sufentanil	Dosage	yes	Genotypes AA + AG are associated with increased dose of sufentanil in people with Lung Neoplasms and Pain, Postoperative as compared to genotype GG.	A		< 0.05				
1183690860	rs2070744	enalapril	Efficacy	yes	Genotypes CC + CT are associated with increased response to enalapril in people with Hypertension as compared to genotype TT.	C		< 0.05	OR			
1183700228	rs2108622	warfarin	Dosage	yes	Allele T is associated with increased dose of warfarin as compared to allele C.	T		= 0.02	OR			
1183697705	rs9934438	warfarin	Dosage	yes	Genotypes AA + AG is associated with decreased dose of warfarin in people with Cardiovascular Diseases as compared to genotype GG.	A		= 0.037	OR			
1183690873	rs61722009	enalapril	Efficacy	no	Allele (AGGGGTGAGGAAGTCTAGACCTGCTGC)2 is not associated with response to enalapril in people with Hypertension.	C		< 0.05	OR			
1451138100	rs2839670	methadone	Dosage	no	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.			= 0.205				
1451137985	rs769404	methadone	Dosage	no	Genotype CT is not associated with dose of methadone in people with Heroin Dependence as compared to genotype CC.			= 0.011				
1451137970	rs3749034	methadone	Dosage	yes	Allele G is associated with increased dose of methadone in people with Heroin Dependence as compared to allele A.			< 0.001				
1183680808	rs1045642	highly active antiretroviral therapy (haart)	Efficacy	yes	Genotypes AA + AG are associated with increased resistance to highly active antiretroviral therapy (haart) in people with HIV Infections as compared to genotype GG.	G		= 0.045	OR	5.01	1.04	24.23
1183697419	rs2032582	tacrolimus	Dosage	yes	Genotype CC is associated with increased dose of tacrolimus in people with Kidney Transplantation.	C		< 0.05	OR			
1183697697	rs2108622	warfarin	Dosage	yes	Genotypes CC + CT is associated with decreased dose of warfarin in people with Cardiovascular Diseases as compared to genotype TT.	T		= 0.015	OR			
1184166145	rs1617640	bevacizumab	Efficacy	no	Genotype AA is not associated with response to bevacizumab in people with Macular Degeneration as compared to genotypes AC + CC.	A		= 0.823	OR			
1184166137	rs10490924	bevacizumab	Efficacy	no	Genotype TT is not associated with response to bevacizumab in people with Macular Degeneration as compared to genotypes GG + GT.	T		= 0.451	OR			
1447680210	rs4645943	warfarin	Dosage	yes	Genotypes CT + TT is associated with increased dose of warfarin in people with heart valve replacement as compared to genotype CC.	T		= 0.009	OR			
1451148582	rs4680	escitalopram	Efficacy	no	Allele A is not associated with response to escitalopram in people with Depression as compared to allele G.			= 0.19				
1184472508	rs4244285	clopidogrel	Efficacy	yes	Genotypes AA + AG is associated with decreased response to clopidogrel in people with Acute coronary syndrome as compared to genotype GG.			= 0.02	OR			
1184510382	rs800292	ranibizumab	Efficacy	no	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.			= 1.0	OR	1.26	0.55	2.85
1184510402	rs1329424	ranibizumab	Efficacy	no	Allele G is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.			= 1.0	OR	0.83	0.46	1.5
1184510348	rs5896	warfarin	Dosage	no	Genotype TT is associated with decreased dose of warfarin as compared to genotypes CC + CT.			= 0.807	OR			
1184511588	rs11676382	warfarin	Dosage	yes	Genotypes CG + GG is associated with decreased dose of warfarin as compared to genotype CC.			= 0.03	OR			
1184473580	rs9923231	warfarin	Dosage	yes	Allele T is associated with decreased dose of warfarin in children as compared to allele C.			= 0.02	OR			
1451141783	rs1799971	naltrexone	Efficacy	no	Allele G is not associated with response to naltrexone in people with Alcoholism as compared to allele A.			= 0.33	OR	1.4	0.72	2.74
1451141783	rs1799971	naltrexone	Efficacy	no	Allele G is not associated with response to naltrexone in people with Alcoholism as compared to allele A.			= 0.78	OR	0.92	0.52	1.64
1449715576	rs12645107	fentanyl	Dosage	no	Allele A is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele G.	A			OR			
1184470351	rs1045642	clopidogrel	Efficacy	no	Allele G is not associated with response to clopidogrel in people with Myocardial Infarction as compared to allele A.	A		= 0.016	OR			
1184483230	rs2228145	tocilizumab	Efficacy	no	Genotype AA is not associated with decreased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes AC + CC.			= 0.11	OR			
1184467472	rs1801131	methotrexate	Efficacy	no	Genotype GT is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype TT.			= 0.55	OR	0.91	0.65	1.25
1451146211	rs775887911	dexmedetomidine	Efficacy	yes	Genotypes CT + TT are associated with decreased response to dexmedetomidine in women with Pain, Postoperative as compared to genotype CC.			< 0.05				
1451146211	rs775887911	dexmedetomidine	Efficacy	yes	Genotypes CT + TT are associated with decreased response to dexmedetomidine in women with Pain, Postoperative as compared to genotype CC.			< 0.05				
1184747491	rs2273697	tenofovir	Toxicity	no	Genotypes AA + AG is not associated with increased discontinuation of tenofovir in people with HIV Infections as compared to genotype GG.			> 0.05	OR			
1184512426	rs7856096	warfarin	Dosage	yes	Allele G is associated with decreased dose of warfarin as compared to allele A.			= 3.93E-5	OR			
1451147960	rs7439366	fentanyl	Efficacy	no	Allele T is not associated with response to fentanyl in women with Pain, Postoperative as compared to allele C.	T		= 0.302				
1451147960	rs7439366	fentanyl	Efficacy	no	Allele T is not associated with response to fentanyl in women with Pain, Postoperative as compared to allele C.	T		= 0.491				
1444936331	rs12714145	warfarin	Dosage	no	Allele T is not associated with dose of warfarin as compared to genotype CC.			= 0.87	OR			
1451148974	rs7224199	morphine	Dosage	no	Allele T is not associated with dose of morphine in people with Lung Neoplasms and Pain as compared to allele G.	C		= 0.115				
1449557938	rs2295553	methotrexate	Efficacy	no	Allele C is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.			= 0.040	OR			
1449557938	rs2295553	methotrexate	Efficacy	no	Allele C is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.			= 0.1	OR	0.81	0.6	1.02
1447680321	rs5443	telmisartan	Efficacy	yes	Genotype TT is associated with decreased response to telmisartan in people with Essential hypertension as compared to genotypes CC + CT.	C		= 0.009	OR			
1185002294	rs7294	warfarin	Dosage	yes	Allele T is associated with increased dose of warfarin as compared to allele C.	T		= 0.032	OR			
1185002301	rs7200749	warfarin	Dosage	yes	Allele A is associated with increased dose of warfarin as compared to allele G.	A		= 0.032	OR			
1185002324	rs7200749	acenocoumarol	Dosage	yes	Genotypes AA + AG is associated with increased dose of acenocoumarol as compared to genotype GG.	A		= 0.001	OR			
1185002340	rs61742245	acenocoumarol	Dosage	yes	Genotypes AA + AC is associated with increased dose of acenocoumarol as compared to genotype CC.	A		= 0.004	OR			
1185002333	rs17878544	acenocoumarol	Dosage	yes	Genotype TT is associated with decreased dose of acenocoumarol as compared to genotypes CC + CT.	C		= 0.002	OR			
1447949678	rs2306283	atorvastatin	Efficacy	yes	Genotype AA is associated with increased response to atorvastatin in people with Hypercholesterolemia as compared to genotypes AG + GG.	G		< 0.05	OR	1.29	0.41	2.08
1451114040	rs204076	naltrexone	Efficacy	no	Allele T is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele A.	T		= 0.67				
1184472517	rs1045642	clopidogrel	Efficacy	no	Allele G is not associated with response to clopidogrel in people with Acute coronary syndrome as compared to allele A.			= 0.9	OR			
1449164090	rs2645400	warfarin	Dosage	no	Allele G is not associated with dose of warfarin as compared to allele T.			= 0.144	OR			
1447519671	rs2359612	warfarin	Dosage	yes	Genotypes AA + AG are associated with decreased dose of warfarin as compared to genotype GG.			< 0.005	OR			
1447519671	rs2359612	warfarin	Dosage	yes	Genotypes AA + AG are associated with decreased dose of warfarin as compared to genotype GG.			< 0.01	OR			
1446765670	rs1045642	sunitinib	Efficacy	yes	Genotype AA is associated with decreased response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.			= 0.005	HR	5.0	1.6	15.2
1446765670	rs1045642	sunitinib	Efficacy	yes	Genotype AA is associated with decreased response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.		A	= 0.02	OR	0.2	0.0	0.7
1446765670	rs1045642	sunitinib	Efficacy	yes	Genotype AA is associated with decreased response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	A		= 0.19	HR	1.7	0.8	3.9
1446765670	rs1045642	sunitinib	Efficacy	yes	Genotype AA is associated with decreased response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	A		= 0.21	HR	1.7	0.7	3.8
1444608095	rs7089580	warfarin	Dosage	yes	Genotype AT is associated with increased dose of warfarin as compared to genotype AA.			= 0.03	OR			
1296598796	rs4253728	phenprocoumon	Dosage	yes	Allele A is associated with increased dose of phenprocoumon as compared to allele G.			= 0.02	OR			
1444705851	rs2108622	acenocoumarol	Dosage	yes	Genotypes CT + TT are associated with increased dose of acenocoumarol as compared to genotype CC.			< 0.001	OR			
1184483601	rs57098334	sertraline	Efficacy	no	Allele (AGCCCACCC)12 is not associated with response to sertraline in people with Depressive Disorder, Major as compared to allele (AGCCCACCC)9.			> 0.05	OR			
1185003533	rs396991	trastuzumab	Efficacy	yes	Genotype CC is associated with increased response to trastuzumab in people with Breast Neoplasms as compared to genotypes AA + AC.			= 0.03	OR			
1447674478	rs1051266	methotrexate	Efficacy	yes	Genotypes CT + TT is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.	T		= 0.03	OR	2.2	1.1	4.4
1445296596	rs1128503	imatinib	Efficacy	yes	Genotype GG is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes AA + AG.			= 0.036	OR	0.59		
981861804	rs1800796	peginterferon alfa-2a	Efficacy	yes	Allele G is associated with decreased response to peginterferon alfa-2a in people with Hepatitis C, Chronic as compared to allele C.			= 0.0489	RR	0.78	0.62	1.0
1447519684	rs7294	warfarin	Dosage	yes	Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.			= 0.008	OR			
1447519684	rs7294	warfarin	Dosage	yes	Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.			= 0.2	OR			
1447946367	rs1128503	tacrolimus	Dosage	yes	Genotype AG is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to genotype GG.	A		< 0.05	OR			
1184483099	rs2032582	cyclosporine	Efficacy	no	Allele A is not associated with response to cyclosporine in people with Psoriasis as compared to allele C.	A		> 0.05	OR			
1446896603	rs6265	olanzapine	Efficacy	yes	Genotype CC is associated with increased response to olanzapine in people with Schizophrenia as compared to genotypes CT + TT.			= 0.032	OR	1.9	1.06	3.41
1446896603	rs6265	olanzapine	Efficacy	yes	Genotype CC is associated with increased response to olanzapine in people with Schizophrenia as compared to genotypes CT + TT.			= 0.034	OR	1.98	1.05	3.73
1449173236	rs2032582	morphine	Dosage	no	Allele A is not associated with dose of morphine in people with Pain, Postoperative as compared to allele C.	A		= 0.12	OR			
1449173236	rs2032582	morphine	Dosage	no	Allele A is not associated with dose of morphine in people with Pain, Postoperative as compared to allele C.	A		= 0.38	OR			
1447674967	rs7552841	atorvastatin	Efficacy	no	Genotypes CT + TT is not associated with response to atorvastatin in people with Hypercholesterolemia as compared to genotype CC.	T		> 0.05	OR			
1449167906	rs7035619	duloxetine	Efficacy	yes	Allele A is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.			< 5E-5	OR	4.4		
1447675725	rs462779	cisplatin	Efficacy	yes	Genotypes AG + GG are associated with decreased response to cisplatin in people with Osteosarcoma as compared to genotype AA.	G		= 0.018	OR	2.6	1.18	5.74
1446908196	rs121434568	afatinib	Efficacy	no	Allele G is not associated with response to afatinib in people with Carcinoma, Non-Small-Cell Lung.			= 0.08	HR	0.49	0.22	1.09
1446908196	rs121434568	afatinib	Efficacy	no	Allele G is not associated with response to afatinib in people with Carcinoma, Non-Small-Cell Lung.				HR	1.12	0.94	1.34
1447946352	rs2032582	tacrolimus	Dosage	yes	Genotype AA is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to genotypes AC + CC.	A		< 0.05	OR			
1447952414	rs74597325	ataluren	Efficacy	no	Allele T is not associated with response to ataluren in people with Cystic Fibrosis as compared to allele C.	T		= 0.124	OR			
1448115881	rs6785930	clopidogrel	Efficacy	no	Genotype AA is not associated with response to clopidogrel in people with Carotid Artery Diseases as compared to genotypes AG + GG.	A		= 0.479	OR			
1448276496	rs9923231	warfarin	Dosage	not stated	Allele T is associated with dose of warfarin.	A			OR			
1448276172	rs2359612	warfarin	Dosage	yes	Genotype GG is associated with increased dose of warfarin as compared to genotypes AA + AG.	G		< 0.0001	OR			
1448123402	rs67376798	capecitabine	Dosage	yes	Genotype AT is associated with decreased dose of capecitabine in people with Colorectal Neoplasms as compared to genotype TT.			= 0.005	OR			
1449154515	rs4646	tamoxifen	Efficacy	yes	Genotype AA is associated with decreased response to tamoxifen in women with Breast Neoplasms and Menopause as compared to genotypes AC + CC.	A		= 0.013	HR	3.614	1.308	9.991
1448254963	rs28362491	etanercept	Efficacy	no	Allele del is associated with response to etanercept in people with Psoriasis as compared to allele ATTG.				OR			
1450933226	rs762551	imatinib	Dosage	yes	Genotype CC is associated with decreased dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to genotypes AA + AC.	C		= 0.001	OR	7.12	2.21	22.9
1450933226	rs762551	imatinib	Dosage	yes	Genotype CC is associated with decreased dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to genotypes AA + AC.	C		= 0.002				
1450933226	rs762551	imatinib	Dosage	yes	Genotype CC is associated with decreased dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to genotypes AA + AC.	C		= 0.657	OR	0.81	0.32	2.07
1447988501	rs594445	azathioprine	Dosage	yes	Genotypes AA + AC is associated with decreased dose of azathioprine in people with Kidney Transplantation as compared to genotype CC.	A		= 0.026	OR			
1447814549	rs121913459	nilotinib	Efficacy	no	Allele T is associated with resistance to nilotinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele C.				OR			
1447814556	rs121913459	homoharringtonine	Efficacy	no	Allele T is associated with response to homoharringtonine in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele C.				OR			
1449164918	rs35511654	methotrexate	Toxicity	no	Allele G is not associated with discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele T.	G		= 0.77	HR	1.09	0.59	2.01
1448122976	rs2032582	losartan	Efficacy	no	Allele C is not associated with increased response to losartan in people with Hypertension as compared to allele A.			= 0.13	OR			
1447964466	rs5182	perindopril	Efficacy	yes	Genotypes CC + CT is associated with decreased response to perindopril in people with Coronary Artery Disease as compared to genotype TT.			< 0.001	OR			
1446906519	rs776746	sunitinib	Dosage	yes	Allele T is associated with decreased dose of sunitinib in people with Carcinoma, Renal Cell as compared to allele C.			= 0.039	OR	2.04	1.04	4.0
1448254981	rs696	etanercept	Efficacy	no	Allele T is associated with response to etanercept in people with Psoriasis as compared to allele C.				OR			
1450933234	rs28656907	imatinib	Dosage	no	Genotype TT is associated with increased dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to genotypes CC + CT.	T		= 0.040	OR	0.19	0.04	0.93
1450933234	rs28656907	imatinib	Dosage	no	Genotype TT is associated with increased dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to genotypes CC + CT.	T		= 0.079				
1450933234	rs28656907	imatinib	Dosage	no	Genotype TT is associated with increased dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to genotypes CC + CT.	T		= 0.385	OR	0.67	0.27	1.66
1450933171	rs2236599	hydroxyurea	Efficacy	yes	Allele C is associated with increased response to hydroxyurea in people with Anemia, Sickle Cell and beta-Thalassemia as compared to allele T.			= 0.039				
1448123675	rs3749442	glibenclamide	Efficacy	yes	Allele A is associated with increased response to glibenclamide in people with as compared to allele G.			< 0.05	OR			
1448123598	rs2303070	glibenclamide	Efficacy	yes	Allele T is associated with increased response to glibenclamide in people with as compared to allele G.			< 0.05	OR			
1448123605	rs2077647	glibenclamide	Efficacy	yes	Allele T is associated with increased response to glibenclamide in people with as compared to allele C.			< 0.05	OR			
1447988330	rs9373839	adalimumab	Efficacy	yes	Genotypes CC + CT are associated with increased response to adalimumab in people with Inflammatory Bowel Diseases as compared to genotype TT.	C		= 1.55E-3	OR			
1448631721	rs96844	etanercept	Efficacy	yes	Genotypes AG + GG is associated with increased response to etanercept in people with Psoriasis as compared to genotype AA.			= 0.009	OR			
1448601802	rs2242446	venlafaxine	Efficacy	yes	Genotype CC is associated with increased response to venlafaxine in people with Depressive Disorder, Major as compared to genotypes CT + TT.	C		= 0.009	OR	1.67	1.13	2.42
1448995964	rs7234029	adalimumab	Efficacy	no	Allele G is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to allele A.	G		= 0.06	OR	0.27	0.07	1.03
1448612558	rs5751876	regadenoson	Efficacy	no	Allele C is not associated with response to regadenoson as compared to allele T.				OR			
1448612548	rs3761422	regadenoson	Efficacy	no	Allele T is not associated with response to regadenoson as compared to allele C.				OR			
1448603676	rs11646054	empagliflozin	Efficacy	no	Allele C is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G.				OR			
1448604042	rs1128503	risperidone	Efficacy	yes	Genotypes AG + GG are not associated with response to risperidone in people with Schizophrenia as compared to genotype AA.			= 0.783	OR			
1448568024	rs833061	pazopanib	Efficacy	yes	Allele T is associated with decreased response to pazopanib in people with Carcinoma, Renal Cell as compared to allele C.	C		= 0.02	OR			
1448632254	rs2868177	acenocoumarol	Dosage	no	Allele A is not associated with dose of acenocoumarol in people with Atrial Fibrillation, heart valve replacement and Thromboembolism as compared to allele G.			= 0.526	OR			
1448637116	rs1000940	glucose	Other	yes	Genotypes AG + GG is associated with decreased concentrations of glucose in people with Bipolar Disorder, Depressive Disorder, Psychotic Disorders and schizoaffective disorder as compared to genotype AA.			< 0.001	OR			
1448637116	rs1000940	glucose	Other	yes	Genotypes AG + GG is associated with decreased concentrations of glucose in people with Bipolar Disorder, Depressive Disorder, Psychotic Disorders and schizoaffective disorder as compared to genotype AA.			= 0.03	OR			
1448633794	rs662	clopidogrel	Efficacy	no	Allele C is not associated with response to clopidogrel as compared to allele T.			= 0.2	OR			
1449005218	rs2108622	warfarin	Dosage	yes	Genotypes CC + CT are associated with decreased dose of warfarin as compared to genotype TT.			= 0.028	OR			
1448531852	rs4661012	ticagrelor	Efficacy	yes	Genotypes GT + TT is associated with decreased response to ticagrelor in healthy individuals as compared to genotype GG.	G		= 0.018	OR			
1449716064	rs1799971	fentanyl	Dosage	yes	Genotypes AG + GG are associated with decreased dose of fentanyl in women with Pain as compared to genotype AA.	G		= 0.022	OR			
1449713732	rs1061622	etanercept	Efficacy	yes	Genotype GT is associated with decreased response to etanercept in people with Spondylitis, Ankylosing as compared to genotypes GG + TT.			= 0.042	OR			
1449713726	rs2234649	etanercept	Efficacy	no	Genotype GT is not associated with response to etanercept in people with Spondylitis, Ankylosing as compared to genotypes GG + TT.				OR			
1449713797	rs1799971	fentanyl	Efficacy	no	Allele G is not associated with response to fentanyl in women with Pain as compared to allele A.	G		= 0.470	OR			
1449713797	rs1799971	fentanyl	Efficacy	no	Allele G is not associated with response to fentanyl in women with Pain as compared to allele A.	G		= 0.836	OR			
1449166128	rs11559290	methylphenidate	Efficacy	no	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.105	OR	1.62	0.9	2.9
1449192323	rs397508602	ivacaftor	Efficacy	not stated	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.				OR			
1449295782	rs57081354	metformin	Efficacy	yes	Allele C is associated with decreased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele T.	C		= 4e-8	OR			
1449168112	rs2419128	duloxetine	Efficacy	yes	Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.			< 5E-5	OR	0.27		
1449166345	rs3761372	methylphenidate	Efficacy	no	Allele T is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.			= 0.365	OR	1.31	0.73	2.33
1449167778	rs4858478	duloxetine	Efficacy	yes	Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	4.11		
1449168217	rs17786400	duloxetine	Efficacy	yes	Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.			< 5E-5	OR	0.18		
1449168246	rs61908404	duloxetine	Efficacy	yes	Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.			< 5E-5	OR	0.18		
1449168252	rs61908405	duloxetine	Efficacy	yes	Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.			< 5E-5	OR	0.18		
1449168179	rs10771999	duloxetine	Efficacy	yes	Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.			< 5E-5	OR	0.13		
1449262642	rs9923231	warfarin	Dosage	yes	Allele T is associated with decreased dose of warfarin in people with Cardiovascular Diseases as compared to allele C.			= 0.004	OR			
1449576323	rs4680	levodopa	Dosage	no	Genotype AA is not associated with dose of levodopa in people with Parkinson Disease as compared to genotype GG.	A		= 0.98	OR	0.8	0.2	2.6
1449576379	rs1799836	levodopa	Dosage	no	Genotype TT is not associated with dose of levodopa in women with Parkinson Disease as compared to genotype CC.	T		= 0.82	OR	1.5	0.3	6.0
1449558016	rs1703794	methotrexate	Efficacy	no	Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.			= 0.4	OR	1.12	0.9	1.5
1449558016	rs1703794	methotrexate	Efficacy	no	Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.			= 0.8	OR			
1449166167	rs10011796	allopurinol	Dosage	no	Allele T is not associated with dose of allopurinol in people with Gout as compared to allele C.			> 0.05	OR			
1449716693	rs4633	fentanyl	Dosage	no	Allele C is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele T.	T		= 0.212	OR			
1449716693	rs4633	fentanyl	Dosage	no	Allele C is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele T.	T		= 0.843	OR			
1449164037	rs11168293	warfarin	Dosage	yes	Genotype TT is associated with increased dose of warfarin as compared to genotypes GG + GT.			= 0.0025	OR			
1449164912	rs3393	methotrexate	Toxicity	no	Allele C is not associated with discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele T.	C		= 0.97	HR	0.99	0.58	1.7
1449164974	rs73598374	methotrexate	Toxicity	no	Allele C is not associated with discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele T.	T		= 0.29	HR	0.61	0.24	1.55
1449155451	rs8177374	ustekinumab	Efficacy	yes	Genotypes CT + TT is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype CC.	T		= 0.0051	OR	9.42	1.96	45.3
1450811595	rs6949448	methadone	Dosage	no	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.			= 0.31				
1450933253	rs2631367	imatinib	Dosage	no	Allele C is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele G.	G		= 0.259	OR	0.51	0.16	1.64
1450933253	rs2631367	imatinib	Dosage	no	Allele C is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele G.	G		= 0.814	OR	0.9	0.38	2.15
1450933253	rs2631367	imatinib	Dosage	no	Allele C is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele G.	G		= 0.924				
1450933458	rs1800810	imatinib	Dosage	no	Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.	G		= 0.217	OR	0.56	0.23	1.4
1450933458	rs1800810	imatinib	Dosage	no	Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.	G		= 0.494				
1450933458	rs1800810	imatinib	Dosage	no	Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.	G		= 0.564	OR	0.54	0.07	4.37
1450821968	rs1051730	nicotine	Dosage	yes	Allele A is associated with decreased dose of nicotine in people with Tobacco Use Disorder as compared to allele G.	A		= 0.022				
1450821968	rs1051730	nicotine	Dosage	yes	Allele A is associated with decreased dose of nicotine in people with Tobacco Use Disorder as compared to allele G.	A		= 0.026				
1450821968	rs1051730	nicotine	Dosage	yes	Allele A is associated with decreased dose of nicotine in people with Tobacco Use Disorder as compared to allele G.	A		= 0.044				
1450821968	rs1051730	nicotine	Dosage	yes	Allele A is associated with decreased dose of nicotine in people with Tobacco Use Disorder as compared to allele G.	A		= 0.061				
1450821968	rs1051730	nicotine	Dosage	yes	Allele A is associated with decreased dose of nicotine in people with Tobacco Use Disorder as compared to allele G.	A		= 0.362				
1450821968	rs1051730	nicotine	Dosage	yes	Allele A is associated with decreased dose of nicotine in people with Tobacco Use Disorder as compared to allele G.	A		= 0.617				
1450933577	rs6877011	imatinib	Dosage	no	Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.	G		= 0.166				
1450933577	rs6877011	imatinib	Dosage	no	Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.	G		= 0.170	OR	2.01	0.74	5.48
1450933577	rs6877011	imatinib	Dosage	no	Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.	G		= 0.225	OR	4.7	0.39	57.4
1450827399	rs11214607	heroin	Toxicity	no	Allele G is not associated with response to heroin as compared to allele T.			> 0.05				
1450928334	rs1801272	varenicline	Efficacy	no	Genotypes AA + AT is not associated with increased response to varenicline in people with Tobacco Use Disorder as compared to genotype TT.			= 0.52				
1444699502	rs6295	clozapine	Efficacy	yes	Genotype GG is associated with increased response to clozapine in people with Schizophrenia as compared to genotypes CC + CG.	C		= 0.04	OR			
1450821457	rs2708092	fentanyl	Efficacy	no	Allele G is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele A.	G		> 0.05				
1450931743	rs1128503	fentanyl	PD	no	Allele G is not associated with response to fentanyl in healthy individuals as compared to allele A.	A		> 0.05				
1450933294	rs2631370	imatinib	Dosage	no	Allele C is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele T.	C		= 0.064	OR	3.08	0.94	10.1
1450933294	rs2631370	imatinib	Dosage	no	Allele C is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele T.	C		= 0.185	OR	1.87	0.74	4.74
1450933294	rs2631370	imatinib	Dosage	no	Allele C is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele T.	C		= 0.399				
1450812691	rs4845652	nicotine	Efficacy	no	Allele T is not associated with response to nicotine in women as compared to allele C.			> 0.05				
1450813976	rs6265	modafinil	Efficacy	no	Allele C is not associated with response to modafinil in people with methamphetamine dependence as compared to allele T.			> 0.01				
1450375599	rs4148157	allopurinol	Efficacy	no	Allele A is associated with decreased response to allopurinol as compared to allele G.			= 2.20E-6	OR			
1450375599	rs4148157	allopurinol	Efficacy	no	Allele A is associated with decreased response to allopurinol as compared to allele G.			= 2.31E-6	OR			
1450371564	rs1801274	tocilizumab	Efficacy	no	Allele A is not associated with response to tocilizumab in people with Arthritis, Rheumatoid as compared to allele G.	A		= 0.279	OR			
1450371564	rs1801274	tocilizumab	Efficacy	no	Allele A is not associated with response to tocilizumab in people with Arthritis, Rheumatoid as compared to allele G.	A		= 0.438	OR			
1450371564	rs1801274	tocilizumab	Efficacy	no	Allele A is not associated with response to tocilizumab in people with Arthritis, Rheumatoid as compared to allele G.	A		= 0.492	OR			
1450371564	rs1801274	tocilizumab	Efficacy	no	Allele A is not associated with response to tocilizumab in people with Arthritis, Rheumatoid as compared to allele G.	A		= 0.545	OR			
1450371564	rs1801274	tocilizumab	Efficacy	no	Allele A is not associated with response to tocilizumab in people with Arthritis, Rheumatoid as compared to allele G.	A		= 0.575	OR			
1450371564	rs1801274	tocilizumab	Efficacy	no	Allele A is not associated with response to tocilizumab in people with Arthritis, Rheumatoid as compared to allele G.	A		= 0.673	OR			
1450371564	rs1801274	tocilizumab	Efficacy	no	Allele A is not associated with response to tocilizumab in people with Arthritis, Rheumatoid as compared to allele G.	A		= 0.747	OR			
1450371564	rs1801274	tocilizumab	Efficacy	no	Allele A is not associated with response to tocilizumab in people with Arthritis, Rheumatoid as compared to allele G.	A		= 0.788	OR			
1450371564	rs1801274	tocilizumab	Efficacy	no	Allele A is not associated with response to tocilizumab in people with Arthritis, Rheumatoid as compared to allele G.	A		= 0.977	OR			
1450371564	rs1801274	tocilizumab	Efficacy	no	Allele A is not associated with response to tocilizumab in people with Arthritis, Rheumatoid as compared to allele G.	A		= 0.986	OR			
1450371564	rs1801274	tocilizumab	Efficacy	no	Allele A is not associated with response to tocilizumab in people with Arthritis, Rheumatoid as compared to allele G.	A		= 1	OR			
1450371564	rs1801274	tocilizumab	Efficacy	no	Allele A is not associated with response to tocilizumab in people with Arthritis, Rheumatoid as compared to allele G.	A		= 1	OR			
1450934565	rs4149056	grazoprevir	PD	yes	Allele C is associated with increased exposure to grazoprevir in people with Hepatitis C, Chronic as compared to allele T.	C		< 0.0001				
1450934565	rs4149056	grazoprevir	PD	yes	Allele C is associated with increased exposure to grazoprevir in people with Hepatitis C, Chronic as compared to allele T.	C		= 0.0002				
1450374150	rs3745274	methadone	Dosage	no	Allele G is not associated with dose of methadone in people with Opioid-Related Disorders as compared to allele T.	T		= 0.20	OR			
1450827429	rs2734833	heroin	Toxicity	no	Allele A is not associated with response to heroin as compared to allele G.			> 0.05				
1450930694	rs3827020	nicotine	Other	no	Allele C is not associated with exposure to nicotine in men as compared to allele T.	C		= 0.340	OR	1.0		
1450342113	rs162561	docetaxel	Efficacy	no	Genotype GG is associated with decreased response to docetaxel in people with Breast Neoplasms as compared to genotypes GT + TT.			= 0.079	OR			
1448123395	rs3918290	capecitabine	Dosage	yes	Genotype CT is associated with decreased dose of capecitabine in people with Colorectal Neoplasms as compared to genotype CC.			< 0.0001	OR			
1450127378	rs2487032	clopidogrel	Efficacy	yes	Allele A is associated with decreased response to clopidogrel in people with Coronary Artery Disease as compared to allele G.			= 3.46e-3	OR			
1450822114	rs510769	ethanol	Dosage	no	Allele T is not associated with dose of ethanol as compared to allele C.			= 0.880				
1450812289	rs6277	nicotine	Efficacy	no	Allele A is not associated with response to nicotine in women as compared to allele G.							
1450811492	rs2036657	nicotine	Efficacy	no	Allele A is not associated with response to nicotine in people with Tobacco Use Disorder as compared to allele G.	G		> 0.22				
1450811492	rs2036657	nicotine	Efficacy	no	Allele A is not associated with response to nicotine in people with Tobacco Use Disorder as compared to allele G.	G		> 0.79				
1450814114	rs1799971	ethanol	Dosage	no	Allele G is not associated with dose of ethanol as compared to allele A.	G						
1450814619	rs363226	bupropion	Efficacy	yes	Genotype GG is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CC + CG.	G		= 0.018				
1450373027	rs689466	celecoxib	Efficacy	yes	Genotype CC is associated with increased response to celecoxib in healthy individuals as compared to genotypes CT + TT.			= 0.029	OR			
1450930657	rs16969968	nicotine	Other	no	Allele A is not associated with exposure to nicotine in men as compared to allele G.	A		= 0.042	OR	1.3		
1450930622	rs667282	nicotine	Other	no	Allele C is not associated with exposure to nicotine in men as compared to allele T.	C		= 0.008	OR	1.1		
1444843349	rs11231809	methotrexate	Efficacy	yes	Genotypes AT + TT are associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype AA.			= 0.031	OR	5.37	1.17	24.71
1447674939	rs10242595	duloxetine	Efficacy	no	Genotype AA is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotypes AG + GG.			= 0.038	OR			
1450933374	rs683369	imatinib	Dosage	no	Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.	G		= 0.786	OR	0.89	0.38	2.07
1450933374	rs683369	imatinib	Dosage	no	Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.	G		= 0.825				
1450933374	rs683369	imatinib	Dosage	no	Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.	G		= 0.849	OR	0.88	0.23	3.34
1450933561	rs699947	imatinib	Dosage	no	Allele C is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele A.	C		= 0.517	OR	1.43	0.48	4.27
1450933561	rs699947	imatinib	Dosage	no	Allele C is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele A.	C		= 0.627	OR	1.27	0.48	3.36
1450933561	rs699947	imatinib	Dosage	no	Allele C is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele A.	C		= 0.630				
1449161179	rs1799971	naltrexone	Efficacy	no	Allele A is not associated with response to naltrexone in people with Alcoholism as compared to allele G.			= 0.51	OR			
1449716754	rs1799971	fentanyl	Dosage	yes	Genotype GG is associated with increased dose of fentanyl in women with Pain, Postoperative as compared to genotypes AA + AG.	A		< 0.05	OR			
1449188815	rs1799971	naltrexone	Efficacy	yes	Allele G is associated with increased response to naltrexone in men with Alcoholism as compared to allele A.			< 0.01	OR	0.75	0.62	0.91
1449716657	rs1799971	fentanyl	Dosage	no	Allele G is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele A.	G		> 0.05	OR			
1451117373	rs9306160	atenolol	Efficacy	yes	Allele T is associated with increased response to atenolol in people with Hypertension as compared to allele C.			= 1.79E-4				
1448276167	rs7294	warfarin	Dosage	yes	Genotype TT is associated with increased dose of warfarin as compared to genotype CC.	T		= 0.0001	OR			
1184755040	rs2973049	paroxetine	Efficacy	yes	Genotypes CT + TT is associated with decreased response to paroxetine in people with Depressive Disorder, Major as compared to genotype CC.			= 0.005	OR			
1184747871	rs2550948	venlafaxine	Efficacy	no	Allele C is not associated with response to venlafaxine in people with Anxiety Disorders as compared to allele T.			> 0.05	OR			
1184166157	rs699947	bevacizumab	Efficacy	no	Genotype CC is not associated with response to bevacizumab in people with Macular Degeneration as compared to genotypes AA + AC.	A		= 0.787	OR			
769173673	rs4673993	methotrexate	Efficacy	yes	Allele C is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.			= 0.04	OR	1.88	1.03	3.43
1449192709	rs75527207	ivacaftor	Efficacy	not stated	Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.				OR			
1450821553	rs11280056	methotrexate	Efficacy	no	Allele del is not associated with response to methotrexate in people with Arthritis, Rheumatoid.							
1448612650	rs6759892	oxcarbazepine	Efficacy	no	Genotype TT is not associated with increased response to oxcarbazepine in people with Seizures as compared to genotype GT.	G		= 0.26	OR			
1450930500	rs16872401	hydrochlorothiazide	Efficacy	yes	Allele C is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to allele T.	C		= 0.025				
1450930602	rs6495307	nicotine	Other	no	Allele T is not associated with exposure to nicotine in men as compared to allele C.	T		= 0.160	OR	1.1		
1447952179	rs77010898	ataluren	Efficacy	yes	Allele A is associated with response to ataluren in people with Cystic Fibrosis as compared to allele G.	A		< 0.0001	OR			
1449154713	rs113993960	ivacaftor	Efficacy	yes	Genotype CTT/del is associated with increased response to ivacaftor in people with Cystic Fibrosis.			< 0.001	OR			
1449154713	rs113993960	ivacaftor	Efficacy	yes	Genotype CTT/del is associated with increased response to ivacaftor in people with Cystic Fibrosis.			< 0.001	OR			
1449154713	rs113993960	ivacaftor	Efficacy	yes	Genotype CTT/del is associated with increased response to ivacaftor in people with Cystic Fibrosis.				OR			
1449154713	rs113993960	ivacaftor	Efficacy	yes	Genotype CTT/del is associated with increased response to ivacaftor in people with Cystic Fibrosis.				OR			
1450930527	rs16872401	atenolol	Dosage	no	Allele C is not associated with dose of atenolol in people with Hypertension as compared to allele T.	C		= 0.691				
1450930485	rs7184292	atenolol	Efficacy	yes	Allele A is associated with increased response to atenolol in people with Hypertension as compared to allele G.	A		= 0.015				
1296666475	rs61734430	pemetrexed	Efficacy	yes	Genotypes CT + TT is associated with decreased response to pemetrexed in people with Carcinoma, Non-Small-Cell Lung and Mesothelioma as compared to genotype CC.	T		= 0.029	OR	3.8	1.15	12.53
1446907728	rs17069895	alendronate	Efficacy	no	Allele C is not associated with response to alendronate in women with Osteoporosis as compared to allele T.				OR			
1446907687	rs11877530	alendronate	Efficacy	no	Allele G is not associated with response to alendronate in women with Osteoporosis as compared to allele A.				OR			
1184748858	rs10197559	methotrexate	Toxicity	no	Genotypes CT + TT is associated with increased discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.			= 0.055	OR			
1184511609	rs11676382	acenocoumarol	Dosage	no	Genotypes CG + GG is not associated with dose of acenocoumarol as compared to genotype CC.			= 0.01	OR			
827864069	rs1024323	metoprolol	Efficacy	no	Genotype CC is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype TT.			= 0.9	HR	1.02	0.65	1.61
1450827419	rs6277	heroin	Toxicity	no	Allele A is not associated with response to heroin as compared to allele G.			> 0.05				
1444699407	rs1360780	clozapine	Efficacy	no	Genotype TT is associated with decreased response to clozapine in people with Schizophrenia as compared to genotypes CC + CT.			= 0.022	OR			
982015355	rs1360780	citalopram	Efficacy	no	Allele T is associated with decreased response to citalopram in people with Depressive Disorder, Major as compared to allele C.				OR			
1450821902	rs1799971	ethanol	Other	yes	Genotypes AG + GG are associated with increased exposure to ethanol in healthy individuals as compared to genotype AA.			= 0.039				
1450821902	rs1799971	ethanol	Other	yes	Genotypes AG + GG are associated with increased exposure to ethanol in healthy individuals as compared to genotype AA.			= 0.085				
1450826727	rs1799971	nicotine	Other	yes	Genotypes AG + GG are associated with increased exposure to nicotine in people with Schizophrenia as compared to genotype AA.			= 0.047				
1450812282	rs1799971	nicotine	Efficacy	no	Allele G is not associated with response to nicotine in healthy individuals as compared to allele A.							
1450812611	rs1799971	ethanol	Efficacy	yes	Genotypes AG + GG are associated with increased response to ethanol as compared to genotype AA.			< 0.01				
1450812611	rs1799971	ethanol	Efficacy	yes	Genotypes AG + GG are associated with increased response to ethanol as compared to genotype AA.			< 0.05				
1450812611	rs1799971	ethanol	Efficacy	yes	Genotypes AG + GG are associated with increased response to ethanol as compared to genotype AA.			< 0.46				
1450808082	rs1799971	heroin	Dosage	no	Allele G is not associated with dose of heroin in people with Heroin Dependence as compared to allele A.			> 0.05	OR			
1451121680	rs1799971	oxycodone	Efficacy	no	Allele G is not associated with response to oxycodone as compared to allele A.							
1183689715	rs1800629	infliximab	Efficacy	no	Genotype GG is not associated with response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AA + AG.			= 0.035	OR			
1444668588	rs1800629	infliximab	Efficacy	no	Genotype GG is not associated with response to infliximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.	A		> 0.05	OR			
1444693775	rs1800629	adalimumab	Efficacy	no	Genotype GG is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.			= 0.18	OR			
1184511734	rs2244613	methylphenidate	Dosage	no	Genotype TT is not associated with dose of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes GG + GT.				OR			
1448995956	rs2233945	adalimumab	Efficacy	no	Allele A is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.	A		= 1	OR			
1448995971	rs2233945	etanercept	Efficacy	yes	Allele C is associated with decreased response to etanercept in people with Arthritis, Rheumatoid as compared to allele A.	A		= 0.023	OR	0.37	0.16	0.87
1449191808	rs397508453	ivacaftor	Efficacy	yes	Allele C is associated with response to ivacaftor in people with Cystic Fibrosis.			< 0.0001	OR			
1447680544	rs9923231	warfarin	Dosage	yes	Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.			= 5e-50	OR			
1448257083	rs9923231	warfarin	Dosage	yes	Genotype TT is associated with decreased dose of warfarin as compared to genotypes CC + CT.			< 0.001	OR			
1450812380	rs2239128	nimodipine	Efficacy	yes	Genotype CC is associated with increased response to nimodipine in healthy individuals as compared to genotype CT.	T		= 0.038				
1448260874	rs4149056	atazanavir	Dosage	yes	Genotype TT is associated with dose of atazanavir in people with HIV Infections.			= 0.001	OR			
1448624730	rs4149056	simvastatin	Efficacy	no	Allele C is not associated with response to simvastatin as compared to allele T.			= 0.310				
1184228585	rs2070950	enalapril	Efficacy	no	Genotype CC is not associated with increased response to enalapril in people with Hypertension as compared to genotypes CG + GG.	C		= 0.065	OR			
1184747642	rs2231142	sulfasalazine	Other	no	Allele T is not associated with discontinuation of sulfasalazine in people with Arthritis, Rheumatoid as compared to allele G.	T		= 0.69	HR	1.15	0.58	2.26
1184512419	rs7856096	warfarin	Dosage	yes	Allele G is associated with decreased dose of warfarin as compared to allele A.	G		=  1.82E-8	OR			
1184512419	rs7856096	warfarin	Dosage	yes	Allele G is associated with decreased dose of warfarin as compared to allele A.	G		= 0.046	OR			
1184513720	rs529520	buprenorphine	Efficacy	yes	Genotype AA is associated with decreased response to buprenorphine in women with Opioid-Related Disorders as compared to genotype CC.			= 0.006	RR	2.15	1.3	2.29
1184513720	rs529520	buprenorphine	Efficacy	yes	Genotype AA is associated with decreased response to buprenorphine in women with Opioid-Related Disorders as compared to genotype CC.			= 0.025	RR	1.65	1.5	2.06
1184513720	rs529520	buprenorphine	Efficacy	yes	Genotype AA is associated with decreased response to buprenorphine in women with Opioid-Related Disorders as compared to genotype CC.			> 0.05	OR			
1184513720	rs529520	buprenorphine	Efficacy	yes	Genotype AA is associated with decreased response to buprenorphine in women with Opioid-Related Disorders as compared to genotype CC.			= 0.05	RR	1.8	1.04	2.02
1448108623	rs1801133	methotrexate	Efficacy	no	Genotype AA is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.			= 0.002	OR			
1296599938	rs1801133	methotrexate	Toxicity	yes	Genotype AA is associated with decreased response to methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AG + GG.			= 0.004	RR	1.64	1.17	2.3
1296599938	rs1801133	methotrexate	Toxicity	yes	Genotype AA is associated with decreased response to methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AG + GG.			= 0.005	RR	1.6	1.15	2.22
1296599938	rs1801133	methotrexate	Toxicity	yes	Genotype AA is associated with decreased response to methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AG + GG.			= 0.35	RR	2.26	0.4	12.68
1449147078	rs1801133	fluorouracil	Efficacy	yes	Genotypes AA + AG is associated with increased response to fluorouracil in people with Colorectal Neoplasms as compared to genotype GG.	A		= 0.006	OR	3.8	1.45	9.92
1183699320	rs1057910	warfarin	Dosage	yes	Allele C is associated with decreased dose of warfarin in people with total knee or hip arthroplasty as compared to allele A.	C		< 0.001	OR			
1448107499	rs3745274	efavirenz	Dosage	not stated	Genotype GG is associated with increased dose of efavirenz in people with HIV Infections as compared to genotypes GT + TT.				OR			
